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ABSTRACT 
The differing susceptibility of individuals to the toxic effects of 
chronic lead exposure has never been fully understood. As the major 
intake of lead in the human is from food and beverages, any variation 
between individuals of the quantity of lead absorbed from the gut, and 
of the distribution and excretion of this lead, may account for the 
differences in individual susceptibility. The food and beverages 
themselves may have an influence, and to investigate their effects on 
absorption, distribution and excretion of lead, experiments were 
performed on normal subjects using a short lived radionuclide of lead, 
203Pb, and instruments generally available in Nuclear Medicine. 
-
Lead absorption be'tween different individuals showed a wide variation--
when 203 Pb was taken as a single dose between meals. The effect of 
fasting was to increase absorption and reduce the variation. This 
suggested that food with the lead in the gut was mainly responsible for 
the variation in lead absorption between individuals. This was 
confirmed when 2 03 Pb was mixed into a control meal and eaten by fasted 
subjects. Lead absorption was again low and variable. In contrast, 
203 Pb taken in distilled water was avidly absorbed with little variation 
between subjects. The absorption of lead in water could be appreciably 
more than lead in food amongst the general population. 
Minerals were found to be mainly responsible for affecting absorption 
when one subject ingested 203 Pb in control meals from which one dietary 
constituent at a time was omitted. The effect of minerals in reducing 
absorption of lead was greatest when they were ingested in distilled 
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water. Lead in water with a low mineral content, such as 'soft' water, 
could be a hazard to population groups living in 'soft' water areas. 
There were also indications from these experiments that dietary 
constituents may affect the distribution and excretion of lead. 
Calcium and phosphorous were found to reduce the absorption of 
203 Pb 
to approximately the same level as that produced by the total minerals. 
Calcium reduced absorption more than phosphorous when these minerals 
were ingested separately with 203 Pb. Paired kinetic experiments 
showed that calcium and phosphorous ingested at the same time as 2
63 Pb 
affected its distribution in the body but not its rate of excretion. 
Using the data from the kinetic experiments, a compartmental model was 
developed which adequately described the kinetics of orally ingested 
203 Pb. 
The model suggested that calcium is mainly responsible for reducing 
absorption of lead from the gut, but that the effect of phosphorous is to 
to increase soft tissue levels of lead at the expense of red cell lead. 
As susceptibility is related to soft tissue levels of lead, this 9uggests 
that the 'protective' effect of calcium in the gut is reduced. This 
could not be confirmed, however, as the kinetic data were insufficient 
for the model to distinguish the tissues particularly vulnerable to lead 
toxicity in tbe soft tissue compartment. 
It was concluded that the calcium and phosphorous in the diet could 
influence susceptibility to lead toxicity through changes in the 
absorption of food and water lead and in the distribution of lead in the 
body. The results suggest that the prophylactic effect of calcium on 
lead absorption should be recognised and applied in this time of 
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PREFACE 
The purpose of this thesis was to investigate the gastrointestinal 
absorption of lead in the human, and the subsequent distribution and 
excretion of this lead. Studies on man's exposure to lead in air, 
therefore, have only been considered when there has been a direct 
relationship between air lead and gastrointestinal absorption. 
The studies described in this thesis were done over a period of five 
years. In that time, very little work has been performed on the 
behaviour of ingested lead in the human which may be compared with the 
results in this thesis. Inevitably, many inferences have been drawn 
from animal studies, but, whenever possible, these were checked by 
further experiments on humans. However, some of the conclusions may 
not be entirely valid, as there may be differences between species. 
A major portion of the work presented is concerned with modelling, 
and it is emphasised that a model is a conceptual representation based 
on observations and experiments, the elements of which may correspond 
to elements in a given real situation. It should be able to accomodate 
known data and to accept known facts as they are discovered, but no 
model is unique or exclusive, it is simply a tool which is used to 
obtain a better understanding of the biological system which is being 
studied. Nevertheless, it is possible using a- model to 
a ) verify or reject a hypothesis 
b) suggest new experiments 
c ) provide insight into unknown mechanisms, and 
d ) provide a framework from which better models can be developed. 
xxii 
The layout of the thesis has been planned to keep most of the details 
about methods, results, figures and computer programs away from the 
main text. Only figures and tables particularly relevant to 
discussion sections have been kept in the main section of the thesis. 
l 
S E C T I O N 1 
INTRODUCTION 
Lead has been mined and worked by man since early antiquity. It was 
a very useful metal for ancient man, because of the widespread 
geographical distribution of lead bear111g ore and the ease with which 
it could be extracted from this ore. Lead objects have been found 
dating from 3000 BC, but lead was not extensively used until 
Classical Greek times. The Greeks discovered that small amounts of 
silver could be parted from lead metal, after the metal had been 
smelted from lead ores. With the advent of silver coinage in 650 BC, 
silver became very important, and so the production of lead rose 
sharply. Huge piles of lead began to accumulate, and these were 
found a multitude of uses by the Greeks. Lead was used in warfare as 
sling bolts and arrow heads, in the transport and storage of drinking 
water, and in the cooking and storage of food and drink. 
From Greek times until the present, the use of lead has become more 
widespread and diverse. It is an essential metal in present day 
industry because of its unique properties of ductility, high resistance 
to corrosion, and low melting point. Lead is the basic ingredient of 
solder, provides a protective sheath around intercontinental 
communication cables, protects against dangerous x-rays and atomic 
radiation, soundproofs buildings, ships and aircraft, produces 
efficient combustion of petrol and is the major component in batteries. 
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Although lead is a most useful metal, it is poisonous to man if 
ingested or inhaled in large quantities. Lead poisoning or 'plumbism' 
was first described by Nicander in the second century BC. It .was 
always thought to be a disease of lead workers, as both the 
swallowing of lead compounds and the inhaling of fumes in smelting 
operations were recognised as dangerous. The danger of the domestic 
use of lead, however, appeared to have been overlooked. In the first 
century AD, Vitruius condemned its use for supplying drinking water, 
but his warning was ignored. The inappropriate use of lead in cooking 
and in the storage of food and drink in Greek and Roman times, 
therefore, caused many outbreaks of lead poisoning. It was not until 
1498 that authorities began to restrict the culinary use of lead. The 
widespread and disastrous results of sweetening wine with lead 
compelled the authorities in Germany to evoke the death penalty for 
this particular practice. 
The authorities in Great Britain introduced legislation to protect 
workers in the lead industry from lead poisoning in 1883. This was 
done because, from the Industrial Revolution onwards, the lead industry 
had expanded rapidly and had caused the incidence of lead poisoning 
to rise. Similar regulations were introduced in the pottery industry 
in 1894. Under the Factories Act of 1895, lead poisoning became a 
notifiable disease, so from this time onwards its incidence was to 
become widely known. Much has been achieved, therefore, in the 
disposal of, and protection from, lead dust and fume, the main hazards 
in the lead industry. The routine screening of all statutory workers 
for signs of developing lead toxicity is now required by law (Ministry 
of Labour, 1965). 
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The lead industry and the consumption and use of its products, 
however, has polluted the environment with lead, and further 
legislation had to be introduced to protect the general population 
from excessive exposure to lead. The World Health Organisation (WHO ) 
has recommended a provisional tolerable weekly intake of 3 mg of lead 
per adult, which includes lead from all sources (WHO, 1972). Sources 
of lead which have caused isolated outbreaks of lead poisoning over the 
years are also controlled in some countries. The United States 
Potter's Association and the United States Food and Drug Administration 
have defined 7 µg/g as the maximum lead release of glazes recommended 
for use on ceramic items intended for food and drink (Ceramic Industry, 
1970). The legal limit for lead in household paints has been set by 
the United States Congress at 0.5% (National Paint and Coatings 
Association, 1975). 
The determination of environmental lead levels which are 'safe' for 
the general population is a complex task. The absorption of lead from 
the environment is not solely dependent on the amount of lead -
presented to the portals of entry. It also depends on the physical 
and chemical state of the lead, and it is influenced by age and 
physiological status of the host. The amount of food eaten, the 
amount of air breathed, together with the fraction of food and air 
lead absorbed into the body, will all be important influences. Manual 
workers breathe more air and eat more food than sedentary individuals 
of the same weight, and children eat almost as much food and breathe 
almost as much air as middle aged adults. There is also uncertainty 
about the degree to which individuals vary in their susceptibility, 




The fractions of lead absorbed in the respiratory and intestinal 
tracts have to be found, so that 'safe' environmental levels of lead 
can be established. Extensive experimental work has been performed 
to estimate these fractions. Most recent work has shown that the 
fraction of lead inhaled that is deposited in the lung can be as high 
as 50% (Chamberlain et al, 1978). In contrast, the accepted level of 
10% absorption for lead in food and water is still based on the long 
term balance studies conducted by Kehoe (1961 ) . The WHO tnvironmental 
Health Criteria 3 (1977 ), however, points out that this figure neglects 
endogenous faecal excretion. Chamberlain et al (1978 ) have shown 
that if it is taken into account, absorption from the gut is 15%. 
Percentage absorption may be even higher if lead is ingested in water 
independently of food (WHO, 1977), and the WHO (1972) recognised 
that dietary constituents such as calcium, phytic acid and protein may 
affect the absorption of ingested lead. However, no detailed work has 
been done to determine the degree by which absorption may be changed 
by dietary constituents. 
Environmental pollution 
The pollution of the environment by lead is caused by both the 
production and uses of lead. In the production of lead, the smelting 
of lead ore gives rise to lead emissions which may cover a considerable 
area. The zone of air pollution extended 5 km away fBom a smelter and 
soil contamination extended a further 5 km (Landrigan et al, 1975). 
It is the use of lead, however, which mainly contributes to air 
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pollution, and the combustion of alkyl lead additives in motor fuels 
accounts for the major part of all inorganic lead emissions. 
Although the storage battery industry consumed most of the lead 
produced in the U.S.A. in 1970 (Mineral Year Book, 1970 ) , it only 
contributed 3% of lead emissions into the air. The p~oduction of 
anti-knock additives contributed 11% of all emissions (Davis, 1973 ) , 
even though the quantity of lead used was a third of that consumed by 
the battery industry. An examination of the annual snow strata in 
North Greenland has revealed that levels of airborne lead have 
increased markedly since the Industrial Revolution and very sharply 
since about 1940. This has been attributed mainly to combustion of 
lead alkyls in petrol (Bryce-Smith, 1971 ) . 
Other sources of pollution can arise from the vast number of lead 
containing items that are subjected to weathering or decomposition. 
It has been found that 50% of the paint was removed from surfaces 
protected by lead pigments in about seven years (Patterson, 1965 ) . 
This will cause heavy contamination of the eust and soil around houses 
painted with lead paints (Ter Haar and Aronow, 1974 ) . 
Although it is probable that human exposure to lead in water pipes, 
food containers, insecticides, and other sources has decreased during 
the past 50 years (Schroeder and Balassa, 1961 ) , it i s l i kely that 
this has been more than compensated for by the additional exposure 
t o airborne lead both directly and indirectly through food and water. 
1. 2 
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Lead levels in air, food and water 
The emissions of lead from centres of human activity are diluted 
during transport away from these centres, but there is evidence that 
long-term global accumulation of l ead has occurred. The levels of 
lead in the air have been assumed to be related to the concentration 
of lead in glacial ice and snow deposits, and a number of studies 
have shown that these concentrations have risen steadily since 800 BC. 
Ice layers examined in 1968 had a concentration 400 times greater than 
natural background (Murozumi et al, 1969 ) . 
The levels of lead in the air will be higher in urban areas than in 
rural areas, and urban levels will be i nfluenced by traffic density 
and the presence of lead producing and consuming industries. Average 
concentrations of 1.1 µg / m3 have been reported f or urban areas, and 
these have fallen to 0.02 µg/m 3 in remote rural areas (McMullen et al, 
1970 ) . Near heavy traffic, however, the average concentration may be 
as high as 6 µg/ m3 (U.S. Department of Health, Education and Welfare, 
1965 ) . The air in the vicinity of a lead smelter may be appreciably 
polluted and may affect the general population, and this has been 
shown near a large smelter in the U.S.A. The annual mean 
concentration was approximately 80 µg/ m3 in the immediate vicinity of 
the smelter and it fell off rapidly to 1 µg/m 3 at 5 km away (Landrigan 
et al, 1973 ) . 
The fall-out of airborne lead will add t o the lead present in food and 
water. I f the pollution of the atmosphere by lead is world wide as 
suggested by the increase in the lead content of arctic snow (Murozumi 
et al, 1969 ) , an increase in lead ,·content of plants and lower forms of 
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animal life might be expected to be a natural sequel to increased 
lead in soil and water. Surprisingly, there has been no absolute 
confirmation of this trend. In Denmark, it has been reported that 
there was an overall decline in the lead content of cereals between 
1962 and 1976 (Solgaard et al, 1978). Petrol consumption increased 
twofold during this period, and tet in only one area north of 
Copenhagen, where the traffic was heavy, was the lead content of 
cereals much above average. The decrease in lead was thought to be 
caused by a different technique in the manufacture of the fertilizer 
used on the crops. 
Crops grown near a busy highway will probably have a high foliar 
deposition of lead from vehicle exhausts, whereas crops grown away 
from the highways will take up lead deposited in the soil by 
sedimentation and precipitation of exhaust lead. Only small quantities 
of lead are transferred from soil across the root membrane, as there 
is poor translocation of lead in plants (Ter Haar, 1975). An increase 
in soil levels, therefore should not have a dramatic effect on the lead 
content of crops, but an increase in foliar deposition of lead could 
be a potential hazard to man. 
Grasses are efficient in capturing particulate lead from vehicle 
exhausts (Little and Wiffen, 1977), so it would be expected that cattle 
and sheep eating this grass would become contaminated. Fortunately, 
cattle 'filter' most of the lead from their diet giving low levels in 
milk (Potter et al, 1971), and, except in liver and kidney, low levels 
have been found in the meat from cows and sheep. The highest 
concentration of 203 Pb in the soft tissue of a calf fed 
203 Pb in its 
diet was in the liver and kidneys. 
(Potter et al, 1971). Ward et al (1978) found concentrations of 
lead up to 20 µg/g in the livers of sheep grazing near roadsides, 
whereas the typical lead content of beef is usually from 0.003 µg to 
0.63 µg / g (De Treville, 1964). 
It is difficult to decide whether airborne lead contributes 
significantly to lead present in food, because the concentration of 
lead in food is highly variable. There appears to be the same 
variation within specific items of food as between different 
categories of foods. Schroeder and Balassa (1961 ) found that the range 
was 0-1.5 mg/kg for condiments, 0.2-2.5 mg/kg for seafood, 0-0.37 mg/kg 
for meat and eggs, 0-1.39 mg/kg for grains, and 0-1.3 mg/kg for 
vegetables. Nevertheless, most studies show lead intake from dietary 
sources to be 200-300 µg/day (WHO, 1977 ) . With such a large range, 
however, any significant contribution from airborne lead would have 
to be very large, such as that found by Kerin ( 1972) of between 
670-2640 µg/day in areas exposed to smelter emissions. 
There has been some concern expressed about the contamination of 
reservoirs by atmospheric lead, particularly in winter when decreased 
utilization of water may result in a doubling of lead content 
(Johnson et al, 1966 ) . Most of the incidents of poisoning caused by 
lead contaminated water, however, have been from the domestic use of 
lead (Bacon et al, 1967; Beattie et al, 1972 ) . The danger of poisoning 
from domestic l ead pipes and lead storage tanks is enhanced by the 
degree of plumbosolvency of the water. In a study of overnight water 
in inhabited houses in 17 country boroughs of England and Wales, 
Crawford and Morris (1967 ) found that 31 out of 95 samples contained 
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more than 100 µg of lead per litre. The highest concentrations were 
found in soft waters, although some hard waters also contained 
excessive amounts. Acidity also appears to influence plumbosolvency 
although the relation is not a consistent one. The average intake of 
lead from drinking water is probably about 20 µg/day (Goyer and Rhyne, 
1973) and the lead content of most municipal water supplies measured 
at the tap is below the WHO (1971) recommended limit of 100 µg/£. 
In certain circumstances, therefore, groups of people may consume food 
containing h!gher than average levels of lead, but the general 
population will only be exposed to a small increase of food and water 
lead attributable to the increase in airborne lead. The magnitude 
of this increase is difficult to determine, and, consequently, any 
potential hazard to the general population cannot be estimated. 
1.3 
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Subclinical lead toxicity 
The concern about the effect of increased levels of environmental 
lead on the population has been the result of an awareness that levels 
of lead in the body, not sufficient to cause the symptoms of classical 
lead poisoning, could cause insidious subclinical lead toxicity 
(Chisolm, 1974). More sensitive biochemical techniques, such as the 
measurements of 6-aminolevalinic acid and red cell protoporphyrin, 
have identified children with metabolic evidence of mental disorders 
but with none of the classical clinical signs of acute lead toxicity 
(Needleman et al, 1979). 
The relationship between lead and mental development of children has 
been investigated by many workers, but with controversial results. 
Moncrieff et al (1964) showed that concentrations of lead 
in blood were frequently raised in mentally subnormal children. 
Bicknell et al (1968), however, found no evidence that moderately 
raised blood lead concentrations had any relation to the original 
cause of the mental retardation. These raised blood leads were found 
in subnormal children suffering from pica. Pica is more common in the 
disturbed retarded cbild, and if lead is present in his surroundings 
he will ingest an excessive amount (Clayton, 1975 ) . Lansdown et al 
(1974 ) measured the blood lead concentration of children under 17 years 
living near a lead smelter, and found a relation eetween blood lead 
and distance from the smelter but no relation with the rate of 
behaviour disorders. 
The relationship between lead and mental development is complicated · 
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by the multifactorial aetiology of the latter, and it is only 
recently that stronger evidence has been found to support the 
relationship. Beattie et al (1975 ) measured the concentration of 
water in lead in the homes occupied, during the first year of life, 
by 77 mentally retarded children aged two to six years and 77 non-
retarded matched controls andin the homes occupied by their mothers 
during pregnancy . The water lead content was significantly higher in 
the retarded group, and the probability of mental retardation was 
significantly increased when water lead exceeded 800 µg per litre. 
They concluded that lead contamination of water may be one factor in 
the multifactorial aetiology of mental retardation. 
Another study was performed by the same group (Moore et al, 1977), in 
which they measured blood lead concentration retrospectively in blood 
contained on cards. This blood had been used to test for 
phenylketonuria in the first two weeks of life. 24 mental retardation/ 
control pairs were compared, and there was a highly significant trend 
towards higher blood concentration in the mentally retarded children. 
The authors stressed that the blood lead concentrations in both groups 
of children were low, and in what would be regarded as t he normal 
range. There was a highly significant regression of blood- l ead on 
domestic water lead concentrations from the maternal home during 
pregnancy. This was similar to that found in adults (Moore~ 
1977 ) . The association of mental retardation with water lead 
concentrations, therefore, reflects principally intrauterine exposure 
with some postnatal exposure to lead. 
Recently, Needleman et al (1979 ) compared the intellectual 
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performance of 58 children with high dentine lead levels and 100 
children with low dentine lead levels. Tests such as the Wechsler 
Intelligence Scale for children, verbal subtests, auditory or speech 
processing, and non-adaptive classroom behaviour showed that 
children with high lead levels scored less well or were poorly 
behaved. 
Lead exposure at levels which do not produce clinical symptoms of 
lead toxicity appears to be associated with neuropsychologic 
deficits in children. This has caused a revision of the lead levels 
assumed to be safe for children. The Centre of Disease Control (1978) 
has now defined a blood lead level of 30 µg/100 gas the threshold for 
undue lead absorption. The recognition of subclinical lead toxicity, 
especially in children, has caused a reappraisal of the environmental 
effects of lead released by the combustion of petrol. Some countries 
have either completely prohibited or considerably reduced the amount 
of lead added to petrol, and have reported substantial reductions 
in airborne lead levels (Waldronand Stofen, 1974 ) . 
1.4 
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Differing susceptibilities to the toxic effects of lead 
Susceptibility to lead toxicity is well known (WHO, 1972; WHO, 1977 ) , 
but , with the recognition of subclinical toxicity, susceptible people 
exposed to the present environmental levels of lead may be more at 
risk. Although individual differences in susceptibility are known to 
occur, the degree by which these differences vary is unknown (WHO, 
1977 ) . Any assessment of these differences will be very dependent on 
determining the dose of lead t hat an individual receives. 
Susceptibility itself may be inherent and may be influenced by co-
existent variables such as, age, sex and nutritional status, adding 
further complications to any assessment. 
Early reports suggested that there were inborne differences in 
susceptibility and Oliver ( 1916), Legge and Goadby (1912) reported 
well Bstablished cases of family susceptibility. There appears to be 
inherent differences between the sensitivity of the nervous system of 
young children and that of adults, but it is also possible that these 
differences could be caused by the intensity of exposure (WHO, 1977 ) . 
More direct evidence has been obtained of the influence of co-exjstent 
variables on susceptibility, such as nutritional status, from animal 
experiments. The absorption of lead from the gastrointestinal tract 
of animals has been shown to be influenced by diet which could alter 
susceptibility to the toxic effects of lead (Goyer and Mahaffey, 1972 ) . 
Although animal studies have been helpful in the study of the 
biological effects of lead on man, they cannot be used to elucidate 
the exact dose-effect relationships in man as this is likely to be 
species specific (WHO, 1977). 
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There have been a number of reports in which individuals, with 
apparent similar levels of lead in their blood, have varied in their 
tendency to exhibit symptoms of poisoning. Beattie et al ( 1972 ) 
described lead poisoning in four families in rural Scotland. The 
source of lead was traced to the domestic water supply which in all 
cases was grossly contaminated from the lead plumbing systems. Two of 
the families used a common supply from a nearby stream. The three 
members of the first family had blood leads of 46.0 µg/100 g, with no 
symptoms, and 59.0 µg/100 g and 75.l µg/100 g with symptoms of lead 
poisoning. The second family had blood lead levels of 46.4 µg/100 g, 
67.5 µg/100 g and 69.3 µg/100 g with no symptoms of lead poisoning. 
In normal children, the upper limit of blood lead has usually been fixed 
at 60 µg/100 g (Chisolm and Harrison, 1956 ) . Bradley et al (1956 a ) 
however, found that eight children with blood lead levels between 50 and 
80 µg/100 g and who were initially asymptomatic, were later admitted to 
hospital with lead encephalopathy and a mean blood-lead level of 43 µg/ 
100 g. 
There is, however, some doubt as to the validity of using blood lead 
levels as an indication of lead toxicity. Gibson et al (1968) 
examined three groups of men with presymptomatic state of lead 
exposure, mild symptoms or mild anaemia, and frank lead poisoning. 
Although the mean blood-lead levels of the three groups, 51.72, 73.69 
and 83.94 µg/100 g were significantly higher than for normal men, 
40 µg/100 g, there was considerable over.lap of the three groups. They 
felt that the urinary excretion of coproporphyrin and o-aminolevalinic 
acid were better indicators of 'metabolically active' and presumably 
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toxic lead in the body. They found no correlation between the 
urinary 
excretion of these substances and blood lead levels. 
Apart from the validity of using blood lead levels as an indica
tion 
of toxicity, there is also considerable analytical variability 
in the 
measurement of blood lead. Keppler et al (1970) reported on a
 study 
conducted by 66 laboratories, which analysed the same blood sam
ple and 
obtained results varying from Oto 29,000 µg/100 g. Berlin e
t al 
(1972 ) reported the results from 22 laboratories in which they f
ound 
the lead analysis of blood ranged from 28% of the mean value to
 over 
twice the mean value. 
The WHO (1977) has stressed, therefore, that blood lead should
 not 
be used as indication of even dose or exposure when dealing wi
th 
individual subjects. It should only be used to assess the expo
sure of 
population groups in which biological effects may occur in a ce
rtain 
proportion of individuals. 
1. 5 
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Possible causes of different susceptibilities 
Susceptibility to lead toxicity is known to be influenced by a number 
of physiological and environmental factors. These are 
(a) Age and sex 
(b) Nutrition 
(c ) Seasonal variations 
(d ) Intercurrent disease, alcohol and other metals (WHO, 1977 ) . 
They may influence both the dose of lead received by an individual 
and the response of the individual to that dose. 
The toxicological effect of a dose has been defined as the amount or 
concentration of a given chemical at the site of effect (Nordberg 
1976 ), butit is often impossible to measure the dose defined in this 
way. Estimates would have to be made of the quantity of lead entering 
the body from air, food, water and various other contacts, including 
drugs and consumer products. In children, sources of lead such as in 
soil, settled dust and paint chips would also have to be considered. 
The quantity of lead entering the body is likely to be variable. The 
amount of food eaten, water drunk and air breathed may differ between 
individuals, and the levels of lead in air, food and water may vary 
considerably. Fortunately in experimental studies, it is possible to 
control the intake of lead into the body to a certain degree, and 
variation of intake is only a complication in general population 
studies. 
The intensity of the toxic effect of lead will also depend on the 
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response of the individual. It has been suggested that there may be 
variations in the degree of resistance of tissues to lead intoxication 
(David et al , 1976 ) , and _ that developing tissues may be more 
susceptible to damage (Bell, 1924 ) . These may be the possible causes 
of the apparent increased susceptibility of children and women to the 
toxic effects of lead. 
Children appear to be more susceptible to the toxic effects of lead 
than any other population gi~up. It has been found that a blood lead 
level of 80 to 100 µg/100 g, which would produce no overt symptoms in 
the adult, can cause convulsions and coma in the child (Goyer and 
Mahaffey, 1972). Blood- lead levels as low as 26 µg/100 g have been 
associated with mental disorders in children (Moore et al, 1977). The 
shift of lead into and out of growing bone of a child may also 
influence biological effects (Byers and Maloof, 1954 ) , and the greater 
incidence of lead encephalopathy may reflect inherent sensitivity of 
the nervous system of a child to lead (Goyer and Rhyne, 1973 ) . 
Children, however, are likely to be exposed to lead from a greater 
number of sources and for a longer time than adults. Lead based paints 
in old buildings (Barltrop, 1968 ) and street dust in crowded urban 
areas (Grandjean, 1975) are two common sources, and the number of hours 
spent out of doors by children increases the risk of exposure to 
ai rborne lead. 
Apart from the likelihood of increased exposure, there is evidence 
that children gastrointestinally absorb more lead than adults. 
Alexander et a] ( 1973 ) found absorption of the order of 50% i n 
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children aged from 3 months to 8.5 years, far higher than the 
accepted 10% for adults (Kehoe, 1961). Unfortunately, this work has 
been criticised because of the large scatter of values and because 
the conclusions were based on a short measurement period of 3 days 
(WHO, 1977). Increased absorption of lead in the young, however, has 
also been reported in animals. Kostial et al _ (1971) found that 
5 - 7 day old rats absorbed at least 55% of oral doses of 
203 Pb, and 
Forbes and Reina (1972) found that the absorption of tracer doses of 
212 Pb were 83% at 16 days after birth, 74% at 22 days, aod 16% at 
89 days. 
Although there is doubt about the inherent sensitivity of children to 
the toxic effects of lead (WHO, 1977), there appears to be stronger 
evidence to suggest that the tissues of women are more sensitive to 
the toxic effects of lead than those of men. _Bell (1924 ) found in 
women the minimum toxic dose of intravenously injected lead was 40 mg, 
but in men it was 100 mg. Women are more likely to develop poisoning 
between the ages of 18 and 23 years, earlier than men and after a 
shorter exposure (Oliver, 1916). The manifestations of lead poisoning 
in women are also different. There is a higher incidence of 
encephalopathy and a lower incidence of paralysis and colic (Hardy, 
1966). 
In a recent experimental study (Stuik, 1974; Stuik and Zielhuis, 1975 ), 
groaps of 5 males and 5 females aged 18 - 26 years received 20 µg/kg 
of lead acetate orally per day for a period of 21 days. The blood lead 
levels of control subjects remained approximately the same at 17.0 µg/ 
100 g, those of the exposed males rose from 20.6 µg to 40.0 µg/100 g, 
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and those of the exposed females rose from 12.7 µg to 30.4 µg/100 g. 
The protoporphyrin IX content of the erythrocytes showed no change 
in either the control or the exposed male group, but in the female 
exposed group, however, it showed a rise during the third week of the 
experiment. It was suggested that this rise was caused by 
interference with the role of iron in the formation of haemoglobin, 
and that the synergism of lead exposure and iron deficiency might be 
responsible for this. 
The dose of lead at a specific site or organ in the body will also be 
influenced by the fraction of the lead intake which is absorbed in the 
gastrointestinal and respiratory tracts, the distribution of this 
absorbed lead in the body, and its excretion. As the major fraction 
of environmental lead enters the body through the gastrointestinal 
tract, the effect of nutrition on gastrointestinal absorption, 
distribution and excretion of lead could be most important in 
affecting the susceptibility of individuals to toxic effects of lead. 
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1.5.l Gastrointestinal absorption of lead 
Lead is absorbed into the body mainly through the gastrointestinal and 
respiratory tracts, occasionally through the skin, and, rarely, from 
subcutaneous tissues. The dietary intake of lead is between 200 - 300 
µg/day (WHO, 1977), and the intake from air lead is approximately 
15 µg / day (Chamberlain et al, 1978). The percentage of ingested lead 
absorbed was shown to be 10% in the classical balance studies of 
(Kehoe, 1961 ) . This low level of absorption was generally accepted 
and increases in dietary lead were not considered hazardous. Certain 
studies have shown, however, that uptake of lead from gut is variable 
and may be of considerable importance. 
Hursh and Suomela (1968 ) were the first to challenge the accepted 
10% absorption of ingested lead (Kehoe, 1961 ) , when they found 
absorptions of 1.3, 8.1 and 16% in three subjects. Unfortunately, 
they did not measure the absorption of their tracer, 
2 12 Pb, directly 
either by whole body counting or by total collection of excreta, but 
by measuring the percentage of the dose excreted in the urine in the 
first 24 hours after ingestion. 
21 2 Pb was injected intravenously into 
the same subjects in order to define the percentage of t he dose which 
would appear in the urine, and it was assumed that the fraction of the 
systemic 21 2 Pb excreted in the ur i ne was the same whether entry was via 
the gut or by intravenous injection. 
Uptake from the gut was also shown to be variable in the experiments 
of Rabinowitz (1974 ) . Stable lead tracers as t he ni trate, sulphide 
and cystei ne were ingested by a fast i ng subject on separate 
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occasions, and absorption was affected by the chemical form of the 
lead. The greatest change occurred, however, when the different 
forms of lead were ingested with food. The uptake of 
2 06 Pb cysteine, 
for instance, was reduced from 30% to 5.8% by the presence of food in 
the gut. Unlike the experiments of Hursh and Suomela (1968 ) 
absorption was measured directly, collecting and measuring onabsorbed 
stable-lead tracer in the faeces for 10 days following ingestion. 
Further studies performed by Chamberlain et al (1978) confirmed those 
of Rabinowitz (1974). Six human subjects ingested, on separate 
occasions, 203 Pb chloride and the less soluble 
203 Pb sulphide with 
food or after fasting. The mean uptake of 203 Pb chloride was 45 ! 
7% (S.E. ) of the ingested dose in fasting subjects, and this was 
reduced by presence of food by a factor of 6.5. A lower mean uptake 
of 12 ~ 4% (S.E. ) occurred with 203 Pb sulphide, but food reduced 
uptake by only a factor of 1.8. This smaller reduction was thought to 
be caused by the extra acidity of the stomach following the ingestion 
of food, making lead sulphide more soluble and, therefore, more 
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available for absorption. The uptake of lead was found directly by 
measuring, with a whole body counter, the radioactivity of 
203 Pb 
retained in the subject's body 5 days after ingestion. 
Apart from the suggestion by Chamberlain et al (1978 ) that the 
acidity of stomach contents may affect gastrointestinal absorption of 
lead, there were no theories or detailed investigations into the 
possible causes of the effect of food on absorption, in any of the 
preceeding studies. There has been, however, extensive work performed 
with animals in which various constituents of food have been shown to 
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influence the absorption of lead. 
Barltrop and Khoo (1975) performed experiments in which 30 day old 
rats were fed, ad libitum for 48 hr, a diet containing lead chloride 
(0,75 g/kg) labelled with 203 Pb and varying amounts of fibre, vitamin, 
protein, fat and minerals. They found that the absorption of lead, 
indicated by levels of 203 Pb in blood, kidneys, femur and liver, was 
increased when protein and minerals were excluded from the diet and 
when the fat content was increased by a factor of four. Absorption 
was reduced when minerals were increased by the same factor. Low fat, 
low fibre, high fibre, low vitamin and high vitamin diets had no effect 
on lead absorption. 
As the greatest effect on absorption was caused by minerals, the 
response to the omission of major and minor compoAents was determined, 
followed by experiments in which individual minerals were omitted. 
Diets that were deficient in calcium, phosphate, magnesium, sodium, 
potassium and chloride caused a marked increase in lead absorption 
but the omission of iron, manganese, copper, zinc, iodine and 
molybdenum from the diet had no effect. The individual minerals 
mainly responsible were found to be calcium and phosphate. Their 
effect was additive, when they were omitted from a diet which 
originally contained calcium and phosphorus concentrations of 7 g/kg 
and 5 g/kg, respectively. 
Further experiments performed by Conrad and Barton (1978) enabled them 
to suggest how dietary constituents could affect the absorption of lead 
from the gut. Their experimental methods were different to that of 
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Barltrop and Khoo (1975 ) , in that they injected the lead and dietary 
constituents into the isolated duodenal loop of fasting rats. A 
single dose of l µg of lead chloride labelled with 2 03 Pb was injected 
with millimolar concentrations of methionine, cysteine, ascorbic acid, 
tyrosine, arginine and each of these compounds increased the absorption 
of 2 03 Pb. These compounds were selected because they are known to bind 
lead in vitro. It was suggested that the increased absorption of lead 
was caused by its increased solubility in the duodenum making it more 
readily available for absorption. This supports the suggestion . of 
Chamberlain et al ( 1978 ) , that the effect of acidity of the stomach 
on lead sulphide was to make it more soluble and available for 
absorption. 
Other compounds such as ferrous chloride, zinc chloride and calcium 
chloride decreased the absorption of 203 Pb, but because these 
compounds did not affect the solubility of lead in in vitro studies, 
it was suggested that their effect was caused by competition with lead 
for shared absorptive sites. 
In contrast to the findings of Barltrop and Khoo (1975 ) , phosphate 
did not reduce the absorption of 203 Pb, and the effect of iron was much 
greater than that of calcium. However, only the duodenum was included 
in the intestinal loop preparation, and Smith et al (1978) showed that 
lead was also absorbed in the distal small bowel of the rat. Phosphate 
absorption in the distal small bowel is stimulated by Vitamin D 
(Kowarski and Schachter, 1969 ) , which suggests that it is actively 
transported at this site. Therefore, phosphate will pBobably inhibit 
lead absorption to the greatest extent in the distal small bowel. The 
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amount of iron used was greater than in the experiments of Barltrop 
and Khoo ( 1975 ) . The human diet consists of calcium and iron in an 
approximate ratio of 100 to l ( ICRP, 1971 ) , so that the results of 
Barltrop and Khoo (1975 ) , who gave a calcium to iron ratio of 330 to 1, 
are probably more relevant to the human. 
The results of the studies of Barltrop and Khoo ( 1975 ) and Conrad 
and Barton ( 1978) show that, in a normal diet , calcium and possibly 
phosphorus are mainly responsible for reducing the absorption of lead. 
Their effect on absorption may be caused by their competi t ion with lead 
for shared absorptive sites in the small bowel. Tse effect of calcium 
and phosphorus on the absorption of lead has been studied by many 
workers. Shields and Mitchell (1941 ) performed long term experiments 
(70 days ) with stable lead (15 - 30 mg/kg ) , and showed that diets rich 
in calcium, phosphorus, calcium and phosphorus, reduced the amount of 
lead retained in the carcases of rats at the end of the expetimental 
period. 
Si milar long term experiments we~e performed more recently by 
Quarterman and Morrison (1975 ) . Larger doses of stable lead (200 mg/ 
kg ) were used and the rats were fed diets with calcium and phosphate 
levels lower than the normal requirements. Retention of lead in the 
carcass was several times greater than that obtained with a normal 
control diet, and the effects of both calcium and phosphate were the 
same and approximately additive. 
Further experiments by thi~ same group of workers (Quarterman et al, 
1978a )showed t hat feedin g rats diets containi ng levels of calcium and 
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phosphate above normal requirements reduced retention of lead. An 
increase in dietary content of both calcium and phosphate together, 
however, had an effect no greater than an increase of either one 
alone. It was sug~ested that the levels of calcium (19 g/ kg ) and 
phosphate (18 g/kg) used weDe each inhibiting the system which they 
influenced to the maximum possible extent. 
In these long term absorption experiments, the effect of calcium and 
phosphorous on the absorption of lead from the gut may also be 
influenced by the nutritional status of the animal. Recent 
experiments have compared the effects of calcium supplemented diets 
to those of calcium and lead given simultaneously, on the absorption 
of lead measured by single tracer doses. 
Meredith et al (1977) found that diets supplemented with calcium, 
to raise the content from 7 g/kg to 14 g/kg, significantly reduced 
the 10 day whole body retention of a single dose of 0.01 µg of lead 
labelled with 203 Pb given by stomach tube. The rats had been fed the 
supplemented diet for 21 days, and they had not been fasted before the 
lead was administered. In a second experiment, they found that giving 
50 mg of calcium at approximately the same time as 1 mg of lead to 
fastino rats, also reduced the 5 day whole body retention of 
203 Pb. 
The results of these experiments suggest that diet, and, hence, the 
nutritional status of the animal has some effect on the absorption of 
lead. This was not confirmed, however, by the studies of Barton 
et al (1978 ) . 
In their studies, Barton et al (197~ ) used fasting rats in both 
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sets of experiments. Three groups of rats were fed diets 
containing 2.39 g/kg, 4.6 g/kg and 13.8 g/kg calcium for 14 days, and a 
single dose of 1 µg of lead labelled with 
203 Pb was injected into 
the isolated duodenal segment of each rat. The~e was no significant 
difference between the 4 hr whole body retention of these rats 
indicating no effect of diet. The 4 hour retention was significantly 
reduced, however, when 0.04 mg of calcium was injected simultaneously 
with 0.21 mg of labelled lead. The authors concluded that diet-
induced calcium deficiency had little influence on lead absorption 
in the gastrointestinal tract, and any changes in absorption were 
caused by the levels of dietary calcium in the gut. 
Unfortunately, no tracer experiments appear to have been performed in 
which the effect of dietary phosphorous deficiency on the absorption 
of lead has been compared to that of phosphorous given simultaneously 
with a single dose of tracer lead. Such a comparison, however, may 
be infered from the experiments of Quarterman et al (1978 a ) and 
Meredith et al (1977). 
In the experiments of Quarterman et al (1978a),phosphorous reduced the 
retention of stable lead in rats by the same amount as calcium when 
rats were fed diets containing above normal requirements of both 
minerals. These experiments were comparable to those of Meredith et 
al (1977) in that the experimental period of 21 days and the 
concentration of calcium given in the normal and supplemented diets 
were approximately the same. The methods of administering the lead 
and estimating lead absorption, however, were different. Quarterman 
et al (1978~)fed the rats stable lead (0.4 g/kg ) as part of their 
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diet and measured retained lead in the carcass at 21 days, whereas 
Meredith et al (1977) measur~d the 10 day retention of a single dose 
of 203 Pb given to non fasting rats at 21 days. 
Even with these differences, Quarterman et al (1978a) and Meredith et 
al (1977) found the calcium reduced the retention of lead by factors 
of 2.3 and 2.8, respectively. In this section, these results of 
Meredith et al (1977) have been shown to be probably caused by the 
interactions of lead and calcium in the gastrointestinal tract of the 
rat and not by systemic calcium. The similar effect of phosphorous 
with that of calcium on the retention of carcass lead in the 
experiments of Quarterman et al (1978a ), and the clo~e agreement of 
the results of these stable lead experiments with those of the tracer 
lead experiments of Meredith et al (1977) suggests that the absence 
of a nutritional effect of calcium on the absorption of lead from the 
gut may also apply with phosphorous. 
The results of the animal studies described in this section show 
that the effect of calcium, and probably phosphorous, on the 
gastrointestinal absorption of ead appears to be caused by 
interactions of these elements in the gut and not by the nutritional 
status of the animal. These interactions may be conveniently studied, 
therefore, by short term experiments in which tracer lead, calcium 
and phosphorous are ingested simultaneously into the gastrointestinal 
tract. The successful use of this type of experiment in animal 
studies suggests that simil1ar experiments may be conveniently 
performed with human subjects. 
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1.5.2 Distribution of lead in the body 
In animals the normal dietary levels of calcium and phosphorous 
affected the fraction of ingested lead absorbed, which will influence 
the lead content of body tissues. Calcium and phosphorous may also 
affect the pattern of distribution of absorbed lead between these 
tissues. A change in distribution causing more soft tissue lead at 
the expense of bone lead may increase susceptibility to the toxic 
effects of lead (Goyer and Rhyne, 1973 ) , over and above any changes 
in susceptibility caused by differences in the absorption of lead in 
the gut. The normal distribution of lead in man has been studied by 
Rabinowitz (1974) using stable lead tracers, but no studies appear 
to have been done to investigate the effect of dietary constituents 
on distribution. There have been a number of animal studies 
performed, however, whose results have shown changes in the 
distribution of lead attributed to dietary constituents. 
In the experiments of Barltrop and Khoo (1975), already described in 
section 1.5.1, low protein, high fat and low mineral diets increased 
and high mineral diet decreased the blood lead concentration. The lead 
concentration of the liver showed a similar relationship, but the 
degree of change was much less. In the kidneys and femurs, however, 
a high protein diet caused an increased lead content compared to that 
in the blood. The greatest changes in lead concentration of the tissues 
occurred between those of rats fed low and high mineral diets. The 
effects of different dietary minerals were examined, and it was found 
that calcium and phosphate were mainly responsible for these changes. 
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The effect of calcium and phosphorous on the distribution of lead in 
animals has been investigated by several groups of workers. Shields 
and Mitchell (1941) performed long term experiments lasting 70 days 
in which rats ingested stable lead (15-30 mg/kg) as part of their 
diet. Lead was measured in bone and in the remainder of the carcass 
which the authors considered soft tissues. They found that decreasing 
the calcium and phosphorous content of a diet from 6.5 g/kg and 
6.1 g/kg (normal requirements) to 1.0 g/kg and 3.7 g/kg, decreased the 
lead content of the soft tissues from 15.11% to 11.62% of the total 
body lead. 
Quarterman and Morrison (1975) performed similar long-term rat 
experiments. The lead content of the diet, however, was higher at 
approximately 200 mg/kg, and they made a more comprehensive study of 
distribution by measuring the lead content of red cells, kidneys, liver 
and the remainder of the carcass which included bone. They reduced 
the calcium and phosphorous content of a diet satisfying normal 
requirements by approximately a third, and found a change in 
distribution such that the lead content of the kidneys increased by 
6 times, the liver by 5 times, the red cells by 2.5 times, and the 
carcass by 7 times. The lead retained in the total body, compared to 
lead ingested, also increased 7 times, so that only red cells failed 
to follow the increasing lead content of other tissues and bone. 
Unfortunately, it is impossible to directly compare the results of 
the two experiments because the distribution of lead has been 
considered differently. If i t assumed, however, that the major 
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portion of carcass lead is in the bone, as found by Shields and
 
Mitchell (1941 ) , then the results of Quarterman and Morrison (1
975 ) 
show that decreasing the calcium and phosphorous content of die
t 
increases bone lead in relation to kidney, liver and blood lead
. This 
agrees with the findings of Shields and Mitchell (1941) since k
idney, 
liver and blood were included in their definition of soft tissu
es. 
Quarterman et al (1978a ) repeated their experiments with diets 
containing above normal requirements of calcium and phosphorous
. An 
increase in these minerals by an approximate factor of 2 caused
 a 
decrease in the lead content of the red cells by a factor of 3.
0, but 
the lead content of the carcass was only decreased by a factor 
of 1.8. 
Diets containing more than normal requirements of calcium and 
phosphorous change the distribution of lead differently to thos
e 
containing less than normal requirements. A difference in the 
effects 
of such diets on gastrointestinal absorption of lead was also n
oted in 
section 1.5.1. 
No animal experiments appear to have been performed showing the
 effect 
of the calcium and phosphorous content of a diet on the distribu
tion 
in the body of a single oral dose of tracer lead. A similar 
experiment was performed by Meredith et al (1977 ) , except they 
investigated the effect of systemic and not dietary calcium. T
hey 
found no change in liver, kidney and femur radioactivities, mea
sured 
7 days after an oral dose of 
2 0 3 Pb, of rats injected intraperitoneally 
each day for 10 days with 50 µg of calcium gluconate, compared 
with the 
radioactivities in the same organs of rats injected intraperiton
eally 
wi th 0.9% NaCl . This suggests no effect of systemic calcium. 
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However, the rats consumed approximately 130 g of food a day with a 
calcium concentration of 7 g/kg. Therefore, their daily input of 
calcium was 0.91 g, so that a daily increment of 50 µg is unlikely to 
have caused any appreciable change in calcium levels of the body, and, 
consequently, any change in the distribution of 
203 Pb. 
From the results of animal studies, therefore, changes in dietary 
calcium and phosphorous appear to alter the distribution of stable lead 
in the body. The effect of such dietary changes on the distribution of 
a single dose of tracer lead is uncertain, and no experiments have 
investigated the effect on distribution of tracer lead of calcium and 
phosphorous ingested simultaneously with the tracer lead. 
1.5.3 Excretion of lead 
Changes in the calcium and phosphorous content of animal diets have 
been shown to have an effect on the gastrointestinal absorption of 
lead, and on the pattern of distribution of absorbed lead in animals. 
The quantity of lead retained in the body, which will influence 
susceptibility, will also depend on the rate of excretion of lead. 
An effect of calcium, and both calcium and phosphorous on excretion 
has been described in animal st~dies. 
The experimental details of the studies performed by Quarterman and 
Morrison (1975), Quarterman et al (1978a), . and Barton et al (1978 ) 
have already been described in sections 1.5.l and 1.5.2. Only the 
relevant details of these experiments concerned with the excretion of 
lead will be considered in this section. 
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Quarterman and Morrison (1975) studied the effect of calcium and 
phosphorous on the retention of stable lead in a group of rats which 
were fed a diet containing stable lead for 8 weeks. At the end of 
this period, half the rats were killed and the lead retained in the 
carcasses was measured. The remaining rats were fed a lead free diet 
for a second period of 8 weeks, at the end of which carcass lead was 
again measured. They found retention at the end of the second period 
was lowest in control rats fed normal amounts of calcium and 
phosphorous, a third higher in the low calcium and low phosphorous 
group, and unchanged in the low calcium group. 
Quarterman et al (1978a ) repeated the experiment with diets supplemented 
with calcium and phosphorous. Retention again was lowest in the 
control group at the end of the second period, but it was 50% higher 
in both high calcium and high phosphorous, and in the high calcium 
groups of rats. The most rapid excretion of lead from the body, 
therefore, was found with dietary calcium and phosphorous at about 
requirement level. 
In a tracer lead experiment, Barton et al (1978 ) intravenously . 
injected 1.0 µCi 210 Pb nitrate (specific activity: 10 mCi/ mg lead ) 
into three groups of rats fed low, normal and high calcium diets. When 
lead retention was compared at 7 days and 6 weeks after injection, that 
of the high calcium group did not differ significantly from normal, 
whereas lead retention of the low calcium group was significantly 
enhanced at 7 days. This difference in lead retention persisted up to 
the final measurement at 6 weeks, showing that the effect of calcium 
on excretion occurred in the first 7 days. 
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The rate of excretion of stable and tracer lead in 
rats is affected 
by dietary calcium and phosphorous, but, again, the
 effect of the 
simultaneous ingestion of calcium, phosphorous and 
tracer lead on 
the excretion of the tracer does not appear to have
 been i nvestigated. 
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S E C T I O N 2 
AIMS OF PRESENT STUDY 
The studies described in this thesis were designed to investigate the 
effect of dietary constituents on the gastrointestinal absorption, 
distribution and excretion of lead in the human. The degree of change 
in these three processes will affect the size and the distribution of 
the body burden of lead in people and, therefore, influence 
susceptibility to lead toxicity. 
The literature already reviewed has shown that the absorption of lead 
in man is variable and the cause was suggested to be food with the -lead 
in the gut. The results of the animal studies suggested that the 
composition of the food was mainly responsible for the variation in the 
absorption of lead. The greatest effect on the absorption was caused by 
the dietary constituents, calcium and phosphorous, and they also affected 
the distribution and excretion of lead. 
Experiments were designed, therefore, to establish the degree of 
variability of absorption of lead in the human, to investigate the 
effects of the main components of diet, and then, more specifically,the 
effect of calcium and phosphorous on absorption. Further experiments 
were designed to relate any effect of calcium and phosphorous on 
absorption to any possible effect on distribution and excretion. From 
the results of these experiments, it was planned to develop a 
compartmental model to describe the behaviour of lead in the body. A 
satisfactory model would provide a better understanding of the 
2. 1 
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interaction of lead; calcium and phosphorous in the human body. 
Choice of experimental methods 
The animal studies described in sections 1.5.1-1.5.3 can be divided 
into long term experiments in which lead was given as part of the diet, 
and short term experiments in which lead was given as a tracer in a 
single dose. Tracer studies were pioneered by Hevesy and, by 
coincidence, he used a natural radionuclide of lead to investigate the 
metabolism of lead in plants. By using a gold leaf electroscope, he was 
able to measure quantitatively the uptake of lead by using small 
quantities of radiolead which did not produce any toxic effects in the 
plants, the fundamental principle of tracer methodology. 
The effects of dietary constituents on the absorption of lead from the 
gut were successfully studied in short-term animal experiments in which 
tracer lead was given at the same time as the constituents. It was 
decided, therefore, to use this type of experiment in the human studies 
presented in this thesis. 
Both stable lead and radioactive lead nuclides can be used in tracer 
experiments. Rabinowitz (1974) used stable lead nuclides 
204 Pb, 206 Pb and 
207 Pb in human studies on the absorption and kinetics of oral lead, and 
he achieved a precision of measurement with a standard error of 1% using 
mass spectrometry. Radioactive lead nuclides, however, have an advantage 
over stable tracers when used in short term experiments. The kinetics of 
lead in part of a dynamic system can be studied without the need of samples. 
For example, an in vivo radiation detecto~ can be placed over the l i ver 
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of a human subject to study the uptake and release of radioactive lead 
from this organ. 
Three radioactive lead tracers are available commercially, 
210 Pb, 212 Pb 
and 203 Pb. 210 Pb has a half life of 19 years and decays through the 
emission of a weak B-ray (197 keV) to the a-emitter 
210 Po, which ·has a 
half life of 138.4 days. Its use in humans is restricted because of the 
high toxicity of 210 Pb, and measurement of the emitted radiations is 
difficult because of their nature and low energy. 
212 Pb (ThB) . ~as the 
disadvantage of having a short half life of 10.6 hours and decaying to 
212 Bi which is an a-emitter and, therefore, toxic. 
203 Pb decays by 
electron capture to stable 
203 T£, emitting a number of gamma rays. The 
main 279 keV gamma ray is suitable for imaging and in vivo counting, and 
the half life of 52 hours is long enough for studies up to two weeks 
in length. 
2 0 3 Pb is the most suitable lead tracer for the type of experiment designed 
in this thesis. With the use of 
203 Pb, it is assumed that the usual 
criteria of tracer methodology hold. These are that lead in the human 
body is in a steady state, that there is complete mixing of the tracer 
with stable lead in the body and that the amount of tracer added is 
negligible to the amount of stable lead in the diet and the body. 
The tracer dictates the instrumentation which will be used to obtain 
the experimental data. As 203 Pb was the tracer of cboice, its 
radioactivity in the body and in body fluids was measured using 
radiation detectors. The instruments used are available in most Nuclear 
Medicine departments, and most of the computer procedures are also 
readily available. 
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S E C T I O N 3 
VARIATION OF GASTROINTESTINAL ABSORPTION OF 2 03 Pb IN 
TEN SUBJECTS 
3. 1 Introduction 
The gastrointestinal absorption of lead in man is variable and work 
confirming this has been reviewed in section 1.5.1. At the time the 
experiments described in this section were performed, only the results 
of Hursh and Suomela (1968) were available. As discussed in section 
1.5.1., their results were based on an indirect measure of absorption. 
This experiment was intended to repeat their work, but a larger number 
of subjects were studied and the use of 203 Pb and a whole body counter 
provided a more direct measurement of absorption. 
3. 2 . Materials and methods 
The ten subjects M.W. to S.L., listed in order in table 11.1, ingested 
10 µCi of 2 03 Pb chloride, without carrier lead, dissolved in 100 ml 
of distilled water two hours after a light breakfast of their choice. 
Whole body retention of 2 03 Pb was measured every day for the next 7 
days using a 'shadow shield' whole body monitor (Warner and Oliver , 
1966 ) , and the 96 hour retention was calculated as described in 
section 11 .3. A counting standard containing approximately the same 
radioactivity as the dose was diluted to l litre with distilled water. 
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3. 3 Results 
3.4 
The whole body retention values at 48 and 96 hours after 
administration of 203 Pb are presented in table 3.3.l. In 6 of the 
subjects, there was appreciable retention at 48 hours after the oral 
dose of 203 Pb. At least 5 of the subjects had a 96 hour retention 
greater than 10%, and the mean value of the retention of the remaining 
5 subjects was 11.47 ~ 0.51 (S.E.). The study on subject K.B. was 
repeated because retention appeared to be so high, but the initial 
figures were confirmed. 
Discussion 
The International Commission on Radiological Protection ( ICRP, 1959 ) 
gastrointestinal model is based on complete evacuation of an oral dose 
in 31 hours, but 6 of the subjects still retained most of the oral 
dose at 48 hours. Similar results were obtained by Hursh and 
Suomela (1968), and they suggested that the disagreement could be 
caused by different personal habits of the subjects. It was assumed 
that the unabsorbed fraction of 203 Pb was cleared by 96 hours as 
there was minimal reduction in retention after 4 days. 
If no unabsorbed 2 03 Pb remains in the body at 96 hours, the percentage 
retention at this time can be regarded as an adequate measure of 
absorption. Hansky and Connell (1962) found that 8 out of 10 normal 
subjects excreted the total recoverable dose of non-absorbable 
radioactive chromic oxide and sodium chromate within 96 hours. 
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TABLE 3.3.l 
% Whole body retention 6f orally ingested 



















* No carrier lead. 
RETENTION AT 48 HOURS 
17.51 ! 0.44 t 
98.53 + - 0.81 
30.12 + - 0.50 
+ 12.87 - 0.46 
+ 41.84 - 0.66 
+ 31.59 - 0.48 
18.90 + - o. tio 
75.88 + - 0.81 
+ 74.60 - 0.36 
+ 66.49 - 0.74 
+ 31.96 - 0.51 
t + 1 standard deviation. 
01 ,a RETENTION AT 96 HOURS 
11.52 ! 0. 72 
13.19 +
 - 0.71 
23.30 + - 0.79 
10 .10 ! 0.75 
16.19 ! 0.90 
11.17 + - 0.69 
16.78 ! 0.79 
63.40 + - 1.18 
67.00 ! 0.44 
+ 11.15 - 0.81 





The percentage retention at 96 hours does not equal the percentage 
of 2 03 Pb absorbed, because a fraction of this 20 3Pb will have been 
excreted in the urine and faeces in the preceding 96 hours. This 
fraction is probably small if absorbed lead is excreted at 
approximately the same rate in the pre-96 hour as in the post-96 hour 
period. 
The gastrointestinal absorption of 2 03 Pb in the ten subjects was 
variable, which agrees with the results of Hursh and Suomela (1968 ) . 
The retention of 5 of the subjects was greater than the 10% absorption 
quoted in the WHO Environmental Health Criteria 3 (1977 ) , but the mean 
value of the remaining 5 subjects agreed with the accepted value. 
The variation of gastrointestinal absorption observed could have been 
caused by, using tracer quantities of 203 Pb, age, diet, intestinal 
contents and individual variation in absorption between subjects. 
The accepted level of absorption, 10%, is based on the long-term 
balance studies of Kehoe (1961 ) in which stable lead was ingested. As 
t he i ntake of lead per day through the gastrointestinal tract is 
between 200 - 300 µg, it could be argued that the tracer amounts of 
l ead used in the present experiment would not behave in the same way 
as larger amounts of stable lead. The tracer lead would mix with stable 
lead already present in the intesti nal contents, and if the movement of 
lead through the gut was relatively slow, the tracer lead would no 
l onger be Lcarrier free 1 • 
Any variations in the transit time of food throagh the gut would affect 
t he mixing of tracer and stable lead, and, possibly , the fraction of 
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tracer lead absorbed. Hansky and Connell (1962 ) measured 
gastrointestinal transit times (mouth to excretion) and found a 
coefficient of variation in ten subjects of approximately 50%, and 
Garber and Wei (1973 ) found that in mice the dose of lead ingested 
can influence the percentage absorbed. It is possible, therefore, 
that some of the variation in absorption observed between subjects was 
caused by using tracer quantities of 203 Pb. 
The ten subjects were healthy, active individuals and were aged 
between 25 and 40 years. There was no indication that absorption 
varied with age in this group, although it is known that absorption is 
increased in the young (section 1.5 ) . 
Each subject enjoyed a normal diet and as they were healthy and had 
no evidence of disease, it is probable that they all had the same 
nutritional status. Even if there were differences, they would be 
unlikely to affect absorption in such a short term experiment, 
particularly, as it has been shown in section 1.5.1 that, in animals, 
intestinal contents appeared to influence absorption much more than 
nutritional status. 
The intestinal contents of each subject could have varied in both 
quantity and composition, as it was only specified that they ate a 
light breakfast of their own choice. These variables, together with 
the use of tracer lead and any individual differences in absorption, 
could all contribute to the variation in gastrointestinal absorption 
of 203 Pb found between subjects. 
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S E C T I O N 4 
EFFECT OF FASTING ON THE GASTROINTESTINAL ABSORPTION 
OF 203 Pb IN THREE SUBJECTS 
4.1 Introduction 
Rabinowitz (1974 ) found that the absorption of oral lead in a fasting 
subject was markedly reduced when the lead was ingested in food 
(section 1.5.1 ) . Some of the variation in 96 hour retention observed 
in the last experiment could have been caused by different quantities 
of food in the subjects gastrointestinal tracts. A repeat experiment 
with fasting subjects should shown the same effects of food on the 
absorption of lead as that observed by Rabinowitz (1974 ) . 
Three subjects from the previous experiment, E.H., S.S. and M.W., were 
available for further absorption studies. Two of these, M.W. and B.S., 
had retained approximately 11% ( table 3.3.1 ) of the oral dose of 
203 Pb 
at 96 hours, and, therefore, their absorption of lead conforms to the 
accepted value of 10% (WHO, 1977 ) . The third subject, E.H., retained 
approximately twice the dose of 
203 Pb at 96 hours than that retained 
by the other two subjects. To reduce the likelihood that this 
increased retention could have been caused by tracer lead behaving 
differently to stable lead (section 3.4 ) , the same weight of carrier, 
lead chloride, was added to the dose of 
2 0 3 Pb given to each subject in 
the present experiment. 
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4. 2 Materials anc methods 
An oral dose of 10 µCi of 203 Pb chloride with 300 µg of lead chloride 
was given in 100 ml of distilled water to the subjects. They fasted 
for 18 hours prior to the dose, and for a further 6 hours after the 
dose was given. Whole body counts were measured and 96 hour retentions 
were calculated in the same way as in the previous experiment (section 
3.2 ) . 
4. 3 Results 
The 96 hour retentions of 203 Pb are presented in table 4.3.l, together 
with each subject's previous reading from table 3.3.l. In all 
subjects, there was a marked increase in retention of 
203 Pb when the 
subjects had fasted, but the order of their percentage retentions 
remained the same. The differences between the higher retention of 
subject E.H. and the retentions of M.W. and B.S. were much less when 
they had all fasted compared to those found in the previous experiment 
(section 3.0). 
4.4 Discussion 
The results of the present experiment confirm the findings of 
Rabinowitz (1974) that the presence of food in the gut reduces the 
absorption of lead. Experiments performed by Chamberlain et al (1S78 ) , 
at a later date than the present one, showed the same effect of food 
on absorption of lead. These workers also confirmed that the order of 
percentage retention was the same in both fasting and non fasting 
experiments performed on the same subjects. 
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TABLE 4.3.l 
% Whole body retention of orally ingested 








% RETENTION AT 96 HOURS* 
(Non-fasted ) 
+ t 23.30 - 0.79 
+ 11.52 - 0.72 
+ 
11.15 - 0.81 
* No carrier lead. 
t + l standard deviation . 
% RETENTION AT 96 HOURS 
(Fasted ) 
+ 
75.82 - 0.69 
+ 
69.95 - 0.66 





The 96 hour retention values agree with those of 67.00% and 63.30% 
found with subject K.8. in section 3.3, but are higher than 
absorption and retention values reported by other workers. Rabinowitz 
(1974 ) obtained a maximum value of 52% absorption in a fasting subject 
who had ingested lead sulphide. Chamberlain et al (1978 ) showed that 
lead sulphide was not absorbed as readily as lead chloride in fasting 
subjects, so that if the subject in Rabinowitz's study had ingested 
lead chloride, a higher absorption may have resulted. Rabinowitz 
(1974 ) also measured absorption from the quantity of lead excreted 
in a 10 day faecal collection. He did not take into account 
endogenous excretion of previously absorbed lead, so that he 
overestimated the unabsorbed fraction of lead in the faeces. 
The results of Chamberlain et al (1978 ) are mare suitable far 
comparison, as they measured whale body retention of 203 Pb. In six 
subjects, they found a mean retention at 5 days of 45 ! 17% (S.D. ) 
compared with a mean retention at 4 days of 69.50: 3.88% (S.D.), 
obtained in the present experiment. The extra day between measurements 
is unlikely ta make any difference between the means, but the amount of 
carrier lead in the dose and the fasting regime followed by the 
subjects were different. They gave their subjects one quarter of the 
carrier lead which was given in the present experiment, and if 
absorption is influenced by the weight of the carrier, then their 
retention measurements should have been higher. Garber and Wei (1973 ) 
found in mice that decreasing the carrier lead given with a tracer 
dose increased absorption of the tracer. The fasting regime was 
different in that their subjects were fasted for 12 hours instead of 
18 hours before the dose, and were not allowed ta eat for 2~ hours 
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instead of 6 hours after the dose had been given. It is possible 
that any food present in the gut, before and after the oral dose of 
2 03 Pb had been given, could reduce the absorption of lead by a 
greater extent in these subjects than in those who took part in the 
present experiment. 
It is also possible that the subjects chosen for the present 
experiment had, when fasted, a naturally high absorption of lead. Two 
of the 6 subjects wbo took part in the experiments of Chamberlain et 
al (1978 ) , retained more than 60% of their oral dose of 203 Pb. A 
comparison of the two means, 45 ! 17% (S.D. ) and 69.50 ! 3.88% (S.D. ) , 
shows that they are not different at the 5% level of significance. 
This suggests that the 25% difference between the means could be due 
to individual variation in absorption of lead between the two groups 
of subjects, and not to differing experimental conditions. 
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S E C T I O N 5 
EFFECT OF DIETARY CONSTITUENTS ON THE GASTROINTESTINAL 
ABSORPTION, DISTRIBUTION AND EXCRETION OF 
203 Pb 
IN TWO SUBJECTS 
5.1 Introduction 
The last experiment and those of Rabinowitz (1974) and Chamberlain 
et al (1978) have all shown that, in man, the presence of food in the 
gut reduces the gastrointestinal absorption of lead. Absorption is 
also affected by chemical form of lead and possibly by the acidity of 
stomach contents, and these effects have been mentioned in section 
1.5.1. No human studies appear to have been performed, however, in 
which the effects of different types of food on the absorption of lead 
have been studied. 
Food could possibly reduce the gastrointestinal absorption of 
203 Pb in 
a number of ways. It could reduce the probability of contact between 
lead in intestinal mucosa. Lead could combine with certain 
constituents in the food and form insoluble compounds that would 
render lead unavailable for absorption, or there could be competition 
between lead and constituents in the food for common intestinal 
transport mechanisms. 
There is strong evidence in the animal studies reviewed in section 
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1.5.1 that dietary constituents can have a major influence on th
e 
gastrointestinal absorption of lead. These studies also showed 
that 
the effect of dietary constituents on absorption could be adequ
ately 
demonstrated when they were ingested simultaneously with a singl
e dose 
of tracer lead. Dietary constituents also affect the distributi
on and 
excretion of lead in animals (section 1.5.2 and 1.5.3), although
 there 
is no evidence from the animal studies that the same effects can
 occur 
with a single dose of tracer lead ingested simultaneously with t
he 
constituents. 
The present experiment, therefore, was designed primarily to 
investigate the effect of dietary constituents on the absorption
 of 
203 Pb by using a control meal devised by Barltrop and Khoo (1975 ) f
or 
their rat experiments, and their method of varying the compositi
on of 
the control meal. Whole body retention, blood and urine levels 
of 
203 Pb were measured in an attempt to find an effect of dietary 
constituents on the absorption, distribution and excretion of 
203 Pb 
in two subjects. 
5.2 Materials and methods 
Subjects K.B. and D.W., whose details are listed in section 11.1
, took 
part in experiments in which they ingested 
203 Pb in the control meal 
with all its constituents ( total meal). Five more were performe
d on 
subject K.B. in which protein, fat, fibre, minerals and vitamins
 were 
omitted, in turn, from the control meal. A further two experim
ents 
were performed on the two subjects in which the 
203 Pb was given in 
distilled water with carrier and minerals, and with carrier and 
49 
without minerals. Finally, subject K.B. ingested 
2 03 Pb in distilled 
water without carrier and without minerals. 
The composition of the control meal is shown in table 5.2.1, and it 
was based on a diet used by Barltrop and Khoo (1975 ) in their rat 
experiments. Each meal was kept isogravic and isocaloric by 
adjusting corn starch and sucrose content, and each meal contained 
300 µg of lead chloride and 50 µCi of 2 03 Pb. The meal was cooked for 
45 mi~~tes at 180°C to give a fudge texture, which was found to be the 
most palatable. Before each experiment, the subjects fasted for 18 
hours and for a further 6 hours after the meal had been eaten. After 
eating the meal, the mouth was swilled with 150 ml of distilled water 
to dislodge any meal left between the teeth, The subjects ate a normal 
diet after the fasting period and in between experiments. 
Approximately the same radioactivity as the ingested dose was diluted 
to l litre with distilled water. Blood and urine standards were made 
up from l ml and 2 ml of this solution, and diluted to 2ml and 150 ml 
with distilled water. The remainder was used as the whole body 
counting standard. Whole body retention of the 
203 Pb was measured 
using a whole body counter, and the retention at 96 hours and the half 
times of retention from 96 hours onwards were calculated, as described 
in section 11.3. It was assumed that the fall i n retention values 
could be described by a single negative exponential. 
5 ml venous blood samples were taken every day, and urine was also 
collected over 24 hour periods during the study. Whole blood and urine 
2 0 3 Pb radioactivities were measured as described in sections 11.8 and 
50 
TABLE 5.2.l 




























* The mineral mix provided the following quantities in g/kg of diet: 
KCl, 3.43; 
ZnC0 3 , 0.050; 
NaCl, 1.27; 
CuS0 4 , 0.020; KI0 3 , 0.0003. 
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11.9, respectively. The total blood volumes of both subjects, K.B. 
and D.W., were measured as described in section 11.7.3, and recorded 
in section 11.1. The total 203 Pb content of blood could then be 
calculated for both subjects. The levels of 
203 Pb in blood and urine 
were then expressed as percentages of 96 hour retention (retained 
dose ) . 
5.3 Results 
Some of the results of the experiment performed on subject D.W. 
(section 8.2. 3) in which he ingested 
203 Pb in distilled water have 
been included in this section. They are the 96 hour retention, half 
time of retention, blood and urine levels of 
2 03 Pb and they are 
annotated in the tables. The inclusion of these results allows a 
better comparison to be made between subjects K.B. and D.W. 
5.3.l Gastrointestinal absorption of 
203 Pb 
The whole body retentions of 203 Pb at 48 and 96 hours of both subjects 
are presented in tables 5.3.l and 5.3.2. As found in previous 
experiments, a comparison of the 48 hour and 96 hour readings shows 
that the unabsorbed fraction of the oral dose was not cleared 
completely in all studies at 48 hours. The 96 hour retentions of both 
subjects were highest after 203 Pb had been ingested with carrier lead 
in distilled water, and there was oo significant change in the 96 hour 
retention of subject K.B. when carrier was omitted. In the series of 
retention experiments performed on subject K.B. ( table 5.3.1 ) , 
retention was below 10% except wben minerals were absent from the 
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TABLE 5.3.l 
% Whole bedy retention of orally ingested 
203 Pb 
with different meals and fluids 
Subject : K.B. 














12.01 ! o.o6t 
+ 44.99 - 0.14 
+ 9.97 - 0.065 
+ 
20.76 - 0.14 
+ 
5.58 - 0.07 
+ 
20.04 - 0.07 
4.43 ! 0.06 
+ 
86.50 - 0.2 
+ 71.56 - 0.18 
+ 3.95 - 0.06 
+ 34.82 - 0.15 
+ 
3.67 - 0.08 
+ 
3.09 - 0.07 
+ 
4.29 - 0.11 
+ 3.ll - 0.05 
+ 
0.94 - 0.06 
+ 60. 76 - 0 .19 
+ 
59.19 - 0.19 
All meals and fluids included carrier lead except where indicated. 
t ! l standard deviation. 
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TABLE 5.3.2 
% Whole body retention of orally ingested 
203 Pb 
Subject D.W. 
MEAL % RETENTION AT 48 HOURS 
Total 
FLUID 
Distilled water and 
minerals 
Distilled water 
21.10 ~ o.01t 
+ 20.86 - 0.83 
94.06 ~ 0.23§ 
All meals and fluids included carrier lead. 
t + 
- l standard deviation, 
§ Results from aection 8.2.3 a). 
% RETENTION AT 96 HOURS 
+ 
8.07 - 0.06 
+ 
1.50 - 0.05 
71.60 ~ 0.23§ 
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control meal. The mean 96 hour retention found in experiments in 
which the minerals were present was 3.48 ! 0.48% (S.D.), giving a 
coefficient of variation of 14%. The lowest retentions were found in 
both subjects when they ingested 203 Pb with minerals in distilled 
water. Subject O.W. always retained more 
203 Pb than subject K.B. in 
every experiment that they shared. 
5.3.2 203 Pb in total blood following ingestion 
Tables 5.3.3 and 5.3.4 show the percentages of the ingested dose of 
203 Pb in total blood. Values range from 30.26% to 0.19% corresponding 
to the highest and lowest values of 96 hour retention. There was no 
consistent time after ingestion at which blood radioactivity peaked 
in any of the experiments. In at least half the experiments, however, 
peaks occurred between 96 hours and 120 hours, and no peaks occurred 
later than 144 hours. 
5.3.3 Urinary excretion and half time of retention of 
203 Pb 
Tables 5.3.5 and 5.3.6 list the percentages of tbe ingested dose of 
203 Pb in 24 hour urine collections. Values range from 1.88% to 0.003% 
and, as with 203 Pb in the blood, correspond to the highest and lowest 
values of 96 hour retention. The half times of whole body retention 
from 96 hours onwards are shown in tables 5.3.7 and 5.3.8. There were 
not sufficient retention values to allow a half time to be calculated 
for subject D.W. in the experiment in which he ingested 
203 Pb with 
minerals in distilled water. The regression coefficients (r ) obtained: 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Percentage of ingested dose of 203 Pb in total blood with 















+ t 1.060 - 0.004 
+ 1.520 - 0.005 
+ 1.434 - 0.005 
+ 
l. 40 l - 0. 007 
1.400 + - 0.008 
+ 1.301 - 0.008 
1.283 + - 0 .013 
1.216 °! 0.017 
WATER AND 
MINERALS 
+ 0.184 - 0.001 
0.234 ! 0.002 
0.293 + - 0.002 
0.316 + - 0.002 
0.312 °! 0.003 
0.300 + - 0.004 
0.340 + - 0.004 
+ 0.336 - 0.007 
All meals and fluids included carrier lead. 
t 
: l standard deviation. 
§ Results from section 8.2.3 d). 
+ 26.16 - 0.12 
30.26 + - 0.09 
27.82 °! 0.16 
29.62 + - 0.21 
+ 26.84 - 0.21 
26.62 + - 0.24 
25.07 + - 0.27 
+ 24.58 - 0.23 
+ 26.99 - 0.28 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































Percentage of ingested dose of 203 Pb in total urine with 
different meals and fluids 
Subject D.W. 
TIME TOTAL WATER WITH 
(hours ) MINERALS 
0-24 + 0.083 - 0.0006 
+ 0.0100 - 0.0001 
24-48 + 0.036 - 0.0004 
+ 0.0050 - 0.0001 
48-72 
+ 0.026 - 0.0004 0.0074 ! 0.0002 
72-96 
+ 0.024 - 0.0004 0.0027 + - 0.0001 
96-120 + 0.026 - 0.0005 0.0090 
+ - 0 .OOll 
120-144 + 0.026 - 0.0004 0.0042 ! 0.0002 
144-168 + 0.018 - 0.0009 
+ 0.0037 - 0.0001 
168-192 0.024 ! 0.0006 + 0.0089 - 0.0003 
192-216 0.026 + - 0.0007 0.0045 ! 0.0002 
All meals and fluids included carrier lead. 
t ! l standard deviation. 
§ Results from section 8.2.3 d). 
WATER§ 
1.35 + - 0.0065 
+ 0.96 - 0.0056 
+ 0.79 - 0.0067 
0.46 + - 0.0048 
0.55 + - 0.0071 
0.51 + - 0.0059 
+ 0.58 - 0.0071 
+ 0.63 - 0.0098 
+ 0.74 - 0.0097 
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TABLE 5.3.7 


















+ t 29.49 - 0.75 
+ 364.74 - 19.20 
+ 90.00 - 9.35 
+ 62.43 - 5.63 
76.66 + - 4.58 







+ 37.26 - 8.40 (3) 
+ 301.31 - 1.31 (7 ) 
+ 771.70 - 36.09 (6 ) 
REGRESSION COEFFICIENT 










All meals and fluids i ncluded carrier lead except where indicated. 
Figures in brackets are number of data points. 
t + 
l standard deviati on. 
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TABLE 5.3.8 











10.s ~ o.32t (6) 
630.00 ~ 57.27§ (6) 
All meals and fluids included carrier lead. 
Figures i n brackets are number of data points. 
t + 
1 standard deviation, 
§ Results from section 8.2. 3 a ) . 
REGRESSION COEFFICIENT 




found with retention values from the total meal experiment of subject 
D.W. and from the experiment in which subject K.B. ingested the meal 
without fat. In the total meal experiment, the half time of retention 
was extremely short at 10.5 hours. The longest half times are 
associated with the highest retentions, and it is noticeable that the 
half time of retention of subject K.B. was twice as long when carrier 
lead was absent from the ingested dose of 203 Pb. 
5.3.4 203 Pb content of blood and urine expressed as percentages of 96 hour 
retention 
Tables 5.3.9 and 5.3.10 show the mean 203 Pb content of total blood and 
of 24 hour urine collections expressed as percentages of 96 hour 
retention. There is considerable variation between values obtained 
from the different meal experiments of subject K.B. The highest and 
lowest values are found when protein was omitted and every constituent 
was included in the total meal, respectively. There was good 
agreement between these last values and those obtained from the 
corresponding experiment performed with subject D.W. There is also 
good agreement between the 203 Pb content of blood and urine found in 
the two experiments in which subject K.B. ingested 203 Pb in distilled 
water with and then without carrier lead. Both blood and urine values 
obtained from total meal experiment and distilled water plus minerals 
experiment of subject D.W. agree well, but there is a marked 
discrepancy between these latter values and those found when 203 Pb 
was given in distilled water. 
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TABLE 5.3.9 
Mean 203 Pb in blood and mean 2 03 Pb in 24 hour urine expressed as 















MEAN TOTAL BLOOD 
(% 96 hour retention ) 
12.89 : l.56t 
+ 14.19 - 0.15 
+ 46.32 - 3.68 
+ 
21.42 - 1.41 
+ 41. 26 - 4.55 
+ 22.86 - 2.38 
28.40: 8.29 
+ 43.82 - 5.12 
+ 39.47 - 4.55 
MEAN 24 HOUR URINE 
(% 96 hour retention ) 
0.405 ! 0.152 
+ 
0.890 - 0 .316 
+ 
1.580 - 0.200 
+ 
0.906 - 0.273 
+ 1.380 - 0.537 
+ 
0.707 - 0.450 
+ 
0.957 - 0.161 
+ 
1.080 - 0.545 
+ 1.250 - 0.667 
All meals and fluids included carrier lead except 1Uhere indicated. 
t+ 
- l standard deviation. 
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TABLE 5 .3 .10 
Mean 2 03 Pb in blood and mean 2 03 Pb in 24 hour urine expressed as 








MEAN TOTAL BLOOD 
(% 96 hour retention ) 
16.23 ~ 2.36t 
+ 15.80 - 4.23 
39.05 ~ 2.96 § 
All meals and fluids included carrier lead. 
t + 1 standard .deviation. 
§ Results from section 8.2.3~. 
MEAN 24 HOUR URINE 
(% 96 hour retention ) 
+ 0.384 - 0.198 
+ 
0.360 - 0.187 
1.010 ~ 0.420 § 
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5. 4 Discussion 
5.4.l r,astrointestinal absorption of 203 Pb 
The results clearly show that, in the two subjects studied, the 
simultaneous presence of food with lead in the gut reduces the 
gastrointestinal absorption of 203 Pb. The 96 hour retention of 
subject K.B. after he had ingested the total meal was approximately 
half the accepted value of absorption, whereas his retention in 
section 3.0 was the highest of the ten subjects in that experiment. 
The retention of subject D.W., however, agreed fairly well with the 
accepted value. The difference in retention between these two 
subjects was probably caused by individual variation in absorption of 
lead, as subject D.W. always retained a higher percentage of 203 Pb 
than subject K.B. in all the experiments they shared. This was 
observed in section 4.0 and confirms the same effect found by 
Chamberlain et al (1978). 
The percentage of 203 Pb retained by subject K.B. was unaffected by the 
amount of carrier lead, 300 µg, present with the 2 03 Pb in the gut. In 
this subject, the absorptive mechanisms responsible for the absorption 
of lead can tolerate these lead levels in the gut without a change in . 
the efficiency of absorption. 
The absorption of lead was reduced, however, eve~y time minerals were 
present with lead in the meals and fluids ingested by both subjects. 
The retention of subject K.B. dropped by a factor of 10 when minerals 
were present in the total meal. Barltrop and Khoo (1975 ) found that 
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the dietary regime of control meal with added minerals was the only 
one which decreased the gastrointestinal absorption of 
2 0 3 Pb in rats. 
When minerals were present in the meal, the absence, in turn, of 
protein, fat, fibre and vitamins did not appear to have any effect 
on the gastrointestinal absorption of 203 Pb in subject K.B. High and 
low protein diets have been shown to increase the absorption of lead 
in rats (Barltrop and Khoo, 1975), although Gontzea et al (1970 ) found 
that only a low protein intake increased absorption. Quarterman et al 
(1978b ) however, accounted for this discrepancy when they found that 
the effect of protein on the absorption of lead in rats was influenced 
by several factors. These were the duration of both feeding by 
experimental diets and intake of lead, and whether or not the rats 
were fed to appetite. Their findings did not support the theory that 
a diet low in protein would necessarily increase lead absorption. 
Fibre, in the form of cellulose, chelates zinc, iron and calcium and 
makes them unavailable for absorption by the human gut (Moynahan, 
1977), but no effect on lead absorption was found in subject K.B. 
Diets deficient in vitamin C have been shown by Pillemer et al (1940) 
to increase lead toxicity, and diets with added vitamin D have 
produced increased lead absorption (Sobel et al, 1940). Barlt~op and 
Khoo (1975), however, found no effect of vitamins on gastrointestinal 
absorption of lead in rats, and there was no effect on subject K.B. 
The greatest reduction in gastrointestinal absorption of 203 Pb 
occurred after lead and minerals were taken orally in distilled water. 
This supports the theory that drinking water containing minerals 
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( 'hard water') is protective against the gastrointestinal absorption 
of water borne lead (Crawford and Clayton, 1973). This protective 
action was confirmed in studies on rats by Meredith et al (1977) when 
they found that 'hard water' decreased the retention of an oral dose 
of 203 Pb. 
5.4.2 Distribution and excretion of 
203
Pb 
The levels of 203 Pb in blood and urine naturally reflected its 
percentage absorption in the gut. The different meals, however, also 
appeared to influence the percentage of the retained dose of 2 03 Pb 
in the blood, in the urine and the half time of retention from 96 
hours onwards. The retained dose in the blood of subject K.8. was 
high when meals were consumed with no protein, no fat, and high in all 
the fluid experiments. Barltrop and Khoo (1975 ) obtained similiar 
results with low protein and low mineral diets in rats, but found, 
however, that high fat diets also gave high blood-lead concentrations. 
The time taken to reach peak 203 Pb radioactivity in the blood was 
longer in most of the present experiments than that found by 
Chamberlain et al (1978 ) in their human studies. They observed peak 
blood radioactivities between 24 - 48 hours when 203 Pb chloride and 
203 Pb sulphide were ingested by humans in fasting and non- fasting 
experiments. The only experiments in which peak times were similiar 
to those found by Chamberlain et al (1978 ) were those in which fat and 
vitamins were absent from the meals ingested by K.B., and those in 
which the total meal and mineral-free fluid meal was ingested by D.W. 
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The percentage of retained 203 Pb in the urine followed the pattern 
of gastrointestinal absorption of 203 Pb observed with the blood. The 
half times of retention also showed a pattern, with the length of 
time corresponding to magnitude of 96 hour retention. The absence of 
carrier lead from the dose of 203 Pb increased the half time of 
retention in subject K.B. If it is assumed that the unabsorbed 
fraction of 203 Pb is cleared from the body in 96 hours and that the 
loss of 203 Pb by other routes of excretion, such as sweating, are 
negligible (Chamberlain et al, 1978 ) , then the fall in retention 
values from 96 hours onwards represents urinary and endogenous faecal 
excretion of 203 Pb. 
The mean endogenous faecal loss of 203 Pb per day, therefore, can be 
indirectly found by subtracting the mean urinary loss of 203 Pb per 
day from the mean reduction in whole body retention per day. The 
ratio of mean endogenous faecal to mean urinary loss per day (F/ u) was 
3~22 ! 1.01 (S.D.) when subject K.B. ingested 203 Pb with carrier lead, 
and 0.945: 0.306 (S.D.) when he ingested 203 Pb without carrier. This 
last result agrees with ratios found by Chamberlain et al (1978). The 
higher weight of carrier lead ingested may account for the higher 
value of F/ U found in subject K.B., and suggests that the amount of 
lead absorbed with 203 Pb in the gut can influence rates of excretion. 
Klaasen and Shoeman (1974) showed in rats that the excretion rate of a 
lead into bile was decreased by decreasing intravenous doses of 
carrier lead. 
The fall in retention of 203 Pb from 96 hours onwards is generally well 
represented by a single negative exponential. 
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The shortest half times of retention were associated with meals and 
fluids containing minerals. Several of these half times, however, 
were calculated from very few data points. It has been assumed that 
the unabsorbed fraction of 203 Pb is cleared from the gut by 96 hours, 
but the effect of any residual unabsorbed tracer would be to decrease 
the half times obtained from retention figures. This could explain 
the short half times observed in experiments in which the unabsorbed 
fraction of lead is very large, resulting in low retentions and very 
few post 96 hour readings. The shortest half time of retention, 
however, was found in the total meal experiment of subject D.W. from 
6 data points, but the regression coefficient was - 0.89, indicating 
that the fall in retention was poorly represented by a single negative 
exponential. This result cannot be compared to those found with the 
other subjects. 
Comparing the results of the experiments that the two subjects shared, 
there is good agreement between the percentages of the retained dose 
in the total blood and urine found when 203 Pb was ingested in the 
total meal and between those when 203 Pb was ingested in distilled 
water. There is also good agreement between blood and urine levels 
found in the experiments in which subject D.W. ingested 2 03 Pb in the 
total meal and 203 Pb with minerals in distilled water. There is a 
difference, however, between the levels obtained from this last 
experiment and those found in the similiar experiment performed on 
subject K. 8. In these experiments, the 96 hour retentions of both 
subjects was very low, 0.94% for subject K.B. and 1.50% for subject 
D.W., so that even a small fraction of unabsorbed 2 03 Pb i n the gut 
69 
would have a substantial effect on retention. If this unabsorbed 
2 03 Pb was present and could be accounted for, both retentions would 
be lower, and, with the subject K.B., it would make the difference 
greater, but with subject D.W., however, such a correction would give 
better agreement. 
From the limited amount of data collected from the experiments in 
this section, there appears to be an effect of dietary constituents 
and carrier lead on the distribution and excretion of absorbed 2 0 3Pb. 
However, the percentages of 203 Pb in blood and urine, expressed 
relative to 96 hour retention, do not entirely agree in the two 
subjects examined, indicating possible individual differences. 
Further experiments should be performed with more subjects and more 
comprehensive collection of data to confirm any effects. 
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S E C T I O N 6 
EFFECT OF CALCIUM AND PHOSPHOROUS ON THE GASTROINTESTI NAL 
ABSORPTION OF 2 03 Pb IN FIVE SUBJECTS 
6.1 Introduction 
In the preceding experiment, the greatest reduction in 96 hour 
retention of 2 03 Pb in two human subjects occurred when they ingested 
the 2 03 Pb with minerals in food and water. Minerals produced a 
similiar effect on the absorption of tracer lead in the rat 
experiments of Barltrop and Khoo (1975) , and, i n further studies, 
these workers showed that calcium and phosphorous were mainly 
responsible for this effect. Meredith et al (1977 ) showed in rats 
that increasing weights of oral calcium reduced the retention of 
tracer lead in an exponential manner. They suggested that the effect 
of calcium on lead retention was caused by the existence of a common 
pathway for the absorption of calcium and other minerals, including 
lead, from the gut. 
Other animal studies investigating the effect of calcium and 
phosphorous on the absorption of lead, were reviewed in section 1.5.1. 
A number of these studies showed that concomitant calcium markedly 
reduced the absorption of tracer lead, but no experiments had been 
performed to investigate a similar effect of phosphorous on absorption. 
Furthermore, no experiments using tracer lead have been performed on 
71 
human subjects to investigate the effects of calcium and phosphorous 
on lead absorption. 
The experiments in this section, therefore, were prompted by the 
animal work of Barltrop and Khoo (1975 ) and Meredith et al (1977). 
The separate effects of calcium and phosphorous on the retention of 
203 Pb were studied in one human subject, and the effect of them 
together was studied in the same subject and in four other human 
subjects. Finally, the effect of different weights of calcium and 
phosphorous on the retention of 203 Pb was examined in one subject in 
an attempt, similiar to that of Meredith et al (1977), to gain some 
insight into the mechanisms that may cause calcium and phosphorous to 
reduce the absorption of lead from the gut. 
6. 2 Materials and methods 
The subjects K.B., J.B., B.C., G.E. and D.W., whose details are listed 
in section 11.1, took part in this experiment. Most of the 
experimental work was performed on subject K.B. He ingested CaC0 3 and 
NaH 2 P0 4 .2H 2 0 in two separate experiments to compare their individual 
effects on retention, and then ingested different weights of them -
together to determine the response of retention to these different 
weights. 
All subjects followed the same fasting regime used in section 5.0, and 
drank their doses of 203 Pb with 300 µg of carrier lead chloride in 
100 ml of distilled water. Subject K.B. received 100 µCi of 2 03 Pb in 
each of his experiments in this section, _andthe doses of 2 0 3Pb given to 
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the other subjects are listed in table 6.2.l. As the present 
experiments were a continuation of those performed in section 5.0, 
the weights of CaC0 3 and NaH 2P0 4.2H 20 (maximum weights ) used in the two 
separate retention experiments performed on subject K.B. are those 
listed in table 5.2.l. One tenth, one twentieth, one hundredth of 
these weights and weights equimolar to that of lead in the dose were 
then given to subject K.B. in separate experiments, but the ratio of 
CaC03 to NaH2PD 4.2H 20 was kept constant. These weights provided an 
adequate number and range of retention results, and they are listed in 
table 6.3.2. All four of the other subjects were given the maximum 
weights of CaC0 3 and NaH 2P0 4.2H 20, and three subjects were given one 
tenth of the maximum in separate experiments, as listed in table 
6.2.l. The CaC03 and NaH2P04.2H20 were mixed in 150 ml of distilled 
water and drunk immediately after the dose of 203 Pb. Whole body counts 
were performed, and the 96 hour retentions and the half times of 
retention were calculated, as described in previous sections. 
6.3 Results 
Results from experiments performed in other sections, but included here, 
have been annotated. The results of the experiments performed on 
subjects J.B., B.C., G.E., D.W. are shown in table 6.3.l and those of 
subject K.8. in table 6.3.2. All subjects responded to the maximum 
weights of the minerals, 1.75 g CaC0 3 and 2.513 g NaH 2P0 4.2H 20, with 
markedly low 96 hour retentions of 203 Pb, with a mean of 1.91 ~ 1.32% 
(S.D. ) . There was also a definite but less marked response to the 
weights of 0.175 g CaC0 3 and 0.251 g NaH 2P0 4.2H20, with a mean of 



























All doses included carrier lead. 
* Dose ingested in experiment, section 5.0. 










The wide scatter of 96 hour retention values found in the subjects, 
when they were given calcium and phosphorous, is in marked contrast 
+ to the minimal variation of the mean, 72.28 - 1.17% (S.D. ) , obtained 
in the non mineral experiments. In these latter experiments, however, 
even though retention values are approximately the same, there is 
considerable variation in the half times of retention, with a mean of 
417.66 ! 157.12% (S.D.). Increasing weights of calcium and phosphorous 
caused half times of retention to decrease progressively. 
The effect of CaC0 3 on the retention of 2 03 Pb in subject K.B. was much 
greater than that of NaH 2 P0 4 .2H 20, but, when both were taken together, 
0.175 g of CaC0 3 and 0.251 g of NaH 2 P0 4 .2H 20 were sufficient to give 
the same 96 hour retention of 203 Pb as 1.75 g of CaC0 3 given on its 
own. 
The response of 96 hour retention of subject K.B. to different weights 
of calcium and phosphorous can be fitted to a mathematical function of 
the form (x 2 = 8.5; 0.05 <P <0.1) 
_44.4ow _1.9ow 203 Pb retention at 96 hours= 74.34e + 6.15e 
where w is the weight of calcium in grams. The data and function are 
shown in figure 6.3.1, and figure 6.3.2 shows the same data plotted 
with 96 hour whole body retention as y-values against £n (weight of 
calcium ) . 
There is considerable variation in the half times of retention found 
in the different experiments performed on the subject K.8., as shown in 
table 6.3.2. The lowest half time was found in the experiment in 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































noticeable that there was no reduction in half time when only 
phosphorous was ingested with the 203 Pb, although retention dropped 
from 60.75% to 47.24% of the ingested dose. 
6.4 Discussion 
Barltrop and Khoo (1975) found that calcium and phosphorous were 
mainly responsible for reducing the gastrointestinal absorption of 
lead in rats, and the results of the present experiment confirm that 
this also occurs in humans. The 96 hour retentions of subjects K.B. 
and D.W. found in this experiment are comparable to those in section 
5.0 (tables 5.3.l and 5.3.2), even though, in the latter experiment, 
the dose of 2 03 Pb was ingested with all the minerals listed in table 
5.2.1. 
The gastrointestinal absorption of lead differed in subjects who had 
received the same weights of calcium and phosphorous with the lead. 
This caused a wide scatter in 96 hour retention values compared with 
values obtained, with the same subjects, when calcium and phosphorous 
were not ingested with the lead. The minimal variation of these last 
retention results suggests thatthe discrepancy noted between the 
results of the retention experiments of Chamberlain et al (1978 ) and 
those obtained in section 4.0 was not entirely caused, as suggested 
earlier, by individual variation in the absorption of lead. Their 
l ower mean and greater scatter of retention values could be explained 
if , after the shorter fasting period of 12 hours, there were still 
t races of food containing calcium and phosphorous present i n the gut 
when the dose of lead was ingested. 
The reduction in the whole body retention of lead caused by calcium 
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and phosphorous was associated with a decrease in the half time of 
retention. In subject K.B., all the minerals, when ingested in 
distilled water ( section 5.0), appear to reduce the half time of 
retention more than that found when only calcium and phosphorous were 
ingested. The standard deviations of both half times ( tables 5.3.7 
and 6.3.2), however, are both large, so there is unlikely to be any 
significant difference between them. 
6.4.l The effects of calcium, phosphorous and both calcium and phosphorous 
together on the gastrointestinal absorption of 203 Pb 
The effect of separate weights of calcium and phosphorous on the 
absorption of lead was only investigated with one subject, K.B. The 
results of these two experiments, therefore, may not be representative 
of those obtained if more subjects had been used. These results, 
however, can be compared to animal experiments in which the separate 
effects of calcium and phosphorous on the absorption of lead have been 
examined. 
Calcium reduced the 96 hour retention of subject K.B. much more than 
phosphorous, even though the actual weights of calcium, 0.7 g, and 
phosphorous, 0.5 g, were approximately the same. The percentage of the 
dose of lead retained at 96 hours is the difference between that 
absorbed in the gut and the percentage of absorbed lead excreted over 96 
hours. Calcium reduced the half time of retention by a factor of 3 more 
than phosphorous ( table 6. 3. 2), and this could be responsible for the lower'. 
96 hour retention. However,if it is assumed that the same percentage of lead 
was absorbed in both experiments, and that absorbed lead was excreted at 
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approximately the same rate in the pre-96 hour as in the post-96 hour 
period, then the retention at 96 hours would only be different by a 
factor of 1.4 instead of the actual factor of 7.3. This suggests, 
therefore, that calcium also interferes more than phosphorous with the 
mechanisms which are responsible for the absorption of lead in the gut. 
The greater effect of calcium than that of phosphorous on the 
absorption of lead was shown in the rat studies of Quarterman and 
Morrison (1975 ) and Barltrop and Khoo (1975). Three groups of rats 
were fed diets low in calcium, low in phosphorous and low in both 
calcium and phosphorous together for a period of 8 weeks (Quarterman 
and Morrison, 1975). The lead retained by the low calcium group was 
3.7 times, and that retained by the low phosphorous group was 2.6 
times, the lead retained by rats fed lead in a normal diet. Although 
the calcium and phosphorous contents of the diet were below the minimum 
estimated requirements of the rat, it is unlikely that the nutritional 
status of the rats had an effect as Barlt~op and Khoo (1975) confirmed 
the findings of Quarterman and Morrison (1975) in a more acute diet 
experiment. They found that a low calcium diet given to rats over 48 
hours increased the retention of oral 203 Pb by a factor of 3.1. A low 
phosphorous diet also increased retention but by only a factor of 1.8. 
The presence of both calcium and phosphorous with 203 Pb in the gut 
reduced the retention of 203 Pb in subject K.B. considerably more than 
calcium or phosphorous alone. This was also shown in the rat 
experiments of Quarterman and Morrison (1975 ) and Barltrop and Khoo 
(1975), and both groups of workers found the effects of calcium and 
phosphorus together on the absorption of lead were additive. In 
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contrast to these two animal experiments, Quarterman et al (1978a ) 
found that in rats an increase above normal requirements in the 
dietary content of calcium and phosphorous together had an effect no 
greater than an increase of either one alone. 
The results of these animal studies suggest certain characteristics 
about the gastrointestinal absorption of lead, if we assume, as argued 
in the start of this section, that calcium and phosphorous reduce 
retention primarily by affecting the absorption of lead from the lumen 
of the gut. The effects of calcium and phosphorous suggest 
competition with lead for absorption by a common pathway, with calcium 
competing more efficiently than phosphorous. As their effects were 
shown by Quarterman and Morrison (1975 ) and Barltrop and Khoo (1975) to 
be additive, the quantities of calcium, phosphorous and lead used in 
these studies were not sufficient to cause any saturation of the common 
pathway. The effects observed by Quarterman et al (1978a ) ,however, do 
suggest that saturation can occur if larger quantities of calcium and 
phosphorous are used. 
In the present experiment performed on subject K.B., calcium and 
phosphorous reduced the 96 hour retention by factprs · of 9.3 and 1.3, 
respectively, so that a reduction of 10.6 would be expected if the 
effect of both was additive when ingested together. Retention was 
actually reduced 40 times. Although it has been reported that the 
transport of phosphorous in the upper duodenum of the rat is increased 
by a factor of 3 by the presence of calcium (Chen et al, 1974 ) , it is 
unlikely that such a synergistic effect could be totally responsible 
for the large reduction in retention observed. However, if lead is 
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absorbed by two separate pathways, one which it shares specifically 
with calcium and the other specifically with phosphorous, then the 
absolute changes in percentage retention of lead in subject K.B., 
caused by separate doses of calcium and phosphorous each saturating 
its specific pathway,could easily account for the change which 
occurred when they were both taken together. 
6.4.2 Effect of different weights of calcium and phosphorous on the 
gastrointestinal absorption of 203 Pb 
Although the full study on the response of retention of lead against 
weights of calcium and phosphorous was only performed on subject K.B., 
the effect of different weights of these minerals on retention was 
examined in four other subjects at the maximum weights and in three of 
these subjects at one tenth the maximum weights of calcium and 
phosphorous. Even though the scatter of the retention results of 
these subjects was consideDable at these two different weights, the 
means were sufficiently far apart to confirm the overall response of 
the retention of subject K.B. against different weights of calcium and 
phosphorous. 
Increasing weights of calcium and phosphorous resulted in progressively 
lower retentions of 203 Pb in the subject K.B. A ~imilar effect was 
observed in rats by Meredith et al (1977) when 203 Pb was administered 
orally with different concentrations of calcium chloride. They found 
that the 5 day retention of 203 Pb decreased exponentially as calcium 
concentration increased, and that doses of calcium above a certain 
concentration did not reduce retention further. In the present 
experiment, however, the relationship between weights of calcium and 
84 
phosphorous and retention could be described by two negative 
exponentials. Unlike the results of Meredith et al (1977 ) , i ncreasing 
weights of calcium and phosphorous continued to reduce retention. The 
fit of the exponential function was not unique, but the presence of the 
more slowly changing second exponential does suggest that phosphorous 
was still reducing retention at high weights of these two minerals. 
The shape of the curve of 96 hour retention of subject K.B. against 
weight of minerals could be explained by the early rapid fall of 
retention caused by calcium and the later slower reduction caused by 
phosphorous. Meredith et al (1977 ) concluded that two mechanisms for 
the transport of lead across the gut wall were responsible for the 
relationship between retention and calcium concentration found in 
their experiment. One of the mechanisms was suggested to be a common 
pathway for the absorption of calcium and other minerals, such as lead, 
from the gut. This had been suggested before by Six and Goyer (1970). 
In the present experiment, the other mechanism could be a .. common 
pathway for the absorption of phosphorous and lead as suggested by 
Smith et al (1978 ) . The results could again be explained, therefore, 
i f lead is absorbed by two separate pathways, one which i t shares 
specifically with calcium and the other specifically with phosphorous. 
The response of 96 hour retention with different weights of calcium 
and phosphorous has three distinct regions, A, 8, and C shown in 
figure 6. 3. 2. 
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a) Region A 
In this region, calcium and phosphorous did not reduce the retention 
of 2 03 Pb, even though the weights of minerals were approximatel y 150 
times the weight of lead at the shoulder of the curve between region 
A and B. A similar effect was observed by Conrad and Barton (1978 ) 
i n rats given 2 03 Pb intragastrically with different amounts of carrier, 
lead chloride. Absorption was not reduced unt i l a carrier weight was 
used 10 5 times greater than the lowest carrier weight. This suggests 
that, in region A, the common pathways for lead, calcium and 
phosphorous are able to accommodate the concentrations of these 
elements present in the lumen, or it suggests pathways that are 
separate for all three. Barton et al (1978 ) found, however, that when 
equimolar quantities of 2 03 Pb chloride and calcium chloride were 
injected into isolated duodenal segments of the rat, absorption of 
2 03 Pb was reduced. Approximately the same reduction in absorption was 
found by Meredith et al (1977 ) when they gave rats oral 2 03 Pb chloride 
and calcium chloride, except that a calcium/ lead ratio of 10:l was 
r equired. Although these results were obtained from animal 
experiments, they appear to contradict the finding of no effect of 
calcium and phosphorous on retention in region A. 
In these three animal experiments of Conrad and Barton (1978), Barton 
et al (1978 ) and Meredith et al (1977 ) , however, tbere are differences 
in the percentage of 2 0 3Pb absorbed by control rats. The retention 
of lead by control rats in the experiments of Conrad and Barton (1978 ) 
and Barton et al (1978) was 4% and 18%, respectively, of the 
administered dose, and it was 2.3% in those of Meredith et al (1977 ) . 
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Although the methods used to measure the gastrointestinal absorption 
of lead differed in the two experiments of Conrad and Barton (1978) 
and Barton et al (1978) when compared with that of Meredith et al 
(1977), the results are comparable as both sets of workers effectively 
measured 203 Pb in the body without the unabsorbed fraction of 203 Pb. 
Conrad and Barton (1978) and Barton et al (1978) measured whole body 
radioactivity, with intestinal segments removed from the carcass, at the 
time of maximal absorption of 203 Pb (4 hours ) after administration of 
the dose. Meredith et al (1977) measured whole body retention at 120 
hours, by which time the unabsorbed fraction of 203 Pb should have been 
excreted. The excretion of previously absorbed lead in this last 
experiment would produce a slight under estimation of absorption. All 
the rats were fasted overnight in each of the experiments, so it is 
unlikely that the presence of food in th~gut influenced absorption. 
There were differences, however, in the solutions administered to the 
rats. Conrad and Barton (1978) and Meredith et al (1977 ) gave rats 
lead doses in l ml of distilled water (neutral pH), but Barton et al 
(1978) administered the doses in a solution of pH 4.0. In the same 
work, Barton et al (1978) found that the solubility of lead was 
dependent on the pH of the solution; lead precipitating at neutral pH. 
Conrad and Barton (1978) showed that the solubility of lead in the 
intestinal contents increased absorption, and that there was a 
difference in absorption of lead from an oral dose compared to that 
from an isolated duodenal loop. The increased absorption of lead from 
the duodenal loops was attributed to differences in the pH of the lead 
solution, prolonged exposure of lead to absorptive cells of closed loop, 
or a possible gastric inhibitor of lead absorption. 
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The low pH of the solutions administered by Barton et al (1978) would 
render lead and calcium more soluble in the intestinal contents. 
Calcium, like lead, is more soluble in solutions of low pH (Wilkinson, 
1976). A larger fraction of lead and calcium would be more available 
for absorption, than if the doses had been given in neutral pH 
solutions. The common pathways of absorption would not be able to 
accommodate these larger fractions, and competitive inhibition of lead 
absorption by calcium would occur. The result would be a higher 
absorption of lead in the absence of calcium and marked reduction of 
lead absorption with concomitant calcium. These were the differences 
between the results of Barton et al (1978) and those of the other two 
groups. 
Therefore, the absence of any effect of increasing weights of calcium 
and phosphorous on absorption of tracer lead in region A, although 
similar to the effect of increasing weight of intragastrically 
administered carrier lead in rats, has not been entirely confirmed in 
animal studies. There is a suggestion that such a non interactive 
region exists but the different experimental conditions of the animal 
studies hinder any positive confirmation. 
b) Region B 
Over the region B, the whole body retention of 203 Pb fell very rapidly 
with increasing weight of calcium and phosphorous, so that it is 
unlikely that lead, calcium and phosphorous have separate absorptive 
' 
pathways. Doubling the weight decreased retention by a factor of 5. 
Barton et al (1978 ) , however, observed a decrease by only a factor of 
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2 on increasing the weight of calcium by a factor of 10 4 , and the same 
decrease in retention occurred in the work of Meredith et al (1977 ) 
when the weight of calcium was increased tenfold. Both groups of 
workers, therefore, observed much smaller reductions in retention than 
that found in this study. 
As the effect of calcium on the absorption of lead in subject K.B. was 
found to be much greater than that of phosphorous, calcium was probably 
responsible for most of the reduction in retention in region B, by 
competing with lead for some common transport mechanism (Six and 
Goyer, 1970 ) . Competitive inhibition of this type is a characteristic 
of active transport, but cannot be used solely to distinguish this from 
other types of membrane permeation (Wilson, 1962 ) . Nevertheless, 
calcium is mainly absorbed by active transport across the intestinal 
wall (Schachter et al, 1960), and the inhibition of lead absorption 
could be caused by lead partially sharing the same active transport 
system. 
Although the bulk of the evidence from animal experiments suggests that 
lead is passively diffused across the intestinal wall (Grunden and 
Stantic, 1975; Blair et al, 1978 ) , most i s derived from an in vitro 
procedure, the everted sac preparation of Wilson and Wiseman (1954) . A 
ratio of serosal-to-mucosal concentration of lead above unity 
indicates the existence of active transport. Grunden and Stantic(l975 ) found 
+ + + ratios of 1.10 - 0.16, 1.15 - 0.12 and 1.32 0.09 for the duodenum, 
jejenum and ileum which does suggest slight active transport even if the 
ratios are not as great as that achieved using calcium, which was 
+ 7.57 - 1.26 for the duodenum segement. 
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The everted sac technique has been used extensively in research into 
intestinal absorption (Smyth, 1972 ) , but there are i ndications that 
the application of the technique may be invalid in the work of Grunden 
and Stantic (1975 ) . They used an incubation time of 90 minutes in 
their experiments, and it has been found that after 60 minutes of 
incubation, sac preparations can deteriorate (Smyth, 1972) . It was 
also not clear from their work how the serosal-to-mucosal ratios were 
measured. If the concentration of 20 3 Pb was measured then the results 
may be in error, as Blair et al (1979 ) have shown that with the e~erted 
sac preparation the transport of lead is related to water movement. 
Serosal-to-mucosal ratios should be measured using the total fluid 
content of 2 03 Pb, as dilution of the serosal lead would decrease the 
ratio if concentrations were measured. 
It has been shown that the presence of bile in t he intestinal lumen can 
increase the gastrointestinal absorption of 20 3 Pb in the rat by a 
factor of 2 (Cikrt and Tichy, 1975; Conrad and Barton, 1978 ) . There 
was no reference to the presence of bile in the sac preparations in 
either of the work of Grunden and Stantic (1975 ) or Blair et al (1979 ) . 
Therefore, the conclusion of Grunden and Stantic (1975 ) that active 
transport of lead does not exist, may not be true. 
Evidence that suggests lead may share the same active transport system 
of calci um was found by Barton et al (1978 ) . They discovered that, 
i n vivo, lead bound to two heat-stable intestinal mucosal fractions 
which also bound calcium. Substantial amounts of lead and calcium 
were found in both fractions with 35.9% of the lead bound to the higher 
molecular we i ght fraction and 8.0% bound to the lower mo l ecular weight 
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vitamin D-induced calcium binding protein (CaBP ) . The addition of 
calcium diminished the amounts of lead bound to the high molecular 
weight protein and vitamin D dependent CaBP by factors of 2.5 and 8, 
respectively. Vitamin D has also been shown to increase lead 
absorption in rats (Sobel et al, 1940 ) , which supports the findings of 
Barton et al (1978) that lead binds to vitamin D-induced CaBP. The 
sharing of binding sites with calcium and the vitamin D dependence 
suggests that lead has an affinity for the active transport 
responsible for calcium absorption. 
In summary, region 8 of the response of whole body retention against 
weights of calcium and phosphorous could describe competitive 
inhibition of lead by calcium for binding sites on the vitamin D-
dependent CaBP (Quarterman et al 1978a; Waldron and Stofen, 1974 ) , 
which is part of the active transport mechanism known to be responsible 
for calcium absorption from the small bowel. 
c) Region C 
In this region, the reduction in retention by increasing weights of 
calcium and phosphorous was much less than in region 8. A change in 
retention by a factor of 4 was only achieved by increasing the weights 
by a factor of 10 . The marked discontinuity between regions Band C 
could be explained if the shared binding sites on the vitamin D-induced 
CaBP become saturated with calcium, another characteristic of an active 
transport system (Wilson, 1962). The maximum capacity of the active 
transport component of calcium absorption in normal humans has been 
calculated to be 8.2 mg/kg/day (Marshall, 1976 a). With subject K.B., 
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weighing 72 kg, and assuming a transit time through the small bowel 
of 4 hours (Eve, 1966), saturation would occur with an ingested 
calcium dose of 98 mg. This agrees quite well with the actual dose 
of 70 mg calcium ingested by the subject at the discontinuity of the 
response curve. The reduction in retention in region C, therefore, 
could be primarily caused by competition between lead and phosphorous 
for common pathways of absorption as suggested earlier. 
7.1 
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S E C T I O N 7 
DISCUSSION 
Results of the four gastrointestinal absorption experiments 
The results of the preceding four sections (3.0-6.0 ) show that 
eight human subjects, who had fasted adequately, absorbed 
approximately 70% (table 7.1.1) of a quantity of lead comparable to 
that of the normal intake per day of dietary lead. Food in the gut, 
particularly the calcium and phosphorous content of that food, reduces 
the gastrointestinal absorption of lead considerably. 
Variation in the gastrointestinal absorption of lead is small between 
subjects who have fasted adequately. The coefficient of variation · 
for the 96 hour retentions of the eight subjects is 4.6% ( table 7.1.1). 
When there is competition between lead, calcium and phosphorous for 
absorption in the gut, however, individuals absorb different amounts 
of lead. This effect may be caused by differences in the efficiency of 
absorption of calcium and phosphorous between individuals, if there are 
common pathways of absorption of these elements and lead in the gut. 
Phang et al (1969) found individual variation in the ability of human 
subjects to utilize an increased dietary calcium load, and Marshall 
(1976 a ) showedi by using a· sjmple compartmental model, t hat t he 
fractional rate of absorption of calcium in 152 normal subjects showed 
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TABLE 7 .1.1 
% Whole body retention of orally ingested 2 03 Pb 













All doses included carrier lead. 
t ! l standard deviation. 
96 HOUR RETENTION 
C ?a) 
65.42 ! o.23t 
71.70 + - 0.27 
73.93 + - 0.24 
71. 71 + - 0.27 
75.82 + - 0.69 






+ - 0.23 
+ - 0.66 
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a l og normal distribution with values ranging from 0.2 hour- 1 to 
1. 4 hour- 1 • Similarly the fractional rate of absorption of phosphorous 
was also shown to be log normally distributed in normal humans, with 
a similar range to that of calcium (Marshall, 1976 a ) . 
Although the solubility of lead in intestinal contents was shown by 
Conrad and Barton (1978 ) to affect the absorption of lead, and, 
likewise, the presence of chelating agents (Garber and Wei, 1974 ) , the 
experiments in section 6.0 were designed to study the effect on 
absorption of only calcium and phosphorous. Any differences in 
absorption observed between different subjects were probably caused by 
individual differences in the efficiency of shared absorptive 
pathways used by lead. 
The effects of calcium and phosphorous on the gastrointestinal 
absorption of lead were produced with levels of these three elements 
which are physiological, and which occur in a normal human diet. The 
weight of carrier lead, 300 µg of lead chloride, is at the top of the 
range, 200-300 µg, estimated by the WHO (1977 ) to be the dietary lead 
consumed per day by humans .• The maximum weights of calcium and 
phosphorous were 0. 7 g and 0.5 g, respectively, whereas the calcium 
and phosphorous intake of reference man is 1.1 g calcium per . day and 
1.4 g phosphorous per day ( ICRP, 1975 ) . Even a tenth of the maximum 
weights of calcium and phosphorous produced a considerable reduction 
in absorption, and the large range of percentage lead absorbed, when 
taken between meals by t he subjects in section 3.0, was probably 
caused by residual calcium and phosphorous in the gut. 
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These findings may significantly affect any assessment of the possible 
risks of environmental lead to certain population groups and to the 
population as a whole. It is emphasised, however, that experiments 
were not carried out with dietary lead in its natural state. Dietary 
lead will exist in different chemical forms which have been shown to 
affect the absorption of lead, and this has not been investigated in 
this thesis. Rabinowitz (1974), however, found that the greatest 
effect on lead absorption was produced by the presence of food in the 
gut and not by different chemical forms of lead. 
Lead must be in solution before it is absorbed and even the most 
'insoluble' lead salts and metallic lead if finely divided are soluble 
in digestive juices (Sollman; 1957 ) . Chamberlain et al (1978 ) 
showed that 14% of insoluble 203 Pb chromate was absorbed in a human 
subject, which they regarded as typical for unspecified compounds and 
dietary states. Rabinowitz (1974 ) found that the absorption rates of 
the tracer, lead nitrate, and of food lead when eaten together were 
nearly the same. 
The lead was ingested as a single dose by the subjects in this thesis 
unlike the normal exposure of humans to multiple intake of unknown 
frequency and duration. The effects of calcium and phosphorous on the 
absorption of lead would be considerably greater in a single dose, but 
even low concentrations of calcium and phosphorous, probably more 
representative of multiple intake , were shown to reduce the absorption 
of lead. 
The effects of calcium and phosphorous on the absorption of oral lead 
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have a special significance in children, women and individuals who 
appear to be susceptible to the toxic effects of lead (section 1.4). 
Dietary surveys of urban poor groups have observed low calcium intakes 
in children. In one study by Stubbs (1965) in Texas, mean calcium 
intakes of pre-school children of white urban poor were 73 percent and 
those of negro pre-school children were 47 percent, respectively, of 
that recommended by the National Research Council (1968) as the daily 
allowance for calcium. In a nationwide survey conducted in the United 
States in 1965, it was shown that the average diets of girls (15 to 17 
years) and of women ( from 35 years on ) were about 35 percent below 
Recommended Dietary Allowances for calcium (Krause and Mahan, 
1979). Diets deficient in calcium would cause increased absorption of 
food and water lead, higher body burdens of lead and, consequently, 
apparent increased susceptibility to the toxic effects of lead. 
The doubts expressed by the WHO that the accepted level of 10% 
absorption may not apply to lead in water and that dietary constituents 
may also alter this percentage (section 1.0 ), have been substantiated 
by the present findings. The highest percentage absorption of lead 
occurred, seven times the accepted level, when it was ingested in water 
with no added minerals. Lead in water, particularly in 'soft water', 
may present a serious hazard to the general population. The accepted 
level of 10% absorption would certainly not apply if diets were 
deficient in calcium, and, to a lesser extent, deficient in 
phosphorous. Because of the relatively large quantities of calcium 
and phosphorous consumed in food compared to lead, they have a profound 
effect on the absorption of lead which can vary from individual to 
individual. Therefore, to establish a mean percentage uptake of 
7.2 
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dietary lead is extremely difficult, but it should be recommended 
that, particularly in children, the dietary levels of calcium and 
phosphorous should not fall below normal requirements. 
Interrelationship between lead, calcium and phosphorous absorption 
From the review of the literature and the results of the lead 
absorption experiments performed so far, it is possible to suggest the 
mechanisms by which lead is gastrointestinally absorbed, and how 
calcium and phosphorous interfere with lead absorption. It must be 
emphasised that none of the experimental work performed can directly 
prove the suggested interrelationship between lead, calcium and 
phosphorous. Before describing this proposed interrelationship, 
it is necessary to summarize the present concepts of calcium and 
phosphorous absorption in the gut. 
7.2.1 Active and passive transport of calcium and phosphorous 
Both calcium and phosphorous are absorbed by active and passive 
transport. Active transport of calcium is dominant in the upper small 
intestine, while diffusion appears to make a relatively greater 
contribution to absorption in the lower small intestine (Marshall, 
1976 a). Phosphorous is absorbed throughout the whole small intestine 
but the active component is small in comparison to the diffusion 
component (Marshall,1976 a ) . There is a correspondence between CaBP 
levels and the efficiency of calcium absorption, with CaBP levels 
highest in the upper small intestine and lowest in the lower small 
intestine (Wasserman and Corradino, 1973 ) . Although phosphorous does 
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not appear to bind the CaBP and no phosphorous binder was found in 
the lower small intestine of the chick (Wasserman and Taylor, 1973 ) 
there is evidence to suggest that phosphorous may be transported by 
a carrier mediated transport in the upper small intestine of man. In 
the normal human, the plasma levels of calcium and phosphorous rise at 
the same rate and reach a maximum at approximately 2 hours after 
their oral administration. It is unlikely that such rapid absorption 
of phosphorous could occur by diffusion alone. In a human with calcium 
malabsorption, however, plasma levels of calcium and phosphorous remain 
low and do not peak at 2 hours. Plasma levels of phosphorous rise 
later and contin8e to rise over a 2-4 hour period which suggests 
diffusion of phosphorous in the lower small intestine (Marshall, 1976 ~) . 
7. 2.2 Inhibition of the absorption of lead by calcium and phosphorous 
Approximately 70% of an oral dose of 203 Pb, mixed with normal dietary 
quantities of lead, is retained at 96 hours when there is no 
concomitant calcium and phosphorous present in the gut. If lead and 
calcium shared the same pathway of absorption in the upper small 
intestine, it should be expected that small amounts of dietary lead 
should be absorbed with the same efficiency as small amounts of 
calcium. The net amount of calcium absorbed in normal humans, however, 
is lower at approximately 31% (Saville, 1973 ) , but the net amount is 
less than true absorbed calcium by an amount equal to the endogenous 
faecal calcium. True absorbed calcium can be as high as 60% when the 
amount of dietary calcium is very low (Wilkinson, 1976 ) . The 
measurement of gastBointestinal absorption of lead is not complicated 
by large amounts of endogenous lead, as both the normal body content of 
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lead and, consequently, the amount of endogenous f aecal lead are much 
lower than those of calcium. Small amounts of lead and calcium, 
therefore, appear to be absorbed by the gut with the same efficiency. 
The addition of calcium and phosphorous to the oral lead dose will 
mean competitive inhibition between lead and calcium, and to a lesser 
extent between lead and phosphorous giving rise to low absorption of 
lead. The synergistic effect obtained by adding phosphorous to calcium 
could be caused by increased competition of both calcium and 
phosphorous with lead for specific-carrier binding sites in the upper 
small intestine or by an intracellular enhancement of calcium 
absorption by phosphorous. Calcium is thought to be transported across 
the intestinal cell by the mitochondria (Wilkinson, 1976 ) , on which it 
is taken up by an energy dependent process (Mela, 1969; Chance 
and Mela, 1966; Ghosh and Chance, 1970 ) . Increasing the 
concentration of phosphate in a bathing medium containing monkey 
kidney cells increased the uptake of calcium in the mitochondrial 
compartment (Borle, 1971 ) , and this may also occur in the intestinal 
absorption cell. Lead may utilise the calcium carrier system of the 
mitochondria in isolated heart mitochondria (Scott et al, 1971 ) , so 
that the increased uptake of calcium in the presence of phosphate 
could reduce the uptake of lead on the mitochondria in the intestinal 
cell. Lead is also passively bound to isolated heart mitochondria, and 
in the presence of phosphate virtually no lead is available to interact 
with the mitochondrion (Koeppe and Miller, 1970; Brierley et al, 1971; 
Cardona et al, 1971). If intracellular binding of lead is reduced, 
lead transported into the cell could diffuse out again into the lumen 
of the small bowel when the concentration of lead in the lumen was 
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lower than that in the cell. The result would be a reduction in the 
amount of lead absorbed giving lower whole body retention. 
Unabsorbed lead further down the small bowel beyond the region of 
maximal calcium absorption, could still be absorbed by the phosphorous 
transport system. The true absorption of phosphorous at low dietary 
levels is approximately 100% (Wilkinson, 1976 ) . If the absorption 
pathways of phosphorous and lead are shared, the remaining unabsorbed 
lead should be completely absorbed giving nearly 100% retention. As 
this does not occur, lead may have less affinity for the absorption 
pathways of phosphorous than those of calcium. This was suggested by 
the greater effect of calcium than that of phosphorous on the 
absorption of lead in subject K.8. 
A fraction of the remaining lead, however, may be unavailable for 
absorption. The solubility of lead in the intestinal contents affects 
absorption (Conrad and Barton, 1978 ) . As the pH of the small 
intestinal contents rises from upper to lower regions (Fordtran and 
Locklear, 1966 ) , lead may complex with phosphate and oxalate becoming 
less available for absorption. The remaining unabsorbed or complexed 
lead passes into the large bowel from which it is eventually excreted 
in the faeces. 
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S E C T I O N 8 
COMPARTMENTAL ANALYSIS OF THE KINETICS OF ORAL 203 Pb 
INGESTED WITH AND WITHOUT CALCIUM AND PHOSPHOROUS 
IN FIVE SUBJECTS 
8. 1 Introduction 
In animals, changes in the dietary levels of calcium and phosphorous 
affect the absorption, distribution and excretion of lead (sections 
1.5.1-1.5.3). The results so far in the present work have shown that, 
in humans, minerals also affect absorption, and, possibly, distribution 
and excretion of tracer lead when they are ingested with a single dose 
of tracer. In section 5.0, the ingestion of minerals with 203 Pb was 
found to reduce the levels of 203 Pb in the blood of two subjects, 
K.B. and D.W., when these levels were expressed as percentages of 96 
hour retention. The degree of change in subject O.W., however, was 
much greater, which could indicate possible individual variation in 
the distribution of 203 Pb between the two subjects. However, his 
levels of 203 Pb in urine were also reduced when expressed in the same 
way as blood, whereas those of subject K.B. were not. It was 
suggested that the discrepancy could be caused by the 96 hour retentions 
of these two subjects not reflecting the absorption of 203 Pb 
accurately. As these retentions were very low, any unabsorbed 203 Pb in 
the body would have a considerable effect on the measurement of 
retention. The problem could not be resolved, however, with the 
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limited data available on distribution of 203 Pb in section 5.0. 
These changes in the distribution of 203 Pb were caused by the total 
minerals, and direct evidence of an effect of only calcium and 
phosphorous has not been demonstrated. However, the change in 
absorption and excretion in 203 Pb caused by all the minerals (section 
5.0) was very similar in degree to that caused by calcium and 
phosphorous alone (section 6.0), which suggests that these two 
minerals were mainly responsible for the distributive changes. 
As calcium and phosphorous are mainly responsible for reducing the 
absorption of lead in the gut of humans, it is important, as outlined 
in section 1.5, that their effect on the distribution and excretion 
of lead should be examined more closely. This will help to evaluate 
their overall influence on the behaviour of lead in the body and on 
the susceptibility of individuals to the toxic effects of lead .. 
The different states of a tracer, characterized by the distribution 
(in a body fluid, in an organ) or by chemical form (protein bound, 
free state or by-product), may be described by a system with a finite 
number of compartments, A model can be built with these compartments 
and with defined . probabilities of transfer of tracer between the 
compartments. This model can then be used to describe the kinetics 
of the tracer in the system. The model may be ~developed from 
some a priori knowledge about the system, from the experimental 
data, or by trial and error and the intuition of the research 
worker. Once the appropriate model is decided upon, it can be 
represented in a mathematical form. The response of any system, 
even non linear, to a tracer is always linear (Berman et al, 1968 a ) ; 
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provided the following assumptions hold. 
(1 ) the system i s in a steady state, 
(2) there is complete mixing of tracer and tracee material in each 
compartment and this mi xing is rapid in comparison with the rates 
of transfer of material between compartments, 
(3) the amount of tracer added to any compartment is negligible in 
comparison to the size of the compartment ( Jacquez, 1972 ) . 
The system can be described mathematically by linear differential 
equations, which can be solved by either analytical or numerical 
procedures. The solution of these equations gives values of the model 
parameters that can be used to reproduce thi experimental data. If 
satisfactory agreement is not obtained between calculated and 
experimental data, the model may be revised until agreement is reached. 
The advantages and disadvantages of compartmental analysis have been 
described by Berman ( 1974) . Mechanistic, biochemical and mathematical 
descriptions of systems may be obtained as an aid in understanding 
physiological processes, such as metabolism. Compartmental models can 
be built compatible with the resolution of data, they can handle 
discrete as well as incomplete data, and all the information contained 
in a tracer response curve can be used. However, care should be taken 
interpreting the results of analysis, as model parameters are 
frequently i dentified with physiological entities without adequate 
confirmation, and this can be highly speculative. Compartmental 
modelling may also be cumbersome, and models are sometimes arbitrary 
in structure or loosely defined. 
104 
8.1.1 Review of models in literature 
Several attempts have been made to describe the kinetics of lead in 
the human by linear compartmental models. Bernard (1977 ) used a 
mammillary compartmental model, and, with published data on baboons 
and reference man (ICRP, 1975), generated equations describing the 
distribution of lead in organs and tissues and the retention of lead 
in the human body. However , no details were given of how the number 
of compartments or pathwayd between compartments were chosen. 
An attempt by Rabinowitz et al (1976) was based on experimental studies 
on five healthy men using stable lead tracers. The subjects ate 
constant low lead diets for 1-124 days, and each day the diets were 
supplemented with 204 Pb nitrate. The concentration and isotopic 
composition of lead was determined serially in blood, urine, faeces 
and diet, and less frequently in hair, nails, sweat, bone and 
alimentary secretions. A three compartmental model consisting of blood, 
soft tissue and bone was developed from the observed isotopic 
composition. The authors stressed, however, that there could be many 
more physiological pools of lead. Linear differential equations with 
time-independent rate constants were used to describe the observed 
concentration · of tracer lead in blood and in other tissues and fluids. 
Their results included the steady-state pool sizes, mean lives, and the 
transport of lead in their model. 
Batschelet et al (1979) used the model developed by Rabinowitz et al 
(1976 ) to assess the effect of increasing daily input from the air on 
lead levels in the blood. They included two more compartments to 
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represent the lungs and gastrointestinal tract, and, using the data 
and the results of kinetic analysis given in Rabinowitz et al (1973 ) , 
obtained a solution to the differential equations describing their 
model. Their results showed that the blood level of lead depended 
linearly on the intake of lead from the air, provided the kinetics of 
lead could be described by linear processes. 
All these models were developed to describe . the behaviour of lead in a 
steady state, and not that of a single dose of tracer lead taken up in 
the body. Rabinowitz et al (1974), however, had performed one 
experiment in which a human subject received a single dose of 204 Pb. 
They found that the isotopic composition of 204 Pb and normal lead in 
red cells and plasma differed widely in blood samples taken at 6 hours 
after ingestion of 204 Pb. They were also unable to account for all the 
absorbed 204 Pb in the blood compartment at 6 hours. They concluded 
that the lead temporarily 'disappeared' into a compartment different to 
blood and returned to the blood during the next day or two. They 
suggested that for short term studies a model suitable for analysis of 
lead kinetics would have to include a plasma, red cell and another 
compartment different to that of the blood compartments. 
Chamberlain et al (1978) suggested a similiar change to the three 
compartmental model of Rabinowitz et al (1974). They proposed that as 
the initial uptake of lead from lung and gut was in plasma, the lead 
would distribute from the plasma to red cells, bone and other storage 
sites. 
Compartmental models developed to describe the steady state levels of 
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lead in the human appear to be inadequate to describe the short term 
kinetics of a single tracer dose of lead. Furthermore, two of the 
models assumed constant input of lead from the environment, and 
the third allowed for changes to occur in the input of lead from 
the air. None of the models allowed for changes in the input of 
lead from gut and the effect of such changes on the model parameters. 
A model that describes the short term kinetics of 203 Pb and the effect 
of calcium and phosphorous on the absorption of 203 Pb could be 
complicated. The two extra compartments suggested by Rabinowitz et al 
(1974) and the two compartments added to their three compartmental 
model by Batschelet et al (1979), gives a model with 7 compartments. 
8.1.2 Choice of compartments 
The first step in the compartmental analysis of the kinetics of a 
tracer in a system is to d~termine the compartments of the model. The 
response of the tracer in the system can often be used to find the 
number of compartments. For example, when a tracer is injected rapidly 
into the blood circulation, the number of exponentials required to fit 
the plasma clearance curve of the tracer is chosen as the number of 
compartments (Berman et al, 1962a ) . However, when the entry of the 
tracer into the blood is relatively slow, as in gastrointestinal 
absorption, no information may be obtained from the exponential 
analysis of tracer levels in the plasma. The initial selection of the 
compartments of a model describing the behaviour of gastrointestinally 
absorbed lead in the human will have to be made from the known 
distribution of tracer lead in humans and animals. 
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Rabinowitz et al (1974; 1976) developed a compartmental model 
consisting of blood, soft tissue and bone compartments. They found 
that their model was inadequate to explain the short term kinetics of 
tracer lead in humans. They suggested, however, that such a model 
would require the blood compartment divided into plasma and red cell 
compartments. A separate plasma compartment was also suggested by 
Chamberlain et al (1978). Other compartments may be found from animal 
studies in which the distribution of tracer lead has been extensively 
examined. Lloyd et al (1970) measured the distribution of 
intravenously administered 210 Pb in a beagle at 28 days post 
injection. They determined the 210 Pb content of 19 different bones~ 
and 24 different tissues, and found that 24% of the administered dose 
was in the skeleton, 8% in the liver, 3% in the blood and 0.5% in the 
kidneys. The liver and kidneys were the organs with the highest 210 Pb 
content. Cohen (1970) administered intravenous 210 Pb to. baboons, and, 
in one baboon sacrified at 24 hours, he measured _the 210 Pb content io 
13 different tissues. He found that the 210 Pb contents of liver and 
kidney were the highest of all tissues at 12.8% and 3.48% of the 
administered dose, respectively. Another study on the distribution of 
tracer lead was performed by Potter et al (1971 ) , in which a single 
dose of oral 203 Pb was administered to a calf. The distribution of 
203 Pb was measured in bone and 17 different tissues and fluids, and 
0.4% of the administered dose was in the liver, 0.4% in the bone and 
0.1% in the kidneys. Barltrop and Khoo (1975) fed rats 203 Pb as part of 
their diet for 48 hours, and sacrificed the animals at tbis time. They 
measured 0.06% of the administered dose in the liver, 0.03% in the 
kidneys, 0.02% in the femur and 0.002% in the blood. 
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The liver and kidneys of different animals, therefore, appear to 
accumulate tracer lead, even when it was administered by different 
routes. If it is assumed that the excretory function of these two 
organs is the same in the human as in animals, it suggests that the 
liver and kidneys wi ll also accumulate tracer lead in man as they 
have been found to do with stable lead (Goyer and Rhyne, 1973). The 
wall of the small bowel has also been shown t o accumulate tracer lead, 
although this has been mainly demonstrated in in vitro studies. 
Grunden and Stantic (1975 ) showed that 55% of the initial mucosa! 
radioactivity of 2 03 Pb was accumulated in the wall of everted sacs 
prepared from the small bowel of rats. Although doubts we~e raised 
about the long incubation time of 90 minutes in this study (section 
6.4.2), accumulation of lead in the wall of the small bowel was 
confirmed by the similar studies of Blair et al (1979 ) . They showed 
rapid and massive binding of tracer amounts of stable lead after 
incubating everted sacs for the more accepted length of time of 60 
minutes. Conrad and Barton (1978 ) confirmed the findings of these 
in vitro studies in experiments on rats injected intravenously with 
210 Pb. The 2 10 Pb content of the small bowel remained at approximately 
3% of the injected dose for the f i rst 8 hours, and then decreased 
rapidly with a 24-hour half life. 
The evidence from animal studies suggests that compartments 
representing wall of small bowel, liver and kidney should be added to 
the steady state model of Rabinowitz et al (1974; 1976) . The original 
blood compartment should be divided into plasma and red cells, and the 
bone and soft tissue compartments retained. These compartments may 
then be sufficient to build a pEeliminary model describing the short 
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term kinetics of tracer lead in the human. 
8.1.3 Experimental data requirements 
Once the compartments have been chosen, it is necessary to determine 
the interconnections or pathways between compartments. The most 
general model would result if tracer is allowed to move in both 
directions between compartments, and only more information about the 
system may decide the selection of a particular model. Such 
information might come from experimental data describing the kinetics of 
the tracer from the system, or from certain physiological and 
biochemical restrictions known about the system which might impose a 
certain structure upon the model. 
The experimental data should be measures of the response of the tracer 
in each compartment of the system, and, if this is the case, the 
parameters of the model can be determined uniquely (Berman et al, 1962 a ) . 
If the data are insufficient, assumptions may be introduced making the 
model simple and of a certain class, but this is not always sufficient 
for uniqueness (Berman, 1963). 
In the model suggested in section 8.1.2, serial measurements of tracer 
can be made directly from plasma and red cells. When radioactive 
tracers are used, external measurements of radioactivity can be 
performed over selected areas of the body that predominantly include the 
compartments of interest. S~rface radioactivity measurements over small 
bowel, liver and kidney will provide information on tracer levels in 
these three organs, and information on soft tissue and bone levels may 
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be obtained from areas in which these tissues predominate, such as the 
calf and ankle, Similiar measurements were performed by Neer et al 
(1967) and Cohn et al (1965 ) , to obtain information on the kinetics of 
47 Ca in normal adult males. In addition, Cohn et al (1965 ) measured 
whole body radioactivity of 47 Ca to provide information on tracer 
levels in all the compartments. 
Once all the information on the system has been collected, it can be 
used to decide on a preliminary structure of the model. This can then 
be represented mathematically by a set of linear differential equations. 
8. 1.4 Model solution 
The solution of the set of linear differential equations, which 
characterize the model, gives values of the parameters that can be used 
to reproduce the e~perimental data. The solution may be obtained 
analytically, but, if the model is complex, the mathematical 
operations required can be difficult. A solution may be found 
numerically, however, and Berman et al (1962b; 1965 ) have developed an 
integrated methodology of general use, programmed for digital computers 
in such a way that it can be used without understanding the 
sophisticated hardware and the complex mathematics. The program is 
called SAAM (Simulation, Analysis and Modelling), and the final version 
is SAAM25 (Berman and Weiss, 1967). 
The SAAM25 program is described in Appendix D, but, in essence, it 
allows the setting up of the differential equations directly and allows 
the values of the variable parameters, such as rate constants between 
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compartments, to be adjusted until a satisfactory fit to the 
experimental data is obtained. This method is highly desirable 
because it calculates the final values of the variable parameters 
directly, yields measures of their uncertainties, can accept data in 
'raw' form and requires no intermediate calculations. However, it has 
several disadvantages. It may be both difficult to decide on the 
number of compartments for the model, and to assign initial estimates 
for the values of the parameters. These initial estimates are required 
for a numerical solution. Convergence may also be slow due to 
interdependence of parameters when fitting the experimental data. 
The SAAM25 program was originally developed for the solution of linear 
compartmental models, such as encountered in radionuclide tracer 
experiments, and has been used extensively to study the kinetics of 
calcium (Cohn et al, 1965; Neer et al, 1967; Phang et al, 1969; 
Birge et al, 1969). Of particular relevance to the proposed ._ 
compartmental analysis in this thesis, was the work of Birge et al 
(1969) on the gastrointestinal absorption of 47 Ca in humans. They 
obtained an input function, representing the entry of 47 Ca into the 
plasma, by the deconvolution of 47 Ca levels in the plasma, and the 
characteristics of this input function were described by a 
compartmental model with 11 compartments. Using this model, they were 
able to distinguish clearly between the effects of disease and calcium 
loading on calcium absorption in human subjects. Similar results will 
be required from the compartmental analysis of the kinetics of orally 
ingested tracer lead, to explain the effects of calcium and 
phosphorous on the behaviour of the tracer in the body. 
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8.1.5 Testing the model 
Finally, the model should be judged to be consistent and unique. 
Systematic deviations between calculated and observed values indicate 
the model is inconsistent and needs a greater degree of freedom. This 
can be done by the addition of new parameters. When systematic 
deviations do not occur, but the calculated parameter values have large 
standard deviations, the model is not unique. This can occur when the 
quantity of information contained in the experimental data is 
inadequate to completely define the model. New experimental data or 
additional physiological and biochemical information about the system 
is required to change the model. Convergence to a least squares 
solution should be obtained. Failure to do so may be caused by 
interdependence of parameters, which will occur when there are a 
number of compartments in series, and haw well the initial estimates 
of the variable parameters have been chosen (Berman et al, "1962 b). 
A poor choice of initial estimates will mean that the adjustment of 
parameters in the iterative procedures will not be sufficient to 
significantly change the sum of squares, so that the solution will 
terminate with no convergence. 
8.1.6 Summary 
It appears possible that effects of calcium and phosphorous on the 
gastrointestinal absorption of lead may be studied by using a 
compartmental model. There is enough information in the literature to 
suggest a model to describe the distribution of lead in the human, and 
there should be enough experimental data available to test such a model 
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if a radioactive tracer such as 203 Pb is used in kinetic studies. 
Therefore, it was planned to perform paired kinetic experiments on 
five subjects, one experiment in which they ingested 
203 Pb, and the 
other in which they ingested 203 Pb with calcium and phosphorous. 
Experimental data will be obtained from various in vitro and in vivo 
procedures , to test a linear compartmental model developed from 
informat~on in the literature and observations from the experiments. 
A succes sfw~ nodel will then be used to try and explain the 
experirnen~al anoma~ies described in section 8.1. It will also be used 
to check the theor y that lead is absorbed by two pathways, one which it 
shares specifically with calcium and the other specifically with 
phospharoJs. This t heor y was developed in secti ons 6.4.l and 6.4.2 
mainly fr om the results of experiments performed on one subject. 
Therefore, i t is important that the theory should be supported by the 
results of further experiments using more subjects. Finally the model 
may provide further insights into the mechanisms responsible for the 
gastrointestinal absorption of lead and reasons why the 
susceptibil ities of individuals to lead toxicity should vary. 
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8.2 Kinetic experiments 
8.2.l Introduction 
The kinetic experiments were performed to provide sufficient data to 
help develop a compartmental model to describe the behaviour of oral 
lead in the body. This model may also show any effects on this 
behaviour of calcium and phosphorous ingested with the lead. The 
necessary requirements of· the experimental data have already been 
outlined in section 8.1.3. 
In section 6.4, it was suggested that, in the human, lead is absorbed 
by two pathways in the gut, one which it shares specifically with 
calcium and the other specifically with phosphorous. Using a model, 
the characteristics of these two absorptive pathways would be best 
studied at the region of the response curve of retention of lead 
against weights of calcium and phosphorous where the action of these 
minerals on retention is greatest. It was also suggested in the same 
section that the common lead/calcium pathway was saturated by the 
maximum weights of calcium and phosphorous, whereas the common 
lead/phosphorous pathway was not. If possible, this should also be 
confirmed by the use of the model. 
8.2.2 Materials and methods 
a) Oral doses of 203 Pb chloride, CaC03 and NaH2P04.2H20 
The five subjects, K.B., J.B., B.C., G.E. and D.W., whose details are 
listed in section 11.l, took part in the paired kinetic experiments 
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performed in this section. The subjects followed the same fasting 
regime described in previous sections and, in the first of the paired 
experiments (Kinetic 1. ) , ingested 2 0 3 Pb chloride and 300 µg of lead 
chloride in 100 ml of distilled water. In the second experiment 
(Kinetic 2. ) , they ingested CaC0 3 and NaH 2 P0 4 .2H 20 mixed in 150 ml of 
distilled water immediately after the dose of lead. 
Four of the subjects, K.B., J.B., B.C. and G.E., received weights of 
CaC0 3 and NaH 2P0 4 .2H 2 0 ( 'half weights' ) calculated to reduce their 96 
hour retentions by 50% of those found in the Kinetic 1, experiments. 
A reduction of this order should give retentions at the region of the 
response curve of 96 hour retention against weights of CaC0 3 and 
NaH 2P0 4 .2H 2 0 where the effects of these minerals on lead absorption 
are probably greatest. The response of subject K.B. was found to be 
approximately exponential in this region, and the contribution of the 
second exponential term was only 8% (section 6.3). Therefore, the 
approximate 'half weights' were calculated using exponential 
interpolation or extrapolation from the 96 hour retention of each 
subject obtained with no CaC0 3 and NaH2P0 4 .2H 20 added to the dose of 
2 0 3Pb and those values obtained with one tenth of the maximum weights 
added ( table 6.3.1 ) . One of the subjects, D. W., received the maximum 
weights of CaC0 3 and NaH 2P0 4 .2H 20 to investigate the responses of the 
absorptive pathways of lead to these large weights. 
The doses of 2 03Pb given to the subjects i n the Kinetic l. experiments 
were the same as that given the first subject studied, D.W. This dose 
was found to be sufficient to allow in vivo measurements, particularly 
surface radioactivity measurements, to be performed up to 8-9 days after 
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the ingestion of the dose. The statistical error of the surface 
radioactivity measurements at 8-9 days was just acceptable (section 
11.12) with a counting time of 20 minutes, which the subjects could 
comfortably tolerate without undue movement. 
As the 96 hour retentions of 203 Pb in the Kinetic 2. experiments were 
expected to be 50% lower than those found in the Kinetic 1. experiments, 
the doses of 203 Pb given were approximately 50% higher. The 
measurements performed in both experiments, therefore, should be 
statistically comparable. It was expected that fewer in vivo 
measurements would be performed on subject D.W. in his Kinetic 2. 
experiment, as his retention will be less than the other subjects because 
of the larger weights of calcium and phosphorous he ingested. The doses 
of 203 Pb and weights of CaC0 3 and NaH 2 P0 4 .2H 20 given to each subject are 
shown in table 8.2.1. 
b) Whole body counts 
Whole body counts we~e performed as described in section 11.3, and at 
least six readings on separate days were obtained from 96 hours onwards .. 
The retentions of 96 hours and the half times of retention from 96 hours 
onwards were calculated as in previous sections. 
c) Gamma camera studies 
Gastrointestinal tract images were recorded, as described in section 
11.4, at approximately every hour for the first 12 hours, at 16, 20 and 
24 hours and then on every day up to 96 hours. Satisfactory images 






































d) Profile scan studies 
Profile scans of 203 Pb radioactivity in subjects and standards, and of 
backgrounds were performed, as described in section 11.5, at 
approximately every hour up to 12 hours, at 16, 20 and 24 hours and 
then once a day until the end of the study. In addition to the serial 
profile scans performed on the subjects after they had ingested 203 Pb, 
single profile scans were also performed on each subject after the 
administration of 113m1n, 113min colloid and 828r on separate occasions. 
Profile-scanner counting conditions for the appropriate radionuclide 
were set using the values listed in table 11.5.1. Data was puoched on 
to paper tape, which was then fed into a Univac 1100 computer via a 
Tektronix 4051 intelligent terminal. 
Profile scans were first aligned using the digital marker corresponding 
to the position of the xiphisternal joint, and marker counts were 
edited from the scans. Backgrounds were subtracted and the profiles 
were smoothed and restored by the methods described in Appendix A.l. 
The number of points chosen to smooth the profiles depended on the 
convergence of the restoration procedure, and it varied from 13 points 
for the first profile, 45 minutes after the ingestion of 203 Pb, to 25 
points for the last profile, 9 days later. The total counts in the 
profiles were also calculated. 
The contributions of 203Pb in the blood and 'soft' tissue extracellular 
fluid (E.C.F.) were then subtracted from these profiles. The term 
'soft' tissue E.C.F. and the rational for subtraction is discussed in 
section 11.7. Blood and 'soft' tissue E.C.F. backgrounds were 
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represented by the profiles obtained with 113mln and 82 Br, 
respectively, after these profiles had been smoothed, restored and 
modified by the appropriate factors. The reasons and assumptions for 
using 113min and 82 Br are described in section 11.7.l and the 
calculations required to obtain the factors are given in section 11.7.5. 
Subtractions were performed using computer programs in Appendix E. 
After subtraction of the 203 Pb blood and 'soft' tissue E.C.F., there 
was still a background of residual 203 Pb. However, the 'soft' tissue 
E.C.F. background was fitted by eye to this residual 203 Pb background 
and subtraction gave a profile consisting of peaks with no significant 
background. 
These final profile scans were then compared to scintigrams performed 
at approximately the same time, and the distribution of peaks in the 
profile scans was correlated anatomically to the distribution of 203 Pb 
uptake in the scintigrams. Any profile peak which could be identified 
with a particular organ visualised in the scintigram, such as the liver, 
was then selected for further analysis. Modified Gaussian functions, 
specific to particular organs, were then fitted to the corresponeing 
organ profile peaks, and only height and position of peak parameters 
were allowed to vary. The fitting was done using parametric and 
non-linear least squares procedures from SAAM 25 (1967). The number of 
counts under each function and the standard deviation of that number 
(Bevington, 1969), were calculated using computer program E.l.14. The 
percentages of ingested dose of 203 Pb in the organs, at particular times 
after the start of the experiment, were calculated from the ratio of 
the counts in the organ profile to the counts in the whole body profile, 
multiplied by the percentage retention of 203 Pb in the body. 
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e) Surface radioactivity measurements 
Surface radioactivity measurements were performed (section 11.6) at 
time intervals similar to those used for profile scan measurements, to 
give information on the 203 Pb radioactivity in small bowel, liver, 
kidney, soft tissue and bone. As with profile scans, the contributions 
of 203 Pb in blood and 'soft' tissue E.C.F. were subtracted from surface 
radioactivity measurements. The measurements of surface radioactivity 
of the blood and E.C.F. tracers, 113mln and 82 Br, are described in 
sections 11.7.3 and 11.7.4. The factors required to adjust these 
measurements so that they represented 203 Pb blood and 'soft' tissue 
E.C.F. backgrounds were derived as shown in section 11.7.6. Blood and 
'soft' tissue E.C.F. backgrounds were subtracted from surface 
radioactivity measured over the organs and medial malleolus, but only 
blood background was subtracted from calf-surface radioactivity 
measurements, as the 'soft' tissue compartment included E.C.F. as 
explained in section 11.7. 
f) Measurement of 203 Pb radioactivities in blood and urine 
Venous blood samples were taken from each subject at 1, 2, 3, 6, 16, 
20, 24 hours and on each day until the end of the study. 203 Pb 
radioactivities in plasma and red cells were measured as described in 
section 11.8. Urine was collected over 24 hour periods during the 
study, and 203 Pb radioactivities in urine were measured as described 
in section 11.9. The half lifes of the loss of 203 Pb from the red 
cells were determined from post 72 hour readings i.e. from data after 
the maximum level of 203 Pb in red cells had been reached. The loss of 
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203 Pb from the red cells was assumed to be represented by a single 
negative exponential. 
g) Calculation of faecal excretion of 203 Pb from 96 hours onwards 
Faecal excretion of 203 Pb was calculated by subtracting mean urinary 
loss per day of 203 Pb from mean reduction in percentage retention of 
203 Pb per day, both calculated from 96 hours onwards. It was assumed 
that the excretion of 203 Pb by other routes, such as in sweat, were 
negl i gible (Rabinowitz, 1974; Chamberlain et al, 1978 ) . 
8. 2.3 Results 
Detailed results obtained from the kinetic experiments are shown in 
columns labelled 'experimental data' in the tables in section 12. All 
results on the maximum levels of 203 Pb in blood, mean urinary loss 
per day and calculated mean faecal loss per day of 203 Pb are 
expressed as percentages of 96 hour retention (retained dose ) . 
a ) Whole body counts 
The percentage reduction in 96 hour retention produced by the weights 
of CaC03 and NaH2P04 .2H20 are shown in table 8.2.2, and in only one 
subject, J.B., was a true prediction made of subject response. 
However, the mean reduction was 50.93 ! 9.10 %(5.E. ) which agrees with 
that planned. Table 8.2.3 shows the 96 hour retentions and the half 
times of retention of 203 Pb in all the subjects. The coefficient of 
variation of 96 hour retentions found in the Kinetic 1. experiments is 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































96 hour retentions found in Kinetic 2. experiments were all 
significantly lower and although the half times of retention were all 
shorter, the differences between them and those found in Kinetic 1. 
experiments were not significant. A half time of retention could not 
be calculated for subject D.W., as his retention could not be measured 
later than 120 hours in the Kinetic 2. experiment. 
b) Gamma camera images 
The gamma camera scintigrams obtained with subjects J.B., 8.C., G.E. 
and D.W., were recorded on small scale photographs, and these have been 
enclosed in the folder at the front of this thesis. Those of subject 
K.B. are shown in the large scale photograph, figure 8.2.1, and these 
will be used to describe the changing distribution of 203Pb. TGe 
scintigrams chosen in the first 24 hours of the study were those in 
which major changes in distribution occurred. 
In figure 8.2.1, it is seen that at 0.15 hour after ingestion, most of 
the 203Pb had already left the stomach and reached the small bowel. By 
3.48 hours, there was a clear image of 203Pb in the liver, indicating 
significant gastrointestinal absorption of the 203Pb. At 10.47 hours, 
there was still 203Pb in the small bowel, and this persisted up to 
16.56 hours when it was masked by radioactivity from the unabsorbed 
fraction of 203Pb in the large bowel. The unabsorbed fraction had 
reached the caecum at 5.40 hours and, by 10.47 hours, it filled the 
ascending portion of th~ large bowel. At 16.56 hours, the transverse 
section of the large bowel had filled with unabsorbed 203Pb, and at 24 
hours practically the whole of the large bowel was filled. Liver and 
body background radioactivities continued to increase in every image up 
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FIGURE 8.2.l 
Gamma camera images of the distribution of 2 0 3Pb in gastrointestinal tract. 
SUBJECT: K.B. EXPERIMENT ·. KINETIC 1 
T = 0,15 hrs T=3,4f3hrs T~ 5,40 hrs 
T= 10,47 hrs T=16,56hrs T = 2 4 hrs 















to 24 hours. 
At 48 hours, there was residual radioactivity in the splenic flexure 
of the large bowel and in the rectum, and at 72 hours, there was still 
some radioactivity at the splenic flexure. By 96 hours, the 
gastrointestinal tract app~ared clear of unabsorbed 203 Pb, and 203 Pb 
radioactivity persisted only in the liver. There appears to be no 
uptake of 203 Pb in the scintigrams which can be identified with the 
anatomical positions of the kidneys. However, low uptake may have 
occurred which could not be discerned because of the proximity of 
2 03 Pb in liver and gut. The stomach, small bowel and large bowel were 
identified using an oral dose of 99 mTc sulphur colloid, and the 
relationship between these organs and the liver was found with an 
intravenous injection of 99 mTc sulphur colloid. 
c) Profile scans 
In the Kinetic 2. experiment of subject D.W., the profile scans only 
showed a large peak due to the unabsorbed fraction of 203 Pb. Once this 
fraction was cleared from the body, there was insufficient radioactivity 
in the body to allow profile scans to be performed. The series of 
profile scans obtained from all the other subjects were very similar, 
and only those of subject K.B. have been included as an example. These 
are shown in figures 8.2.2 to 8.2.10, and were selected from the Kinetic 
1. experiment. They were performed at approximately the same times as 
the gamma camera images shown in figure 8.2.1, so that profile peaks 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The first profile scan, at 0.43 hour, shows a broad peak and a 
background spreading the whole length of the body due to 203 Pb 
absorbed and distributed throygh the body. At 3.82 hours, the single 
peak has narrowed and lies at the level of the iliac crest, and it was 
produced by 203 Pb in the wall and lumen of the small bowel. There is a 
small peak just below the xiphisternal joint caused by 203 Pb in the 
liver, as this organ is clearly seen on the 3.48 hour scintigram. The 
5.65 hour profile scan shows that 203 Pb distributed through the body 
was still increasing, that the peak at the iliac crest has decreased, 
and that the main peak has spread towards the symphysis pubis which 
corresponds to 203 Pb near the caecum on the 5.40 hour scintigram. At 
10.80 hours, a peak due to 203 Pb in the liger can be seen below the _ 
xiphisternal joint, and although 203 Pb can be seen in the small bowel 
on the corresponding scintigram, the small bowel peak is superimposed 
on the unabsorbed fraction of 203 Pb in the ascending large bowel. This 
unabsorbed fraction of 203 Pb can also be seen in the transverse large 
bowel in the 16.56 hour scintigram, and has caused a distinctive peak 
superimposed on that due to 203 Pb in the liver in the 16.65 hour profile 
scan. 
There is no appreciable change between the 16.65 hour profile and the 24 
hour profile, and there is very little difference between the 
corresponding scintigrams. At 48.00 hours, the peak due to 203 Pb in the 
liver can be clearly seen, although the scintigram shows some residual 
203 Pb in the splenic flexure of the large bowel which can be seen 
superimposed on the inferior edge of the liver peak. The same profile 
distribution occurs in the 72 hours profile, although residual 203 Pb in 
the large bowel appears to be much less in the corresponding scintigram. 
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By 96 hours, the peak due to liver 203Pb can be clearly seen, and 
profile scans performed on later days were an identical shape to the 
96 hour profile. In both the 96 hour gamma-camera image and the 96 
hour profile scan, there is no indication of unabsorbed 203 Pb in the 
gastrointestinal tract of subject K.B. or in those of the other subjects. 
Thus, only 203 Pb radioactivity in liver gave profile peaks which could 
be clearly seen in the profile scans. The profile peak caused by small 
bowel radioactivity was always superimposed on the peak due to the 
unabsorbed fraction of 203 Pb in the large bowel. There appeared to be 
no profile peak caused by radioactivity in the kidneys. 
Profile scan analysis could only be performed, therefore, on the liver 
profile peak, and as the peak and the superior edge of the liver profile 
peak could only be clearly seen in profile scans from 48 hours onwards, 
these profile scans were the only scans which could be analysed. The 
factors required to transform the 113m1n and 82Br profile scans into 
blood and 'soft' tissue E.C.F. backgrounds are shown in tables 8.2.4 
and 8.2.5, and the result of the subtraction of these backgrounds is 
shown for the 96 hour profile in figure 8.2.11. The final subtraction, 
with a 'soft' tissue E.C.F. background adjusted by eye, gave one peak 
caused by liver 203 Pb radioactivity as shown in figure 8.2.12. A 
modified Gaussian function, which was determined from the 113min-colloid 
liver profile as described in Appendix A.3, was fitted to this single 
profile peak. Figure 8.2.13 shows the fit between calculated values and 
experimental data for the 96 hour profile. The fit is good on the 
superior side of the peak, but on the inferior side, there appears to be 
a superposition of gut radioactivity. The percentages of the ingested 
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TABLE 8.2.4 
Factor to transform 113 m!n profile scan to 203 Pb blood 
background profile scan 
Subject K.B. 






















Factors to transform 82 Br profile scan to 2 03 Pb 
'soft' tissue E.C.F. background profile scan 
Subject K.B. 




















Factor to transform 1 1 3min profile scan to 82 Br blood background 




















































































































































































































































































































































































































































































































































































dose of 203 Pb calculated to be in the liver of subject K.8. are shown 
in table 8.2.6. 
c) Surface radioactivity measurements 
In the Kinetic 2. experiment of subject D.W., only some of the surface 
radioactivity measurements performed during the first 24 hours over his 
small bowel had sufficient statistical accuracy (section 11.12). This 
was due to the presence of the large unabsorbed fraction of 203 Pb, which 
at various times during the first 24 hours, was in the 'field of view' 
of the in vivo detector~ Surface radioactivity measurements performed 
over the other sites all had large statistical errors and could not be 
used. Although surface radioactivity measurements were continued up to 
9 days after the ingestion of 203 Pb with all the other subjects, a 
number of_measurements, particularly the later ones performed over the 
calf, had to be rejected because of large statistical counting errors. 
In the other subjects, small bowel surface radioactivity decreased very 
rapidly over the first 12 hours after ingestion of 203 Pb. However, a 
sharp increase occurred at 16 hours which persisted until 48 hours. 
From 72 hours onwards, the measurements decreased very slowly. Surface 
radioactivity over the liver rose rapidly to a peak within 24 hours, 
and either remained at this level or increased slightly over the rest of 
the study. A more ~apid rise in surface radioactivity occurred over 
the medial calf in comparison to that which occurred over the liver. A 
peak was reached within 12 hours, but there was considerable scatter in 
the results, so no particular trend could be identified from post-24 
hour results. The rise in surface radioactivity over the medial 
malleolus was very similar to that which occurred over the calf during 
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TABLE 8.2.6 
Percentage of ingested dose in liver profile peaks 












t ! l standard deviation. 
Experiment Kinetic 1. 
~~ INGESTED DOSE 
15.11 ::: o.25t 
+ 17 .11 - 0 .30 
+ 14.98 - 0.27 
+ 13.85 - 0.31 
+ 9.67 - 0.24 
+ 13.38 - 0.46 
13.66 + 0.51 
+ 14.63 - 0.60 
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the first 12 hours. However, unlike the calf, post-24 hour results 
continued to rise steadily to the end of the study. 
d ) 203 Pb levels in blood and urinary and faecal losses of 203 Pb 
The 203 Pb levels in total plasma were always less than 0.1% of the 
ingested dose in all experiments. These levels generally peaked at 24 
hours and then decreased fairly rapidly. Unfortunately, the 203 Pb 
levels in plasma of subject D.W. in his Kinetic 2. experiment were too 
low to be measured with sufficient statistical accuracy (section 11.12 ) . 
With the other subjects, there was sufficient 203 Pb radioactivity in 
the plasma for measurements to be performed to at least 96 hours. The 
203 Pb levels in total red cells rose rapidly to peak between 24 and 48 
hours in the Kinetic 1. experiments, but in the Kinetic 2. experiments, 
levels rose more slowly and peaks generally occurred later. The 
levels of 203 Pb in accumulative urine rose linearly over the period of 
study for all subjects. 
The maximum 203 Pb content of total plasma, total red cells, the 
urinary loss per day and the calculated faecal loss per day of 
203 Pb are shown in tables 8.2.7 - 8.2.10, respectively. Table 8.2.11 
shows the half life of 203 Pb in the red cells. All regression 
coefficients are close to unity except that found from the Kinetic l. 
experimental data of subject D.W. Results from the Kinetic l. and 
Kinetic 2. experiments were compared using a paired 't' test (Mould, 
1976), and there was a significant decrease (P < 0.05) in only the 
maximum red cell content of 203 Pb . 
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TABLE 8.2.7 










percentage of 96 hour retention 
MAXIMUM 2 03 Pb CONTENT OF PLASMA 
(% 96 hour retention ) 
Kinetic 1. 
0.113 ! o.002t 
+ 0.102 - 0.002 
+ 0.062 - 0.002 
0.074 ! 0.002 





0.130 ! 0.001 
+ 0.139 - 0.001 
0.060 + - 0.003 




t ! 1 standard deviation. 
§ Result excluded from paired 't' test. 
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TABLE 8.2.8 










percentage of 96 hour retention 
MAXIMUM 2 03 Pb CONTENT OF RED CELLS 
(% 96 hour retention ) 
Kinetic l. 
35.97 = o. mt 
45.17 + - 0.22 
+ 30.80 - 0.12 
47.87 + - 0.21 





28.56 + - 0.14 
+ 34.53 - 0.14 
24.07 + - O .10 
29.27 + - 0.81 




Kinetic 1. results different from Kinet i c 2. results (P < 0.05 ). 
t ! 1 standard deviation. 
§ Results excluded from paired 't' test. 
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TABLE 8.2.9 










percentage of 96 hour retention 
URINARY LOSS OF 203 Pb PER DAY 
(% 96 hour retention ) 
Kinetic 1. 
1.37 ! o.007t 
+ 1.14 - 0.006 
+ 0.94 - 0.004 
+ 1.13 - 0 .007 
. + § 





0.99 ! 0.004 
1.00 + - 0.004 
0.82 :!:° 0.004 
1.00 + - 0.006 




t + l standard deviation. 
§ Results excluded from paired 't' test. 
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TABLE 8.2.10 










percentage of 96 hour retention 
FAECAL LOSS OF 203 Pb PER DAY 
(% 96 hour retention ) 
Kinetic 1. 
2.39 ~ o. nt 
2.53 + - 0.15 
1. 91 + - 0.20 
3.30 + - 0.44 





3.37 + - 0.12 
4.16 + - 0.12 
6.37 + - o .17 




t + 1 standard deviation, 




























































































































































































































































































































































































The Kinetic 2. experiment of subject D.W. was not a complete success, 
The maximum weights of calcium and phosphorous reduced his absorption 
of 203 Pb to such an extent that no whole body counts from 120 hours 
onwards, useful profile scans, useful surface radioactivity or plasma 
measurements could be performed with sufficient statistical accuracy. 
Although it was anticipated that his lead absorption would be low, 
from his re Jlts when he ingested 203 Pb with minerals (section 5.0 ) , it 
was hoped that sufficient in vivo and plasma measurements could be done 
for future compartmental analysis. 
In only one subject, J.B., was a 50% reduction in 96 hour retention 
achieved between Kinetic 1. and Kinetic 2. retention values. The mean 
reduction, however, was approximately 50%. The calculation of the 
'half weights' of calcium and phosphorous was based on the response 
curve of 96 hour retention against weights of calcium and phosphoBous 
of one subject,K.B. The shape of this response curve would appear to be 
different for the other subjects for which the calculation was not 
correct. However, this does not explain why the retention of subject 
K.B. was not reduced by 50%. At this time, this last discrepancy is 
unresolved. 
The paired experiments were designed, however, to only investigate the 
effects of added calcium and phosphorous on the behaviour of an oral 
dose of 203 Pb in the body. The actual reductions in retention caused 
by these minerals were all statistically significant. The values of 
the retentions probably correspond to those in the region of the response 
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curve where the effects of calcium and phosphorous on lead absorption 
are considerable, even if they did not exactly agree with the 50% 
values. 
a) Whole body retention 
The 96 hour whole body retentions of all subjects were significantly 
reduced by the simultaneous presence of calcium and phosphorous with 
203 Pb in the gut, but the half times of retention were not. The 
variation of 96 hour retentions in Kinetic 1. was low as found earlier 
in section 4.0, and the mean of 70.71 ! 1.51% (S.E. ) agrees well with the 
mean of 69.50 ~ 2.24% (S.E. ) obtained in that earlier section. 
b) Gamma camera images, profile scans and surface radioactivity 
measurements 
The gamma camera studies in all subjects were characterised by very 
rapid emptying of 203 Pb from the stomach, uptake in the wall of the 
small bowel and liver, and no evidence of localised uptake due to 
unabsorbed 203 Pb in the gut at 96 hours. The only exception was toe 
study obtained in the Kinetic 2. experiment of subject D.W., in which 
only the distribution of the unabsorbed fraction of 203 Pb in the 
gastrointestinal tract was visualised. 
A similar pattern of the uptake found in the gamma camera images was 
observed in the profile sca~s, except that it was difficult to 
distinguish between uptake in the wall of the small bowel, in the liver 
and the unabsorbed fraction of 203 Pb in the early scans. As with the 
gamma camera images, there was no indication of peaks due to localised 
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unabsorbed 203 Pb in the gut at 96 hours. However, there was a 
generalised superposition of gut radioactivity on the inferior side 
of the liver profile peak, which occurred even in the analysis of the 
last profile scans at 9 days in all subjects. This could have been 
caused by endogenous 2 03 Pb in the gut. 
Surface radioactivity measurements could be easily performed over liver 
and small bowel as count rates were moderately high, in contrast to 
those found over medial calf and medial malleolus which were low. 
Surface radioactivity measurements of subjects 8.C. and G.E. were 
mainly affected by their lower than planned retentions. 
There was no evidence of appreciable 2 03 Pb uptake in the kidneys of 
any of. the subjects, in either gamma camera images or profile scans. 
However, any uptake occurring before the gastrointestinal tract was 
clear of large amounts of radioactivity, may have been masked. 
In post-48 hour profile scans, any appreciable uptake would have 
been seen as a distinct peak on the inferior side of the liver 
peak. During the surface radioactivity measurements, the posterior 
anatomical positions of the kidneys of each subject were surveyed by 
the in vivo detector, but, on the right of the body, count rates from 
203 Pb in the liver predominated. On the left side, count rates were 
affected by 203 Pb in the gut, but even when that had cleared from the 
body, no appreciable uptake could be found in that region. 
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c ) 203 Pb radioactivity in plasma and red cells 
The mean of the maximum retained dose of 203 Pb in the plasma found in 
the Kinetic 1. experiments was 0.089 ! 0.01% (S.E. ) , which is lower 
than that found by Chamberlain et al (1978) of 0.3% and Hursh et al 
(1969) of 1.5%. These last two studies were performed on subjects who 
received tracer lead by other routes not orally, which could possibly 
account for the differences. There was no significant difference 
between the plasma levels of 203 Pb found in the Kinetic 1. and Kinetic 
2. experiments, and Rabinowitz (1974) found that plasma levels 
remained constant despite changes in whole blood lead. Rosen et al 
(1974) reported that the plasma lead levels in normal and lead 
intoxicated children were nearly the same. 
The mean of the maximum retained dose of 203 Pb in the red cells found 
in the Kinetic 1. experiments was 37:95 ! 3.46% (S.E. ) and agrees with 
that found by Chamberlain et al (1975) in similar experiments of 
44.5 ! 4.6% (S .E. ) of absorbed dose of 203 Pb in whole blood. However, 
in later work Chamberlain et al (1978) obtained a higher percentage of 
52 ! 2% (S.E.). The differences between means could have been caused 
by the selection of subjects with differing red cell volumes or 
different estimations of these volumes. There was a significant 
decrease in the 203 Pb levels in the red cells found in the Kinetic 2. 
experiments compared with those found in the Kinetic 1. experiments . The 
mean half life of 203 Pb in the red cells was 17.44 ! 1.75 days (S.E. ) 
in the Kinetic 1. experiments, which agrees with that found by 
Chamberlain et al (1978 ) of 15.4 ! 2.7 days (S.E. ) . 
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d) Urinary and faecal excretion of 203 Pb 
+ The mean urinary loss per day of 1.07 - 0.07% (S.E. ) of the retained 
dose of 203 Pb found in Kinetic 1. experiments is comparable to 
that found by Chamberlain et al (1978 ) of 1.08 + 0.08% (S.E. ) in their 
experiments with fasted subjects. In the same work, a faecal loss of 
0.86 ~ 0.03% (S.E. ) was found in fasted subjects, which is less than 
the mean faecal loss per day of 3.01 ~ 0.28% (S.E. ) found in the 
Kinetic 1. experiments. However, the subjects in the present 
experiment ingested 300 µg of carrier lead with the 2 03 Pb, compared to 
75 µg ingested in the experiments of Chamberlain et al (1978). This 
may account for the differences in faecal loss of 2 03 Pb, as explained 
in section 5.4.2. 
The ratio of mean faecal to mean urine loss per day (F/ U) in the 
Kinetic }._experiments was 2.81, and this is comparable to that found in 
patients with chronic plumbism after their removal from exposure to 
lead (Cantarow and Trumper, 1944 ) . There is considerable variation 
in F/ U values from other published work. 0.7 and 1.1 ha~e been found 
in baboons injected with 210 Pb (Cohen, 1970; Strehlow, 1971). In rats 
injected with 210 Pb, a F/ U of 2.2 was obtained (Castellino and Aloj, 
1964), and in rats injected with 203 Pb a F/ U of 1.0 was found (Morgan 
et al, 1977 ) . Similarly in dogs ratios of 0.2 (Stover, 1959) and 
1.85 (Hursh, 1973 ) have been found. Klaasen and Schoeman (1974) showed 
that the rate of biliary excretion varied in animals of different 
species. They also observed that increasing intravenous doses of 
carrier lead increased the rate of biliary excretion. Therefore, the 
differences of F/U values of animals of the same species could be 
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caused by different levels of systemic lead. 
e) Distribution and excretion of 203 Pb 
Calcium and phosphorous ingested simultaneously with 203 Pb caused a 
significant decrease, in all subjects, of the 203 Pb content of red 
cells. In the four subjects, K.B. , J.B., B.C., G.E., there was a 
decrease in urinary excretion and an increase in the faecal excretion 
of 203 Pb, and in the three subjects K.B., J.B., and G.E. there was 
also an increase in plasma levels of 203 Pb. However, these changes 
were not statistically significant. The half time of 203 Pb in red 
cells was also reduced, but the change was only significant at the 10% 
level of probability. 
These results can be compared to those in section 5.0, in which the 
two subjects K.B. and D.W. ingested 203 Pb with minerals. A decrease in 
the retained dose of 2 0 3 Pb in the red cells was also observed in both 
subjects, but a decrease in the retained dose in the urine was only 
found in subject D.W. These decreases were questioned at that time, 
however, because the 96 hour retentions of the two subjects were below 
' 2%. It was argued that the possible presence of some of the unabsorbed 
fraction of 203 Pb in the body would have a significant effect on such 
low values of 96 hour retention. 
The results described in the present section show that a decrease in 
the retained dose of 203 Pb in the red cells can occur with 96 hour 
retentions of approximately 40%, so that the decrease found in section 
5.0 is probably correct. However, the magnitude of that decrease may 
still be influenced by the unabsorbed fraction of 203 Pb as argued above. 
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8.3 Compartmental model describing the kinetics of orally ingested 203 Pb 
8.3.1 Structure of compartmental model developed from the literature and 
results of kinetic experiments (section 8.2 ) 
The adequacy of the experimental data from the kinetic experiments to 
define the proposed model is unknown. The preliminary model, therefore, 
should be simple and restricted to one class (Berman, 1963 ) . The 
least number of compartments and pathways between compartments should 
be chosen that are compatible with the known distribution of lead from 
the literature and the results of the kinetic experiments. 
The mammillary model was the class of compartmental model chosen in the 
studies reviewed in section 8.1.1. The central compartment of the model 
proposed by Bernard (1977) represented mainly blood lead, although there 
was not a direct one-to-one correspondence. A fraction of another 
compartment also contributed to the blood lead. Rabinowitz et al (1974 ) 
chose blood as their central compartment, as did Batschelet et al (1979 ) . 
All these models had pathways in both directions between the central 
compartment and the other compartments. 
These models describing steady state levels of lead in the human, 
however, were found to be inadequate to explain the short term kinetics 
of tracer lead. Rabinowitz et al (1974 ) suggested that plasma and red 
cells should be regarded as separate compartments to explain the early 
distribution of tracer lead. Chamberlain et al (1978) implied that 
plasma should be the central compartment with lead entering from lung 
and gut and rapidly distributing to red cells, bone and other storage 
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sites. A further refinement of the mammi llary model with a central 
plasma compartment was suggested by Baloh (1974 ) . In his model, the 
central compartment was di f fusible plasma lead and the other 
compartments were non diffusible lead, red cell lead, 'soft' tissue 
lead (brain, kidney, bone marrow, etc. ) , and ' hard' tissue lead (dense 
bone, hair, teeth, etc.) 
The mammillarymodel with plasma as the central compartment was chosen 
as the basis of the preliminary model, and the number of compartments 
in series was kept to a minimum. The compartments and the pathways of 
the simplest model that may be constructed from basic physiology, the 
literature and observations from the kinetic experiments is shown in 
figure 8.3.1. The development of the model and the relationship between 
experimental data and the model is explained in the following sections. 
The SAAM 25 nomenclature and symbols used are shown in figure 8.3.2. 
a ) Lead in the gut 
2 °'Pb enters the stomach 0 and clears rapidly into the small bowel 
0 , as there was no 
t he 3. 22 hours scintigram 
evidence of r adioacti vity i n the stomach on 
(figure 8.2.1 ) . Lead is not absorbed from the 
stomach, but it is absorbed frmm the small bowel (Cantarow and Trumper, 
1944) , 203pb also appears to be temporarily stored in the wall of 
~ , as shown in t he scintigrams taken between 3.22 
hours and 16.08 hours. This was suggested by the everted sac studies 
the small bowel 
of Grunden and Stantic (1975 ) and Blair et al (1979 ) and the in vivo 
rat experiments of Conrad and Barton (1978) , reviewed in section 8.1.2. 







































































































































































































































































































































































































































Qc (J' T) 
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FIGURE 8.3.2 





Value of F(I,T ) at start 
of solution ( Input of tracer ) 
Primary (non-linear ) parameter 
Secondary parameter (linear ) , 
summing coefficient 
Secondary (linear ) parameter, 
proportionally coefficient 
Function generated from the 
F(I,T), T and other parameters. 
For a SUMMER 
Qc(J,T) = E S(J,I) x F(I , T) 
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obtained over the region of the small bowel is described in the . 
section, Summer compartments (f). 
The unabsorbed fraction of 203 Pb passes through the small bowel td a 
series of compartments G -G representing large bowel, lllhere 
it is assumed no absorption occurs (ICRP, 1959). 
Compartments G -G provide a delay segment to simulate the 
transit of the lead through the large bowel to the rectum, from which 
it is excreted in the faeces. The movement of the unabsorbed fraction 
of 203 Pb through the large bowel can be clearly seen in the scintigrams 
from 10.47 hours to 48 hours. 
b) Lead in plasma and red cells 
203 Pb enters the plasma 0 from the wall of the small bowel 8 G and is rapidly taken up by red cells . This occurred in all 
subjects. Hursh and Suomela (1968) and Chamberlain et al (1978) found 
the same avidity of lead for red cells, when human subjects were 
injected with 212 Pb and 203 Pb, respectively. Lead is lost from the red 
cells by red cell death (Hursh and Suomela, 1968), but Chamberlain et 
al (1978) found a biological half life of 15.4 days for their human 
subjects, and a mean half life of 17.44 days was found in section 8.2.3. 
These are less than the half life of 20 - 35 days of 51 Cr in normal 
human blood (Waldron, 1966), which suggests another loss mechanism apart 
from red cell death. 
The percentages of ingested dose measured in the total plasma and red cells 
were absolute data, which were found by directly 'sampling' the plasma G and red cell 0 . This data was used directly in the 
162 
solution of the model. 
c ) Lead in 'soft' and 'hard' tissues 
Baloh (1974) suggested a broad classification of 'soft' and 'hard' 
tissues, and this was adopted as it reduces the number of compartments 
required to explain the distribution of lead. Lead transfers very 
rapidly from plasma to extracellular spaces and 'soft' tissue ~ , 
but as the plasma lead concentration drops, there is a partial return 
from this compartment (Stover, 1959 ) . Lead is also taken up in 'hard' 
tissue ~ , and although bone lead is thought .to be 'metabolically 
inactive', it may be released to the 'soft' tissue or plasma under 
conditions of bone resorption (Byers and Maloof, 1954). Surface 
radioactivity measurements over the medial aspect of the left calf 
( 'soft' tissue) and left medial malleolus ('hard' tissue ) represent 
proportional data, and they require the summers ~ and ~ . to 
make them compatible with the model. 
d) Lead in liver and kidneys 
Appreciable uptake of 203 Pb occurred in the liver~ , which can be 
clearly seen in the scintigrams from 3.22 hours onwards. This agrees 
with the findings in the animal studies described in section 8.1.2. 
Lead has been assumed to be transferred to the liver from the plasma 
(Klaasen and Shoeman, 1974). The relationship between the model and 
the surface radioactivity data obtained from measurements over the liver 
is described in the section, Summer coefficients (f ) . 
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There was no evidence of kidney uptake of 203 Pb in the kinetic 
expetiments performed in section 8.2. Although kidney uptake of lead 
was found in animal st8dies (section 8.1.2 ) , it was always much less 
than liver uptake when lead was taken by mouth. Slight uptake of 2 03Pb 
in the kidney could have occurred, which was undetected in the kinetic 
experiments. Kidneys were assumed, however, to be part of the 'soft' 
tissue compartment, as suggested by Baloh (1974 ) . 
e ) Excretion of lead 
Lead is primarily excreted in the bile (Blaxter and Cowie, 1946; 
Castellino et al, 1966; Cikrt, 1972; Klaasen and Shoeman, 1974) and in 
the gastric and intestinal secretions (Rabinowitz, 1974; 1976 ) . Although 
Rabinowitz et al (1976) found that gastric juices may be a major source 
of endogenous faecal excretion of lead, secretin and cholecystokinin were 
used to stimulate secretions, so their results may not reflect the normal 
state. They also found in human subjects that only after a few months of 
continuous tracer uptake was there appreciable amounts of tracer lead in 
bile and gastrointestinal secretions. Other work described by Chamberlain 
et al (1968 ) , suggested that endogenous faecal excretion is established 
at the same time as urinary excretion. Therefore, the results of 
Rabinowitz et al (1976 ) may not be relevant in a short-term tracer study. 
In the present study, the gamma camera scintigrams from 3.22 hours 
onwards show appreciable uptake of 203 Pb in the liver, which could cause 
substantial biliary excretion of 203 Pb. Klaasen and Shoeman (1974) 
found in rats injected with low doses of lead that the positive 
concentration gradient of lead from liver to bile was one tenth 
that from plasma to liver. They also found that biliary excretion 
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is the major route of excretion of lead in the rat. In the preliminary 
model ( figure 8.3.1 ) , endogenous faecal excretion of 2 03 Pb was assumed 
to only occur from the liver~ . 
Although it has been suggested that there may be entero-hepatic 
circulation of lead (Cantarow and Trumper, 1944 ) , it has not been 
studied in man (Goyer and Mahaffey, 1972 ) , and in rats it has been found 
t o be very low (Cikrt and Tichy, 1975 ) or non existent (Conrad and 
Barton, 1978 ) . It has been assumed not to occur in this preliminary model, 
so that clearance of lead from the liver is directly into non absorbing 
segments of the large bowel ~ The relationship of data on 2 03 Pb 
radioactivity in the liver to the model i s discussed in the section, 
Summer coefficients ( f ) . 
Lead is excreted in the urine, and compartment ~ represents the 
accumulative urine excreted over the period of study. The urine data 
i s absolute and it was used directly in the solution of the model. Lead 
is also excreted in sweat but the amount lost by this route is negligible 
in comparison to faecal and urinary losses (Rabinowitz, 1974; 
Chamberlain et al, 1978 ) . 
f ) Summer compartments 
The whole body counter data represents the sum of all com~artments, 
summer~ , and the contribution of each compartment i n the model to 
this summer i s unity. Data obtained from surface radioactivity 
measurements are proportional data, representif!9 the 203 Pb radioactivity 
in the fraction of the various compartments 'seen' by the in vivo 
detector. Therefore, summer or proportional i ty coeffi cients are 
165 
required to make these data compatible with the model. 
Over the region of the small bowel, surface radioactivity measurements 
represented by summer ~ will consist of count rates arising from 2 0 3Pb 
in the lumen~ , ' 03 Pb in the wall of the small bowel~, 
endogenous '°'Pb G~} , and will include contributions fr~m '°'Pb 
in the 'soft' tissue 0 and 'hard' tissue 0 . The presence of 
the unabsorbed fraction of lead which passes through the field of view 
of the in vivo detector between 16 - 48 hours is represented by either 
summer 5(3,21 ) or (3,22 ) . 
Proportional data from surface radioactivity measurements performed over 
the liver are represented by summer~, and they will include 
contributions from 2 0 3 Pb in 'soft' tissue ~ and 'hard' tissue 
~ -- . Proportional data from surface ra~tivity measurements were 
used instead of the absolute data from the profile scan analysis, 
because only profile scans from 48 hours onwards could be analysed, as 
discussed in section 8.2~3. The profile scan analysis was not 
completely rigorous, because of the fit by eye of an adjusted 
'soft'-tissue background profile to enable the liver profile peaks to 
be isolated. The mean values and standard deviations of the percentages 
of ingested dose· calculated to be in the liver, therefore, were only 
used to define the maximum and minimum limits of the summer coefficient 
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8.3.2 Solution, testing and adjusting of compartmental model 
In this section, all the work on developing the final model was 
performed with data from the experiments performed on subject K.8. He 
was the first subject to complete the paired kinetic experiments, and 
most of the work was done using the data from his Kinetic 1. experiment. 
Any major changes in the model were checked for compatability with the 
data from his Kinetic 2. experiment. 
a ) Initial values of variable parameters 
It was stated in section 8.1.4 that it is necessary to find initial 
values for the variable parameters when the model is set up in terms 
of the differential equations directly, and when the solution of these 
equations is achieved by numerical procedures. 
First, the compartmental model proposed in section 8.3.l was reduced 
to a basic input/output system. This was used to find initial values 
for the rate constants representing the transfer of 203 Pb between 
small bowel and stomach, L( l9,18), wall of small bowel and lumen, 
L(l ,19 ) , and large bowel and lumen of small bowel, L(20,19). This is 
shown in figure 8.3.3 where~ and ~ represent the absorbed and 
the unabsorbed fractions of ingested lead in the body, respectively. A 
solution was obtained using only whole body radioactivity data. 
The next step was to use an exchangeable body compartment~ to find 
initial values for path~ays exchanging with plasma ~ , as sho~n in 
figure 8.3.3. Whole body and small-bowel surface radioactivity data 











8 Absorbed 2 0 3 Pb in body 
G Stomach 
~ Lumen of small bowel 
0--8 Large bowel 
& Summer ( whole body ). 
*100?~ Oral 2 0 3 Pb 
Input/ output model with exchangeable body compartment 
' ' 






' ' \ ' ' \ ', ' \ ... ' ' \ 
1 
.... ,,,':~~~\ I 
...... , .. 
- --- - - - .- .. -· 25 
.. -- " 
C"Vf"DC"Tn 







8 Wall of small bowel 
0 Plasma 
~ Exchangeable body 
G Stomach 
~ Lumen of small bowel 
0---G Large bowel 
~ Summer (small bowel ) 
£ Summer ( whole body ) 
169 
using the data from other compartments as a guide to their order of 
magnitude, it was possible to estimate L(J,I ) parameters for other 
pathways. 
b) MODEL I 
The preliminary model developed in section 8.3.1 was called MODEL I, 
and a solution was obtained giving the parameter values and the 
residual sums of squares shown in table 8.3.2. The standard deviations 
of the L(J,I ) parameters are very low, except for L( l6,ll ) , rate 
constant representing transfer of lead to 'hard' tissue from plasma. 
However, the residual sums of squares are high for 6. and 0 , 
representing liver and red cells. The fits between calculated values 
and early experimental data were poor, suggesting that the rates of 
input of 203 Pb into these compartments were too low. 
As they both directly communicate with plasma 0 , it was decided 
to try a solution excluding plasma data. In effect, this removes 
constraints on the plasma compartment, which should allow the other 
communicating compartments to receive 2 03 Pb at higher rates, The 
result is shown in table 8.3.3, and the values of L(6,ll ) and L(13,ll ) , 
rate constants representing the transfer of 203 Pb to liver from plasma 
and to red cells from plasma, respectively, have increased from 11.43 
and 30.57 to 352.91 and 500.00, and the residual sums of squares for 6. and 0 have improved from 0.0389 and 0.0187 to 0.0068 and 
0.0037. 
There are very large standard deviations, however, of L(J,I ) parameters 
associated with the output of tracer from plasma ~ . This 
170 
TABLE 8.3.2 
RESULTS OF COMPARTMENTAL ANALYSIS USING 
ALL EXPERIMENTAL DATA 
SUBJECT:K.B. 
PARAMETER 
L ( 1 r 1 9 ) 
L ( 11, 1) 






L (16,11) . 
L (11,16) 









































* +- 1 STANDARD DEVIATION 

















RESULTS OF COMPARTMENTAL ANALYSIS USING 
ALL EXPERIMENTAL DATA EXCEPT PLASMA DATA 
::;LJBJECT: f(. 8. 
PARAMETER 
L ( 1, 19) 
L < 1 1 , 1 ) 








L C 20, 6) 
L (19,18) 
L (20, 19) 
L (21,20) 
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suggests that the quantity of tracer leaving ~ is not 
sufficient to satisfy the calculated values needed to fit the 
experimental data of liver~. Reducing this output would allow 
more ' ''Pb to enter the compartments communicating with ~ , and 
this may be achieved by introducing a second liver compartment,~ , 
between~ and ~ • The calculated values required to fit the 
experimental liver data are now generated from two compartments, and 
the contribution of these two compartments to the summer~ will be 
the same. Therefore, 5(8,4 ) was allowed to vary and 5(8,6 ) was kept 
equal to the value of 5(8,4 ) by a dependence equation. With these 
changes, the rate constant representing output of 203 Pb from ~ to 
~, L(6,ll ) , should now decrease in magnitude. These changes were 
included in a new model, MODEL II (figure 8.3.4 ) . 
c) MODEL II 
i) Absorbed fraction of 203 Pb 
A solution was obtained using MODEL II, which gave values of parameters 
and residual sums of squares as shown in table 8.3.4. L(6,ll ) and the 
standard deviations of the L(J,I ) parameters are reduced, and the 
residual sums of squares have improved for all compartments. However, 
the percentage of the ingested dose of 203 Pb absorbed, L(l,19) x 100/ 
(L(l ,19 ) + L(Z0,19 )) , is 94.55 which does not agree with the 
percentage of 65.42 retained at 96 hours, measured by whole body 
counting ( table 8.2.3 ). Therefore, the rate constants describing the 
transport of 2o 3 pb to wall from lumen of small bowel, L(l,19), and 
movement of 203 Pb to large bowel from lumen of small bowel, L(20,19), 
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RESULTS OF COMPARTMENTAL ANALYSIS USING 
ALL EXPERIMENTAL DA TA EXCEPT PLASMA DATA 
::;Ue.JECT: K. B. 
PARAMETER 
L ( 1, 19 > 
L ( 4 r 1 ) 
L ( 1 1 , 4) 






L ( 16,11) 
L (11,16) 
























































* +- 1 STANDARD DEVIATION 
175 
absorbed and unabsorbed fractions, and the rate at which the 2 03 Pb is 
absorbed into the wall of the small bowel. This rate will depend on 
the calculated levels of 2 03 Pb required in the body compartments to 
fit the experimental data. TheBefore, L( l,19 ) and L( Z0,19 ) should 
not be allowed to vary between wide limits, but they should be 
constrained so that initial values of absorbed and unabsorbed fractions 
of 203 Pb are the same as those found by whole body counting. 
i i ) Plasma levels of 2 03 Pb 
The solution of MODEL II was found without the constraints of 
experimental plasma data. In order to examine the behaviour of plasma 
2 03 Pb in MODEL II, a simulation was performed with the values of the 
variable parameters listed in table 8.3.4. This simulation gave 96 
hour values of 2 03 Pb in various compartments as shown in table 8.3.5. 
The agreement between simulated and experimental values is good, 
except for the plasma compartment for which the simulated value is 
approximately 10-2 smaller than the experimental value. This 
discrepancy could be explained if the 2 03 Pb in the plasma was in two 
different forms. 
Baloh (1974 ) suggested that plasma lead is made up of two fractions, 
the plasma protein-bound fraction and the diffusibl e fraction, and that 
probably the diffusible form is a very small percentage of the t otal 
plasma lead. A similar suggestion was made by Goyer and Mahaffe y (1972 ) 
t hat lead in the body must exist in two forms; a diffusible or mobile 
form and a non diffusible or fixed form. They also suggested that lead 
in the plasma can be chelated to small diffusible ligands, a form of 































































































































































































































































The level of plasma 203 Pb found by the simulation of MODEL II is the 
result of 2 03 Pb exchanging with the red cell, 1soft 1 tissue and 'hard' 
tissue compartments. This behaviour and the low level of simulated 
plasma 203 Pb compared to the experimentally determined level are 
similar to that of the diffusible plasma lead suggested by Baloh 
(1974 ) and Goyer and Mahaffey (1972 ) . The experimentally determined 
level probably arises from a slowly diffusible fraction of plasma 2 03 Pb. 
d ) MODEL III 
i ) Changes to model 
The two forms of plasma lead could arise from two different absorptive 
pathways for lead in the small bowel. Two pathways were suggested by 
the results of experiments performed in section 6.0, one that lead 
shares specifically with calcium and the other specifically with 
phosphorous. In the model, therefore, a second pathway was introduced 
to a second compartment, representing wall of small bowel, from the 
lumen of the small bowel. Lead was transferred to a second plasma 
compartment from the new wall compartment via a second liver 
compartment. 
Figure 8.3.5 shows the schematic for MODEL III with pathways to the 
small-bowel wall compartments~ and~ from the lumen of small 
bowel compartment ~ . Therefore, the rate constants L(l,19 ) and 
L(Z,19 ) represent the common lead/calcium and common lead/phosphorous 








































































































































































































































































































































































































compartment communicates with one of the two plasma compartments 0 and 0 . The experimental plasma data is now represented 
by the summer ~ , and contributions from 0 and G to 6 
are both unity. The liver compartment~ has been introduced to 
maintain compatibility between the two pathways from~ and~ 
to the plasma compartments 0 and 0 . Compartment 8 
contributes to~ by the summer coefficient 5(8,5 ) . This 
coefficient was made equal to 5(8,4 ) by a dependence equation. Uptake 
of 20 3Pb in liver compartment 8 also occurs from 0 , and 
urinary excretion of 20 3 Pb from G is by a pathway represented by 
the rate constant l ( l2,10). 
Summer coefficients 5(3,1 ) , 5(3,2 ) , 5(3,16 ) and 5(8,14 ) were all very 
small and removed from the model. The values of 5(3,19 ) and 5(3,20) 
were very close, so only 5(3,19) was allowed to vary and 5(3,20 ) was 
made equal to 5(3,19 ) by a dependence equation. 
ii) Constraints on l ( l,19 ) , l (2,19 ) and l ( Z0,19 ) 
The constraints on l ( l,19 ) , l ( 2,19 ) and L(Z0,19 ) , rate constants 
describing the transport of 2 03 Pb to wall from lumen of small bowel 
and movement of 203 Pb to large bowel from lumen of small bowel, were 
imposed by using the intercept from the equation of the regression line 
f i tted to the whole body retention from 96 hours onwards ( table 11.1.2). 
The absorbed percentage of 203Pb in the model, 
( l ( l,19 )) + l (Z,19 ) ) x 100 / ( L( l,19 ) + L( 2,19 ) + L(Z0,19 )) , was made 
equal to the intercept value, and the unabsorbed percentage, 
L(Z0,19 ) x 100 / (l ( l,19 ) + L(Z,19 ) ~ l (20, 19)) , equal to 100% minus 
180 
the intercept value. A solution using these contraints was obtained 
giving an absorbed fraction consistent with whole body retention of 
The rates of input and output of 203 Pb in the body compartments have to 
be satisfied and these are reflected in the magnitudes of L(l,19) and 
L( Z,19 ) . A further solution was found in which L( l,19) was allowed to 
vary between wide limits, but dependence equations were used to ensure 
that L( Z,19) and L(Z0,19) were always a fixed fraction of L( l,19 ) . 
This maintained the percentages of absorbed and unabsorbed 203 Pb found 
in the previous solution. 
Finally, the values of L(l,19), L( Z,19) and L(Z0,19) found in this last 
solution were used as initial values in a solution in which they were 
allowed to vary freely. In this way, it was possible to produce the 
necessary absorbed and unabsorbed fractions consistent with whole body 
retention, and still allow the magnitudes of L(l,19) and L(Z,19) to 
vary to enable the calculated values from the model solution to fit the 
experimental data. The results of the final solution of MODEL III are 
shown in table 8.3.6. 
e) MODEL IV 
From the results of the solution of MODEL III, it can be seen that the 
rate constant describing urinary excretion from plasma G 
L(lZ,10 ) , is very small. This pathway can be removed from the model 
without affecting the fit of the calculated values to experiment data. 
The standard deviation of the rate constant L( l6,9 ) , representing 
transfer of 2 0 3 Pb between the 'hard tissue' compartment G and 
181 
TABLE 8.3.6 
RESULTS OF COMPARTMENTAL ANALYSIS USING 
ALL EXPERIMENTAL DATA 
SUBJECT:K,B. 
PARAMETER 
L ( 1 , 1 9 ) 
L ( 2, 19) 
L ( 4, 1 ) 
L ( 5, 2) 
L ( 9, 4) 
L ( 10, 5) 
L ( 6, 9) 
L < 1 2 , 9) 
L (12,10) 
L < 13, 9) 
L ( 9,13) 
L < 14, 9) 
L ( 9, 14 > 
L < 16, 9) 
L ( 9, 16) 
L ( 6, 10) 
L (19,18) 
L (20, 6) 
L (20,19) 
L (21,20) 
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plasma compartment-~ is still high, and the fit between calculated 
values and experimental data is poor. The rate constant L(12,9), 
representing urinary excretion of 203 Pb from~' had a low standard 
deviation, and as both the experimental accumulative urine and 'hard' 
tissue data increased continuously over the period of the study, it 
was decided to try a solution without L(9,16). 
With the introduction of the second absorption pathway and its 
associated compartments , the fit to the liver and whole body data has 
deteriorated. of data, 
indicating that a delay compartment may be necessary between~ and 
~ . Therefore, the changes to the model were the exclusion of 
The fit was poor at later times for. both sets 
pathways L(l2,10 ) and L(9,16) and the introduction of a liver delay 
compar~~~nt ~, to give MODEL IV. 
Figure 8.3.6 shows the schematic for MODEL IV with an extra summer 
S(B,7) so that~ ffiay contribute to the calculated data for the 
liver. As with the other liver summer coefficients, 5(8,7) was made 
equal to 5(8,4) by a dependence equation. Therefore, all liver 
compartments contribute equally to~. This assumes that the 
in vivo detector 'sees' the same fraction of ingested dose in each 
liver compartment-. Table 8.3.7 shows the results of the solution with 
a better fit to whole body and liver data. 
f) Other subjects 
MODEL IV was used in the compartmental analysis of the experimental 
data from both Kinetic 1. and Kinetic 2. experiments of all the other 




























































































































































































































































































































































































































RESULTS OF COMPARTMENTAL ANALYSIS USING 




L ( 1 , 1 9 ) 0 .135 
L ( 2, 19) 0.025 
L ( 4 , 1 ) 724.182 
L ( 5, 2) 632.800 
L ( 9, 4) 1.404 
L < 10, 5) 0.006 
L ( 6 r 9) 50.373 
L < 12, 9) 29.468 
L C 13, 9) 409.412 
L ( 9,13) 0.018 
L (14, 9) 510.557 
L ( 9, 14) 0.021 
L < 16, 9) 0.899 
L ( 6, 10) 0.842 
L ( 7 r 6 ) 32.167 
L (20, 7) 0.008 
L (19,18) 2.317 
L (20,19) 0.070 
L (21,20) 0.099 
RESIDUAL SUMS OF SQUARES 
TOTAL 0.03023 
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as there was insufficient experimental data. Even with the lower than 
planned absorption of 203 Pb in the Kinetic 2. experiments of subjects 
B.C. and G.E., there was sufficient in vivo data to perform 
compartmental analysis. 
There were a few minor changes required in the model, and these 
involved only summer coefficients. A better fit between calculated 
values and experimental small bowel data from the Kinetic 2. experiment 
of subject B.C. was obtained using the summer coefficient 5(3,21 ) 
instead of 5(3,22). This was caused by the faster transit time of 
203 Pb in the large bowel of subject B.C. in his Kinetic 2. experiment, 
as indicated by the high value of L(21,20 ) compared with those found in 
the analysis of data from other subjects. 
The contribution of 203 Pb in the 'hard' tissue to the liver surface 
radioactivity measurements, represented by summer coefficient 5(8,16 ) , 
was only significant in subject G.E. There was also little 
contribution to the surface radioactivity measurements performed over 
the small bowel of 'soft' tissue 203 Pb, represented by summer 
coefficient 5(3,14 ) , in this same subject. 
8.3.3 Results 
a) Compatibility of MODEL IV with kinetic data 
Tables comparing and figures showing the fits between model calculated 
values and experimental data are listed in sections 12 and 13, 
respectively. Visual inspection shows that, overall, fits are 
generally good. The exceptions are those to the red cell data from 
186 
the Kinetic 2. experiments of subjects, K.B., J.B. and B.C., to the 
'hard' tissue data from both experiments of subjects K.B. and G.E. and, 
at later times, to the 'soft' tissue data from both experiments of 
subject B.C. There were also poor fits to smali bowel data from the 
Kinetic 2. experiments of all subjects except subject K.B. These were 
the result of the large unabsorbed fraction of 203 Pb moving back 
through the field-of-view of the in vivo detector between 16 - 48 hours. 
Table 8.3.8 shows the residual sums of squares for the fits to all the 
experimental data, and the total values are lower for absolute data 
than for proportional data. It is noticeable that if the residual sums 
of squares of the fits to red cell data are compared between Kinetic l. 
and Kinetic 2. experiments, those of the latter are usually smaller. 
This contradicts the visual inspection, but the discrepancy occurred 
because the model was unable to fit the early rapid phase of red cell 
uptake of 203Pb in the first 3 hours during the Kinetic l. experiments. 
This same effect occurred with the fits to the early phases of 'soft' 
and 'hard' tissue data. 
Tables 8.3.9-13 list the variable parameters obtained from the 
compartmental analysis, using experimental data from the paired kinetic 
experiments. There was insufficient data from the Kinetic 2. 
experiment of subject D.W. to allow a full compartmental analysis. 
There are very large uncertainties in the variable parameters L(4 ,l), 
L(5,2) and L(7, 6), rate constants representing the transfer of 203 Pb 
between wall of the small bowel and liver, and between liver 
compartments in the route of biliary excretion of 2° 3Pb. All model 














































































































































































































































































































































































































































































































































































COMPARISION OF VARIABLE PARAMETERS FROM 
PAIRED KINETIC EXPERIMENTS 
SUBJECT:K.B. 




L ( 1,19) 
L < 2,19) 
L < 4 , 1 > 
L ( 5, 2) 
L < 9, 4) 
L (10, 5) 
L ( 6, 9) 
L (12, 9) 
L (13, 9) 
L < 9,13) 
L (14, 9) 
L < 9,14) 
L (16, 9) 
L ( 6,10) 
L < 7, 6) 




S ( 3,14) 
S ( 3,19) 
S < 3,22) 










































































































COMPARISION OF VARIABLE PARAMETERS FRON 
PAIRED KINETIC EXPERIMENTS 
:3UBJECT: J.B. 
PARAMETEf.: 
L < 1,19) 
L < 2,19) 
L ( 4 , 1 ) 
L < 5, 2) 
L < 9, 4) 
L (10, 5) 
L < 6, 9) 
L (12, 9) 
L (13, 9) 
L < 9,13) 
L (14, 9) 
L < 9,14> 
L (16, 9) 
L < 6,10) 
L < 7, 6) 
L (20, 7) 
L (19.18) 
L <20,19) 
L < 21, 20) 
S < 3,14) 
S ( 3,19) 
S < 3,22) 
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TABLE 8.3.11 
COMPARISION OF VARIABLE PARAMETERS FROM 
PAIRED KINETIC EXPERIMENTS 
SUBJECT:B.C. 




L < 1,19) 
L < 2,19) 
L < 4 , 1 ) 
L ( 5, 2) 
L < 9, 4) 
L (10, 5) 
L < 6, 9) 
L (12, 9) 
L (13, 9) 
L < 9,13) 
L (14, 9> 
L < 9,14) 
L (16, 9) 
L < 6,10) 
L < 7, 6) 




S C 3,14) 
SC 3,19) 
S < 3,22) 










































































































COMPARISION OF VARIABLE PARAMETERS FRON 
PAIRED KINETIC E >{ F' E f.'. IM ENT!:; 
SUBJECT:G.E. 
PARAMETER KINETIC 1. KINETIC 2. 
( HR-1) ( HR-1) 
L ( 1, 19) 0.143+- 0.011* 0.098+- 0.007 L ( 2, 19) 0.024+- 0.004 0.005+- 0.002 
L ( 4' 1) 318.251+- 4052.469 9.550+- 2.518 L ( 5, 2) 7334,979+-221460.200 67.302+- 204.789 L ( 9, 4) 5.640+- 1.653 2.705+- 0.213 
L C 10, 5) 0.009+- 0.001 0.030+- 0.002 
L ( 6' 9) 35.370+- 14.787 139.175+- 22.840 
L ( 12 1 9) 21.613+- 2.849 22.695+- 4.428 
L ( 13, 9) 602.990+- 77.277 244.795+- 49.290 
L ( 9, 13) 0.025+- 0.002 0.014+- 0.001 
L < 1 4 , 9) 354.887+- 74.514 877.931+- 170.929 
L ( 9, 14) 0.016+- 0.002 0.030+- 0.003 
L ( 16, 9) 0.990+- 0 .126 0.899+- 0.176 L ( 6, 10) 1.663+- 0.257 1.246+- 0.401 
L ( 7, 6) 688.693+- 11486.660 11.532+- 30.003 L (20, 7 ) 0.017+- 0.013 0.020+- 0.004 L (19,18) 2.061+- 0.782 2.210+- 0.914 
L (20,19) 0.055+- 0.010 0.227+- 0.011 L (21,20) 0.093+- 0.017 0.117+- 0.004 s ( 3 ,19) 0.063+- 0.007 0.083+- 0.008 s ( 3,22) 0.109+- 0.075 0.131+- 0.017 s ( 8, 4) 0.174+- 0.008 0.126+- . 0.002 s ( 8 r 16) 6.569+- 2.872 6.077+- 0.765 s (15,14) 0.003+- 0.001 0.002+- 0.000 s (17,16) 1. 000+- · 0.025 1 . 000+- 0.022 
* +- 1 STANDARD DEVIATION 
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TABLE 8.3.13 
COMPARISION OF VARIABLE PARAMETERS FRON 
PAIRED KINETIC EXPERIMENTS 
SUBJECT:O.W. 
PARAMETER KINETIC 1. KINETIC 
< HR-1l ( HR-1> 
L ( 1 7 19) 0 .139+- 0.007* 
L ( 2,19) 0.036+- 0.003 
L 4, 1) 10000.000+- 32015.560 
L ( 5 7 2) 167.729+- 453.455 
L ( 9, 4) 10.076+- 3.657 
L < 10, 5) 0.005+- 0.001 
L ( 6, 9) 43.477+- 10.823 
L < 12, 9) 20.724+- 2,411 
L < 1 3 , 9) 471.259+- 52.096 
L ( 9, 13 > 0.020+- 0.002 
L ( 1 4 7 9) 256.998+- 39.321 
L . < 9, 14) 0.018+- 0.002 
L: ( 16 7 9) 0.660+- 0.074 
L ( 6,10) 1. 573+- 0.216 
L ( 7 7 6) 11.045+- 27.405 
L (20, 7) 0.003+- 0.001 
L (19,18) 2.069+- 0.118 
L (20,19) 0.068+- 0.006 
L (21,20) 0.080+- 0.005 s ( 3,14) 0.024+- 0.007 
s ( 3 7 19) 0. 177+- 0.010 s ( 3,22) 0.313+- 0.050 s ( 8, 4) 0.171+- 0.004 
C· 
o;J (15,14) 0.004+- 0.000 s (17,16) 1.000+- 0.022 
* +- 1 STANDARD DEVIATION 
2. 
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b) Comparison of variable parameters obtained from MODEL IV solutions 
using kinetic data from the paired experiments 
Rate constants from l ( l,19 ) to L( 21,20 ) have been compared with the 
paired Student's 't' test (Mould, 1976 ) , for the subjects K.B., J.B., 
B.C. and G.E., and the results are shown in table 8.9.14. Significant 
changes between Kinetic l. and Kinetic 2. values occurred in rate 
constants, L(2,19 ) , representing the transport of 2 03 Pb to wall from 
lumen of small bowel via the common lead/ phosphorous pathway, L(l3,9 ) 
and L(l4,9 ) , representing the uptake of 2 03 Pb in red cells and 'soft' 
tissue compartments and L(20,19), representing the movement of the 
unabsorbed fraction of 2 0 3Pb ta large bowel from lumen of small bowel. 
The only consistent changes in the values of the summer coefficients 
were in 5(15,14 ) , the 'soft' tissue coefficient. The values found in 
the model solutions using data from Kinetic 2. experiments were always 
lower by an approximate factor of 2 than those found using data from 
Kinetic 1. experiments. 
c) Comparison of percentages of ingested dose of 203 Pb absorbed in common 
lead/ calcium and common lead/ phosphorous absorptive pathways in paired 
kinetic experiments 
The percentages of ingested dose absorbed in the common lead/ calcium 
and common lead/phosphorous absorptive pathways were calculated from 
the i r representative rate constants L(l,19 ) and L(2,19 ) , respectively, 
and L( 20 , 19 ) , rate constant representing the movement of unabsorbed 
2 0 3 Pb f rom lumen of small bowel to l arge bowel. These percentages are 
listed in t able 8.3.15 f or both kinetic experiments. The reduction in 
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TABLE 8.3.14 
Results of paired Student's 1 t 1 test of rate constant 
changes between the results of the paired 
kinetic experiments 
RATE CONSTANT It I 
L(l,19 ) 2.87 
L(2,19)* 4.40 
L(4,l ) 1.04 
L(5,2) 0.91 
L(9,4 ) 1.49 
L(l0,5) 0.85 
L(6,9 ) 1.50 
L(l2,9) 2.34 
L(l3,9 )* 4.04 
L(9,13 ) 1.45 
L(l4,9)* 3.69 
L(9,14) 2.31 




L(20,7 ) 1.63 
L(20,19)* 3.67 
L(Zl,.20 ) 1.04 














































































































































































































































































































































































































percentages of ingested dose absorbed in both pathways was 
significantly reduced in the Kinetic 2. experiments. 
d) Model derived percentages of absorbed dose of 203Pb in liver, 
'soft' and 'hard' tissue compartments 
~xperimental data obtained from surface radioactivity measurements 
performed over liver, medial aspect of calf and medial malleolus were 
proportional data. Summer coefficients relating this data to absolute 
calculated values of percentage ingested dose in the liver, 'soft' and 
'hard' tissue compartments were estimated in the compartmental analysis. 
These absolute calculated values can either be derived from simulations 
of the model, or from the proportional calculated values matched to the 
experimental data and the values of the corresponding summer 
coefficients. Table 8.3.16 shows the maximum 203 Pb contents of liver, 
'soft' and 'hard' tissue compartments expressed as percentages of 
calculated absorbed dose. There were significant increases in 'soft' 
tissue levels of absorbed dose of 203Pb found in the Kinetic 2. 
experiments compared with those found in the Kinetic l. experiments. 
There were no other significant changes. 
e ) Rate constants of MODEL IV pathways determined with data from 
Kinetic l. experiments 
Table 8.3.17 lists the values of the rate constants obtained from the 
solution of MODEL IV using the data from the Kinetic 1. experiments of 
all subjects. The means and standard deviations of each set of rate 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Rate constants with high mean values are L(4,l ) , representing transfer 
of 2 03 Pb from wall of small bowel of the common lead/ calcium pathway 
to liver, L(l4,9 ) and L(l3,9 ) , representing uptake of 2 0 3Pb in 'soft' 
tissue and red cell compartments. Low mean values were found for rate 
constants L(l0,5 ) , representing transfer of 2 03 Pb, absorbed in common 
lead/phosphorous pathway, from liver to plasma, and L(20,7 ) , 
representing biliary excretion of 2 03Pb. 
1 • Coefficients of variation were low for L(l9,18 ) , representing transfer 
of 2 0 3 Pb from stomach to lumen of small bowel, L(Z0,19 ) , representing 
movement of unabsorbed 203 Pb from lumen of small bowel to large bowel, 
L( Zl,20 ) , representing movement of 20 3Pb in the lumen of the large 
bowel and L(l2,9 ) , representing urinary excretion of 2 03 Pb. 
Rate constants L(4,l ) and L(5,2 ) had extremely large coefficients of 
variation, and L(Z,19 ) , rate constant representing transport of 
2 0 3 Pb in common lead/phosphorous pathway, and L(l3,9 ) , L(9,13 ) and 
L(20,7 ) had large coefficients of variation. 
8.3.4 Discussion 
A 'universal' model was developed to f i t t he experimental data from all 
subjects and experiments. The fitting of a full model to all the data 
simultaneously reduces the possibllity of overlooking inconsistencies 
that are not apparent intuitively. The complexity of the f inal model 
evolved after efforts to derive a compatible, less complicated model, 
failed. 
It may appear that a model consisting of many compartments should be 
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able to fit any data. However, when the experimental data are 
extensive, such as the eight data curves in the present work, have 
sufficient structure and when the model contains constraints, it may 
be quite difficult to fit data to a particular model, even if it 
contains a large number of compartments (Berman et al, 1968 b ) . 
The model was developed on the assumption that there exists a 
'universal' model to represent the kinetics of lead in the body. 
Differences in kinetics between individuals and those caused by the 
effects of calcium and phosphorous are also assumed to be reflected in 
quantitative changes in the values of model parameters. 
All transport processes in the compartmental model have been 
represented by one rate constant for each process, and this is 
probably a simplification as long-term animal studies have shown that 
these processes may consist of two or even three rate constants. 
Barton et al (1978 ) injected 210 Pb into rats and measured retention 
over a period of six weeks which showed at least two phases of 
elimination. Cohen (1970) fitted a two exponential function to the 
~hole body retention of baboons that had been injected with 210 Pb and 
measured over a year. In the same work, the release of 210 Pb from the 
blood was best fitted by a two exponential function, and Hursh (1973) 
needed three exponentials to fit the release of injected 210 Pb from the 
blood of dogs over a period of 9 months. 
Rabinowitz et al (1976) measured the blood levels of the stable tracer 
204Pb in five subjects whose food intake had been supplemented each day 
by 2 0 ~Pb from 1-124 days. They were able to fit the blood data with a 
two compartmental model, after discontinuing the ingestion of lead 
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tracer by the subjects. However, the blood 2 04 Pb did not decrease as 
rapidly towards zero as predicted from the two compartmental model. 
The authors suggested that there existed a component of blood with a 
long biological half-life of lead, and that this was caused by the 
return of 204 Pb from a third compartment with a slow turnover of lead, 
namely, the dense cortical bone of the skeleton. However, the 
discrepancy in the fit occurred at about 100 days after the cessation 
of tracer lead input, so that the loss of lead from the blood can 
probably be represented by a single exponential up to 100 days. 
The number of exponentials required to fit the data from long term 
studies is influenced by the resorption of lead from the skeleton, a 
pathway which it was not necessary to include in the final 
compartmental model in this thesis. The transport processes can be 
adequately described by one rate constant for each process over the 
study length of nine days, and probably even longer from the evidence 
of Rabinowitz et al (1976). 
The rate of lead absorption along the small bowel was represented by 
two pathways in the model, but it is unlikely to be discontinuous 
occurring at only two rates. However, it is significant that attempts 
to produce a compatible model with less than two independent rates were 
unsuccessful. 
a ) Compatibility of MODEL IV with kinetic experimeotal data 
The fits between model calculated values and the experimental data were 
generally good with few systematic deviations, indicating that the 
degrees of freedom of the model were sufficient (section 8.1.5 ) . The 
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best fits were obtained between absolute experimental data and 
calculated values. Both the closer relationship between absolute data 
and the model, and the lower statistical error of the data were 
responsible for the better fits. 
The model was unable to represent the early rapid partitioning between 
red cells, 'soft' and 'hard' tissue compartments. However, this 
occurred within the first 3 hours after the ingestion of 203 Pb, which 
represents a small fraction of the total study time of 8-9 days. 
Another discrepancy was the poor fit at later times between calculated 
values and the experimental red-cell data from the Kinetic 2. 
experiments of subjects K.B., J.B. and B.C. 
The structure of the red cell data curves from the Kinetic 2. 
experiments, however, was generally different to those from the 
Kinetic 1. experiments. Those from the latter had one initial slope 
rising sharply to a peak, and from this peak the 203 Pb content 
decreased in a single exponential manner. The 203 Pb content of red 
cells in the Kinetic 2. experiments had the same first phase as that 
found in the Kinetic l. experiments, except that the slope was less. 
However, there was also a second phase, with content rising at a slower 
rate before the peak was reached. This second phase was most noticeable 
in the red cell data from the Kinetic 2. experiment of subject D.W. In 
this experiment, subject D.W. ingested the maximum weights of calcium 
and phosphorous with 203 Pb, and the second phase was particularly long 
as the maximum 203 Pb content of red cells was not reached until 144 hours. 
In the analysis of data from the Kinetic 2. experiments, the model was 
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able to match the slope of the first phase of red cell uptake of 203 Pb 
by decreasing the values of rate constants L(l, 19 ) , describing the 
transfer of 2 03 Pb to wall from lumen of small bowel via the common 
lead/ calcium pathway, and L(l3,9 ) , describing the uptake of 20 3 Pb by 
the red cells. However, it could not accomodate the slower second 
phase. There appears to be a delay in the uptake of 203 Pb in the red 
cells when it is ingested with calcium and phosphorous, and Chamberlain 
et al (1978 ) observed a similar delay when their subjects ingested 
2 0 3 Pb in food. 
To investigate the two phases of red cell uptake of 203 Pb, compartments 
which had represented the large bowel were used as delay compartments 
between plasma 0 and the red cell 0 . These delay 
compartments would allow the model to still match the initial slope of 
the red cell data curve, and allow longer storage of 203 Pb. The curve 
could now continue to rise to the peak at a slower rate during the 
second phase before the release ~of 20 3 Pb back into the plasma 
compaEtment. A solution was attempted without whole body data, with 
model parameters fixed except those communicating with the plasma 
compartment and with experimental data from the Kinetic 2. experiment 
of subject J.B. The results showed a much better fit between 
~alculated values and the experimental red cell data as seen in figure 
JB-RC-2A. There were no significant changes in any of the important 
variable parameters, such as L( l3,9) and L( l4,9 ) . 
Poor fits were obtained between calculated values and experimental 
'hard' tissue data of subjects K.B. and G.E. Their 'hard' tissue data 
i nitially rose rapidly as in the other subjects, but did not rise as 
204 
rapidly over the remainder of the study period. The discrepancies 
in the fits showed the same trends for both subjects and both kinetic 
experiments. This suggests that experimental errors were not the 
source of the discrepancies, but that the behaviour of lead in the 
'hard' tissues of the two subjects was different to that which occurred 
in the other subjects. 
The poor fits to some of the small bowel data were caused by the 
inability of the model to describe the unabsorbed fraction of 203 Pb 
moving through the transverse portion of the large bowel. The values 
of the rate constants representing the movement of 203 Pb in the lumen 
of the large bowel were primarily obtained from the fit to the whole 
body data. The faecal excretion of unabsorbed 203 Pb is a much slower 
process than its movement in the transverse portion of the large bowel. 
The transport of the contents of the transverse colon is thought to be 
by a mass movement which may occur one to four times a day, and the 
contents are then stored in the descending colon and rectum (Eve, 1966). 
Both gamma camera and profile scan studies in section 8.2.3 had shown 
both the fast movement through the large bowel and storage in rectum of 
unabsorbed 203 Pb. 
The movement of unabsorbed 203 Pb in the transverse colon would be 
better described by the model if the rate constants representing the 
movement of 203 Pb in the lumen of large bowel were allowed to vary 
individually and more compartments were included in the large bowel 
segment. The values of some of the rate constants could rise to give 
a faster input and output in a number of compartments to suit the 
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relatively fast movement of 203 Pb in transverse colon. The increase 
in the number of compartments would maintain the overall delay in the 
excretion of the unabsorbed fraction of 203 Pb. 
A solution was attempted with compartments that had been used as summer 
compartments, & , ~ and. & , · included with the other 
large boll(Ol · compartments G -0 Only those parameters in 
the large-bowel delay segment were allowed to vary, all others were 
fixed. The experimental data used was that from the Kinetic 2. 
experiment of subject G.E., without data on liver, 'soft' and 'hard' 
tissue compartments. The results show a much better fit between 
calculated values and the experimental small-bowel data, as shown in 
figure GE-S8-2A. 
The 'soft' tissue data of subject 8.C. was poorly fitted by model 
calculated values, because the data kept rising from 24 hours onwards. 
This subject was the most heavily built of all the subjects who took 
part in the kinetic experiments. Therefore, it is possible that his 
tibia and fibula, representing . a fraction of the 'hard' tissue 
compartment, may have been included in the field of view of the 
in vivo detector, even though the detector was carefully positioned to 
avoid this possibility. lhis was checked by allowing the 'hard' tissue 
to contribute to the 'soft' tissue calculated values, by including in 
the model the summer coefficient 5(15,16). A good fit was obtained to 
the experimental data as seen in figures BC-ST-lA and BC-ST-2A. 
However, there was no significant change in the model derived 
percentages of absorbed dose in the 'soft' tissue compartments. 
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The rate constants representing movement of 203 Pb from wall of small 
bowel to liver, L(4,l ) and L(5,2), and the rate constant representing 
transfer of lead between the two liver compartments in the route of 
biliary excretion, l(7,6), all had consistently large uncertainties. 
The experimental liver data was inadequate, therefore, to completely 
define the structure of the liver compartments in the model (section 
8.1.5 ) . 
The uncertainties were also associated with compartments in series, so 
that there would be a certain interdependence of parameters. Such 
interdependence affects the precision with which the parameters may be 
estimated (Berman et al, 1968 ) . The experimental data describing the 
kinetics of 203 Pb in the liver was proportional, and the results of the 
profile scan analysis could only be used to provide constraints on the 
liver summer coefficients. Therefore, the model solutions obtained 
would give the parameters, associated with the liver, larger 
uncertainties than if the experimental liver data were absolute. 
Convergence to a least squares solution was obtained with the 
compartmental analysis of all the kinetic data from every subject and 
every experiment. The methods used in section 8.3.2 (a ) helped to 
obtain a good choice of initial values for the variable parameters, 
and, consequently, convergence of the model solutions. 
The compatibility is satisfactory between MODEL IV and most of the 
experimental data from the Kinetic 1. experiment, according to the 
criteria described in section 8.1.5. It is not as good between the . 
model and the experimental data from the Kinetic 2. experiment. 
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Supplementary analysis showed, however, that additional compartments 
were required to improve compatibility, but these could not be 
included in MODEL IV because of the limited number of compartments and 
variable parameters allowed in SAAM25 (1967 ) . As the additional 
compartments required were operational, i.e. delay compartments, and no 
significant changes occurred in the values of important parameters in 
the supplementary analysis, the results of the compartmental analysis 
of the Kinetic 2. data can be used to examine the effect of calcium and 
phosphorous on model parameters. 
b ) Effect of calcium and phosphorous on model parameters 
Calcium and phosphorous ingested simultaneously with 203 Pb 
significantly reduced the percentages of ingested 203 Pb absorbed via 
pathways L(l,19) and L(2,19), representing the transport of 203 Pb by 
the common lead/calcium pathway and the common lead/phosphorous 
pathway, respectively. This reduction was reflected in the lower 96 
hour retentions of all subjects in the Kinetic 2. experiments. The 
relative change in these model derived percentages absorbed via the two 
pathways was by a factor of 1.3 for l(l,19 ) and by a factor of 3.2 for 
L(2,19), showing that the second pathway was more sensitive to the 
effect of calcium and phosphorous on lead absorption. The rate of 
absorption of 203 Pb via l(l,19) was not significantly reduced by 
calcium and phosphorous. A significant reduct i on occurred, however, in 
the rate for the L(2,19) pathway. The different responses of the rate 
constants suggest that the nature of the transport mechanisms mainly 
responsible for lead absorption, which they represent, are different. 
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The value of l(20,19 ) was increased significantly by the presence of 
calcium and phosphorous with 203Pb in the gut. However, the value of 
this rate constant represents the fraction of 203 Pb unabsorbed with 
which it correlates very well ( r=0.92 ) . 
There were significant reductions in the values of l ( l3,9) and a 
significant increases in the values of L( l4,9), rate constants 
representing the uptake of 203 Pb in the red cell and 'soft' tissue 
compartments, respectively. As both these compartments are connected 
to the diffusible-plasma lead compartment, it is possible that their 
changes are dependent. The significance of these changes will be 
discussed in section 9.0. 
It is impossible to compare the variable summer coefficients for a given 
compartment between subjects. These summer coefficients relate the 
surface radioactivity measurements to the model, and these measurements 
depend on local tissues and detector geometry, gamma ray absorption in 
the tissues, and the sensitivity of the detector. These uncontrolled 
variables will be different for different subjects and for different 
measurement sites on the same subject. It is valid to compare the 
coefficients of compartments at the same site, and there was a 
consistent reduction by a factor of 2 in the value of the 'soft'-tissue 
summer coefficient, 5(15,14), found in the Kinetic 2. experiments for 
each subject. This shows that a lower fraction of the ingested dose of 
lead in the 'soft' tissue compartment was 'seen' by the in vivo detector 
in the Kinetic 2. experiments. The significance of this effect will be 
discussed in section 9.0. 
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) Md l d · d t f 203 Pb i·n 1 · ' ft' t · d c o e erive percen ages o iver, so issue an 
'hard' tissue compartments 
i) Liver compartments 
There was no significant effect of calcium and phosphorous on the 
model derived percentages of the absorbed dose of 203 Pb found in the 
liver. + The mean value of these percentages, 20.48 - 2.86% (S.E. ) , was 
comparable to the 20% found in dogs at 28 days after an injection of 
21 0Pb (Lloyd et al, 1970). Cohen (1970) measured a lower 210 Pb content 
of 12.8% in a baboon who received the lead intravenously and was 
sacrificed 24 hours later. A 203 Pb content of liver, 10.8%, was found 
by Meredith et al (1977), when rats ingested 203 Pb and were sacrificed 
at 7 days. Similarly, a liver content of 10.48% was found by Conrad 
and Barton (1978) after the intravenous injection of 210 Pb in rats. 
This last measurement was done, however, at l hour post injection and 
the liver content at a time comparable to that used by Meredith et al 
(1977) was only 0.42%. This suggests that ingested and intravenous lead 
behave differently in the liver. As the liver removes lead from the 
portal blood, it would be expected that the fraction of ingested lead 
stored in the liver would be greater than that stored of injected lead 
(Cantarow and Trumper, 1944). 
ii) 'Soft' and 'hard' tissue compartments 
Although the mean percentage of absorbed 203 Pb in the 'hard' tissue 
was reduced in the Kinetic 2. experiment, the change was not 
significant. In the 'soft' tissue compartment, however, there was a 
significant increase in the mean percentage of absorbed dose, and this 
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will be discussed later in section 9.0. 
The model derived values of absorbed dose of 203 Pb in the 'hard' 
tissue compartment were much less than those in the 'soft' tissue 
compartment. It was expected that they would be higher as the 'hard' 
tissue compartment represented bone, and it has been shown in animal 
studies that the early distribution of tracer lead is towards high 
uptake in bone. Hammond et al (1967) injected 210 Pb into rats and 
found at 72 hours that 53.4% of the injected dose was in bone and only 
6.5% was in total soft tissues. The results of the present work show 
that, in the Kinetic 1. experiment, the mean percentage of absorbed 
dose of 203 Pb is 0.15% in the 'hard' tissue compartment and 37.36% in 
the 'soft' tissue compartment at 72 hours after the ingestion of 203 Pb. 
The significance of the differences in the percentages of absorbed dose 
calculated to be in the 'hard' and 'soft' tissue compartments will 
depend on the structure of the model, how these compartments are 
defined in the model and how they relate to the different tissues in 
the field-of-view of the in vivo detector. 
As the experimental data representing 203 Pb radioactivity in the 'hard' 
and 'soft' tissue compartments were proportional, the model derived 
values of absorbed dose in these compartments will depend on how they 
are arranged in the structure of the model. During the development of 
the model (section 8 . 3), different configurations of the 'soft' tissue, 
'hard' tissue and the diffusible-plasma lead compartments were tried, 
such as connecting the 'hard' tissue to the 'soft' tissue and not to 
the plasma compartment. Model solutions obtained using these different 
combinations were all inferior to the final structure (figure 8.3.6), in 
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both the uncertainties in the estimates of the 'soft' tissue and 'hard' 
tissue variable parameters and residual sums of squares. 
Both the 'soft' and 'hard' tissue compartments are c6nnected to the 
diffusible-plasma lead compartment, and they are two of a total of 
five receiving lead from this plasma compartment. The others are liver, 
red cells and accumulative urine compartments, and the last two are well 
defined by absolute experimental data. The output from the plasma to 
the liver compartment is constrained by proportional liver data, but as 
this output affects the biliary excretion of lead in the model, it is 
also defined by the absolute whole body data. The 'hard' and 'soft' 
tissue compartments are, therefore, less well defined, and they 
represent all lead in the body apart from red cell, liver, and plasma 
lead, i.e. lead in the bone and other soft tissues. 
The experimental data describing the 2 03 Pb radioactivity in the 'hard' 
tissue compartment was obtained from surface radioactivity measurements 
performed over the medial malleolus. The different tissues 'seen' by 
the in vivo detector placed over this site were 'soft' tissue, 
trabecular bone, cortical bone, and blood and 'soft' tissue E.C.F. 
2 0 3 Pb. These last two are subtracted from surface radioactivity 
measurements before the data is used in analysis. In the development 
of the model, it was found unnecessary to include a summer f rom 'soft' 
tissue compartment G ta the 'hard' tissue summer Lfu , 
indicating that the contribution of 'soft' tissue to 'hard' tissue data 
is negligible. The remaining tissues are, therefore, trabecular and 
cortical bone, and the behaviour of lead in these two tissues has been 
suggested to be different. 
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Baloh (1974 ) suggested that bone lead may exist in two compartments, 
the readily exchangeable fraction in trabecular bone and the relatively 
non exchangeable fraction in the dense cortex. Rabinowitz et al (1976 ) 
found in their studies of steady state levels of lead in humans, that 
the ratio of tracer to total lead was about two to three times greater 
in trabecular than in the cortex. Cantarow and Trumper (1944) have 
suggested that the lead stored in the trabeculae is more mobile than 
that stored in the cortical bone. They reported that there was 52% 
more lead in the cortex than in the trabecular portion of the sternum 
of a normal human subject, but 78% more lead in the trabecular than in 
the cortical bone in a subject with active lead poisoning. This 
suggests that recently absorbed lead is deposited as a loosely bound 
compound in the trabeculae, before it is eventually deposited as a 
relatively fixed compound in the cortical bone. This last type of bone 
receives a relatively small percentage of the circulation (Baloh, 1974 ) ,, 
and may be expected to be the site of long term storage of lead 
(Chamberlain, 1975). 
The low value of the rate constant describing the uptake of 203 Pb in 
the 'hard' tissue compartment, L( l6,9 ) , and the low ~percentage of 
absorbed dose derived from the model in this compartment, suggests that 
the experimental data obtained from measurements over the medial 
malleolus was mainly from 20 3 Pb radioactivity in cortical bone. The 
bony structures included in the field-of-view of the in vivo detector 
were the ends of the tibia and fibula and the talus bone. All three 
consist of trabecular bone with a surface covering of the more dense 
cortical bone. The surface area of these three bony structures will be 
greater than that of the same volume of bone in a single bony structure, 
213 
such as the calcaneum. Therefore, the fraction of cortical bone 'seen' 
by the in vivo detector placed over the medial malleolus will be 
greater than that 'seen' over the calcaneum. 
Osteodensitometry measurements (section 11.11) performed over the 
medial malleolus and calcaneum in four of the subjects who took part 
+ in the kinetic studies, gave mean values of 1.11 - 0.02 g/cm 2 (S.E.) 
+ and 0.567 - 0.039 g/cm 2 (S.E.), respectively. The higher mean found 
over the medial malleolus indicates a higher density of bone in that 
region reflecting a larger proportion of cortical bone. 
The experimental data describing the 203 Pb radioactivity in the 'soft' 
tissue compartment was obtained from surface radioactivity measurements 
over the medial aspect of the calf. The predominant tissue in the 
field-of-view of the in vivo detector was muscle, as the detector was 
positioned carefully to exclude bone from the field-of-view. From the 
work of Hammond et al (1967), the 210 Pb content of muscle in rats 
injected with 210 Pb was only 0.12% of the injected dose at 72 hours. If 
this low lead content of muscle also occurs with tracer lead in man, 
which is suggested by low steady-state lead levels (Barry, 1975), then 
the major fraction of 203 Pb in the 'soft' tissue compartment must be in 
some other types of tissue in this compartment. However, this assumes 
that the changing lead content of muscle reflects that occurring in the 
remainder of the tissues which constitute the 'soft' tissue compartment. 
If surface radioactivity measurements performed over the medial 
malleolus mainly represent 203 Pb radioactivity in cortical bone, then 
the 'soft' tissue compartment will include the readily exchangeable 
fraction of trabecular bone lead. This is also suggested by the levels 
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of absorbed lead found in the 'soft' tissue compartment which are of 
the same order as those found in the bone of animals a few days after 
the administration of lead. Apart from the experiments of Hammond et 
al (1967) already described, Hackett and Sikov (1977 ) found that rats 
injected with 210 Pb had 30% of the injected dose in the skeleton at 90 
minutes, and 40% at 11 days. 
The trends of the 203 Pb radioactivity in the 'hard' and 'soft' tissue 
compartments are similar to those found by Knop et al (1977) in their 
compartmental model describing the kinetics of 47Ca injected into normal 
humans. The levels of 47Ca in their 'fixed' bone calcium compartment 
rose slowly over the 10 day period of study, whereas those in the 
'exchangeable' bone calcium compartment rose to a peak within 48 hours 
and decreased slowly from that time onwards. 
d) Rate constant values obtained from the compartmental analysis of 
experimental data from Kinetic 1, experiments 
The data from the Kinetic 1. experiments were obtained, as far as 
possible, with identical experimental conditions. The compartmental 
model was found to be compatible with most of this kinetic data, so 
that it adequately represents the behaviour of 203 Pb in the body. 
Therefore, any differences in parameter values obtained from the 
analysis of data from each subject, could be caused by individual 
variation between subjects. 
The rate constant describing the transport of 2 03 Pb from lumen of small 
( ) + -1 bowel to wall, L 1,19 , has a mean value of 0.154 - 0.032 hr , which 
is of the same order as those found by Birge et al ( 1969 ) for the 
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rate constants describing the absorption of 47Ca from the small bowel in 
6 normal humans. This suggests a similar transport mechanism for 
calcium and lead, and strengthens the hypothesis advanced in section 
6.4.l that lead and calcium share the same absorptive pathways. 
The large value of L(4,l), rate constant describing the transfer of 
203 Pb from wall of small bowel of the common lead/calcium pathway to 
liver, cannot be commented on because of a very large coefficient of 
variation. The large values of L(l4,9 ) and L( l3,9 ) , rate constants 
describing the uptake of 203 Pb in 'soft' tissue and red cells, are 
consistent with the observations of other workers that lead rapidly 
exchanges between plasma and extracellular fluid (Stover, 1959 ) , and 
is taken up avidly by red cells (Hursh and Suomela, 1968). They are of 
the same order, as suggested by Chamberlain et al (1975 ) and Hursh et 
al (1969 ) . The low values of rate constants L(l0,5) and L(20,7), 
representing transfer of 203 Pb, absorbed via the common lead/phosphorous 
pathway, from liver to plasma, and biliary excretion of lead are 
consistent with suggestions that the liver acts as a storage compartment 
for lead (Barltrop, 1968; Cantarow and Trumper, 1944 ) . 
The low coefficients of variation of L(l9,18) and L(21,20 ) , 
representing transfer of lead from stomach to lumen of small bowel and 
movement of 203 Pb in the lumen of large bowel, respectively, are not 
surprising. It was assumed in the model that these pathways did not 
involve absorption and the 'mechanical' process of stomach emptying and 
movement of lead in the lumen of the large bowel should show li ttle 
variation. The rate constant, L(20,19), representing the unabsorbed 
fraction of lead, should have a small coefficient of variation as the 
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absorption of 203 Pb in all the subjects was approximately the same in 
the Kinetic l.experiments. 
The coefficient of variation of the rate constant describing the 
urinary excretion of 20 3 Pb, l(l2,9), is surprisingly low at 15%. This 
suggests that the wide range of urine lead concentrations found in 
community studies is probably caused by differences in the absorption 
of lead from the gut. This small variation is in direct contrast to 
that found with the rate constants describing uptake and release of 
2 0 3 Pb in red cells, L(l3,9) and L(9,13 ) , of approximatel y 45%. Waldron 
and Stfifen (1974 ) have reported work which shows that the capacity of 
red cells to hold lead may show variation from one person to another. 
Mylroie et al (1977 ) maintained that not only were blood lead 
measurements inappropriate as the sole criterion in therapy and 
toxicological studies, as suggested by Chisolm et al (1975 ) , but that 
blood lead measurements should not be used as a sole measure of 
environmental exposure to lead. As mentioned in section 1.4, the WHO 
(1977 ) have accepted that blood lead should not be used as an 
i ndication of exposure when dealing with individual subjects. 
The large coefficients of variation of the mean values of L(4,l ) and 
L(S,2 ) , rate constants representing the transfer of 20 3Pb from wall of 
small bowel to liver compartments, reflect the large uncertainties of 
these rate constants found in the solutions of the model. The rate 
constant representing biliary excretion of lead, L(20,7 ) , also has a 
large coefficient of variation which may account for the large scatter 
i n the half times of retention found in the subjects who t ook part in the 
Kinetic 1. experiments. 
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8.4 Use of compartmental MODEL IV 
8.4.l Introduction 
Throughout this thesis, the 96 hour whole body retention of 203 Pb has 
been regarded as a reliable measure of 203 Pb absorption. The results 
of the compartmental analysis can now be used to check this assumption. 
The 96 hour retentions of the subjects who took part in the kinetic 
experiments can be compared with the percentages of ingested 203 Pb 
absorbed by these subjects, calculated from the values of their model 
parameters. 
If there is any discrepancy between retentions and calculated absorbed 
doses, the cause may be the presence of some unabsorbed 203 Pb still in 
the gut at 96 hours. It was suggested in section 5.4.2 that some of 
the short half times of retention calculated with retention data from 
96 hours onwards could have been caused by such unabsorbed 203 Pb. 
Simulations of MODEL IV with and without the unabsorbed fraction of 
203 Pb in the gut should show any effects of unabsorbed 203 Pb on 96 hour 
retentions and half times of retention. 
The interrelationship between lead, calcium and phoi~horous absorption 
in the gut, suggested in section 7.2, may be further examined by using 
the model. As minimal changes were required in model parameters to 
describe the effect of calcium and phosphorous on the kinetics of 203 Pb 
in the body, it should be possible to analyse the limited kinetic data 
from the Kinetic 2. experime~t of subject D.W. This could be done by 
using model parameter values obtained in the analysis of his Kinetic l. 
experimental data. Such an analysis would be an important check on the 
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flexibility of the model and on the responses of model parameters to 
the maximum weights of calcium and phosphorous. The effect of carrier 
lead on lead absorption in subject K.B. may be investigated in a 
similar manner, using the experimental data obtained from this subject 
in section 5.0. 
The maximum weights of calcium and phosphorous ingested together by 
subject K.B. reduced his 96 hour retention of 203 Pb from 60.76% to 
1.51% ( table 6.3.2). This indi ~ates an inhibition of lead absorption 
which is nearly complete. The effects of separate doses of the same 
weights of calcium and phosphorous were much less, reducing retention 
to 6.51% and 47.24%, respectively. However, if lead shares the common 
pathways of calcium and phosphorous absorption, then the effects of 
separate doses may be explained by the complete inhibition of lead 
absorption in the lead/calcium pathway by calcium and in the 
. --~ 
lead/phosphorous pathway by phosphorous. This can be checked by 
simulations of the model giving calculated values of retention that can 
be compared with the data from the separate dose experiments. 
The experimental data of 203 Pb levels in plasma and liver were fitted to 
a linear combination of calculated values from the two plasma and four 
liver compartments. The calculated values from each compartment can be 
found by a simulation of MODEL IV. A comparison of the levels of 203 Pb 
in these compartments may provide a better understanding of the 




a ) Effect of the unabsorbed fraction of 203 Pb on 96 hour retentions 
and half times of retention 
Simulations were performed for all subjects and experiments using the 
model parameters listed in tables 8.3.9-13, allowing the unabsorbed 
20 3 Pb to move down the large bowel compartments 0 -G in the 
normal manner, and then repeated, removing the unabsorbed 203 Pb from 
the large bowel. This was done in the model by changing pathway 
l(20,19) to l(0,19). The half times of retention from 96 hours onwards 
were then calculated from the simulated whole body retention values 
using a non-weighted least squares regression. 
b) Compartmental analysis of limited kinetic data 
Because of the low percentage of 203 Pb absorbed by subject D.W. in the 
Kinetic 2. experiment, whole body counts could only be performed up to 
120 hours and useful profile scans, plasma and surface radioactivity 
measurements could not be obtained. The 203 Pb content of the red cells 
and the 203 Pb excreted in the urine, however, could be measured with 
acceptable statistical accuracy up to 9 days. Data from the experiment 
in which subject K.B. ingested 203 Pb without carrier lead (section 5.0), 
included measurements on 203 Pb radioactivity in the whole body, whole 
blood and urine performed up to 8-9 days after the ingestion of 203 Pb. 
Solutions were tried using MODEL IV, allowing parameters to vary that 
had shown a significant change between paired experiments. The other 
parameters were fixed to the values obtained from the compartmental 
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analysis of the data from Kinetic 1. experiments. The parameters 
allowed to vary were the input rate constants L(2,19 ) and L(20,19 ) , 
describing the transport of 203 Pb to wall from lumen of small bowel via 
the common lead/phosphorous pathway and the movement of 203Pb to large 
bowel from small bowel, respectively. Internal rate constants allowed 
to vary were L( l3,9) and L(l4,9 ) , rate constants desctibing uptake of 
lead in red cell and 'soft' tissue compartments, respectively. 
c ) Simulati on of the effects of separate doses of CaC03 and NaH2P0~.2H20 
on the whole body retention of subject K.B. 
Subject K.B. had ingested 203Pb with CaC03 and then with NaH2P0 4 .2H 20 
in two separate experiments (section 5.o) ·. Whole body retention 
measurements found in these two experiments were simulated using 
MODEL IV and the parameter values obtained from the compartmental 
analysis of the Kinetic 1. data of subject K.B. In the first 
simulation, the rate constant representing the transport of 203 Pb via 
the common lead/calcium pathway, L(l,19 ) , was set equal to zero. The 
rate constant representing the transport of 203Pb via the common 
lead/phosphorous pathway , L(2,19 ) , was then set equal to zero i n a 
second simulation. These conditions represented the complete 
inhibition of 203 Pb absorption by the maximum weights of CaC0 3 and 
NaH 2P0 4 .2H 20, respectively. 
d ) Simulation of 203 Pb levels in compartments with summer coefficients 
A simulation was performed using MODEL IV and the mean values of the 
variable parameters found in the compartmental analysis of the 
experimental data from the Kinetic 1. experiments of all subjects. The 
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compartments chosen for the simulation were the two plasma 
compartments, 8 and 0, and the four liver compartments 8 , 
0, G)and() 
8.4.3 Results 
Table 8 .4.1 shows the 96 hour retentions found in each of the kinetic 
experiments, except the Kinetic 2. experiment of D.W., and the 
percentages of the ingested dose calculated to have been absorbed by the 
subjects in these experiments. These percentages were determined from 
the values of the model parameters L(l,19), l(2,19) and l(20,19), 
representing transport of 203 Pb to wall from lumen of small bowel and 
movement of 203 Pb from lumen of small bowel to large bowel. A linear 
regression of 96 hour retention on the percentage of the ingested dose 
absorbed gave the following equation. 
96 hour retention= 1.003 x % ingested dose absorbed - 3.06 
with a regression coefficient, r = 0.99. 
Figure 8.4.l shows a plot of 96 hour retention against the percentage of 
the ingested dose absorbed, and the regression line. 
The simulated 96 hour retentions and half times retention found with 
and without the unabsorbed fraction of 203 Pb present in the gut of 
MODEL IV are shown in table 8.4.2. The exp~rimental values of 
retentions and half times are also included for comparison. There is 
good agreement between experimental and simulated values obtained using 
the normal model configuration, except between values found in the 
Kinetic 2. experiment of subject D.W. There are differences between 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































but they are probably only significant for the values found in the 
Kinetic 2. experiment of subject B.C. 
When the unabsorbed fraction of 203 Pb was removed from the gut by 
simulation, the 96 hour retentions were always lower than those 
obtained by simulation of the normal model configuration. However, 
the differences are only large between experimental and simulated 
values for the Kinetic 2. experiment of subject D.W. and the Kinetic 1. 
experiment of subject B.C. The simulated half times of retention were 
always longer when the unabsorbed fraction of io 3Pb was removed from 
the gut. The mean percentage decrease in simulated 96 hour retention 
values, excluding the Kinetic 2. experiment of subject D.W~, caused by 
the absence of the unabsorbed fraction of 203 Pb is 3.76 ! 0.75% (S .E. ), 
whereas the mean percentage increase in half times of simulated 
retention is 24.00 ! 6.94% (S.E.). 
Table 8.4.3 shows a comparison between the values of the parameters 
allowed to vary in the compartmental analysis of the limited data from 
the Kinetic 2. experiment of subject D.W., and the values of the same 
parameters found in the analysis of the data from his Kinetic 1. 
experiment. The rate constants L(l,19), representing transport of 203 Pb 
from lumen to wall of ' small bowel via the common lead/calcium pathway, 
L(20,7), describing the biliary excretion of 203 Pb, and L(21,20), 
representing the movement of 203 Pb in the lumen of the large bowel, 
had to be included in the variable parameters to give a good fit 
between calculated values and experimental data. There is a marked 
decrease in both L(l,19) and l ( 2,19 ) , rate constants describing the 
transport of 203 Pb from lumen to wall of small bowel. However, only 
the difference in L( l,19) is significant, as the uncertainty of L(2,19) is 
very large. Both l (20,19) and L(21,20), representing the magnitude and 
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TABLE 8.4.3 
Comparison of variable parameters from model solutions 
using experimental data from Kinetic 1. and Kinetic 2. 
experiments of subject D.W. 
RATE CONSTANT KINETIC 1. KINETIC 2. 
(hour- 1 ) (hour-
1
) 
L(l,19) + t 0.139 - 0.007 0.0007 + - 0.0001 
L(2,19 ) + 
_5 + _5 
0.036 - 0.003 10 - 3 X 10 
L(l3,9) 471.26 + - 52 .10 + 560.55 - 12.70 
L(l4,9) 257 .00 + - 39.32 775.56 + - 293.72 
L(ZO, 7) 0.003 + - 0.001 + O.llO - 0.08 
L(20,19) 0.068 + - 0.006 + 0.084 - 0.004 
L(Zl,20) + 0.080 - 0.005 0.206 2: 0.007 
t 2: l standard deviation. 
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movement of the unabsorbed fraction of 2 03 Pb in the gut, respectively, 
and L(20,7 ) are all increased in the analysis of Kinetic 2. data. 
Reasonable fits were obtained between model calculated values and 
experimental data as shown in figures 8.4.2-8.4.4. 
A comparison between parameter values found in the compartmental 
amalysisof the kinetic data from the experiment in which subject K.B. 
ingested 2 03 Pb without carrier lead, and the corresponding values from 
his Kinetic 1. experiment is shown in table 8.4.4. L(l,19 ) , L( 20,7 ) 
and L(21,20 ) were again included as variable parameters. 2 03 Pb 
radioactivity in the red cells was not directly measured in the 
experiment. Plasma levels of 2 03 Pb were found to be less than 0.1% 
of the ingested dose in subject K.B.,in the Kinetic 1. experiment. 
Therefore, whole blood radioactivity approximates 2 03 Pb radioactivity 
in the red cells, and whole blood data was used in the model solution. 
There was no change in the rate of 2 03 Pb absorption in pathway L(l,19 ) . 
The percentage of the ingested 203 Pb absorbed in this pathway, calculated 
+ from model parameters, was 62.58 - 19.98% (S.D. ) , and agrees well with 
that calculated using the parameter -values found ~in the Kinetic 1. 
experiment, of 60.08 ! 7.75% (S.D. ) (table 8.3.15 ) . The greatest 
change occurred in the value of L( 2,19 ) , rate constant representing 
transport of 203 Pb by the cmmmon lead/ phosphorous pathway. This 
decreased to practically zero. The second greatest change occurred 
by a factor of 2 in L(20,7), but the uncertainty of this parameter 
was high. The changes in the other parameters were not significant. 
Table 8.4.5 compares the calculated values of 96 hour retention and 
half time of retention with the experimental data, and there is good 
agreement. Figures 8.4.5-8.4.7 show the good fits between calculated 



















































































































































































































































































































































































































































































Comparison of variable parameters from model solutions 
using experimental data from Kinetic 1. experiment 
and no carrier lead experiment of subject K.B. 
RATE CONSTANT KINETIC 1. NO CARRIER LEAD 
-1 
(hour ) - 1 (hour ) 
L(l,19) + t 0.135 - 0.009 0.138 + - 0.036 
L(2,19 ) + -6 + 
_5 
0.025 - 0.008 5xl0 - 4xl0 
L(l3, 9 ) + 409.41 - 124.57 + 509.00 - 12.39 
L(l4,9) + 510.56 - 151.11 725.75:: 70.46 
l( 20, 7) 0.008 + - 0.002 + 0.004 - 0.005 
L(20,19) 0.070 + - 0.008 0.083 + - 0.021 
l(21,20) + 0.099 - 0.004 0.121 :: 0.015 
































































































































































































































































































































































































































































































































































































































































































Table 8.4.6 shows the experimental retention data and simulated values 
for the two experiments in which subject K.8. ingested 203 Pb with 
calcium and phosphorous separately (section 6.0 ) . Table 8.4.i shows 
the values of the few rate constants, L(20,7), L(20,19 ) and L(21,20 ) 
which were required to change for both simulations. Figures 8.4.8 
and 8.4.9 show the good fits between simulated and experimental whole 
body data. 
The simulated levels of 203 Pb at 96 hours found in all the plasma and 
liver compartments are shown for comparison in table 8.4.8. The level 
of 2 0 3 Pb in plasma 0 is only 2?~ of that in plasma 0 . There 
was no 203 Pb found in liver~ , a low level in liver~, and 
approximately the same level of 203 Pb in liver compartments ~ 
and 8 . Figures 8.4.10-15 show the levels of 203 Pb in each of the 
compartments. It is noticeable that the 203 Pb peaks very rapidly in 
plasma 0 , within 2 hours of ingesting the dose of 203 Pb, whereas 
the peak occurs at approximately 16 hours in plasma ~ . The 
uptake and release of 203 Pb in liver~ is extremely rapid. The 
2 0 3 Pb in liver 0 .peaks at 15 hours and gradually falls away, 
whereas in liver~, it follows the trends of plasma lead in the 
plasma compartments 0 and 0 , and in liver O , it 








































































































































































































































































Rate constant changes required to simulate the 2 0 3 Pb 
whole body retention of subject K.B. f ound with 
RATE CONSTANT CaC0 3 EXPERIMENT NaH 2 P0 4 .2H 20 EXPERIMENT 
- 1 (hour ) ( l. 75 g) (2.513 g) 
L(l ,19 ) 
L(2,19 ) 0 
L(20,7 ) 0.025 0.020 
L(20 , 19 ) 0. 286 0.113 













































































































































































































































































































Simulated 96 hour percentages of ingested dose of 203 Pb 
in plasma and liver compartments of MODEL IV determined 
using means of rate constants from 
Kinetic l. experiments 
COMPARTMENT INGESTED DOSE 203pb 
(?~) 
Liver 8 
Liver 8 5.53 
Liver 0 0.010 
Liver 0 9.89 
Plasma 8 0.001 





































































































































































































































































































































































































































































































































































































































































8. 4 .4 Discussion 
a ) 96 Hour whole body retention as a measure of absorption of 
203 Pb and 
the effect of unabsorbed 
203 Pb on 96 hour retention and half time 
of retention 
The assumption that the 96 hour retention of ingested 
203 Pb is a 
reliable measure of lead absorption appears to be valid. There was a 
good correlation between 96 hour retentions and the percentages of 
ingested dose absorbed that were calculated from model parameters. The 
96 hour retention of subject D.W. found in the Kinetic 2. experiment 
was excluded, as there was doubt about the reliability of very low 
retentions as measures of lead absorption. 
In the development of MODEL IV, retention values were used to constrain 
the percentages of ingested dose absorbed, but this was only done for 
the first model solution. The final solution was performed with rate 
constants L( l,19 ) , l (2,19) and L( 20,19 ) allowed to vary independently, 
and in which calculated values were fitted to all experimental whole 
body data from 6 hours to at least 216 hours. These rate constants 
represented the transport of lead from l umen to wall of small bowel and 
the movement of unabsorbed lead from lumen of small bowel to large 
bowel. 
Although gamma camera and profile scan studies showed no localised 
2 0 3 Pb radioactivity in the large bowel and rectum of each subject at 96 
hours, the results of the simulations suggested that some unabsorbed 
2 0 3Pb may have been present. The effect of such unabsorbed 
2 03 Pb on 96 
hour retention was minimal, however, in most of the sub j ects. 
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It only appreciably affected the simulated 96 hour retentions of the 
Kinetic 1. experiment of subject B.C. and the Kinetic 2. experiment of 
subject D.W. 
The presence of the unabsorbed 
203 Pb in the simulation of the retention 
found in the Kinetic 1. experiment of subject B.C. caused an 8% 
increase in 96 hour retention. In contrast, the simulation of retention 
found in the Kinetic 2. experiment of the same subject showed no effect 
of unabsorbed 203 Pb. In this experiment, the unabsorbed 
203 Pb cleared 
rapidly from the body. This was shown by the rapid decrease of whole 
body retention (figure BC-WB-2) and the large value of the rate 
constant L(21,20). This rate constant represents the movement of 
203 Pb 
-1 
in the lumen of the large bowel, and it had a value of 0.36 hour in 
-1 
the Kinetic 2. experiment compared with its value of 0.075 hour in the 
Kinetic 1. experiment. The movement of the unabsorbed 
203 Pb in the 
lumen of the large bowel of this subject was well described by the model. 
If there is an even larger unabsorbed fraction of 
203 Pb present in the 
gut, as in the Kinetic 2. experiment of subject D.W., 96 hour retention 
can be increased by a far greater amount i.e. 50%. If such a 
correction is applied to the 96 hour retention of this subject when he 
ingested 203 Pb with minerals (section 5.0), the reduction in retained 
·doses of 203 Pb in his red cells and urine caused by the minerals would 
be much less. The magnitude of the changes would be com~arable to those 
which occurred with the retained doses of 
203 Pb in the red cells and 
urine of the other subject in that section, K.B. Therefore, 96 hour 
retentions of 1-2% may be considerably influenced by unabsorbed 
203 Pb in 
the gut, and they may not be reliable measures of absorption of lead. 
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The presence of unabsorbed 203 Pb in the gut was shown by the 
simulations to have a considerable effect on the half times of 
retention calculated with retention data from 96 hours onwards. When 
the unabsorbed 203 Pb was removed from the gut by simulation, the mean 
increase in half times of retention was greater by a factor of 6 than 
the decrease in 96 hour retentions. Half times of retention, therefore, 
may nnt be as good a measure of urinary and endogenous faecal excretion 
of 203 Pb, as 96 hour retentions are a measure of absorption of 
203 Pb. 
There was still a decrease in the half times of retention when calcium 
and phosphorous were ingested with 203 Pb, which cannot be completely 
explained by the presence of a 'tailing edge' from the unabsorbed 
fraction of 203 Pb. The simulated half times of retention for the 
Kinetic 2. experiments were always less than those found for the Kinetic 
1. experiments, and, in three subjects, still less even when · there was no 
unabsorbed fraction of 203 Pb in the simulation. 
It is surprising that the presence of unabsorbed 
203 Pb in the large 
bowel of subject B.C. was not detected as a peak of localised 
radioactivity in the 96 hour profile scan performed on this subject in 
the Kinetic 1. experiment. Although the presence of the unabsorbed 
203 Pb at 96 hours was only suggested by simulations of the model, the 
movement of the unabsorbed 203 Pb in the lumen of the large bowel of this 
subject was well described by the model. 
Non-endogenous faecal 203 Pb in the gut at 96 hours may have come from 
another source apart from the unabsorbed fraction of 20
3 Pb, and it is 
necessary to discuss the delayed passage of unabsorbed lead in more 
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detail. Some idea of the dynamic behaviour of unabsorbed 203 Pb in the 
gut can be found in radiological studies of barium described by Eve 
(1966). It is thought that the transport of the contents of the 
transverse colon is by a mass movement effect which may occur one to 
four times a day. This mass movement would cause the unabsorbed 203 Pb 
to move quickly through the transverse colon into the descending colon, 
and this was confirmed by the peak of short duration between 16-24 
hours in the surface radioactivity measurements performed over the small 
bowel. In the perfect physiological reflex, the peristaltic wave which 
sweeps the contents of the transverse colon into the descending colon 
will empty the transverse colon completely, but frequently some 
fragments are left in its wake. Such fragments of the unabsorbed 203 Pb 
probably caused the areas and peaks of localised radioactivity 
frequently seen in the region of the descending colon in the 48 hour and 
72 hour scintigrams and profile scans. 
The delayed passage of unabsorbed tracer in the gut of the human was 
investigated by Rabinowitz et al (1976). They administered a tracer, 
207 Pb, for 10 days to two subjects who had already ingested the tracer 
204 Pb daily for a length of time sufficient to produce steady state 
conditions of 204 Pb in the body. Ingestion of both tracers was 
discontinued simultaneously, and faecal excretion of 207 Pb was not 
detected 20 days ~fter it had been discontin~ed. The authors presumed 
that the excretion of the 204 Pb more than 20 days after ingestion of 
both tracers was stopped, represented endogenously excreted 204 Pb. This 
suggests that it took 20 days for the unabsorbed fraction of 2 07 Pb to be 
cleared. 
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This study was based on certain assumptions, and the first was that 
there was no endogenous faecal excretion of the absorbed fraction of 
207 Pb in the 20 days. Although this is consistent with the 
compartmental model of Rabinowitz et al (1974; 1976), in that 
endogenous faecal excretion of tracer is delayed by about 40 days after 
ingestion, work described by Chamberlain et al (1978) suggested that the 
only delay in endogenous faecal excretion is because of the time taken 
for the passage of faecal matter through the gut. 
The second assumption was that the rate of reabsorption of endogenously 
excreted lead tracer was similar to the absorption of the ingested lead 
tracer. This has not been confirmed in animal studies. Experiments on 
rats have shown that very little if any reabsorption of endogenous lead 
occurs (Cikrt and Tichy, 1975; Conrad and Barton, 1978), and in the 
compartmental model developed in this thesis, no pathway for 
reabsorption was necessary to explain the kinetics of orally ingested 
203Pb. 
Rabinowitz et al (1976) were probably measuring unabsorbed and 
endogenous faecal 207 Pb during the 20 days after ingestion of 207 Pb was 
stopped. After this time, they probably were unable to detect the 
presence of endogenous faecal 207 Pb as it was only ingested for a period 
of 10 days so that the levels of 207 Pb in the body would be much lower 
than those of 20 ~Pb. In another work, Rabinowitz et al (1974) had stated 
that the experimental error in the determination of endogenous faecal 
lead is significant. This would also make it difficult to detect small 
quantities of endogenous 207 Pb in faecal matter. 
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The suggested increase in 96 hour retentions, shown by the simulations 
and attributed to the 'tailing edge' of unabsorbed 
2 03 Pb, may be due to 
exfoliation of mucosal cells of the small bowel. Exfoliation of 
mucosal cells as a mechanism of lead excretion was suggested by Conrad 
and Barton (1978 ) . They found in fasting rats injected with 
2 1 0 Pb that 
the disappearance of 210 Pb from the small intestine approximated the 
2-day life span of mucosal cells. 
This mechanism of excretion together with the storage of 
2 0 3 Pb in the 
wall of the small bowel observed in the kinetic studies (section 8.2 ) , 
would probably not cause a localised pattern of 
203 Pb in the gut, but a 
more generalised distribution. Such a distribution was observed in the 
inferior edge of the isolated profiles of 2 03 Pb radioactivity in the 
liver during profile scan analysis (section 8.2.3 ) . In that section, 
the distribution was attributed to endogenous faecal 20
3 Pb. 
However, whether the suggested increase in 96 hour retentions was caused 
by the 'tailing edge' of the unabsorbed fraction of 
2 0 3 Pb or 
exfoliation of mucosal cells containing 2 0 3Pb from the small bowel, 
cannot be proved from the experiments performed in this thesis. 
b) Compartmental analysis of data from Kinetic 2. experiment of subject D. W. 
The effect of the maximum weights of calcium and phosphorous ingested 
by subject D.W. was to dramatically reduce the absorption of lead in 
both the common lead/calcium and common lead/phosphorous absorptive 
pathways. The percentage of ingested dose absorbed was calculated to be 
0.83%, and it agrees well with the simulated 96 hour retention of 0.77% 
of this same subject when the unabsorbed fraction of 
2 03 Pb was removed 
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from the gut by simulation. The values of the rate constants 
representing absorption of 203 Pb were considerably lower than those 
which were found from the analysis of the data from the Kinetic 1. 
experiment of this subject. 
From the results of the dose response experiment performed on subject 
K.B. (section 6.4.2), it was suggested that no absorption of 
203 Pb 
occurred via the common lead/calcium pathway but it did via the common 
lead/phosphorous pathway when 2 03 Pb was ingested with the maximum 
weights of calcium and phosphorous. The use of the model with the data 
from the Kinetic 2. experiment of subject D.W., however, has shown that 
absorption still appears to occur via the common lead/calcium pathway, 
as indicated by the 203 Pb radioactivities in red cells and urine. The 
extremely low value of the -rate constant representing absorption of 
203 Pb via the common lead/phosphorous pathway suggests no absorption, 
but as the uncertainty of the value was very high, this cannot be 
confirmed. The value of the rate constant representing absorption via 
the common lead/calcium pathway was also greatly reduced, which ~ay 
suggest a change in the nature of the transport mechanisms responsible 
for the absorption of 203 Pb in this pathway. 
There was the expected increase in L(l4,9), rate constant representing 
the uptake of 203 Pb in the 'soft' tissue compartment, as this had 
occurred in the other subjects in their Kinetic 2. experiments. The 
rate constant representing the uptake of 203 Pb in the red cell 
compartment, l(l3,9), was also increased, which is the opposite to which 
occurred in the other subjects. However, the model was unable to 
completely describe the changing levels of 203 Pb in the blood, as these 
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levels rose very slowly with time. 
The large changes in the values of l (20,7 ) and L(21,20 ) , rate constants 
representing the biliary excretion of 2 0 3Pb and movement of 
2 03 Pb in 
the lumen of the large bowel, and the large uncertainty of l (20,7) are 
the result of the lack of experimental data, particularly on liver 
2 03 Pb radioactivity and on post-96 hour whole body radioactivity. The 
value of l (20,19 ) is very low, as it represents the fraction of 
2 03 Pb 
which is unabsorbed and, hence, its value will depend on that of l ( l,19 ) . 
c ) Effect of carrier lead on absorption and excretion of 
2 0 3Pb in subject 
K.B. 
Both the value of the rate constant and the percentage of ingested dose 
of 2 03 Pb absorbed via the common lead/calcium pathway, L(l, 19 ) , were 
unchanged by the presence of carrier lead with 
2 0 3 Pb. This confirms 
the suggestion made in section 5.4.l that the weight of carrier lead 
used, 300 µg lead chloride, can be tolerated by the transport 
mechanisms responsible for the absorption of lead. There appearea t o oe no 
absorption via the common lead/phosphorous pathway. 
Although both L(l3,9 ) and l (l4,9 ) , rate constants describing the uptake 
of 2 03 Pb in red cell and 'soft' tissue compartments, are increased 
compared with their values from the analysis of data from the Kinetic 1 . 
experiment, the changes are not signifi cant. 
Of t he other rate constants allowed to vary, t he only large change 
occurred in the rate constant l (20,7 ) , represent i ng bil i ary excreti on 
of 2 03 Pb. This was decreased by a factor of 2. However, the _ 
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uncertainty of this rate constant was large, and this was caused by 
the lack of experimental data on liver 203 Pb radioactivity. 
The half time of retention was decreased by an approximate factor of 2 
by the presence of carrier lead with the dose of ingested 203 Pb. The 
96 hour retentions were approximately 60%, and the results of the 
simulation of the effect of unabsorbed 203 Pb on the retention data of 
subject K.8. showed a possible 20% increase in half times of retention. 
The effect of any unabsorbed t ~03 Pb present in the gut, therefore, could 
not completely account for the difference in half times. Only by the 
inclusion of L(20,7) in the model solution and a marked change in its 
value could the calculated values of retention be made to match the 
experimental data. 
Although this application of MODEL IV with the limited data from the 
experiment in which subject K.B. ingested 203 Pb without carrier lead 
suggests that carrier lead increases the biliary excretion of 203 Pb, 
more experimental data from more subjects are required to confirm this 
effect. 
d ) Effects of separate doses of calcium and phosphorous on the absorption 
of 2 0 3 Pb in subject K.B. 
The whole body retention data of subject K.B. were successfully 
simulated using MODEL IV by not allowing any absorption of 203 Pb by the 
common lead/calcium pathway and the common lead/phosphorous pathway in 
two separate simulations. This suggests that the maximum weights of 
calcium, 1.75 g CaC0 3 , and -phosphorous, 2.513 g NaH 2 P0~.2H2 0, ingested 
with the lead in these two experiments, almost completely inhibited the 
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absorption of lead in the pathway common to either of the minerals and 
lead. This supports the theory advanced in section 6.4.1 that lead is 
probably absorbed by at least two pathways, one which it shares 
specifically with calcium and the other specifically with phosphorous. 
The value of L(20,19 ) will be different between the two experiments as 
it represents the percentage of ingested dose not absorbed. The values 
of l (20,7 ) aod L(21,20), rate constants representing the biliary 
excretion of 2 0 3Pb and movement of 2 0 3Pb in the lumen of the large 
bowel, are comparable between the two experiments, although they are 
larger than the values found from the analysis of data from the Kinetic 
1. experiment of subject K.B. 
The different value of l (20 , 7 ) is not onexpected, as no other 
experimental data apart from the whole body retention was available. 
Other rate constants such as L(l3,9 ) and L(l4,9 ) , representing uptake 
of 203 Pb in red cell and ' soft' t i ssue compartments could not be : 
included. Such rate constants could have changed the levels of 2 03 Pb in 
body compartments and influenced the value of L(20,7 ) . The larger value 
of l( 21,20) could have occurred because of a difference in the bowel 
motility of subject K.8. between the times of these experiments and the 
kinetic experiments. 
The half times of retention for each experiment were very different. 
The 96 hour retentions were not of the order of 1-2%, and the results of 
t he simulation of the effect of unabsorbed 2 03 Pb on the retention data 
of subject K.8. showed a possible 20% increase i n half times of 
retention. The effect of any unabsorbed 2 03 Pb present i n the gut from 
258 
96 hours onward cannot completely account for the differences in half 
times. Even the values of L(20,7 ) , rate constant representing biliary 
excretion of 203 Pb, are too close to account for the difference between 
half times. 
Therefore, the fraction of 2 03 Pb ingested in each of the two pathways 
in the small bowel has a great effect on the half times of retenti on. 
This could explain the shorter half t imes of retention found in 
experiments in which 2 03 Pb was ingested with calcium and phosphorous. 
e ) Possible physiological roles of plasma and liver compartments 
Lead and calcium have been suggested to share the same metabolism 
(Aub et al, 1926; Six and Goyer, 1970 ) . Similarities of behaviour in 
the gut have also been described (Barton et al, 1978 ) , and work in this 
thesis has shown that lead appears to share the same active transport 
as calcium. Baloh (1974) suggested that plasma lead probably exists in 
two forms, diffusible and protein bound, in an analogous manner to 
plasma calcium. Two forms of plasma lead had to be introduced into the 
compartmental model developed in this thesis, to make the model 
compatible with experimental data on the kinetics of l ead in the body. 
The results of simulating the levels of 20 3Pb in the plasma and liver 
compartments shows that the two forms of lead in the plasma appear to 
behave quite differently. In the model, the lead entering the plasma 
from the common lead/calcium pathway has been defined as the diffusible 
form, and i t reaches a peak i n the plasma at approximately 2 hours after 
i ngestion of 20 3Pb. Plasma levels of 4 7 Ca reach a peak in a similar 
t ime after the ingestion of 4 7Ca by fasted normal humans (Tothill et 
259 
al, 1970). Calcium is actively transported in the ionised form 
(Schachter et al, 1960), and the similarity between the trends of 
47 Ca 
plasma levels and the simulated levels of diffusible plasma 
203 Pb 
suggests that lead may also be transported in the ionised form. 
The non-diffusible plasma lead has been suggested to enter the plasma 
via the common lead/phosphorous pathway. From the simulation, this form 
of plasma lead appears to constitute 98% of the total plasma lead. It 
peaks at approximately 16 hours, which suggests a delayed absorption. 
At this time, this could mean absorption from the large bowel or 
absorption from the small bowel, uptake in an organ and subsequent 
release into the general circulation. The most likely mechanism is 
small bowel absorption and uptake in and release from the liver. This 
is the first organ that receives the portal circulation, which will 
contain the gastrointestinally absorbed lead. This mechanism was 
adopted in the compartmental model, which was able to generate 
calculated values satisfactorily matching the experimental liver data. 
As the liver is the site of albumin synthesis in the body (Samson 
Wright, 1965), the lead released slowly from the liver could be protein 
bound and, therefore, non diffusible. Calcium also exists in the plasma 
mainly bound to albumin (Peders~n, 1972 ) , and, similarly, lead has been 
found predominantly in the albumin and a 1 - globin fractions of the 
plasma proteins (Waldron and Stofen, 1974). 
The simulation showed that the diffusible plasma lead was approximately 
2% of the non diffusible or protein bound lead. The levels of 
diffusible and non-diffusible plasma calcium are approximately the same 
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(Marshall, 1976 b ) , Calcium does not bind to red cells, however, as 
avidly as lead. The relatively lower level of diffusible plasma lead 
compared to that of diffusible plasma calcium could be caused by the 
greater uptake of lead in the red cells. Measureable uptake of calcium 
by red cells only occurs in non physiological conditions (Robertson, 
1976) . This difference in the behaviour of calcium and lead with red 
cells could be caused by the lower affinity of calcium for sulphydryl 
groups. Red cells are rich in sulphydryl groups, and the order of 
activity for different metals is Hg> Ag> Pb> Cd> Zn> Ca> Mg (Waldron 
· and Steffen, 1974) . 
The behaviour of lead in the liver was described by four compartments 
in the model. Two of the compartments appear to have no recognised 
physiological roles. The uptake and release of lead is extremely rapid 
in the liver compa~tment in the pathway by which the diffusible lead 
enters the plasma of the general circulation. The use of this 
compartment appears to be operational as does the use of the other liver 
compartment that combines the outputs from the two plasma compartments 
of the model. 
The behaviour of lead in the other two compartments may be 
physiological. The slow rate of release of lead from the compartment in 
the pathway by which non diffusible lead enters the plasma of the general 
circulation is consistent with the suggestion made · earlier that lead is 
bound to albumin in the liver. The storage of lead in the compartment 
from which lead is biliary excreted is also consistent with the 
suggestion of Barltrop (1968 ) that lead is stored in the liver. Lead in 
this compartment of the liver may be compared to the mitochondria 
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fraction of lead isolated by Castellino and Aloj (1969 ) , which was 
found to be strongly bound to the mitochondria. 
9.1 
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S E C T I O N 9 
DISCUSSION 
Interrelationship between lead, calcium and phosphorous absorption 
The interrelationship between lead, calcium and phosphorous absorption 
discussed in section 7.2 was based on the hypothesis suggested in 
section 6.4.l that oral lead was absorbed by two pathways, one which it 
shares specifically with calcium and the other specifically with 
phosphorous. The effects of calcium and phosphorous, singly and 
together, on the retention of 203 Pb in one subject, K.B., was 
explained by this hypothesis (section q.4.1 ) . 
Later work on the compartmental analysis of the kinetics of orally 
ingested 203 Pb in five subjects (section 8.0 ) , confirmed that at least 
two pathways of lead absorption were necessary to make a 'universal' 
model compatible with the kinetic data from these five subjects. 
Furthermore, the effects of separate doses of calcium and phosphorous 
on the retention of subject K.8. were explained by using the model and 
assuming that calcium and phosphorous would specifically inhibit 
absorption of lead in the appropriate common lead/calcium and common 
lead/phosphorous pathways. 
The responses of the suggested common lead/calcium and common 
lead/phosphorous absorptive pathways to increasing weights of calcium 
and phosphorous were investigated in section 6.0. The results were 
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discussed in section 6.4.2, and it was suggested that as the weights 
of calcium and phosphorous given with the oral dose of 
203 Pb were 
increased, calcium specifically inhibited the absorption of 
203 Pb in 
the common lead/calcium pathway, but there was little effect of 
phosphorous on 203 Pb absorption in the common lead/phosphorous pathway. 
With large weights of calcium and phosphorous, calcium completely 
inhibited the absorption of 203 Pb in the common lead/calcium pathway, 
but absorption still occurred in the other pathway. This theory was 
used to explain the shape of the response curve of 96 hour retention 
of subject K.8. against weights of calcium and phosphorous. 
The results of the compartmental analysis of the data from the paired 
kinetic experiments suggests that this theory should be re-examined. 
The analysis of data from the Kinetic 1. experiments showed that the 
fraction of ingested lead absorbed by the common lead/calcium pathway 
was approximately 7 times that absorbed by the common lead/phosphorous 
pathway. This ratio was increased to approximately 14 to 1 when lead 
was ingested with the intermediate weights of calcium and phosphorous 
given in the Kinetic 2. experiments of all the subjects except D.W. 
This shows that phosphorous inhibits lead absorption in the common 
lead/phosphorous pathway much more than calcium does in its respective 
pathway. At large weights of calcium and phosphorous, it is unlikely 
that any measurable absorption of lead would occur by the common 
lead/phosphorous pathway, as suggested above. 
Furthermore, the analysis of the limited data from the Kinetic 2. 
experiment of subject D.W. showed that absorption of lead by the common 
lead/calcium pathway could still occur at large weights of calcium and 
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phosphorous. This contradicts the suggestion made earlier that large 
weights of calcium would completely inhibit the absorption of lead in 
the common lead/calcium pathway. 
The results of the compartmental analysis of the data from the paired 
kinetic experiments also showed that the values of the rate constants 
describing the transport of lead via the two pathways changed. There 
were no significant changes in the rate constant representing the common 
lead/calcium pathway caused by intermediate weights of calcium, but 
when large weights were ingested by subject D.W., the value of this rate 
constant was reduced. This suggests a change in the nature of the 
transport mechanism represented by this rate constant. It was 
noticeable that the value of the rate constant representing the common 
lead/phosphorous pathway was reduced by intermediate weights of 
phosphorous. 
A reduction in the fraction of lead absorbed by a pathway but no change 
in therate constant representing absorption suggests that competitive 
inhibition of active tran~port is taking place. A reduction in both the 
fraction absorbed and in the rate constant suggests competition for a 
slower transport process, which could be diffusion. If lead were to 
share both active and passive transport mechanisms of calcium and 
phosphorous, the results above would be compatible with the known 
characteristics of calcium and phosphorous absorption. 
Calcium is predominantly absorbed at low calcium concentrations by active 
transport in the upper small bowel, that saturates at high calcium 
concentrations. Absorption then takes place by a concentration-dependent 
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diffusion transport, which is unsaturable (Marshall, 1976 ·· a ) . 
Phosphorous is absorbed lower down the small bowel than calcium, and 
the saturable component of phosphorous absorption is small in comparison 
with the diffusion component (Marshall, 1976 a ) . 
Small quantities of lead entering the small bowel will be mainly 
absorbed by the active transport of calcium, and unabsorbed lead will 
move further down the bowel and be absorbed by the active transport of 
phosphorous. However, certain 'digestive' factors appear to affect the 
absorption of phosphorous (Wilkinson, 1976 ) , so that some of the lead 
will pass out of the small bowel into the large bowel and will be 
excreted in the faeces. This could explain the high absorption of lead 
in the Kinetic l, experiments, and the larger fraction of this lead 
absorbed by the common lead/calcium pathway. 
The presence of intermediate weights of calcium and phosphorous with 
lead in the small bowel would correspond to region B of the dose 
response curve of 96 hour retention against weights of calcium and 
phosphorous of subject K~B. (figure 6.3.2). There would be 
competitive inhibition of lead absorption by calcium in the common 
lead/calcium pathway, but active transport would still exist, as shown 
by little change in the value of the rate constant representing this 
pathway. The large change in the value of the rate constant 
representing the common lead/phosphorous pathway shows that the active 
transport of phosphorous is already saturated and absorption is probably 
taking place by diffusion. As the fraction of ingested lead absorbed 
by the common lead/calcium pathway is much greater than that absorbed 
by the common lead/phosphorous pathway, the absolute change in total 
9.2 
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absorption produced by calcium will be much greater. Region B, as 
suggested in section 6.0, does appear to represent the interaction of 
mainly calcium and lead in the small bowel. 
In region C, the large weights of calcium will have saturated :.the active 
transport of calcium, as suggested in section 6.4.2. Lead absorption 
can now only take place by the diffusion pathways of calcium. This was 
shown in the Kinetic 2. experiment of subject D.W., with a drop in 
the value of the rate constant representing the common lead/ calcium 
pathway indicating that active transport had ceased. Lead may still be 
absorbed by the diffusion pathways of phosphorous, but the fraction of 
ingested lead absorbed is probably minute. Region C, therefore, 
appears to represent the competition of lead and calcium for the 
diffusion pathways of calcium. 
Possible systemic effect of calcium and phosphorous on t he distribution 
and excretion of .: lead 
In section 5.0, two subjects ingested 203 Pb with and without minerals 
in separate experiments, and the levels of 203 Pb in their blood and 
urine were measured. When these 2 03 Pb levels were expressed as 
percentages of each subject's 96 hour retention ( retained dose), 
minerals had reduced the retained dose in the blood of .bath subjects 
and that in the urine of one subject, respectively. The 96 hour 
retentions of the subjects when they had ingested 
2 03 Pb with minerals 
were approximately 1-2% of the ingested dose. Subsequent work showed 
that unabsorbed 203 Pb in the body at 96 hours could have a considerable 
effect on such low measurements of retention and, therefore, on any 
result expressed as a percentage of retention. 
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More comprehensive experiments were performed in section 8.2 to study 
the effect of calcium and phosphorous on the kinetics of 
203 Pb in five 
subjects. The results of these experiments (section 8.2.3 ) confirmed 
the changes in retained dose of 203 Pb in blood but not those in the 
urine found in section 5.0. 
9.2.l Distribution 
The compartmental model showed the effect of ingesting calcium and 
phosphorous simultaneously with lead caused a significant reduction in 
the rate constant representing the uptake of lead in the red cell 
compartment and a significant increase in the rate constant 
representing the uptake of lead in the 'soft' tissue compartment~ 
The changes in these rate constants were associated with a sig~ificant 
decrease in retained dose of 203 Pbin the red cells and a significant 
increase in the model derived levels of absorbed dose in the 'soft' 
tissue compartment. A reduction in the value of the summer coefficient 
relating the experimental 'soft' tissue data to the absolute calculated 
values accompanied the increase in 'soft' tissue levels. This summer 
coefficient represents the fraction of the ingested dose of 
203 Pb in the 
'soft' tissue compartment 'seen' by the in vivo detector. A reduction 
in this fraction suggests that the apparent size of the 'soft' tissue 
compartment may have increased. 
The changes in the rate constants representing uptake of lead in the red 
cells and 'soft' tissue compartments may have been caused by differences 
in plasma levels of calcium and phosphorous between the paired kinetic 
experiments. In the Kinetic 2. experiments, the calcium ingested will 
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be absorbed by active transport in the upper small bowel, and 
increasing levels of ionised calcium in the plasma will cause a 
homeostatic response in the three organs, intestine, bone and kidney. 
Parathyroid hormone will be released which will reduce the absorption 
of calcium from the gut, reduce the release of calcium from the bone 
and increase the excretion of calcium. The effectiveness of these 
mechanisms is such that variations in plasma calcium due to absorbed 
calcium are extremely difficult to detect (Nordin, 1976). 
The absorption of phosphorous ingested in the Kinetic 2. experiments 
will increase as it moves from upper to lower small bowel, and plasma 
levels of phosphorous will increase. These levels are highly 
dependent on the amount of phosphorous in the gut (Robertson, 1976) , 
and the normal levels .of plasma phosphorous are less controlled than 
those of calcium (Robertson, 1976). Intestinal absorption of 
phosphorous will influence the plasma concentration of phosphorous 
throughout the day (Robertson, 1976) . Therefore, plasma phosphorous 
will probably be raised compared to plasma calcium. 
If the early partitioning of gastrointestinally absorbed 203 Pb between 
red cells and soft tissues is ·assumed to be competitive, then the raised 
plasma levels of phosphorous may have a considerable effect on the 
uptake of 203 Pb in red cells and soft tissues. It is known that 
phosphorous, as phosphate, inhibits the uptake of lead by red cells. 
Lead suspended in whole blood caused less damage to red cells than lead 
suspended with red cells in phosphate-free Ringer suspension, owing to 
the protection afforded by the plasma inorganic phosphate (Clarkson and 
Kench, 1958 ) . 
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Diets rich in phosphorous have been shown to decrease blood lead 
levels in animals. Sobel et at (1940 ) fed rats diets with different 
quantities of calcium and phosphorous to which large amounts of lead 
carbonate (8 g/kg) were added. After 29 days on the diets, the rats 
were sacrificed and lead levels in blood and bone ~ere measured. They 
found that the addition of phosphorous to the diet caused a significant 
decrease in blood lead levels. Morrison et al (1974) fed smaller 
amounts of lead (0.2 g/kg) as part of the diet to lambs for l year. A 
group of lambs were fed phosphate supplements, and, in this group , 
blood lead was lower than in a group fed a diet with normal amounts of 
calcium and phosphate. There was no difference in the lead content of 
livers and kidneys between the two groups, which suggests that the 
phosphate caused a change in distribution of lead away from blood in 
favour of soft tissues other than liver and kidney. 
The high plasma levels of phosphorous, which probably occurred in the 
Kinetic 2. experiments, could have reduced the uptake of 
203 Pb in the 
red cells. An extra delay compartment was required in the model 
between plasma and red cell compartments to obtain a good fit between 
calculated values and experimental data from the Kinetic 2. experiments. 
The slower uptake of 2 03 Pb in the red cells caused the model to 
respond by decreasing the rate constant describing this uptake. More 
2 03 Pb will be transfered : by the com~eting pathway to the 'soft' tissue 
compartment, and this was reflected in an increase in the rate constant 
representing uptake in this compartment. 
The levels of 203 Pb in the red cell and 'soft' tissue compartments will 
be affected by the change in the rate constants representing uptake of 
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203 Pb in these two compartments. There were no significant changes in 
the rate constants representing the release of 
203 Pb from the red cell 
and soft tissue compartments. Therefore, the result will be a decrease 
in levels of 203 Pb in the red cell compartment, and an increase in 
levels in the 'soft' tissue compartment, the changes which occurred. 
Apart from the increases in the rate constant representing uptake of 
203 Pb and the levels of 203 Pb in the 'soft' tissue compartment, there 
was an apparent increase in the size of this compartment. A similar 
effect was described by Nordin (1976) , when calcium was intravenously 
infused into normal subjects. The weights of calcium per hour infused 
were of the same order as the weights of calcium given to the subjects 
in the Kinetic 2. experiments. The plasma concentration of calcium 
resulting from the infusion did not increase at a rate which would be 
expected if the size of the labile calcium compartment remained constant. 
The apparent size of the compartment increased as infusion progressed, 
and it was suggested that this was caused by extracellular calcium 
moving into bone. Bone was also though to contribute to plasma 
calcium homeostasis by acting as a buffer which resisted changes in 
plasma calcium above the prevailing level determined by the kidney. 
Aub (1935) suggested that the deposition of lead in the bone is 
analogous to that of calcium. The buffering effect of bone will 
probably be caused by calcium moving into an 'exchangeable' bone 
calcium compartment which will be physiologically represented by 
trabecular bone. The 203 Pb absorbed with calcium from the gut, which is 
not taken up by the red cells, will probably move into the soft tissues 
and, like calcium, also move into the trabecular bone (Aub, 1935 ) . 
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This type of bone has been suggested to be part of the 'soft' tissue 
compartment (section 8.3.4 c ) . The result will be an apparent increase 
in size of the 'soft' tissue. compartment. 
9.2.2 Excretion 
The results of the compartmental analysis of the data from the kinetic 
experiments showed that there was no significant effect of calcium and 
phosphorous on the rate constants describing urinary and biliary 
excretion of 203 Pb. The half times of retention calculated from 96 
hours onwards in the Kinetic 2. experiments were all shorter than · 
those found with retention data from the Kinetic l. experiments. It 
was shown that the presence of unabsorbed 
203 Pb in the gut at 96 hours 
could have a considerable effect on half times calculated with 
retention data from 96 hours onwards. However, the reduction found in 
three of the subjects could not be explained by the presence of 
unabsorbed 203 Pb. 
The simulations of the retention data obtained in the two experiments 
in which subject K.B. ingested 203 Pb with only calcium and then with 
only phosphorous, showed that the different half times calculated from 
the retention data of these two experiments were associated with changes 
in the fraction of 203 Pb absorbed in the two absorptive pathways. 
When no absorption of calcium was simulated in the common lead/calcium 
pathway, the half time of retention was approximately a third ~shorter 
than when no absorption of phosphorous was simulated in the common 
lead/phosphorous pathway. This occurred with no change in the rate 
constant representing urinary excretion and a small change in the rate 
9.3 
272 
constant representing biliary excretion. 
There appears to be very little systemic effect of calcium and 
phosphorous on excretion of 203 Pb, but half times of retention are 
influenced by the gut interactions of lead, calcium, and phosphorous. 
Speculation on the overall influence of calcium and phosphorous on 
susceptibility to the toxic effects of lead 
The overall influence of calcium and phosphorous on susceptibility to 
the toxic effects of lead will depend on the interactions between lead, 
calcium and phosphorous in the gut and the systemic effect of calcium 
and phosphorous on lead. The experiments performed in this thesis have 
shown that the absorption of lead from the gut can be dramatically 
reduced by calcium and phosphorous. This will result in lower body 
burdens of lead, which should reduce susceptibility to the toxic effects 
of lead. Evidence from experiments on the kinetics of lead in the body 
performed in this thesis suggests that soft tissue levels of lead may 
be increased by a systemic effect of calcium and phosphorous. 
Susceptibility will also depend on the distribution of absorbed lead, 
and a change in distribution causing more soft tissue lead at the 
expense of bone lead could increase susceptibility. 
In the kinetic experiments, the weights of calcium and phosphorous 
ingested with the lead caused a mean reduction of 50% in the 
gastrointestinal absorption of ingested lead in four subjects. 
Compartmental analysis of the data from these experiments showed that 
the calcium and phosphorous also caused a mean increase of 56% in the 
absorbed lead levels in the 'soft' tissue compartment of the model. 
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Therefore, the absolute mean reduction in the levels of ingested lead 
in this compartment is 22%. 
Susceptibility to lead toxicity is influenced by soft tissue lead 
(Goyer and Rhyne, 1973), so that the 'protection' afforded by calcium 
and phosphorous in reducing gastrointestinal absorption of lead appears 
to have been lessened by the systemic effect of these minerals in 
raising soft tissue levels of lead. This systemic effect, however, was 
shown in the compartmental analysis of data on the kinetics of the 
tracer 203 Pb in the body, and the analysis was based on a number of 
assumptions. 
The compartmental model itself is only a conceptualisation of the lead 
system in the human body as 'seen' by the radionuclide kinetic 
technique. It was assumed that the 'soft' tissue compartment of the 
model included all the lead in body except for lead in plasma, red 
cells, liver and cortical bone. The levels of lead in this compartment 
were also assumed to be represented by those in muscle. The 
experimental data on lead levels in muscle were proportional, and, 
therefore, the structu~e of the model influenced the model derived 
values of lead in the 'soft' tissue compartment. Even with all these 
assumptions, the model was found to be compatible with most of the 
kinetic data, and it was accepted that the model adequately represented 
the behaviour of lead in the body. 
The compartments of the model developed in this thesis were assumed to 
correspond to physioloqical and anatomical entities, although this is 
not always true of compartmental models. However, even if the 'soft' 
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tissue compartment can be defined in this manner, the significance of 
any change in lead levels on susceptibility to the toxic effects of 
lead will depend on the lead content of the different tissues 
represented by this compartment. 
The symptoms of lead toxicity are related to the content of lead in the 
haematopoietic system, the liver and the kidneys (Goyer and Rhyne, 1973 ) . 
The liver was represented in the model as an individual organ, and the 
compartmental analysis of the data from the kinetic experiments showed 
no systemic effect of calcium and phosphorous on levels of absorbed 
lead in the liver. The haematopoietic system and the kidneys were 
included in the 'soft' tissue compartment, and the experimental data 
from the kinetic experiments was inadequate to enable the different 
tissues to be distinguished in the 'soft' tissue compartment. 
The increase in the levels of absorbed lead in the 'soft' tissue 
compartment was mainly caused by an apparent increase in the size of 
this compartment. It was suggested in section 9.2 that this may have 
resulted from a movement of lead into the trabecular bone, analogous 
to that of calcium. The levels of absorbed lead in the other tissues in 
the compartment could remain unchanged. These tissues would include the 
haematopoietic system and kidneys, and the absence of any systemic 
effect of calcium and phosphorous on the levels of absorbed lead in 
these tissues would agree with the same result found with the liver. 
Similar findings were obtained by Morrison et al (1974) when they fed 
lambs diets rich in phosphate and found no effect of phosphate 
supplementation on the lead contents of liver and kidoey. 
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The overall influence of calcium and phosphorous on susceptibility to 
the toxic effects of lead cannot be accurately assessed, as the 
experimental data was inadequate to define the lead content of all the 
organs and tissues which are particularly vulnerable. However, the 
reduction in the absorption of lead by calcium and phosphorous in the 
gut could still be most important in protecting people against the 




The results of this thesis have been obtained from experiments using 
the relatively short lived radionuclide of lead, 
203 Pb. Any 
conclusions drawn can only strictly apply to short term processes acting 
in the first nine days after the 20
3 Pb was ingested. Gastrointestinal 
absorption in man is a short term process, and any influences of single 
doses of tracer lead and normal dietary constituents on absorptive 
mechanisms should have ended within 9 days after ingestion. The 
distribution and excretion of lead have been represented by transport 
processes described by one rate constant. Long term animal experiments, 
however, have shown that these processes may consist of two or even three 
rate constants. Changes in distribution and excretion found during the 
nine day experimental period, therefore, may not be significant in the 
long term. 
The results show that the gastrointestinal absorption of lead between 
normal humans is variable, and the major cause is the presence of food 
with lead in the gut. After fasting, the absorption of dietary levels 
of lead is high and the amount .absorbed does not vary appreciably 
between individuals. Lead absorption, however, can be dramatically 
reduced by calcium and, to a lesser extent, by phosphorous in the food in 
the gut. The effect of these two minerals was explained by assuming 
that they compete with lead for shared absorptive pathways in the small 
bowel. Calcium and phosphorous absorption is known to vary between normal 
individuals. This will affect the competitive inhibition of lead absorption 
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by calcium and phosphorous and could account for the variable 
absorption of food lead in man. 
Variations in gastrointestinal absorption of dietary lead and in the 
calcium and phosphorous content of diet would be sufficient to explain 
the wide scatter of blood and urine lead levels found in community 
studies. Furthermore, the different amounts of dietary lead absorbed 
by people will change their body burdens of lead, and, indirectly, 
influence the susceptibility of individuals to the toxic effects of lead. 
Susceptibility to the toxic effects of lead does not solely depend on 
the body burden. The major symptoms of lead intoxication are related to 
the content of lead of the soft tissues, so that the distribution and 
excretion of lead will influence susceptibility. By using a 
compartmental model, calcium and phosphorous ingested at the same time 
as a single dose of tracer lead were shown to affect the distribution 
of the tracer in the body. 
The distribution of lead between the red cells and the soft tissues was 
changed, with a reduction of red cell uptake and an increase in soft 
tissue levels of lead. These changes were suggested to have been caused 
by systemic phosphorous. The release of lead from the red cells and soft 
tissues was also shown by the model to be relatively slow compared to 
uptake. The levels of lead in the red cells ·and soft tissues, therefore, 
will mainly d~pend on the initial partitioning of lead between them, so 
that the changes shown by this short term study may · be significant in _ 
the long term. 
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The changes in the distribution of lead shown by the model could reduce 
the 'protective' effect of calcium and phosphorous on the absorption 
of lead in the gut. The experimental data were inadequate, however, to 
enable the model to determine the changes in lead levels of particular 
soft tissues which are vulnerable to the toxic effects of lead. The 
changes were also shown by using a compartmental model, and the 
limitations ~nd assumptions inherent in mathematical modelling should 
be taken into account. The reduction in gastrointestinal absorption 
of lead mainly caused by calcium was still sufficient to substantially 
reduce the absolute levels of soft tissue lead found in the model. 
The compartmental model suggested that lead is absorbed from the gut by 
at least two pathways, one which it shares specifically with calcium and 
the other specifically with phosphorous. Lead appears to share both the 
active and passive transports of calcium and phosphorous. Absorption 
of lead in the different pathways gives rise to at least two different 
forms of plasma lead, analogous to those of calcium. It must be 
emphasised, however, that there was no direct proof of these concepts 
from the work in this thesis, but that they were suggested by the 
compartmental analysis of the kinetics of orally ingested lead tracer. 
In conclusion, short term studies with a single dose of tracer lead are 
adequate to investigate the gastrointestinal absorption of lead in man. 
They show that dietary calcium at requirement level will minimise the 
absorption of lead from food and beverages. The result will be lower 
soft tissue levels of lead, which should reduce susceptibility to the 
toxic effects of lead exposure. There are groups of the population, 
however, whose · diets contain less than the Recommended Dietary 
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Allowance for calcium. The children of the urban poor form one of 
these groups, so that it is essential for the health of these 
children that the prophylactic effect of calcium on lead absorption 
should be recognised and applied in this time of increasing 
environmental levels of lead. 
11.1 
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S E C T I O N 11 
DETAILED MATERIALS AND METHODS 
Subjects 
All the subjects were male with an age range of 23-40 years, a 
weight range of 58-100 kg and a height range of 1.63-1.91 m, as shown 
in table 11.1.1. There were no abnormalities detected on full history 
and clinical examination, urinalysis, full blood count, serology and 
blood electrolytes. Red cell porphyrins were normal in all subjects. 
Table 11.1.2 shows the results of the measurements of red cell, plasma 
and E.C.F. volumes of the subjects who took part in the kinetic 
experiments. The intercept of the reg~ession equation fitted to their 
whole body retention from 96 hours onwards is also shown. All studies 
were performed with the informed consent of the subjects, who were . 
members of the professional and technical staff from the Departments of 
Medical Physics, Nuclear Medicine, Biomedical Engineering and 
Radiotherapy, University of Cape Town. 
11.2 Radionuclide 203 Pb 
2 03 Pb has a half life of 52.l hours, decays by electron ~apture 
emitting a main gamma ray of ene~gy 279 keV (81%), gamma · rays with 
energies of 401 keV (5%) and 680 keV (1% ) and characteristic x-rays of 
T£ from 70 to 84 keV. 
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TABLE 11. l. l 
Subject details 
SUBJECT AGE WEIGHT HEIGHT 
(years) (kilograms) (metres) 
M.W. 40 65 1.68 
M.P. 27 72 l. 72 
E.H. 30 80 1.82 
C.H. 26 82 1.63 
P.H. 26 85 1.90 
A.F. 25 74 l. 75 
M.W. 30 68 l. 73 
K.B. 35 72 1.82 
B.S. 40 100 1.81 
s .L. 39 75 1.65 
J.B. 23 58 l. 74 
B.C. 30 95 1.80 
G.E. 30 66 1.91 
















































































































































































































































































































































































203 Pb was prepared by bombarding natural Thallium (as the metal) with 
16 MeV deuterons. The production reaction was 
203T£ (d, 2n)203Pb 
and after bombardment 0.2-0.3 mm of the surface of the target was 
removed for chemical separation of the 203 Pb. This was done by an ion 
exchange method based on that of Strelow and Toerien (1966). The final 
chemical form of the carrier free 203 Pb was the chloride dissolved in a 
solution of lM HCl. 
The production and chemical processing of the 203 Pb chloride was 
performed by the National Accelerator Centre, Council for Scientific 
and Industrial Research, Pretoria, South Africa. 
Whole oody counts 
Whole body, standard, body background and counter background counts 
were measured using a NE 8108 Whole Body Monitor (Warner and Oliver, 
1966) fitted with four 102 mm x 76 mm NaI (T£) crystals, two above 
and two below the movable couch top. The pulse height analyser was set 
to detect both the Compton and photopeak pulses of the 279 keV gamma 
ray of 203 Pb. This reduced the variation in count response with 
changing distribution of a radionuclide in the body (Warner and Oliver, 
1966). Couch speed was set at 500 mm/min giving a whole body counting 
time of 6 minutes, which was sufficiently long enough to give a 
coefficient of variation of less than 10% on 96 hour readings. 
Altho~gh both Compton and photopeak pulses were included in pulse-height 
analyser window, the count response of the whole body monitor was still 
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affected by the early redistribution of the 
203 Pb in the body. A 
maximum change of 10% occurred in series of retention results done on 
one subject ( table 11.3,1 ) . The count at 6 hours was taken as the 
100% ingested dose reading in all subjects, and readings were 
normalised to this value. The percentage retention and its standard 
deviation were calculated by the method of Anderson and Warner (1970) 
using computer program E.1.1. 
Whole body counts were performed, when possible, once a day. From 96 
hours onwards, at least six readings were obtained for estimating the 
half time of retention. Half times were calculated using a weighted 
linear regression of £n (% retention) on time (hours ) with post-96 
hour data using computer program E.1.2. 
11.4 Gamma camera studies 
A Nuclear Chicago Pho Gamma IV gamma camera was used to image the 
203 Pb in the gastrointestinal tracts of the subjects. Uniformity, 
resolution and linearity measurements were done on the gamma camera 
before each study to check that its performance was optimal. The 
camera was set to detect the 279 keV gamma ray of 
203 Pb and fitted with 
a 1200 hole medium-energy diverging collimator. The collimator-to-
subject distance was adjusted so that the whole of the gastrointestinal 
t ract appeared in the field-of-view of the camera. The images of the 
distribution of 203 Pb in the body each contained an accumulated count 
of 50 000, and they were recorded on polaroid film. At approximately 
48 hours after the oral dose , an image was recorded of the distribution 
of 203 Pb in the liver of each subject. This was performed with a 1200 
hole medium-energy parallel holed collimator to produce a larger image 
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TABLE 11.3.1 
















t ! 1 standard deviation. 
PERCENTAGE RETENTION 
(Normalised to 6 hour reading ) 
90.33 ! o.25t 
+ 
91.74 - 0.25 
96.58 ! 0.26 
+ 98.23 - 0.27 
+ 
98.28 - 0.27 
+ 99.24 - 0.27 
100.00 !° 0.27 
100.35 !° 0.28 
100.59 ! 0.28 
99.78 !° 0.28 
+ 99.91 - 0.28 
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of the liver. The same procedure was used to image the distribution 
of 113m1n colloid in the liver of each subject, except for changing 
the camera settings to detect the 393 keV gamma ray of 
113m1n. 
11. 5 Profile scans 
The NE 8108 whole body monitor was used for producing profile scans of 
the radioactivities in the subjects. Specially constructed 
collimators (Appendix B) were fitted between upper and lower Nal (T£ ) 
crystals to improve the spatial resolution of the system. These 
collimators were designed to focus at the approximate mid-line (150 mm 
above the couch ) of a subject lying on the couch top. The Full Width 
at Half Maximum was 21 mm at this mid-line, and the 50% isocount 
contours _were continuous between both collimators. 
The pulse height analyser was set to detect the major gamma ray emitted 
from the radionuclide used. Settings are shown in table 11.5.l. The 
logic output of the pulse height analyser was fed into a 400 channel 
Intertechnique multi-channel analyser (M.C.A. ) set in multiscaling 
mode with a time increment of 1 second. The couch speed was set at 
300 mm/min to give a scanning time of 400 seconds, which was long 
enough to enable a profile of the total length of each subject to be 
recorded. On every occasion that a profile scan of a subject was 
performed, profiles of standard and background were done. All profile 
data was punched on paper tape for further analysis. 
The outputs from top and bottom NaI(T£ ) crystals were separately 
recorded on two ratemeters attached to two Labograph recorders running 
at chart speeds of 50 mm/ min. The following anatomical landmarks were 
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TABLE 11.5.l 
Pulse height analyser settings of profile scanner 
















marked on the recorder paper: 
l. Vertex of head 
2. Suprasternal notch 
3. Xiphisternal joint 
4. Iliac crest 
5. Symphysis pubis 
6. Knee 
7. Ankle 
The position of the xiphisternal joint (x-s ) was marked digitally in 
the profile recorded in the M.C.A. system. This was done by a pulse 
generator, which was activated manually when the x-s passed through 
the centre of the field of view of the detectors. The landmarks were 
used to align profile scans correctly for the computer analysis of 
profile scans (Appendix A). 
Surface radioactivity measurements 
Surface radioactivity was measured using a Ohio Nuclear Series 84 
rectilinear scanner. Table 11.6.l shows the pulse height analyser 
settings used to detect 2 03 Pb, 113min and 82Br. Two analysers were used 
to detect both the x-rays and gamma ray of 203Pb, so that if necessary, 
the statistical accuracy of counting could be improved by summing the 
count rates from both pulse height analysers. A focussing collimator 
was used with a 127 mm geometrical focal length. This gave sufficient 
depth response to measure radioactivity at depth in the liver. 
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TABLE 11.6.l 
Pulse height analyser settings of rectilinear scanner 
RADIONUCLIDE PHOTON ENERGY 
(ke:V ) 
70-84 (x-rays ) 
279 (y-ray ) 
393 (y-ray ) 













The approximate position of organ measurement sites were found by 
using a scintigram image in which the organs could be clearly seen. 
From these approximate positions, the organs were surveyed individually 
with the probe of the rectilinear scanner immediately after the 
scintigram was taken, until the positions giving the highest count rates 
were found. These were marked on the skin and on a polythene template 
to help with future positioning of the probe. At all measurement sites, 
the collimator was placed in contact with the subject's skin, and 
subsequent repositioning was done by using skin marks and the collimator 
light beam. 
The precision of surface radioactivity measurements could be affected by 
an error in repositioning the detector at a counting site. Therefore, 
at 24 hours, when count rates were high, each subject was counted and 
repositioned several times. A typical set of readings from one subject 
is shown in table 11.6.2. Overall, the coefficients of variation were 
only slightly greater than that due to statistical variation, so that 
error due to repositioning was negligible. 
On every occasion surface radioactivity measurements were performed, 
standard~ and background count rates were also recorded. Body background 
measurements were also performed at all sites with each subject, when no 
radioactivity was present in the body. Counter backgrounds recorded 
during surface radioactivity measurements were then corrected by the 
ratio of body to counter backgEounds. The ratios for subject K.B. are 
shown in table 11,6.3. The standard was used to avoid correcting 
surface counts for radioactive decay of 2 0 3 Pb and to compensate for any 
















































































































































































































































































































































Body background / counter background ratios 
Subject K.B. 
LIVER SMALL BOWEL MEDIAL CALF 
+ t + 0.94 - 0.03 (3) 0.95 - 0.03 (3) 0.99 ~ 0.05 (3) 
Figures in brackets are number of data points. 
t ~ l standard deviation. 
MEDIAL MALLEOLUS 
+ 0.99 - 0.05 (3 ) 
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intended to simulate an aliquot of the ingested dose in the region or 
organ of interest. Surface radioactivity measurements, therefore, 
were expressed as proportional units of percentage ingested dose not a
s 
absolute units, and these were calculated using computer program E.1.3
. 
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11.7 Subtraction of blood and 'soft' tissue backgrounds from profile scans 
and surface radioactivity measurements 
Radioactivity in the field of view of the detector is usually 
distributed in the organ of interest, the circulating blood and other 
extracellular or intracellular compartments. Therefore, the net counts 
due to radioactivity in the organ can only be obtained by subtracting 
the contribution from the other compartments. This may be done by 
using other radionuclides, such as 113 min and 
82 Br, that are known to be 
confined to spaces which approximate to_ the circulating blood and 
extracellular compartments. 
Profile scan and surface radioactivity measurements were performed on 
the subjects after the radionuclide of interest 
203 Pb, and the blood 
and extracellular fluid (E.C.F.) tracers, 113min and 
82 Br, had been 
administered to them on different occasions. The estimation of blood 
and 'soft' tissue backgrounds from these measurements depend on how 
the blood and 'soft' tissue compartments are defined. In the 
compartmental model developed in this study, the red cells, plasma and 
'soft'tissues are all separate compartments. Blood background will 
consist of 203 Pb radioactivities in red cells plus plasma, whereas 
'soft' tissue background will be caused by intracellular plus 
extracellular minus plasma 2
03 Pb radioactivities. This last entity 
represents a 'soft' tissue E.C.F. In the determination of 'soft' tissue 
E.C.F. backgrounds, it has been assumed that the concentration of 
203 Pb 
in the E.C.F. was the same as in the plasma, and that the 'soft' tissue 
E.C.F. volume equals total E.C.F. volume minus plasma volume. 
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The profile scan and surface radioactivity measurements of 
113 mrn and 
82 Br radioactivities in the body have to be adjusted to make them 
represent the radioactivity of 
203 Pb in the blood and 'soft' tissue 
E.C.F. It was first of all necessary to determine the detector 
responses of each of the radionuclides, and this was done using phantoms
 
to simulate the organ of interest and its adjacent tissues as regards 
position, size and shape. Using the relative detector responses of 
113min and 82 Br to that of 203 Pb and the radioactivities of these 
radionuclides, the profile scan and surface radioactivity measurements 
of 113min and 82 Br were adjusted to represent 100% of the ingested dose 
of 203 Pb in blood and 'soft' tissue E.C.F. These measurements were then
 
reduced in proportion to the actual percentage ingested doses of 
2 03 Pb 
measured in the blood and 'soft' tissue E.C.F. compartments during the 
experiments. This gave the 
203 Pb backgrounds required to be subtracted 
from the gross profile scan and surface radioactivity measurements. 
The measurement times of the blood and 'soft' tissue E.C.F. data 
were often different to those of the surface radioactivity and profile 
scan measurements. It was necessary, therefore, to interpolate between 
data points to f i nd the percent9ge of i ngested dose at the required 
time, and this was done using computer program E.1.4. 
11 .7 .l Radionuclides used as blood and extracellular tracers 
a ) Blood tracer 
The accepted method of measuring plasma volume is by using labelled 
proteins such as 131 I or 
1 25 I-human serum albumin. Hosain et al (1969 ) 
used 113min, which binds plasma transferrin, to esti mate plasma volume 
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and found it very satisfactory except that it overestimated the plasma 
volume obtained by using 
131 1-human serum albumin. Wootton (1976 ) 
found the same over estimation of plasma volume using 
113m1n chloride 
but he derived a regression equation to correct it. In the present 
study, 113mrn chloride 111as used as a blood tracer to measure plasma 
volume and to estimate blood 
203 Pb backgrounds. Its 393 keV gamma ray 
is more convenient for in vivo experiments than 12 s I
, and it gives a 
much lo111er absorbed radiation dose to the body than 
131 1 (Hosain et al 
1969 ) . 
b) Extracellular fluid tracer 
The chloride ion has been regarded as most suitable for the measurement 
of extracellular volume, provided the chloride space is corrected for 
the chloride content of the red cells. A more convenient ion is the 
bromide ion through its radionuclide 
82 Br, 111hich has a half life of 36 
hours. The gamma rays emitted from 
82 Br are also convenient for 
in vivo measurements. Corrections have to be applied for urinary loss, 
presence of proteins in plasma and entry of bromide into red cells. 
82 Br 111as used as the extracellular tracer to measure E.C.F. volumes 
and to estimate the 'soft' tissue E.C.F. backgrounds of 
203 Pb. 
11.7.2 Determination of in vivo detector responses of 
203 Pb, 113m1n and 82 Br 
An Alderson 111hole body phantom 111as used to determine the detector 
responses of the rectilinear and profile scanners. Unfortunately, this 
phantom has a 'modified gastrointestinal tract' 111hich does not 
simulate small bo111el, so that it 111as only possible to measure detecto~ 
responses over the liver, calf and ankle of the phantom. The detector 
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responses over the small bowel were assumed to be the same as those 
measured over the liver. The lower left leg and liver of the phantom 
were filled, on different occasions, with measured radioactivities of 
2A 3~b, 1 13 m1n and 82 Br, and surface radioactivity measurements were 
performed at the chosen sites using the procedures described in section 
-
11.6. In a similar way, profile scans were also performed (section 
11.5) of the radioactivities of the three radionuclides in the liver of 
the phantom. Detector responses were expressed as counts/second/µCi 
and profile counts/µCi and responses were normalised to the 
2 03 Pb 
readings as shown in tables 11.7.1 and 11~7.2. 
11.7.3 Measurement of plasma and red cell volumes and surface radioact
ivities 
using 1 13 m1n 
l mCi of 1 13 m1n chloride was injected intravenously over a period of 
about a minute as recommended by Hosain et al (1969). The 
113mrn 
chloride was obtained by elution from a generator (TRC, Code: TFC3) 
with 0.05 MHCl. Approximately the same radioactivity as injected was 
diluted with distilled water to a final volume of 1 litre, and l ml of 
this volume was used as a standard for blood, 50 m~ as a standard for 
surface radioactivity measurements and the remainder used as the profile
 
scan standard. 
Venous blood was taken from an antecubital vein in the arm opposite to 
that used for injection. 5 ml ~load samples were obtained at 10, 20, 
40, and 60 minutes post injection. The blood was then centrifuged, the 
plasma was separated and known volumes of plasma and standard were 
counted in a Packard automatic counter (Model 3002) set to detect the 
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TABLE 11. 7. 2 










+ t + 0.331-0.006 0.341-0.005 
+ + 0.542-0.009 0.543-0.005 
+ + 21.18-0.28 19.82-0.24 
+ 34.22-0.52 
+ 31. 73-0.43 














+ 3.16- 0.03 
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made to a coefficient of variation of less than 1%, after correction 
had been made for background and physical decay. 
Plasma volume was calculated from the intercept at zero time of the 
weighted regEession line fitted to the serial radioactivity 
measurements. The plasma volume measured using 113min chloride is 
greater than that measuring using 125 I-human serum albumin, and it was 
corrected using the regression equation determined by Wootton (1976 ) . 
Venous haematocrit was measured in each subject, corrected for trapped 
plasma and corrected to body haematocrit (Belcher and Vetter, 1971 ), 
which was then used to calculate the red cell volume from the plasma 
volume. The regression and calculations were done with computer 
program E.1.5. 
Profile scan and surface radioactivity measurements were performed at 
least 20 minutes after the injection, as described in sections 11.5 and 
11.6, respectively. The pulse height analysers were set to detect the 
393 keV gamma ray of 113 min, and the times of each measurement were 
noted. Profile scans were smoothed and restored by the methods 
described in Appendix A.l. 
11.7.4 Measurement of extracellular fluid volume and surface radioactivities 
using 828r 
100 µCi of 82 Br in the form of ammonium bromide was given orally after 
a 4 hour fast. The same radioactivity was diluted with distilled 
water to a final volume of l litre, and l ml of this volume was used as 
a standard for blood and urine sample counting and 50 ml as a standard 
for surface radioactivity measurements. The remainder was uses as the 
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profile scGn standard. A period of 6 hours was allowed for 
equilibration (Belcher and Vetter, 1971), during which time all urine 
was collected. A 5 ml specimen of blood was then taken into a 
heparinised tube. The blood was centrifuged immediately and the plasma 
separated. 
The total volume of urine collected was measured, and known volumes of 
plasma, red cells, urine and the standard were measured in a Packard 
automatic counter (Model 3002 ) ~ith the- pulse-heiqht analyser window 
set to detect the multiple gamma rays emitted from 8 2Br in the range 
400 - 900 keV. Enough counts were collected to give a coefficient of 
variation of the net counts of 1%. The apparent bromide space was 
calculated from the equation. 
Apparent bromide space (ml) = (sd - vu ) 
p 
wheres is the counting rate of diluted standard, d the dilution factor 
of standard, v the volume of urine collected (ml ) , u the counting rate 
of urine sample and p the counting rate per ml of the plasma sample. 
A correction factor must be used for the concentration of 8 2 Br in the 
plasma being less than its mean concentration in extracellular fluid 
and for the 8 2 Br content of the circulating red cells. For the first 
correction, a factor of 0.90 has been used on an empirical basis by 
Bradley et al (1956b ) t o estimate extracellular fluid volume from the 
apparent bromide space. The 82 Br content of the red cells was 
estimated from the count r ate per ml of the red cell sample and the 
calculated red cel l volume. 
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Combining these two corrections, the extracellular fluid volume is 
given by 
Extracellular fluid volume (ml) = ((sd - vu) - rV) x 0.90 
p 
where r is the count rate of 1 ml of red cells and V the red cell 
volume in ml. Calculations were done using computer program E.1.6. 
Profile scan and surface radioactivity measurements were performed as 
described in sections 11.5 and 11.6, respectively, with pulse height 
analysers set to detect the main 777 keV gamma ray 82 Br. Profile scans 
were smoothed and restored by the methods described in Appendix A.l. 
11.7.5 Derivation of blood and 'soft' tissue E.C.F. background factors for 
pro~i1e scans 
a) 203 Pb blood background factor 
The method of adjusting the profile scan of the blood tracer, 113min, 
to represent the 203 Pb blood background has been outlined in section 
11.7. In addition, the percentage ingested dose of 203 Pb measured or 
calculated to be in the blood at the time of a particular profile scan 
must be reduced ·by the decay of 203 Pb, which had occurred by the time 
the profile scan was recorded. The blood content of 203 Pb must also be 
corrected by the efficiency of the profile scanner in detecting 203 Pb 
radioactivity in the body. Efficiency will vary from subject to 
subject, and it was found by comparing the total counts in the 6 hour 
profile scan of each subject with the total counts in the corresponding 
profile scan of the standard. 
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The blood background factor to adjust the profile scan of 
113min 
radioactivity in the whole blood was derived as follows. 
Let P. = 113min profile scan l 
T. = time of 113min injection l 
T = time of 113min profile p 
'-· l = decay constant of 
113min 
C. = 113min response factor for profile scanner from table 11.7.2 
l 
D. = 113min injected dose l 
D = 203pb ingested dose p 
s. = 203pb profile standard count at T = 6 hours 
l 
s = 203pb profile standard count at time T. p 
E = efficiency of detection of 
203 Pb by profile scanner for 
p 
a particular subject. 





203 Pb blood background profile to be subtracted at time T 
= P. x Ep x F. x Sp x (% I.D. of 203 Pb in blood at time T) 
l l 
100 s . 
l 
Calculation of blood background factors was done using computer 
program E. l. 7. 
b ) 203 Pb 'soft' tissue E.C.F. background factor 
To obtain a 'soft ' tissue E.C.F. background profile, it was first of 
all necessary to subtract from the original 82 Br profile scan the 
contribution from 82 Br in the blood. The profile scan obtained using 
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the blood tracer, 113min, was transformed to represent a 
82 Br profile 
using the appropriate response factor from table 11.7.2, reduced by 
the measured 82 Br content of plasma plus red cells and then subtracted 
from the original 82 Br profile scan. This subtracted 
82 Br profile scan 
was transformed into the 203 Pb 'soft' tissue E.C.F. background by the 
same methods used in section 11.7.5 (a). 
The 'soft' tissue E.C.F. background factor was derived as follows: 
Let Vp = plasma volume 
V = red cell volume r 
V = E.C.F. volume e 
Pb = 82 Br profile scan 
pbr = 01 I.D. of s2Br in plasma ,o 
Rbr = 
01 I.D. of a2Br in red cells ,o 
ubr = OI 1.D .. of · 
82 Br ·in urine ,o 
Db = a2Br ingested dose 
Cb = a2Br response factor for profile scanner from table 11.7.2. 
S. = 203pb profile standard count at T = 6 hours l 
Sp = 203pb profile standard count at time T 
Ep = efficiency of detection of 
203 Pb by profile 
particular subject 
Blood background factor of 11
3min = F. 
l 
scanner for a 
Fraction of total 82 Br counts which was due to 
82 Br blood content 
= (Pbr + Rbr) 
(loo ubr ) 
113mrn profile was multiplied by the following factor to make it 
represent the percentage ingested dose of 82 Br in whole blood. 
Fi (Pbr + Rbr ) Cb Db 
Dp (100 - ubr) 
This 82 Br blood profile was then subtracted from the original 
82 Br 
profile to give a 'soft' tissue E.C.F. profile (P ) . Adjustment to e 
100% of the ingested dose of 82Br in 'soft' tissue E.C.F. and 
transformation to represent 100% of the ingested dose of 
203 Pb, gave 
the following background factor 
= 
100 Op 
203 Pb 'soft' tissue E.C.F. background profile to be subtracted at 
time T 
P x E x Fb x Sp x (% I.D. of 203 Pb in 'soft' tissue E.C.F. 
e P = 
100 S. 
l 
at time T) 
Calculation of 'soft' tissue E.C.F. background factors was done using 
computer program E.1.8. 
11.7.6 Derivation of blood and 'soft' tissue E.C.F. background factors for 
surface radioactivity measurements 
a ) 203 Pb blood background factor 
In addition to the manipulations described in section 11.7, 
113min 
surface radioact i vity measurements were first corrected for 
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radioactive decay from the time of the standard count. Surface 
radioactivity measurements are expressed in proportional units of 
percentage ingested dose, so that it was unnecessary to adjust the 
percentage ingested dose in the blood for the decay of 2 0 3 Pb. 
The blood background factor was derived as follows. 
Let S. = 113min surface radioactivity measurements expressed as 
l 
percentage injected dose 
T = Time of 113min surface radioactivity measurement 
s 
Tst = Time of 11 3min standard measurement 
A. 




= 1·13 m1n response factor for rectilinear scanner from 
table 11.7.2 
o. = 113min injected dose 
l 
D = 2 03 Pb i ngested dose 
p 




2 03 Pb blood background to be subtracted at time T 
= F. x (% I .D. of 2 03 Pb in blood at time T) / 100 
l 
= F . 
l 
Calculation of blood background factors was done using computer program 
E.1.9. 
b) 20 3 Pb 'soft' tissue E.C.F. background factors 
To obtain a ' soft' tissue E.C.F. background measurement, it was 
necessary to subtract from the original 82 Br surface radioactivity 
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measurement the contribution from 82 Br in the blood. This was done 
with the surface radioactivity measurements obtained using the blood 
tracer, 113min, which were first of all changed to represent 82 Br 
surface radioactivity measurements by using the appropriate response 
factor from table 11.7.2. They were then reduced by the measured 82 Br 
content of plasma plus red cells and subtracted from the original 82Br 
measurements. This subtracted 82 Br surface radioactivity measurement 
was made to represent the 203 Pb 'soft' tissue E.C.F. background, as 
described in section 11.7. 
The 'soft' tissue E.C.F. background factor was derived as follows: 
Let Vp = plasma volume 
V = red cell volume r 
V = E.C.F. volume e 
\ = a2Br surface radioactivity measurements expressed 
as ?~ ingested dose 
pbr = 
a, I.D. of a2Br in plasma 10 
Rbr = 
a, I.D. of s2Br in red cells , o 
ubr = 
a, I.D. of a2Br in urine , o 
Db = a2Br ingested dose 
Cb = s2Br response factor for rectilinear scanner from 
table 11. 7 .2 
Surface radioactivity from 100% 82 Br in blood - derived from 113 min 
measurements 
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Surface radioactivity from measured 82 Br in blood 
= Cb Db Fi (Pbr + Rbr) 
D (100 - Ub ) 
P r 
Surface radioactivity from 82 Br in 'soft' tissue E.C.F. 
= Sb - Cb Db Fi (Pbr + Rbr ) 
Dp (100 - ubr ) 
containing (100 - Ubr - Pbr ) % of ingested 82Br 
Surface radioactivity from 100% 82 Br in 'soft' tissue E.C.F. 
Surface radioactivity from 100% 2 03 Pb in 'soft' tissue E.C.F. 
= Dp (Sb - Cb Db Fi (Pbr + Rbr )) / Cb Db (100 - Ubr - pbr ) 
Dp (100 - ubr ) 
= ' soft' tissue E.C.F. background factor (Fb ) 
2 03 Pb ' soft' tissue E.C.F. background to be subtracted at time T 
= Fb x (% I.D. of 2 03 Pb in 'soft tissue' E.C.F. at time T) / 100 
Calculati on of 'soft' tissue E.C.F. background factors ~as done using 
computer program E.1.10. 
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11.8 2 o 3 pb radioactivity in blood 
5-10 ml of venous blood samples were taken into heparinised containers. 
When the 2 03 Pb content of plasma and red cells were required, the blood 
was centrifuged immediately after sampling, and the plasma was 
separated carefully from the red cells. A known volume of whole blood 
or red cells was lysed with saponin. Measured volumes of whole blood 
or red cells and plasma were counted in a Packard automatic 
counter (Model 3002). For all measurements, background and a known 
aliquot of the oral dose of 2 03 Pb were counted. 
The pulse height analyser of the counter was set for maximum counting 
efficiency with a threshold of 10 and a window of 340. This window 
included the 70 - 84 keV x-rays as well as the 279 keV gamma ray of 
2 03 Pb. The window levels were set by using the figure of merit, 
Q = vC - vB (Belcher and Vetter, 1971), as shown in table 11.8.1. 
The 203 Pb radioactivity in the plasma samples was usually so low that 
t he counting time of the gamma counter was set to its maximum of 100 
minutes. Red cell samples were counted in the same run as plasma 
samples, but the 2 03 Pb radioactivity in red cells was much higher than 
that in plasma, so that the maximum preset count limit of 9 x 10
5 counts 
was usually reached during red cell sample counting. Consequently, the 
coeffi cient of variation of ned cell counts, usually less than 5%, was 
considerably lower than that of plasma counts. 
The percentage ingested dose of 2 0 3 Pb in total blood or in red cells 
and plasma was calculated by computer program E.1.11 ~12, using t he red 
cell and plasma volumes determined by the 1 1
3m In plasma volume method 
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TABLE 11.8.l 
Calibration of Packard gamma counter (blood) and N.E. 
5502 counter (urine ) for maximum sensitivities (
2 03 Pb) 
Threshold* Windo\1/* Packard gamma counter 
(Q) 
250 100 83.54 
200 150 91.91 
150 200 95.92 
100 250 105.51 
50 300 131.25 
40 310 133.85 
30 320 133.75 
20 330 132.80 
10 340 134.05 
0 350 122.52 
* l MeV expansion of pulse-height analyser settings. 















(section 11.7.3 ) . The half life of 
203 Pb in the red cells was 
calculated with a weighted linear regression of £n (% ingested dose) 
on time (hours), using computer program E.1.2. 
203 Pb radioactivity in urine 
Urine was collected over 24 hour periods, and 150 ml samples of these 
24 hour collections were counted in a Nuclear Enterprises (N.E. ) 5502 
counter with a 5 cm diameter flat-topped NaI ( T£) crystal. For all 
measurements, background and a known aliquot of the oral dose of 
203 Pb 
were counted. The pulse height analyser was set with a threshold of 
30 and a window of 320 to include both the 70 - 84 keV x-rays as well as 
the 279 keV gamma ray of 203 Pb. These settings were found using the 
figure of merit, Q, as shown in table 11.8.1. Coefficient of variation 
using these settings was usually less than 5%. The total volume of 
urine excreted in the 24 hour periods was measured, and the 
accumulative 203 Pb radioactivity excreted in the urine was then 
calculated as a percentage of the ingested dose, using computer program 
E. l.13. 
Summation of rectilinear-scanner count rates arising from x-rays and 
gamma ray emitted from 203 Pb 
Because of the low count rates obtained over the medial calf and medial 
malleolus, the count rates from both windows, set to detect the x-rays and 
gamma ray of 203 Pb, of the rectilinear scanner were summed to improve 
statistical accuracy. Subtraction of blood and 'soft' tissue E.C.F. 
backgrounds depend on the ratios of the detector responses of 
2 03 Pb to 
those of the vascular and E.C.F. tracers, 1 13m1n and 




.are different for t he x-rays and gamma ray of 2 0 3 Pb (table 11.7.2). 
Therefore, the blood and 'soft' tissue E.C.F. backgrounds were 
subtracted f r om each count rate arising from the x-rays and gamma 
r ay, before t he count rates were summed. 
Osteodensitometry measurements 
Osteodensitometry measurements were performed using a Norland-Cameron 
178 Bone Mineral Analyser. The sites surveyed were the medial 
malleolus and calcaneum, and a water bag was used t o compensate for the 
irregular shape of these structures. Four measurements were done at 
each site, and the mean readings were expressed as g/cm 2 by dividing 
the bone mineral reading by the measured bone width. The units are 
arbitrary and are only relevant to measurements made with this type of 
bone mineral analyser. Table 11.11.l shows the results obtained from 
four of the subjects who took part in the kinetic experiments. 
Statistical considerations 
Counts arising from radioactivity were rejected if the net counts above 
background were less than three times the standard deviation of the 
background count (Mehl, 1967). The experimental data obtained from all 
experiments was assumed to be normally distributed. The standard 
deviations of measurements were calculated by the method of sums of 
variances and relative variances (Belcher and Vetter, 1971 ) . The 
standard deviations of the results of calculations, except for whole 
body retention, were calculated by the method of partial differentials 




















































































































































































































































































































































































































































































































standard deviation of combined data were calculated using the ':relative 
weights of individual data (Bevington, 1969). If means ~ere compared, 
they were checked for equal variances and the appropriate test was 
selected from Documenta Geigy (6th edition). 
The parameter values obtained from the compartmental analysis are a 
'best estimate' and as such are the maximum value of a likelihood 
function (Brandt, 1976). This function has been assumed to have a 
normal distribution, so that the 'best estimate' is the mean of this 
distribution and the square root of the variance of the distribution 
about the 'best estimate' can be taken as the uncertainty of that 
estimate. Statistical comparisons were made by Student's 't' test 
for paired data (Mould, 1976). 
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The tables in this section list a comparison of experimental data 
and calculated values found from the compartmental analysis of the 
data from kinetic experiments performed in section 8.0. 
They are listed in subject order, 
K.B., J.B., B.C., G.E. and O.W., 
experiment order for each subject, 
Kinetic 1. and Kinetic 2., 
and compartment order for each experiment, 
whole body, plasma, red cells, urine, small bowel, liver, 
'soft' tissue and 'hard' tissue. 
All tables have been named with the following format. 
Subject initials-compartment initials-kinetic experiment 
e.g. Subjects K.8.'s small bowel data from Kinetic 1. experiment 
KB-SB-1 
Experimental data is shown with: 1 standard deviation. 
Abbreviations 
hrs hours 
%I.0. percentage ingested dose 
%P.I.D. percentage proportional ingested dose 
317 
TABLE:KB-WB-1 
COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT: K. e .. KINETIC:1. 
WHOLE B1)DY 
TIME EXPERIMENTAL DATA ( ,;io) CALCULATED RESULTS< 1;ic > 1;ic I QO 
<HRS) (%I.0.) <i:I.D.> 
6.00 100.000 +- 0.237 98.785 0.98 
24.00 94.647 +- 0.237 96. 134 1.01 
48.00 80.817 +- 0.224 83.881 1. 03 
72.00 73.094 +- 0.232 71. 604 0.98 
96.00 65.418 +- 0.234 65.317 0.99 
120.0IJ 61.104 +- 0.261 62 .154 1.01 
144.00 58.679 +- 0.294 59.865 1. 02 
168.00 56.432 +- 0.336 57.721 1.02 
192.00 56.720 +- 0.412 55.583 0.98 
216.00 53.118 +- 0.488 53.445 1.00 
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TABLE:KB-PL-1 
COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:K.B. KINETIC:1. 
PLASMA 
TIME EXPERIMENTAL DATACG!O) CALCULATED RE SUL TS C 1;ic > G!C/G!O 
<HRS> c;n.D.> c;n.o. >, 
1. 00 0.019 +- 0.001 0.009 0.47 . 
2.00 0.030 +- 0.001 0.020 0.65 
3. 00 o. 031 +- 0.001 0.030 0.95 
6.00 0.065 +- 0.001 0.052 0.78 
10. 00 0.056 +- 0.001 0.066 1. 15 
17.00 0.073 +- 0.001 0.071 0.96 
24.00 0.058 +- 0.001 0.070 1. 19 
48.00 0.053 +- 0.002 0.061 1.13 
72.00 0.052 +- 0.002 0.053 0.99 
96.00 0.041 +- 0.003 0.046 1.10 
120.00 0.043 +- 0.004 0.040 0.91 
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TABLE: KB-f.:C-1 
COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:K.B. KINETIC:1, 
RED CELLS 
TIME EXPERIMENTAL DATACQO) CALCULATED RESULTS(QC) QC/QO 









































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:K.B. KINETIC:!. 
URINE 
TIME E)<PERIMENTAL OATA(QO) CALCULATED RESULTS ( G!C) 1JC/OO 
<HRS) c;-:r.o.> <i:I.D.> 
24.00 1.900 +- 0.012 2.287 1. 20 
48.00 2.906 +- 0.015 3.006 1. 03 
72.00 3.725 +- 0.017 J.689 0.99 
96.00 4.557 +- 0.020 4.347 0.95 
120.00 4.989 +- 0.021 4.980 0.99 
144.00 5.797 +- 0.023 5.589 0.96 
168.00 6.523 +- 0.025 6.175 0.94 
192.00 7.259 +- 0.027 6.740 0.92 
216.00 8.037 +- 0.029 7.283 0.90 
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TABLE:KB-SB-1 
COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:1<.B. l<INETIC:1, 
SMALL BOWEL 
TIME EXPERIMENTAL DATA(QO) CALCULATED RESULTS(QC) QC/QO 


































































































COMPARISON OF EXPERIMENTAL DATA ANO CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:K.B. KINETIC:!. 
LIVER 
TIME EXPERIMENTAL DATACQO) CALCULATED RESULTSCQC) QC/QO 







































































































COMPARISON OF EXPERIMENTAL DATA ANO CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:K.B. KINETIC:!. 
1 SOFT 1 TISSUE 






















































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:K.B. KINETIC:1, 
' ' HARD TISSUE 
TIME EXPERIMENTAL DATA(QO) CALCULATED RESULTS(QC) QC/QO 























































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:K.B. KINETIC:2. 
WHOLE BODY 
TIME EXPERIMENTAL DATA(QO) CALCULATED RESULT'.:; ( 1~C) 1~C/QO 
<HRS) (i~I.0.) (i: I. D. ) 
6.00 100.000 +- 0.181 99.217 0.99 
24.00 98.877 +- 0. 187 95.696 0.96 
48.00 79.754 +- 0 .168 75.394 0.94 
72.00 57.793 +- 0. 140 57.221 0.99 
96.00 48.360 +- 0.137 49.328 1. 02 
120.00 45.409 +- 0.148 46.161 1.01 
144.00 42.579 +- 0 .164 44.243 1. 03 
168.00 41.700 +- 0.191 42.560 1.02 
192.00 39.882 +- 0.220 40.910 1. 02 
216.00 37.814 +- 0.256 39.279 1.03 
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TABLE:KB-PL-2 
COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT: I(. B. l<INETIC:2. 
PLASMA 
TIME EXPERIMENTAL DATA(QO) CALCULATED RESULTS(QC) QC/QO 




































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:K.B. KINETIC:2, 
RED CELLS 






















































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:K.B. KINETIC:2, 
URINE 
TIME EXPERIMENTAL DATA(QO) CALCULATED RESULTS ( t~C) QC/Q() 
(HRS) <XI.D. > (%I.D.) 
24.00 1.135 +- 0.005 1. 267 1. 11 
48.00 1.558 +- 0.006 1.625 1. 04 
72.00 1.932 +- 0.006 1. 965 1.01 
96.00 2.276 +- 0.007 2.290 1. 00 
120.00 2.641 +- 0.008 2.601 0.98 
144.00 3.015 +- 0.009 2.899 0.96 
168.00 3.380 +- 0.010 3.184 0.94 
192.00 3. 797 +- 0.011 3.458 0.91 
216.00 4.316 +- 0.013 3.721 0.86 
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TABLE:KB-SB-2 
COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:K.8. KINETIC:2, 
SMALL BOWEL 
TIME EXPERIMENTAL DATA(QO) CALCULATED RESULTS<QC) QC/QO 

































































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:K.B. KINETIC:2, 
LI VE~: 
TIME EXPERIMENTAL DATA(QO) CALCULATED RESULTS(QC) QC/QO 







































































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT: K. B,. KINETIC:2. 
'SOFT 1
 TISSUE 
TIME EXPERIMENTAL DATA(QO) CALCULATED RESULTS(QC) QC/QO 
























































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:1<,B. l<INETIC:2, 
'HARD' TISSUE 
TIME EXPERIMENTAL DATA(QO) CALCULATED RESULTS(QC) QC/QO 
























































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:J.B. KINETIC:l. 
WHOLE BODY 
TIME E)<PERIMENTAL OATAC111)) CALCULATED RESULTSCQC) G!C/f,1() 
<HRS> Ci:I.D.) c:n.o. > 
6.00 100.000 +- 0.238 98.260 0.98 
24.00 95.011 +- 0.240 96.494 1. 01 
48.00 92.930 +- 0.257 88.858 0.95 
72.00 86.596 +- 0.264 79.919 0.92 
96.00 71.701 +- 0.268 74.257 1.03 
120.00 69.206 +- 0.284 70.823 1. 02 
144.00 66.359 +- 0.315 68.191 1.02 
168.00 63.221 +- 0.358 65.733 1. 04 
192.00 61.818 +- 0.432 63.290 1.02 
216.00 58.571 +- 0.451 60.844 1. 03 
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TABLE:JB-F'L-1 
COMPARISON OF EXPERIMENTAL DATA ANO CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:J.B. KINETIC:!, 
PLASMA 
TIME EXPERIMENTAL OATACQO) CALCULATED RESULTSCQC) QC/QO 


























































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:J.B. l(INETIC:1, 
RED CELL:3 
TIME EXPERIMENTAL DATA(QO) CALCULATED RESULTS(QC) QC/QO 









































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:J.B. t<INETIC:1, 
URINE 
TIME EXPEF.: I MENTAL DATA(G!O) CALCULATED RESULTS(QC) 
QC/QO 
<HRS) (%I.0.) (%!.D.) 
24.00 2.344 +- 0.014 2.641 1.12 
48.00 3.085 +- 0.015 3.283 1.06 
72.00 3. 927 +- 0.016 3.892 0.99 
96.00 4.626 +- 0.017 4.470 0.96 
120.00 5.375 +- 0.020 5.020 0.93
 
144.00 5.800 +- 0.021 5.543 0.95 
168.00 6. 314 +- 0.022 6.041 0.95 
192.00 6.748 +- 0.022 6.516 0.96 
216.00 7.383 +- 0.024 6.968 0.94 
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TABLE: JB-!:;B-1 
COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:J.B. KINETIC:1. 
SMALL BOWEL 
TIME EXPERIMENTAL OATACQO) CALCULATED RESULTS(QC) QC/QO 







































































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:J.8. KINETIC:1, 
LIVER 
TIME EXPERIMENTAL DATA(QO) CALCULATED RESULTS(QC) QC/QO 

































































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 




TIME EXPERIMENTAL DATA(QO) CALCULATED RESULTS(QC) QC/QO 








































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:J.B. l(INETIC:1, 
,HARD 1 TISSUE 
TIME EXPERIMENTAL DATA(QO) CALCULATED RESULTS(QC) QC/QO 







































































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
sue.JECT:J.B. KINETIC:2. 
WHOLE BODY 
TIME EXPERIMENTAL DATA(QO) CALCULATED f.:E~3UL T~; ( G!C) QC/G!O 
<HRS> (%I.0.) (;-:r.o.> 
6.00 100.000 +- 0.176 99.200 0.99 
24.00 88.654 +- 0. 162 86.490 0.97 
48.00 48.214 +- 0.105 58.579 1. 21 
96.00 36.633 +- 0.104 36.796 1.00 
120.00 33.429 +- 0.110 34.218 1. 02 
144.00 31.248 +- 0. 120 32.667 1.04 
168.00 29.334 +- 0.139 31.359 1. 06 
192.00 28.204 +- 0.164 30.098 1.06 
216.00 27.202 +- 0.191 28.849 1. 06 
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TABLE:JB-PL-2 
COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:J.B. KINETIC:z. 
PLASMA 
TIME EXPERIMENTAL DATACQO) CALCULATED RESULTS(QC) QC/QO 









































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:J,B, KINETIC:2. 
RED CELL::; 

















0.801 +- 0.002 
1.980 +- 0.006 
Z.990 +- 0.009 
6.171 +- 0.019 
8.636 +- 0.027 
10.250 +- . 0.032 
11.853 +- 0.037 
12.653 +- 0.039 
11.378 +- 0.035 
10.765 +- 0.034 
9.762 +- 0.030 
9.463 +- 0.029 
8.958 +- 0.028 
































COMPARISON OF EXPERIMENTAL DATA ANO CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:J.B. KINETIC:z. 
URINE 
TIME E}{PERIMENTAL DATA ( 1:;:io) CALCULATED RESULTS ( 1JC) 
(K /I]() 
<HRS) C·!I.D.) (i!I.D. > 
24.1)0 1.006 +- 0.004 l. 022 l.01 
48.00 1. 329 +- 0.005 1.373 1. 03 
72.00 1. 694 +- 0.006 1.697 1.00 
96.00 2.034 +- 0.007 1.999 0.98 
120.00 2.332 +- 0.007 2.282 0.97 
144.00 2.597 +- 0.008 2.549 0.98 
168.00 2.866 +- 0. 009· 2.801 0.97 
192.00 3. 044 +- 0.009 3.039 0.99 
216.00 3.288 +- 0.009 J.265 0.99 
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TABLE:JB-SB-2 
COMPARISON OF EXPERIMENTAL DATA AND CAL CULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:J.B. fCINETIC:2. 
SMALL BOWEL 
TIME EXPERIMENTAL DATA<QO) CALCULATED RESULTS(QC) QC/QO 


































































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:J.B. KINETIC:2. 
LIVEJ.: 
TIME EXPERIMENTAL DATA(QO) CALCULATED RESULTS(QC) QC/QO 







































































































COMPARISON OF EXPERIMENTAL DATA ANO CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:J.B. KINETIC:2. 
' ' SOFT TI Sf;LJE 
TIME EXPERIMENTAL DATACQO) CALCULATED RESULTSCQC) QC/QO 
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COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:J.B. f(INETIC: 2, 
\ I 
HARD TISSUE 
TIME EXPERIMENTAL DATA(QO) CALCULATED RESULlSCQC) QC/QO 





























































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:B.C. KINETIC:1, 
WHOLE BODY 
TIME E>(F'ERI MENTAL DATACG!O) CALCULATED f.:E::;UL TS< ,;ic) ,;i C / ,;i 0 
<HRS) O!I.0.) (Y.I.0.) 
6.00 100.000 +- 0.221 99.999 1. 00 
24.00 99.287 +- 0.231 97. 158 0.97 
72.00 83.535 +- 0.237 83. 144 0.99 
96.00 73.931 +- 0.239 75.876 1.02 
168.00 71.331 +- 0.360 67.478 0.94 
192.00 68.594 +- IJ.405 66.305 0.96 
216.00 64.770 +- 0.468 65.242 1. 00 
288.00 59.749 +- 0.886 62',113 1.04 
336.00 52.844 +- 1.453 60.008 1.13 
350 
TABLE:BC-PL-1 
COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:B.C. KINETIC:!. 
PLASMA 
TIME E><PER I MENTAL DATA(G!O) CALCULATED RE~;UL T~; ( r)C) r)C/QO 
<HRS) c;~ I. D. ) (i!I.D.) 
1. 00 0.020 +- 0.001 0.018 0.86 
2.00 0.026 +- 0.001 0.020 0.76 
3. 00 0.030 +- 0.001 0.022 0.70 
5.00 0.034 +- 0.001 0.027 0.76 
7. 00 o. 039 +- 0.001 0.031 0.78 
16.00 0.026 +- 0.001 0.040 1.51 
24.00 o. 045 +- 0.001 0.040 0.86 
41.50 0.042 +- 0.001 0.037 0.86 
72.00 0.038 +- 0.002 0.032 0.82 
96.00 0.036 +- 0.003 0.029 0.79 
351 
TABLE:BC-RC-1 
COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:B.C. l(INETIC:1. 
RED CELLS 
TIME EXPERIMENTAL DATA(QO) CALCULATED RESULTS(QC) QC/QO 




































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:B.C. KINETIC:1. 
URINE 
TIME EXPERIMENTAL DATA(t;10) CALCULATED RE SUL TS ( t~C > OC/t;lO 
<HRS> Ci~I.D.) (%I .D.) 
24.00 2.131 +- 0.010 2.432 1.14 
48.00 3.043 +- 0.013 2.956 0.97 
72.00 3.379 +- 0.014 3.465 1.02 
96.00 4.053 +- 0.015 3.964 0.97 
120.00 4.605 +- 0.016 4.451 0.96 
144.00 5.140 +- 0.017 4.929 0.95 
168.00 5.485 +- 0.018 5.397 0.98 
192.00 5. 833 +- 0.019 5.857 1. 00 
216.00 6.273 +- 0.021 6.307 1.00 
353 
TABLE:BC-SB-1 
COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT;B.C. KINETIC:1. 
SMALL BOWEL 
TIME EXPERIMENTAL DATA(QO) CALCULATED RESULTS(QC) QC/QO 







































































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUE S 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:B.C. KINETIC:1. 
LIVER 
TIME EXPERIMENTAL DATA<QO) CALCULATED RESULTSCQC) QC/QO 







































































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:e..C. KINETIC:1. 
'soFT 1 TISSUE 
TIME EXPERIMENTAL DATA(QO) CALCULATED RESULTS(QC) QC/QO 
























































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:B.C. KINETIC:1, 
' I HARD TISSUE 
TIME EXPERIMENTAL OATA(QO) CALCULATED RESULTSCQC) QC/QO 


























































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT: e .. C. f(INETIC: 2. 
WHOLE BODY 
TIME EXPERIMENTAL DATA(QO) CALCULATED RESULT::; < G!C) 17,!C/G!O 
<HRS> (~!I.D.> (;·!I.D.> 
6.00 100.000 +- 0.113 98.331 0.98 
24.00 35.822 +- 0.093 37.858 1.05 
48.00 31.110 +- 0.086 26.827 0.86 
72.00 26.542 +- 0.086 25.524 0.96 
96.00 25.090 +- 0.093 24. 196 0.96 
120.00 20.842 +- 0.095 22.859 1.09 
144.00 19.867 +- 0 .108 21.544 1. 08 
168.00 18.483 +- 0.124 20.271 1.09 
192.00 16.591 +- 0.160 19.052 1. 14 
216.00 16.069 +- 0. 187 17.891 1.11 
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TABLE:BC-PL-2 
COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:B.C. f<INETIC:2. 
PLASMA 
TIME EXPERIMENTAL DATA(QO) CALCULATED f.:ESUL TS< ,;ic > ,~c;,;io 
<HRS> (%I.0.) ( %I. D.) 
3.00 0.003 +- 0.000 0.006 1. 79 
16.00 0.015 +- 0.000 0.012 0.81 
24.00 0.014 +- 0.000 0.012 0.84 
48.00 0.009 +- 0.001 0.011 1.16 
72.00 o. 008 +- 0.000 0.010 1. 15 
96.00 0.010 +- 0.001 0.009 0.88 
120.00 0.009 +- 0.001 0.009 0.85 
144.00 0.009 +- 0.001 0.008 0.79 
168.00 o.010 +- 0.001 0.007 0.65 
192.00 0.007 +- 0.002 0.006 0.81 
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TABLE:BC-RC-2 
COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:B.C. f<INETIC:2. 
RED CELLS 
TIME EXPERIMENTAL DATA(QO) CALCULATED RESULTS(QC) QC/QO 




































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:B.C. KINETIC:z. 
URINE 
TIME E)<PER I MENTAL DATA C GIO) CALCULATED RES UL TS C GlC > 1:;lC/1~0 
<HRS> Ci!I.D.> (i!I .D.) 
24.0fJ 0.567 +- 0.003 0.467 0.82 
48.00 o. 624 +- 0.003 0.652 1. 04 
72.0IJ 0.745 +- 0.003 0.820 1.10 
96.00 o. 959 +- 0.004 0.975 1. 01 
120.00 1.157 +- 0.004 1. 118 0.96 
144.00 1.236 +- 0.004 1.251 1. 01 
168.00 1. 531 +- 0.006 1.374 0.89 
192.00 1. 701 +- 0.006 1.489 0.87 
216.00 1. 851 +- 0.006 1. 597 0.86 
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TABLE:BC-SB-2 
COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:B.C. KINETIC:2, 
SMALL BOWEL 
TIME EXPERIMENTAL DATACQO) CALCULATED RESULTS(QC) QC/QO 
























































































COMPARISON OF EXPERIMENTAL DATA ANO CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:B.C. KINETIC:2, 
LIVER 
TIME EXPERIMENTAL OATA(QO) CALCULATED RESULTS(QC) QC/QO 





























































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:B.C. KINETIC:z. 
\S(>FT' TISSUE 
TIME EXPERIMENTAL DATACQO) CALCULATED RESULTSCQC) QC/QO 









































































COMPARISON OF EXPERIMENTAL DATA AND CAL CULATED VALUES 




TIME EXPERIMENTAL DATA(QO) CALCULATED RESULTS(QC) QC/QO 



















































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:G.E. KINETIC:1, 
WHOLE BODY 
TIME EXPE f.: I MENTAL DATA(G!O) CALCULATED f.:ESUL TS< ,;ic) t?C/Q(l 
(HRS> c~:r.o.> c~:r.o.> 
6.00 100.000 +- 0.289 98.883 0.98 
24.00 98.590 +- 0.298 97.104 0.98 
48.00 98.551 +- 0.316 88.030 0.89 
72.0fJ 79.274 +- 0.286 77.462 0.97 
96.00 71.709 +- 0.272 70.942 0.98 
120.00 68.629 +- 0.297 67.070 0.97 
144.00 62.791 +- 0.327 6/t,137 1. 02 
168.00 61.241 +- 0.354 61.496 1.00 
192.00 60.037 +- 0.433 59.003 0.98 
240.00 52.651 +- 0.528 54.431 1.03 
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TABLE:GE-PL-1 
COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:G.E. KINETIC:1. 
PLASMA 
TIME E}<PERIMENTAL DATA ( 1]0) CALCULATED RESULTS< G!C) (~C / 11 <) 
<HR::;) (i!I.D.) <:·!I.D.) 
1.00 0.011 +- 0.001 0.013 1. 09 
2. 00 0.022 +- 0.001 0.021 0.95 
3.00 0.032 +- 0.001 0.028 0.85 
14.00 0.045 +- 0.001 0.050 1. 10 
20.00 0.051 +- 0.001 0.050 0.95 
24.00 o. 052 +- 0.001 0.048 0.91 
48.00 0.045 +- 0.002 0. 040 0.87 
72.00 o. 029 +- 0.003 0.033 1. 12 
96.00 0.027 +- 0.007 0.027 0.97 
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TABLE:GE-RC-1 
COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:G.E. l(INETIC: 1. 
RED CELLS 
TIME EXPERIMENTAL DATA<QO) CALCULATED RESULTS(QC) QC/QO 














































































COMPARISON OF EXPERIMENTAL DATA ANO CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:G.E. KINETIC:1, 
URINE 
TIME E)<PERIMENTAL DATA(QO) CALCULATED RE!3UL TS ( GlC) GlC/1]<) 
<HRS> (i!I.D.> (i!I.D, ) 
24.00 1.600 +- 0.012 1. 882 1. 1 7 
48.00 2.600 +- 0.015 2.527 0.97 
72.00 3.500 +- 0.017 3 .140 0.89 
96.00 3.640 +- 0.017 3.732 1. 02 
120.00 4.310 +- 0.017 4.305 0.99 
144.00 4. 900 +- 0.020 4.861 0.99 
168.00 5.530 +- 0.023 5.400 0.97 
192.00 6. 110 +- 0.025 5.923 0.96 
216.00 7.310 +- 0.033 6.432 0.88 
369 
TAe.LE:GE-SB-1 
COMPARISON OF EXPERIMENTAL DATA ANO CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:G.E. KINETIC:1. 
SMALL BOWEL 
TIME EXPERIMENTAL DATACQOJ CALCULATED RESULTS(QC) QC/QO 
























































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:G.E. KINETIC:1, 
LIVER 
TIME EXPERIMENTAL DATACQO) CALCULATED ":ESULTS(1~C> G!C/G!O 







































































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:G.E. KINETIC:!. 
'soFT 1 TISSUE . 
































































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:G.E. KINETIC:1. 
' I HARD TISSUE 
TIME EXPERIMENTAL DATACQO) CAL CULATED RESULTS(QC) QC/QO 







































































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:G,E. i<INETIC:2. 
WHOLE BODY 
TIME EXPERIMENTAL DATA(G!O) CALCULATED RESULTS(QC) G!C I QO 
(HRS) (%I.D.> (%I.0.) 
6.00 100.000 +- 0.202 99.534 0.99 
2't. 00 91.900 +- 0.191 92.217 1.00 
48.00 66.866 +- 0.155 57.488 0.86 
72.00 38.411 +- 0.111 34.823 0.90 
96.00 26.483 +- 0.097 27, 170 1. 02 
120.0lJ 23.551 +- D .106 24.188 1.02 
144.00 21. 535 +- 0.116 22.217 1. 03 
168.00 19.978 +- 0. 135 20.532 1.02 
192.00 19.468 +- 0.162 19.014 0.97 
216.00 18.667 +- 0. 198 17.635 0.94 
374 
TABLE:GE-PL-2 
COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:G.E. KINETrc:2. 
PLASMA 
TIME E}<PERIMENTAL DATA(QO) CALCULATED RES UL TS ( G!C) OC I(~ 0 
<HRS) (i~I.D.) (%I.D. > 
1.00 0.004 +- 0.000 0.006 1. 33 
2. 00 0.010 +- 0.000 0.013 1. 27 
3.00 0,024 +- 0.000 0.019 0.77 
6.00 0.030 +- 0.000 0.028 0.89 
16.50 0.014 +- 0.000 0.026 1. 71 
20.00 0.020 +- 0.000 0.023 1. 11 
24.00 0.015 +- 0.000 0.021 1.32 
48.00 0.010 +- 0.000 0.010 0.95 
72.00 0.011 +- 0.001 0.005 0.46 
96.00 0.005 +- 0.001 0.003 0.53 
375 
TABLE:GE-RC-2 
COMPARISON OF EXPERIMENTAL DATA ANO CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:G.E. KINETIC:z. 
RED CELLS 
TIME EXPERIMENTAL OATA(QO) CALCULATED RESULTS(QC) QC/QO 














































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:G.E. KINETIC:2. 
URINE 
TIME EXPERIMENTAL DATA(G!Ol CALCULATED REf:;LJL TS< QC l QC/(~() 
<HRS> Ci:I.D.) C%I.D.> 
24.00 0.615 +- 0.005 0.752 1 ,..,,, • -=-~ 
48.00 0.944 +- 0.006 1.002 1.06 
72.00 1.172 +- 0.006 1.228 1. 04 
96.00 1.368 +- 0.007 1. 435 1.04 
120.00 1.622 +- 0.007 1.625 1. 00 
144.00 1.799 +- 0.008 1.800 1.00 
168.00 2.045 +- 0.008 1.961 0.95 
192.00 2.221 +- 0.009 2.111 0.95 
216.00 2.393 +- 0.010 2.251 0.94 
377 
TABLE: GE-!:;B-2 
COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:G.E, KINETIC:2. 
SMALL BOWEL 
TIME EXPERIMENTAL DATA(QO) CALCULATED RESULTS(QC) QC/QO 


































































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:G.E. t< INETIC:2, 
LIVER 
TIME EXPERIMENTAL DATACQO) CALCULATED RESULTSCQC) QC/QO 











































































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:G.E. KINETIC~Z. 
' ·-·c·iFTJ Trc-c-uE ·=" .. .._ •. _. 
TIME EXPERIMENTAL DATA(QO) CALCULATED RESULTS(QC) QC/QO 
(HRS) <i:P.I.D.> (i:P.I.D.) 
0.75 

















































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:G.E. KINETic:z. . ; 
HARD TISSUE 
TIME EXPERIMENTAL DATA(QO) CALCULATED RESULTS(QC) QC/QO 





























































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:D.W. KINETIC:1. 
WHOLE BODY 
TIME E}{PERIMENTAL DATA< 1:;io) CALCULATED RESULTS ( 1)C) ,:;ic 1 ,:;i o 
<HRS) (i!I.D.) (i!I.D.) 
6.00 100.000 +- 0.210 98.844 0.98 
22.00 97.708 +- 0.215 97.582 0.99 
48.00 94.062 +- 0.227 89.768 0.95 
72.00 82.881 +- 0.225 79.158 0.95 
96.00 71. 604 +- 0.228 71. 826 1.00 
120.00 69.246 +- 0.255 67.917 0.98 
144.00 68.385 +- 0.298 65.698 0.96 
192.00 64.238 +- 0.415 62.521 0.97 
288.00 58.091 +- 1.192 56. 190 0.96 
353.00 53.459 +- 2.218 51.776 0.96 
382 
TAe.LE:DW-PL-1 
COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:o.w. l<INETIC:1, 
PLASMA 
TIME EXPERIMENTAL DATA(QO) CALCULATED RESULTSCQC) QC/QO 
( Hf.:!:; ) ( ; ' 1 • D • ) C ;n . D • > 






























































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:D.W. KINETIC:1. 
RED CELLS 
TIME EXPERIMENTAL DATACQO) CALCULATED RESULTS(QC) QC/QO 



















































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:D.W. KINETIC:1, 
URINE 
TIME EXPERIMENTAL DATA(l)O) CALCULATED RESULTS ( GlC > CK/I;:)() 
<HRS> (i!I.D.> C:·~I.D.) 
24.00 1.351 +- 0.006 1.991 1. 4 7 
48.00 2.316 +- 0.008 2.599 1. 12 
72.00 3.110 +- 0.010 3.180 1.02 
96.00 3.566 +- 0.011 3.740 1. 04 
120.DIJ 4.112 +- 0.013 4.278 1.04 
144.00 4.624 +- 0.015 4.795 1. 03 
168.00 5.206 +- 0.016 5.294 1.01 
192.00 5.834 +- 0.019 5.775 0.99 
216.00 6.577 +- 0.021 6.237 0.94 
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TABLE:DW-SB-1 
COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:D.W. KINETIC:1, 
SMALL BOWEL 
TIME EXPERIMENTAL DATA(QO) CALCULATED RESULTS(QC) QC/QO 























18.679 +- 0 .162 
11.068 +- 0.103 
11.811 +- 0.108 
10.166 +- 0.096 
9.320 +- 0.089 
8.404 +- 0.083 
7.883 +- 0.079 
6.697 +- 0.068 
5.855 +- 0.062 
5.785 +- 0.063 
4.811 +-,- 0.056 
3.893 +- 0.046 
3.269 +- 0.046 
3.883 +- 0.053 
2.234 +- 0.035 
1.327 +- 0.024 
1.039 +- 0.022 
0.598 +- 0.017 
0.591 +- 0.017 
0.678 +- 0.021 
0.535 +- 0.025 
















































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:D.W. f( INETIC: 1. 
LIVER 
TIME EXPERIMENTAL DATA(QO) CALCULATED RESULTS(QC) QC/QO 

















































































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 




TIME EXPERIMENTAL DATA(QO) CALCULATED RESULTS(QC) QC/QO 







































































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:D.W. l<INETIC:1. 
' I HARD TISSUE 
TIME EXPERIMENTAL DATA(QO) CALCULATED RESULTS(QC) QC/QO 

















































































































COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:o.w. l<INETIC:2, 
WHOLE BODY 
TIME EXPERIMENTAL DATA(QO) CALCULATED RE SUL TS< 17>.C) G!C/f::!O 
<HRS> (;{I,D,) (%LO.) 
b.00 100.000 +- 0.215 99.941 1. 00 
24.00 70.175 +- 0.171 78.044 1.11 
48.00 20.857 +- 0.838 21.292 1. 02 
72.00 6.114 +- 0.066 3.944 0.64 
96.00 1.651 +- 0.062 1.167 0.70 
120.00 0.594 +- 0.078 0.776 1.30 
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TABLE: DW-f.:C-2 
COMPARISON OF EXPERIMENTAL DATA ANO CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:D.W. KINETIC:2. 
RED CELL~; 
TIME EXPERIMENTAL DATA(QO) CALCULATED RESULTSCQC) QC/QO 













































































T ,rn LE : D W - UR - 2 
COMPARISON OF EXPERIMENTAL DATA AND CALCULATED VALUES 
FROM COMPARTMENTAL ANALYSIS 
SUBJECT:o.w. KINETIC:z. 
URINE 
TIME EXPERIMENTAL DATA ( t;!()) CALCULATED RESULTS ( rK > Id C / ,;i (l 
(HRS) <Y.I.D.> (%I.0.) 
24.00 o. 010 +- 0.000 0.013 1. 27 
48.00 0.015 +- 0.000 0.019 1 
r,c· 
• ,:;_ t.J 
72.00 0.022 +- 0.000 0.024 1. 06 
96.00 0.025 +- 0.000 0.029 1.14 
120.00 0.034 +- 0.000 0.034 0.98 
144.00 0.038 +- 0.000 0.038 0.99 
168.00 0.042 +- 0.000 0.043 1. 01 
192.00 0.051 +- 0.000 0.047 0.92 
216.00 0.055 +- 0.000 0.051 0.92 
392 




The figures in this section show the fits between experimental data 
and calculated values found from the compartmental analysis of the 
data from kinetic experiments performed in section 8.0. 
They are listed in subject order, 
K.B., J.B., B.C., G.E. and D.W., 
experiment order for each subject, 
Kinetic 1. and Kinetic 2., 
and compartment order for each experiment, 
whole body, plasma, red cells, urine, small bowel, liver, 
'soft' tissue and 'hard' tissue. 
All figures have been named with the following format. 
Subject initials-compartment initials-Kinetic experiment 




%I.D. percentage ingested dose 
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Quantitative analysis of profile scans 
A profile scanner produces a one dimensional image of the distribution
 
of radioactivity in a subject, and it was first described by Pochin 
(1950 ) . Most of the work done with profile scanning has been 
qualitative, but it is possible to make a quantitative estimate of the
 
radioactivity in a defined part of the body. Calibration procedures to
 
yield quantitative results have been reported by Tothill and Galt (197
1) 
and Blake and Hering (1973). 
The identifing and stripping of profile peaks from the general 
distribution of radioactivity in blood and tissues are necessary for 
quantitative results, and although methods have been discussed briefly 
(Tothill, 1974 ) , no rigorous techniques have been developed. Smoothing
, 
image restoration and other techniques commonly used in -gamma ray 
spectroscopy can be applied to profile scans to improve the accuracy o
f 
measurements of organ radioactivity. 
Smoothing and image restoration of profile scans 
Image restoration of profile scans has been described by Iinuma and 
Nagai (1967 ) . They deconvoluted profi l e scans using iterative 
approximation procedures. The solution does not converge , however, 
unless the data are smoothed before deconvolution (Hepburn, 1976 ). As
 
deconvolution was performed in the spatial domain, the data were 
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smoothed using a spatial filtering technique, and the method chosen 
was that of Savitzky and Golay (1964). This has been used in nuclear 
physics for many years. 
A.1.1 Savitzky f ilter 
The Savitzky filter technique of smoothing is basically the least 
squares fitting of a power function to the observed data. The profile 
scan data can be defined as an array C. The number of counts in 
channel i is Ci and i ranges from l ton, the number of channels in the 
scan. 
The smoothing value of Ci is defined as Di, and is computed from 
j = m 
Di = N-1 E m (am,j Ci + j) 
j = -m 
The constants am,j and the normalizing constant, Nm, are from tables 
presented by Savitzky and Golay (1964 ) . The index m means that 
2m + l points (channels) are used in computing Di. As an illustration, 
a five point smooth (m:2 ) is computed thus 
Di = 3; (-3 Ci- 2 + 12 Ci~ 1 + 17
 Ci+ 12 Ci+ 1 - 3 Ci + 2) 
This computation can be repeated for channels i:3 to i=n- g to give the 
smoothed profile scan. 
The choice of mis very important when statistical variations in count 
data are smoothed. If mis too large, the smoothed profile scan will 
tend to have shallow peaks and valleys and will generally be distorted; 
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if mis too small, the smoothed profile scan will not be smooth, and 
in the extreme cases will not be as smooth as the raw data. 
A.1.2 Iteration approximation method of Iinuma and Nagai 
The fallowing expression represents the smoothed profile scan 
+ CX) 
G ( x' ) = f F ( X ' - X ) R ( X ) dx 
- CX) 
(1) 
where F(x) is the ideal image and R(x) is the point source response of 
the profile scanner. The deconvolution of equation (1) ta find F(x) 
can be done using iterative approximation methods. 
The nth iteration can be expressed as fallows: 
x) R(x)dx} 
and 
Hn (x') _ +Jw Gn (x' - x)R(x)dx 
- CX) 
The following expression is used ta def i ne the limi t -af the approximation. 
N 
E { G ( x ) - Hn ( x) } 2 
x=l G(x) 
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N is the total number of increments in the original image, and this 
expression is based on the criterion that the iteration should be 
terminated when the difference between iterated im~ges becomes of the 
order of one statistical standard deviation of G(x) . 
Convergence will depend on the statistical error of the counts 
accumulated by the profile scanner. Therefore, in a series of profile
 
scans in which the radioactivity is decreasing because of the physical 
decay of the radionuclide, the degree of smoothing will have to be 
increased by increasing the value of m. 
The combination of Savitzky filter and the image restoration technique 
of Iinuma and Nagai was tested by the frillowing experiments. A profile
 
scan obtained with poor resolution conditions was smoothed, image 
restored and compared with a profile scan obtained with good resolution
 
conditions. 
A.1.3 Materials and methods 
The experiments were performed on a Nuclear Enterprises NE 8108 
'shadow-shield' whole body counter with the profile collimators removed
. 
The adjustable slot collimators were set 2 cm apart and a couch speed o
f 
500 mm/min was used. The pulse height analyser was set to eetect the 
393 KeV gamma ray of 11
3min, and its logic output fed into a 400 channel 
Inter-technique multichannel-analyser (M.C.A. ) . The M.C.A. was set to 
multiscale with a time increment of 690 msec. over 150 channels. 
Eight 11 3min sources of 100 µCi each were placed with their long axes 
perpendicular to the direction of motion of the couch. The sources we
re 
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25 mm in diameter and 60 mm in length, and they were placed 100 
mm 
apart with two point sources placed at either end to act as mark
er 
sources. The digital marker had not been constructed at this st
age. 
Profile scans of sources plus marker sources, marker sources on
ly, 
and background were recorded in the M.C.A. system. Profile scan
s were 
recorded -with a collimator slit width of 2 cm (good resolution) 
aod 
4 cm (poor resolution). This latter profile scan was performed 
approximately 2 hours after the former, so that the counts accum
ulated 
would be approximately equal. The profile scans, therefore, we
re 
statistically comparable. 
The data was punched on paper tape, and fed into a Univac 1100 
computer via a Tektronix 4051 intelligent teDminal. Preparation
 of 
the data ·before smoothing and restoration, was done by aligning 
the 
profiles using the marker sources, subtracting the marker source
s 
from total source profiles and subtracting the background from m
arker 
source profiles. Smoothing and image restoration were performed
 on 
the poor resolution profile using computer programs E.2.1-3. A
 17 
point Savitzky filter smooth was used and convergence occurred 
at the 4th iteration · (table A.1.1 ) . 
A.1.4 Results 
The profiles recorded at a slit width of 4 cm are degraded in 
comparison to those recorded at the ·smaller slit width, as shown
 in 
figure A.1.1. Figure A.1.2 shows the comparison of the restored
 image 
of the sources and the image obtained with good resolution. Co
nsidering 
the original degradation of the image, smoothing and image resto
ration 
have been successful. 
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TABLE A.l.l 
Convergence of Iinuma and Nagai image restoration technique 
applied to profile scan obtained with poor resolution conditions 




















































































































































































































































































































































































































































































Determination of the radioactive content of organs in the body 
After smoothing and image restoration, the next step is to decide which 
organs gave rise to the observed profile peaks, to subtract peak 
backgrounds caused by blood or soft tissue radioactivities, and to 
separate peaks produced by neighbouring organs. 
The correspondence between profile peaks and organs can be found by two 
dimensional imaging, and by relating the position of the peak to the 
anatomy of the body. With the wide range of radiopharmaceuticals now 
available, it is possible to visualise most of the organs of the body 
and to identify a particular organ with the shape and position of its 
profile peak. 
Blood and E.C.F. backgrounds can be found using nan diffusible and 
diffusible tracers, such as 113 m1n and 
82 Br. P~ofiles obtained with 
only one of these radionuclides present in the body at one time, can be 
scaled down by factors related. to the ' radioactivities of the tracers 
113min and 82 8~, by the radioactivity of the radionuclide of interest in 
the blood and E.C.F. and by the different detector responses of the 
radionuclides. 
The tissue background under the peaks of interest can be estimated from 
data points outside the peak, and a baseline interpolated to distinguish 
the radioactivity due to background from that in the peak itself. Linear 
interpolation and interpolation using polynomials for this purpose have 
been discussed by Covell (1959) and Quittner (1972 ) . 
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Once the peaks due to organ radioactivities have been isolated, the 
area under each peak can be found. If the peaks overlap, however, the 
determination of peak area can be difficult, and the best approach is 
to perform a weighted least squares fit of the individual peaks, which 
gives a solution having the smallest statistical error. Data describing 
the individual profile peaks can be obtained from the specific uptake 
of radiopharmaceuticals in the organs of interest, or the fit can be 
performed with an analytical function. Unfortunately, it is difficult to 
obtain the profiles of an individual organ, unless the radionuclide or 
radiopharmaceutical is totally specific to that organ, such as 
131 I in 
the thyroid. The liver accumulates much more labelled colloid than the 
spleen, and can be effectively isolated .by shielding the spleen with 
lead. But the opposite, the subtraction or shielding of the liver to 
give individual profiles of spleen will result in considerable 
statistical error in the final profiles. Because of these large errors, 
the least squares fitting of these individual profiles to a composite 
profile will be invalidated (Salmon, 1974 ) . However, it may be 
possible to fit an analytical function to the shape of the profile 
peaks of each organ obtained from subtraction or shielding. The 
compesite profile scan, which may consist of a number of organs, can 
then be fitted by least squares methods using the appropriate 
analytical functions for each organ. 
A.2.1 Modified Gaussian function 
In this study, a single analytical function was developed that could fit 
each organ profile. The basis of this function is a modified Gaussian 
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of the form 
y ( x ) = exp (- (x-p)
2 
which has been proposed by Heath (1964) to fit radionuclide spectra 
obtained from Nal (Tt) detectors. The parameters A, p, cr, a 1 , a 2 , m and 
n are determined for each peak. Unfortunately, this modified Gaussian 
is symmetrical about the value p, and profile peaks of organ 
radioactivities tend to be unsymmetrical. An additional function is 
required, which will operate only on one side of the modified Gaussian 
peak. A sigmoidal type of function (Karam, 1974 ) was chosen with an 
analytical form of 







that can be made to rise steeply to the value Smax at any value of x by 
the judicious choice of the constants Kand x50 ( the value of x at 
Smax/2 ) , This sigmoid type function was incorporated into the modified 
Gaussian by replacing the parameters a 1 and a 2• 
The total expression now becomes 
y(x) = A(l + S { (x-p)m + (x-p )n} ) exp (- (x-p )
2 / 2cr 2 ) 
and to check that this expression could fit different organ profiles 
containing different radioactivities, the phantom experiments in the 
following section were performed. 
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A.2.2 Materials and methods 
The same experimental set up was used as i n A.1.1 except that the 
resolution of the profile scanner was improved by reducing the slit 
width between the slot collimators to 5 mm. Organ profile studies 
were done using a Picker Organ Scanning Phantom. Liver, pancreas 
and spleen phantoms could be placed individually or together in the 
abdomen section. Approximately 3 mCi of 1 13 m1n was placed in each organ 
phantom, and the phantom and the perspex shell of the abdomen filled 
with water. The liver, pancreas and spleen, therefore, were immersed 
in a scattering medium. 
Profiles were recorded of liver and pancreas organ phantoms together 
and then of each individual organ phantom. The organ phantoms were 
placed in approximately the correct anatomical positions in the 
abdomen, and, in each study involving different organ phantoms, care 
w~s taken to preserve the original geometrical relationship between 
phantoms. The spleen phantom was then chosen to provide three profile 
scans of an organ containing differing amounts of radioactivity. These 
scans were performed at O hour, l hour and 2 hours. Finally, the line 
source respoese of the profile scanner was obtained using a source of 
250 µ Ci 113m1n immersed in water. 
The profile scans were corrected for decay, background radiation, 
smoothed and image restored using the methods described previously. 
The modified Gaussian function was then fitted to liver, pancreas, 
spleen and liver/ pancreas composite profiles using parametric and 
non-linear least squares fitting procedures from the Simulation, 
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Analysis and Modelling (SAAM 25) computer program of Berman and Weiss 
(1967). 
A.2.3 Results 
Table A.2.1 shows the effectiveness of the smoothing and restoration 
techniques, by comparing the object length of the organ phantoms to the 
smoothed and restored image length. The percentage difference is 
greatest with the smallest organ [ oancreas), because the techniques 
involved cannot restore completely the sharp leading edges of organ 
radioactivity. Figures A.2.l-A.2.3 show the fits obtained between 
calculated and experimental data for pancreas, spleen and liver 
phantoms and table A.2.2 lists the parameter values. It was found that 
two modified Gaussian functions were required to fit the restored liver 
profile. The fits are not perfect, but the total counts under the 
peaks for the experimental and theoretical profiles agree (table A.2.3).
 
The spleen profiles obtained with different radioactivities were fitted 
with the modified Gaussian function, and it can be seen from table 
A.2.4 that the only parameter which varies appreciably is the peak 
height. Thus, once the shape of the profile has been fitted with tae 
modified Gaussian, only the height and displacement of the peak will 
vary with radioactivity and position of the organ. 
Figure A.2.4 shows the fit of the modified Gaussian functions to the 
composite liver and pancreas profile scan .. Once the parameters for a 
particular organ are found, a combination of organ profiles can be 
fitted using the method of . weighted least squares. Using the parameter 
values found from the composite fit, the number of counts under the 
497 
TABLE A.2.1 
Comparison of object lengths and image 
restored lengths of organ phantoms 
(ll3mrn) 
ORGAN PHANTOM OBJECT LENGTH IMAGE RESTORED 
LENGTH 
(cm) (cm ) 
Pancreas 6.5 8.4 
Spleen 10.5 11.5 















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































modified Gaussian functions can be calculated. 
The radioactivity in the organ of interest can then be found from the 
calibration method of Blake and Hering (1973 ) , the calculated counts 
under the organ profile peaks and the counts under the profile of a 
standard containing a known percentage of the administered dose. If 
whole body counts are being measured concurrently with the profile 
scans, the percentage ingested dose in the organ of interest can be 
calculated from the ratio of counts in the organ profile to the counts 
in the whole body profile, multiplied by the percentage retention in 
the whole body. 
A. 3 Determination of modified Gaussian function to fit liver profile peak 
A.3.1 Introduction 
A profile peak of 203 Pb radioactivity, after subtraction of 
backgrounds, may overlap with other organ peaks. The number of counts 
under this specific peak can only be accurately found by fitting a 
number of analytical functions to the series of peaks. A suitable 
function is the modified Gaussian function described in A.2.1., and 
once the variable parameters of this function have beeri·found by fitting 
the function to 203 Pb profile peak, the area under the function will 
give the number of counts in the peak if the fit is good. 
There are radiopharmaceuticals which are preferenti ally taken up in 
the liver. A modified Gaussian function may be fitted to the profile of 
liver radioactivity, as there will be minimal interference from 
radioactivity elsewhere in the body. 
A.3.2 Materials and methods 
113min chloride was obtained by elution from a generator (TRC, 
Code: TFC 3) with 0.05 MHCl and suspended in a colloid form using 
a labelling kit (TRC, Code: N.82). l - 3 mCi of the colloid was 
injected intravenously and, after 20 minutes, gamma camera studies were 
done (section 11.4 ) on each subject to image the hepatic and splenic 
distribution of the 113mln colloid. The limits of the splenic 
distribution were marked on the skin of the abdomen. Profile scans 
were performed (section 11.5 ) , at approximately 30 minutes after 
injection, with the spleen carefully shielded with lead both 
anteriorly and posteriorly, so that the resulting profile would be due 
to liver radioactivity only. 
The profiles were corrected for background, smoothed and image 
restored. Unlike the phantom studies described in Appendix A.2 when 
two modified Gaussian functions were required to fit the profile peak 
of the liver phantom, only one function was necessary. This was 
probably caused by differences in _·the anatomical shape of the livers 
of the subjects compared with that of the 0,liver phantom, or by 
differences in the colloidal distribution compared with uniform 
distribution of 2 03 Pb in the water contained in the phantom. The 
modified Gaussian function was fitted to the profiles by parametric and 
non-linear least squares procedures (SAAM 25, 1967 ) . 
A.3.3 Results 
Figure A.3.1 shows th~ similarity of the hepatic distribution of 203 Pb 
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colloid profile for fitting purposes. The fit of the modified Gaussian 
function to the profile scan of the liver containing colloidal 113mln 
is shown in figure A.3.2 for the subject K.8. The values of the 










































































































































Parameters of modified Gaussian function fitted to 
profile due to 113 mrn colloid in liver 
Subject K.B. 
A p m n (J Smax- k Xs o 
2131 308 2 3 8.14 309 
511 
APPENDIX B 
Focussing slot collimators 
Two focussing slot collimators were fitted between the movable 
collimator blocks of the profile scanner to improve its spatial 
resolution. The collimators were designed to give the best possible 
resolution taking into account the difficulties of engineering the 
tapered slabs of lead, the detector diameters, the distance between 
detectors and collimator blocks and the foaal plane of the collimators 
that had to coincide with the midline between the faces of the 
detectors. 
Figure B.l shows the dimensions of the collimator designed to give a 
calculated focal distance at the focal plane of 24 mm. The sensitivity 
was calculated to be a factor of 4 greater than that obtained with the 
previous arrangement of collimator blocks set 20 mm apart. 
Using a line source of 
203Pb, a Full Width at Half Maximum of 21 mm was 
measured, and sensitivity was improved by a factor of 5. These 
measurements agree well with the calculated values. Figure B.2 shows 
the depth response of the two focussing collimators with the 50% 









































Width large end of taper= 10 mm 
Width small end of taper= 5.6 mm 
FOCAL PLANE 
RESOLUTION DISJANCE = 24 mm 




l 0 2 0 8 
BOTTOM COLLIMATOR 
FIGURE B.2 Variation of sensitivity between top and bottom profile 
focussing collirnators shown as isocount contours 
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APPENDIX C 
C.l Dosimetry of 203 Pb 
The decay scheme for 203 Pb was obtained from published tables (Lederer 
et al, 1968) and the calculations were based on the formulisation 
developed by Loevinger and Berman (1968). 
203Pb 











Table C.l.l shows the 'input' data for the decay of 
203 Pb and table 
C.1.2 shows the absorbed dose calculations for the whole body. For 
the total body absorbed dose, a uniform distribution .of l mCi 
203 Pb 
in the total body of a standard man (70kg) was assumed with no 
elimination of 203 Pb from the body i.e. worst possible case~ 
D (v-.. v) = cv ri¢i1U ( v ++ v) 
cv = 1.44 C Teff 
C concentration of 203 Pb 
1000 µCi/g = = 
70 000 
Teff = effective half life of 
203 Pb = physical half life= 52.l hrs . 
. D (v~v) = 1.44 X 1000 X 0.351 X 52.l 
70 000 


























































































































































































































































































































































































































































































































































































































The subjects who took part in the kinetic studies received the largest 
radiation doses and these subjects are the only ones considered in this 
section. 
The whole body radiation from 203 Pb has been calculated for standard 
man in Appendix C.l and the radiation dosi met r y for the other 
radiopharmaceuticals used are listed in t ?~le C.2.1. The r adiation 
dose received by each of the subjects is listed in table C.2.2. The 
radiation dose from 203 Pb was determined using the percentage of 
203 Pb 
absorbed calculated from model parameters and effective half life 
equal to the physical half life of 
2 0 3Pb. Although the half time of 
retention was measured in the experiments, this was only done over 
approximately 9 days, and was not used in the calculation. It is 
probable that there exists a longer half time, which has been found in 
work with animals (Barton et al, 1978). Using the measured half time of 
retention would have underestimated the dose. 
The radiation doses listed in table C.2.2. were usually received over a 
calender quarter and are well below the maximum permissible dose for a 
designated person of 3000 mrem per calender quarter (Ministry of Health, 
1964 ) . 
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TABLE C.2.1 
Whole body radiation doses from radiopharmaceuticals 
used . in kinetic studies 
RADIOPHARMACEUTICAL RADIATION DOSE 
(mrads/mCi ) 
2500 
113min Colloid 20 
l l3ffiin 17 
REFERENCE 
Wang (1969 ) 
Hine and Johnston (1970 ) 
Van der Merwe et al (1970 ) 
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TABLE C.2.2 
Whole body radiation received by subjects 









D.l SAAM 25 program 
The SAAM 25 program was run on a UNIVAC 1100 main frame computer with 
524 K words of memory and disk drives, each with a capacity of 200 
megabytes. The SAAM 25 package was originally developed for t he 
solution of linear compartmental systems, such as are encountered with 
radionuclide tracer experiments (Berman et al, .1962 b; Berman, 1965 ) . 
It is possible to treat simultaneously 25 differential equations that 
may arise as responses of a system having up to 60 parameters of which 
a maximum of 25 can be variable. 
D.2 SAAM 25 nomenclature 
A circle containing a letter or number e.g.~,~, ~ , is 
used to represent a compartment schematically and the pathway to compartment 
8 f ram compartment 8 is represented by an arrow with a direction to 
J from I. The rate constant or primary parameter for the pathway J, I 
is represented by L(J,I ) . A summer or secondary parameter, S(H,I ) , is 
an operational unit that represents a linear combination of compartments 
and is expressed mathematically by the relationship. 
Qc (H,T ) = t 1 S(H,I ) x F( I,T ) 
where Qc (H,T ) is the function describing the Summer H, 
F (I, T) the functions 'for compartment 8 , 
and Tis the independent variable. 
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When only one compartment is involved 
Qc (H,T) = S(H,I) x F(I,T ) 
and the summer can be eliminated by the use of a proportionality 
coefficient, K(I) 
Qc (H,T ) = K(I) x F(I,T) 
The value of F( I,T) at the start of solution or the initial input of 
tracer into compartment~ is IC ( I ) . 
The symbols representing all these operational entities and the 
schematic of a two compartmental model is shown in figure D.l. The 
schematic implies the following set of differential equations. 
dF(I,T) = ~L (JT I) x F(I,T) - L(0,I) x F(I,T) + L( I,J ) x F( J,T ) 
dT 
dF (J,T) = L(J,I) x F(I,T) - L(I,J) x F(J ,T ) 
dT 
~( I,0) = IC(I) 
-
These equations are implied in SAAM 25 through entries of the f ollowing 





















Value of F( I,T ) at start 
of solution (Input of tracer ) 
Primary (non-linear ) parameter 
Secondary parameter (linear ), 
summing coefficient 
Secondary (linear) parameter, 
proportionality coefficient 
Function generated from the 
F( I,T), T and other parameters. 
For a SUMMER 
Qc (J , T) = E ~(J,I) x F( I,T } 
l 
TWO COMPARTMENT MODEL 
* IC (I) 






8 S(J,I ) 
S(J,H ) 
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D.3 Methods of solution 
The implied differential equations are solved by numerical procedures, 
such as the 4th order Runge-Kutta method (Collatz, 1960), and initial 
values of parameters L(J,I) and IC(I) are required for solution. The 
calculated values of F(I,T) are then matched to the observed data 
Qo(I,T), which can be either absolute or proportional. If the observed 
data is absolute, obtained by directly 'sampling' a compartment such as 
red cells, or if the summer and proportional coefficients S(H,I ) and 
K(I) are known, the Qc (I ,T) can be calculated directly from the F(I,T ) . 
If the S(H,I) and K(I) are not known, their values may be estimated 
from the observed quantities Qo(I,T) using a least squares linear 
regression analysis (Anderson, 1958). Qc(I,T) then describes the 
theoretically calculated values resulting from the matching procedures. 
The 'goodness of fit' between Qo(I,T) .and Qc(I,T) is then tested using 
a least squares fitting procedure (Bevington, 1969) and the initial 
estimates of L(J,I), S(H,I) and K(I) are automatically adjusted until 
a least squares fit to all the data is obtained. 
The final results include values of the adjusted parameters L(J,I), 
S(H,I) and K(I) with their respective standard deviations. Both 
calculated values, Qc(I,T), and observed data, Qo(I,T) are listed with 
the ratio of Qc(I,T) / Qo(I,T), an~ the residual 9ums of squares of the 
fit of Qc(I,T) to Qo (I,T) for each compartment. 
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D.4 Simulation 
The calculation of a specified set of Qc(I,T ) , given a model and 
values for L( J , I ) , S(H,I ) and K( I ) , is referred to as simulation and 




The profile scan analysis was performed using computer programs 
written in FORTRAN Von a UNIVAC 1100 computer. Curve fitting was 
performed using SAAM 25 (1967), also on the UNIVAC 1100. All other 
calculations were performed using programs written in BASIC on a 
Tektronix 4051 computer. 








E .1. 7 
E.1.8 
E .1. 9 
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List of BASIC programs 
Calculation of retention and S.D. of retention 
Weighted linear regression of £n (retention ) against time 
Calculation of surface radioactivity results 
Interpolating program for blood and E.C.F. data 
113 m1n plasma and red cell volume determination 
8 2Br E.C.F. volume determination 
Factor to transform 1 13 min profile to 
2 0 3 Pb blood profile 
Factor to transform 82 Br profile to 2 0
3 Pb E.C.F. profile 
Factor to transform 1 13 m1n in vivo data to 
203 Pb blood 
background 
E.1.10 Factor to transform 82 Br in vivo data to 
203 Pb E.C.F. 
background 
E. l.ll Calculation of 
o, ingested dose in red cells ,o 
E.l.12 Calculation of 
o, ingested dose in plasma and E.C.F. ,a 
E.1.13 Calculation of accumulative% ingested dose in urine 
E.1.14 Area under modified Gaussian function 
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TABLE:E.1.1 
CALCULATION OF RETENTION ANO S.O. OF RETENTION 
100 REM CALCULATION OF RETENTION AND S.D. OF W.B. COUNTS 
110 DIM A(15),B(15),C(15),D(15),E(11) ,F(11),G(4),H(4) 
120 PIUNT "SUBJECT IDENTIFICATION NO.?" 
130 INPUT Z$ 
140 GO TO 790 
150 PRINT "I"; 
160 PRINT "6HR. COUNTER BACKGROUND="; 
170 INPUT Bl 
180 PIUNT "I"; 
190 PRINT "SUBJECT BACKGROUND="; 
200 INPUT P1 
210 PRINT "I"; 
220 PRINT "6HR. STANDARD COUNT="; 
230 INPUT S1 
240 PRINT "I"; 
250 PRINT " 6HR. SUBJECT COUNT="; 
260 INPUT 01 
270 A$="TIME" 
280 B$="BACKGR0UND" 
290 C$= 11 STANOAR0 11 
300 0$=" ~;UBJECT 11 
310 PRINT USING 320:A$,B$,CS,O$ 
320 IMAGE4A,13X,10A,8X,8A,10X,7A 
330 PRINT USING 340: 
340 IMAGE4("-") ,13X,10("-") ,8X,8("-") ,10X,7("-") 
350 FOR I=l TO Nl 
360 INPUT T 
370 PRINT "KI"; 
380 INPUT 82 
390 PRINT" KI /"; 
400 INPUT T2 
410 PRINT "!<II"; 
420 INPUT S2 
430 PRINT " KII / 11 ; 
440 INPUT T3 
450 PRINT "KIII fl; 
460 INPUT 02 
470 PRINT fl KIII /fl; 
480 INPUT T4 



















670 INPUT Y$ 




120 R$=" ;n. o. " 
730 :;$= 11 S.D. 11 
740 PRINT @3,32: USING 750:P$,QS,R$,S$ 
7 5 o IM AGE " J " , 11 A , 7 x , 4 A , 1 o >{ , 5 A , 1 a}< , 4 A 
760 PRINT @3,32: USING 770: 
770 IMAGE11 C "-") ,7}<,4< 11 - 11 ), 10}<,5< 11 - 11 >, 10}<,4< 11 - 11 > 
780 RETUf.:N 
790 PRINT "WHOLE BODY DATA (YORN)?" 
800 GOSUB 670 
810 GO TO YO OF 1000,820 
820 PRINT "ENTER NO. OF DATA POINTS" 
830 INPUT Nl 
840 PAGE 
850 PRINT "I", 
860 PRINT "WHOLE BODY DATA" 
870 GOSUB 150 
880 FIND 18 
890 PRINT @3,32: USING 900:2$ 
900 IMAGE40X,30A 
910 M$="FILE:18" 
920 PRINT @3,32: USING 950:MS 
930 E$="FINAL WHOLE BODY READINGS" 
940 PRINT @3,32: USING 950:ES 
950 IMAGE"J",40X,30A 
960 GOSUB 700 
970 N=25 
980 FOR I=l TO Ni 
990 PRINT @33: USING 1000:N,ACI),BCI),C(I) 
1000 IMAGE3D,9X,6D.6D,X,2CX,7D.60) 
1010 PRINT 17!3,32: USING 1020:N,ACI),BCI),CCI) 
1020 IMAGE"J" ,30,9}{,60.60,ZCX,70.60) 




WEIGHTED LINEAR REGRESSION OF LN<RETENTION) AGAINST TIME 
100 REM LINEAR REGRESSION OF WHOLE BODY DATA 
110 INIT 
120 DIM A(9),B(9),C(9),T(9) 
130 GO TO 340 
140 PRINT "JI"; 
150 PRINT "TIME" 
160 PRINT USING 170: 
170 IMAGE18X,4("-") 
180 PRINT "KKII"; 
190 PRINT";{ RETENTION" 
200 PRINT USING 210: 
210 IMAGE36}{,11("-") 
220 FOR I=l TO Ni 
230 PRINT "I"; 
240 INPUT Tl 
250 A(I)=Tl 
2 60 P IU NT II KI I 11 ; 
270 INPUT Rl 
280 B<I>=LOG<R1> 
290 PRINT "KII +-"; 
300 INPUT S1 
310 C(I)=S1/R1 
320 NEXT I 
330 RETURN 
340 PAGE 
350 PRINT "I"; 
360 PRINT "LINEAR REGRESSION OF WHOLE BODY DATA" 
370 PRINT "I"; 
380 PRINT USING 390: 
390 IMAGE36 < 11 - 11 > 
400 PfUNT "J" 
410 PRINT "SUBJECT:"; 
420 INPUT 2$ 
430 PRINT "J" 
440 PRINT "ENTER NO. OF DATA POINTS:"; 
450 INPUT Nl 







530 FOR I=l TO Nl 





















740 f.:$= 11 REGRESSION COEFF. 11 
750 S$= 11 LINEAR REGRESSION OF WHOLE BODY DATA 11 
760 PRINT USING 870:P$,Q$,R$ 
770 PRINT USING 890: 
780 PRINT USING 910:A1,D2,B1,D3,R1 
790 PRINT @3,32: USING 800:S$ 
800 IMAGE40X,60A 
810 PRINT @3,32: USING 820: 
820 IMAGE40X,48( 11 - 11 ) 
830 Y$= 11 SUBJECT:" 
835 X$= 11 NO. OF DATA POINTS= 11 
840 PRINT @3,32: USING 850:Y$,Z$ 
850 IMAGE30X, 8A,30A 
860 PRINT @J,32: USING 870:P$,Q$,R$ 
870 IMAGE"J",7X,09A,14X,5A,10X,17A 
880 PRINT @J,JZ: USING 890: 
890 IMAGE7X,09("-"),14X,5( 11 -"),10X,17( 11 - 11 ) 
900 PRINT @J,32: USING 910:A1,D2,B1,D3,R1 
910 IMAGE2<5D.4D, "+- 11 ,20.40,5){) ,50.4D 





CALCULATION OF SURFACE RADIOACTIVITY RESULTS 
100 REM SURFACE RADIOACTIVITY CALCULATIONS 
110 INIT 
120 DI 11 E < 4 ) , F < 4 ) , G < 4 ) , H < 4 > 
130 GO TO 1170 










































P$= 11 ANKLE 11 
1~$= 11 CALF 11 
R$="LIVER" 
S$= 11 SMALL BOWEL" 
RETUf.:N 
PRINT USING 300:P$,Q$,R$,S$ 
IMAGE5A,12X,4A,14X,5A,13X,11A 
PRINT USING 320: 
IMAGE5( "-" >, 12X,4< 11 - 11 >, 14X,5( 11 - 11 ), 13X, 11 ( 11 - 11 > 
RETURN 






















560 PRINT "KI /"; 
570 INPUT T4 
580 GOSUB 170 
590 GC2J=C6 
600 HC2)=C5*C6 
610 PRINT "KII"i 
620 INPUT S2 
630 PRINT "KII /"; 
640 INPUT T4 
650 GOSUB 170 
660 G(3)=C6 
670 H(3)=C5*C6 
680 PRINT "KIII"; 
690 INPUT S2 
700 PRINT "KIII /"; 
710 INPUT T4 
720 GO~;UB 170 
730 G(4)=C6 
740 H<4>=C5*C6 
750 PRINT "J" 
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760 PRINT "ENTER CORRECTION FACTOR:"; 
770 INPUT F9 
780 FOR I=l TO 4 
790 GCI>=G(I)/F9 
800 H(I>=H<I>IF9 
810 NEXT I 
820 RETURN 
830 PRINT @3,32: USING 300:P$,Q$,R$,S$ 
840 PRINT @3,32: USING 320: 
850 PRINT @3,32: USING 860:G(1>,H<1>,G<2>,H<2>,G<3>,H<3>,G<4l,H(4) 
860 IMAGE4(1D.3D,"+-",1D.JD,5X) 
870 RETURN 
880 INPUT X 
890 G < 1 > =)< 
900 PRINT "K +-"; 
910 INPUT Y 
920 H < 1) =Y 
930 PRINT "KI"; 
940 INPUT X 
950 GC2>=X 
960 PRINT "KI 
970 INPUT y 
980 HCZ>=Y 
990 PRINT "KII"; 
1000 INPUT ){ 
1010 G(3)=X 
1020 PRINT "KII 
1030 INPUT y 
1040 H(3)=Y 
1050 PRINT "KIII"; 
1060 INPUT X 
1070 GC4l=X 
1080 PRINT "KIII 






1120 FOR I=l TO 4 
1130 ECI>=GCI) 
11't0 FCI>=HCI) 
1150 NEXT I 
1160 RETURN 
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1170 PRINT "ENTER BLOOD 100% VALUES - RAW DATA (YORN>?" 
1180 GOSUB 140 
1190 GO TO YO OF 1310,1200 
1200 PAGE 
1210 PRINT "I"; 
1220 PRINT "BLOOD" 
1230 PRINT "J" 
1240 GOSUB 240 
1250 GOSUB 340 
1260 L$="100% BLOOD VALUES" 
1270 PRINT @3,32: USING 1280:L$ 
1280 IMAGE"L",40X,30A 
1290 GOSUB 830 
1300 GOSUB 1120 
1310 PRINT "ENTER CALCULATED BLOOD 100% VALUES <YORN)?" 
1320 GOSUB 140 
1330 GO TO YO OF 1390,1340 
1340 PAGE 
1350 GOSUB 240 
1360 GOSUB 290 
1370 GOSUB 880 
1380 GOSUB 1120 
1390 PRINT "ENTER E.C.F. 100% VALUES-RAW DATA <YORN)?" 
1400 GOSUB 140 
1410 GO TO YO OF 1510,1420 
1420 PAGE 
1430 PRINT "I"; 
1440 PRINT "E.C.F." 
1450 PRINT "J" 
1460 GOSUB 240 
1470 GOSUB 340 
1480 M$= 11 1oo;.: E.C.F. VALUES" 
1490 PRINT @3,32: USING 1280:M$ 
1500 GOSUB 830 
1510 PRINT "ENTER CALCULATED E.C.F. 100% VALUES <YORN>?" 
1520 GOSUB 140 
1530 GO TO YO OF 1580,1540 
1540 PAGE 
1550 GOSUB 240 
1560 GOSUB 290 
1570 GOSUB 880 
1580 REM INPUT NEXT FILE 
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100 REM SURFACE RADIOACTIVITY CALCULATIONS FOR ORGANS 
110 DIM A(5),B(5),C(5) 
120 GO TO 1080 
130 PRINT ""; 
140 PRINT "TIME="; 
150 INPUT T 
160 PRINT "JI"; 
170 PRINT "BACKGROUND="; 
180 INPUT B1 
190 PIUNT "KI 
200 INPUT T2 
210 PIUNT "I 
220 INPUT 82 
230 B1=B2+B1 




250 PRINT "";A$;" BACKGROUND/COUNTER BACKGROUND="; 
260 INPUT Rl 
270 PRINT "I( 
280 INPUT R3 
290 PRINT "J" 
300 PRINT "";B$;"BACKGROUND/COUNTER BACKGROUND="; 
310 INPUT RZ 
320 PRINT "K 
330 INPUT R4 
340 PRINT "JI"; 
350 PRINT "STANDARD="; 
360 INPUT S1 
370 PRINT "KI 
380 INPUT T3 
390 PRINT "I 
400 INPUT S3 
410 S1=S3+S1 
420 PRINT "J" 
430 RETURN 
II' , 
440 PRINT USING 450:A$,8$ 
450 IMAGE 5A,12X, 7A 
460 PRINT USING 470: 
/ II ; 









560 INPUT Y:$ 
570 YO=P0SC"NY" , Y$,1) 
580 RETURN 
590 INPUT S2 
+-II; 
+- II j 
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600 PRINT "K / II ; 
610 INPUT T4 




660 GOSUB 490 
670 RETURN 
680 PRINT "!(KI II; 
690 INPUT sz 
700 PRINT II KI / II ; 
710 INPUT T4 
720 PRINT It I II ; 








810 Q$= II s. D. II 
820 PRINT USING 8JO:P$,Q$ 
830 IMAGE17X,5A,13X,4A 
840 PRINT "BLOOD: "; 
850 PRINT II I"; 
860 INPUT }{ 1 
870 PRINT "KII"; 
880 INPUT Zl 
890 PRINT "E.C.F: "; 
900 PRINT II I"; 
910 INPUT X2 
920 PRINT "KII"; 
930 INPUT 22 




980 IF I=Z THEN 1040 
990 IF I=J THEN 1040 




1040 PRINT @JJ: USING 1050:N,ACI>,B<I >,C<I > 
1050 IMAGE30,9X,60.60,2C70.60) 
1060 NEXT I 
1070 RETURN 
1080 PRINT "ENTER NO. OF DATA POINTS" 
1090 INPUT Nl 
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1100 PRINT "ENTER %I.D.IN STANDARD" 
1110 INPUTS 
1120 N=17 
1130 FIND 17 
1140 FOR J=l TO Nl 
1150 PRINT "ENTER ANKLE AND CALF DATA (YORN)?" 
1160 GOSUB 560 
1170 GO TO YO OF 1340,1180 
1180 PAGE 
1190 PRINT "I"; 
1200 PRINT "ANKLE ANO CALF DATA " 
1210 PRINT "J" 
1220 A$="ANKLE" 
1230 B$="CALF" 
1240 GOSUB 130 
1250 GOSUB 440 
1260 GOSUB 590 
1270 A<l>=T 
1280 B< 1>=C6 
1290 C(1)=C5*C6 




1340 PRINT "ENTER LIVER AND SMALL BOWEL DATA (YORN)?" 
1350 GOSUB 560 
1360 GO TO YO OF 1560,1370 
1370 PAGE 
1380 PRINT "I"; 
1390 PIUNT "LIVER AND SMALL BOWEL DATA AT T=";T;"HRS" 
1400 PRINT "J" 
1410 A$="LIVER" 
1420 B$="S.80WEL" 
1430 GOSUB 130 
1440 GOSUB 440 








1530 PRINT "J" 
1540 GOSUB 800 
1550 NEXT J 
1560 END 
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INTERPOLATING PROGRAM FOR BLOOD AND E.C.F. DATA 
100 REM INTERPOLATION OF BLOOD AND E.C.F. PLOTS USING DIGITISER 
110 INIT 
120 PAGE 
130 DIM AC15),BC15) 
140 PRINT "SUBJECT IDENTIFICATION NO." 
150 INPUT Z$ 
160 PRINT "ENTER COMPARTMENT" 
170 INPUT 8$ 
180 PIUNT "ENTEF.: COMPA!s:TMENT NO." 
190 INPUT N 
200 Pf.:INT "JJENTER Ff.:OM DIGITH':EF.:: ", "J" 
210 PRINT "ORIGIN" 
220 GOSUB 950 
230 IF X=-1 THEN 220 
240 PRINT 11 KI 11 ,X,Y, 11 G" 
250 LET }{ 1 =X 
260 LET Y1=Y 
270 GOSUB 950 
280 IF X=-1 THEN 300 
290 GO TO 270 
300 PRINT 11 MAX-XAXIS 11 
310 GOSUB 95fJ 
320 IF X=-1 THEN 310 
330 PRINT 11 KI",}<,Y, 11 G 11 
340 LET X2=}( 
350 LET YZ=Y 
360 GOSUB 950 
370 IF X=-1 THEN 390 
380 GO TO 360 
390 PRINT "MA}<-YAXI :3" 
400 GOSUB 950 
















IF X=-1 THEN 









FROM KEYBOAf.:D: II 
II • , 
II' , 
542 PRINT "ENTER NEWT VALUES <YORN>?" 
544 INPUT L$ 
546 LO=P0S("NY",L$,1) 
548 GO TO LO OF 620,550 
550 PRINT "ENTER NO. OF DATA POINTS" 
560 INPUT Nl 
570 F'fUNT "ENTER T VALUE::;" 
580 FOR I=l TO Nl 
590 INPUT T 
600 A(I)=INT(T/Cl+0.51 
610 NEXT I 
539 
620 PRINT ''JJ-----------NOW DIGITISE COORDINATEs------------J" 
630 I=l 
640 INPUT @2,32:X,Y 




690 IF X7 <>A<I> THEN 640 
700 A<Il=}{7 
710 B<Il=Y6 
720 PRINT "GGGG" 
730 IF X7=A(N11 THEN 760 
740 I=I+l 
750 GO TO 640 
760 P$= 11 COMF'ARTMENT 11 
770 1J$="TIME 11 
780 ":$="%A.O." 
790 S$= 11 S.D. 11 
800 F'RINT @3,32:"L" 
810 PRINT @3,32:ZS 
820 PRINT @3,32:"J" 
830 PRINT @3,32:"INTERPOLATED ";B$;" VALUES" 
840 PRINT @3,32: USING 850:P$,Q$,R$,S$ 
850 IMAGE"J",11A,7X,4A,10X,5A,10X,4A 
8~0 PRINT @3,32: USING 870: 
870 IMAGE11 < 11 - 11 I, 7X, 4< 11 - 11 I, 10>{,5< "-" >, 10)<, 4< "-" > 
880 FOR I=l TO Ni 
890 A<I>=A(I)*C1 
900 B<I>=B<I1*C2 
910 PRINT @3,32: USING 920:N,A<I>,B<I> 
920 IMAGE 11 J 11 ,30,1D){,60.2D,5X,70.2D 
925 A<I>=INT<A<II/C1+0.5) 
930 NEXT I 
940 END 
950 FOR I=l TO 5 
960 INPUT @2,32:X,Y 
























REM IN-113M PLASMA AND RED CELL VOLUME DETERMINATION 
INIT 
DIM A(3) ,B(3) ,C(3) ,T(3) 
GO TO 560 
PIUNT "JI"; 
PRINT "%A.O. IN STANDARD="; 
INPUTS 
A$= 11 TIME 11 
P~'. INT "JI"; 









D$= 11 SAMPLE 11 
290 PRINT "J" 
300 PRINT USING 310:A$,D$ 
310 IMAGE4A,13X, 6A 
320 PRINT USING 330: 
330 IMAGE4("-"),13}<, 6( 11 - 11 ) 
340 FOR I=1 TO N1 
350 INPUT Tl 
360 PRINT "!( I"; 
370 INPUT S2 
380 PRINT II KI / 11 ; 
390 INPUT T4 








/ II 7 






530 INPUT Y$ 
540 YO=P0S( 11 NY 11 ,Y$,l) 
550 RETURN 
560 PAGE 
570 PRINT "I"; 
580 PRINT "IN-113M PLASMA AND RED CELL VOLUME DETERMINATION" 
590 PRINT "I"; 
600 PRINT USING 610: 
610 IMAGE48("-") 
620 PIUNT "J" 
630 PRINT "SUBJECT?" 
640 INPUT 2$ 
541 
650 PRINT "ENTER HAEMATOCRIT (%)" 
660 INPUT H1 
665 Hl=Hl*0.9*0.97 
670 PRINT "ENTER NO. OF PLASMA SAMPLES" 
680 INPUT Nl 
690 PRINT "ENTER SAMPLE VOLUMES" 
700 PRINT "J" 
710 FOR I=l TO Nl 
720 PRINT "SAMPLE#";!;"="; 
730 INPUT X 
740 TCI)=){ 
750 NEXT I 
760 PRINT "I"; 
770 PRINT "IN-113M PLASMA READINGS" 







850 FOR I=1 TO Ni 
860 )<l=A <I) 
870 Yl=B<I) 


















1060 R$="REGRESSI0N COEFF." 
1070 S$="IN-113M PLASMA AND RED CELL VOLUME DETERMINATION" 
1080 PRINT USING 1190:P$,Q$,R$ 
542 
1090 PRINT USING 1210: 
1100 PRINT USING 1230:A1,02,B1,D3,R1 
1110 PRINT @3,32: USING 1120:S$ 
1120 IMAGE40X,60A 
1130 PRINT @3,32: USING 1140: 
1140 IMAGE40X,48("-") 
1150 Y$= 11 SUBJECT: 11 
1160 PRINT @3,32: USING 1170:YS,ZS 
1170 IMAGE30X, 8A,30A 
1180 PRINT @3,32: USING 1190:PS,Q$,R$ 
1190 IMAGE"J",7X,09A,14X,5A,10X,17A 
1200 PRINT @3,32: USING 1210: 
1210 IMAGE7X,09("-"),14X,5("-"),10X,17("-") 














1360 H$="EQUIVALENT ALBUMIN PLASMA VOLUMECML)" 
1370 !$="EQUIVALENT ALBUMIN RED CELL VOLUME<ML)" 
1380 JS="EQUIVALENT ALBUMIN TOTP1L BLOOD VOLUME C ML)" 
1390 IMAGE10X,3(50.4D,"+-",2D.4D,20X) 
1400 IMAGE 11 J II , 7}<, 33A, 2}<, 36A, 2}{, 38A 
1410 IMAGE7}{,33( 11 - 11 ) ,2}{,36( 11 - 11 )·,ZX,36( 11 - 11 ) 
1420 PRINT @3,32: USING 1400:H$,IS,J$ 
1430 PRINT @3,32: USING 1410: 




BR-82 E.C.F. VOLUME DETERMINATION 
100 REM BR-82 E.C.F. VOLUME DETERMINATION 
110 DIM 8(3),C(3),T(3) 
120 GO TO 660 
130 PRINT "I"; 
140 PRINT "BLOOD COUNTS" 
150 PRINT "JI"; 
160 PRINT "~I.D. IN STANDARD="; 
170 INPUTS 
180 PRINT "JI"; 
190 PRINT "BACKGROUND="; 
200 INPUT Bl 
210 PRINT "KI /"; 
220 INPUT T2 
230 PRINT "JI"; 
240 PRINT "STANDARD="; 
250 INPUT S1 
260 PRINT "KI /"; 
270 INPUT T3 
280 A$="PLASMA COUNTS" 
290 8$= 11 RED CELL COUNTS" 
300 C$="URINE COUNTS" 
310 PRINT "J" 
320 PRINT USING 330:A$,B$,C$ 
330 IMAGE13A,4X,15A,4X,12A 
340 PRINT USING 350: 
350 IMAGE13("-"), 4}(,15("-"),4X,12("-"l 
360 FOR I=l TO 3 
370 IF I=l THEN 520 
380 IF I=2 THEN 560 
390 IF I=3 THEN 610 
400 GOSUB 450 
410 8(I)=C6/T(I> 
420 C(Il=C5/T(Il 









520 INPUT S2 
530 PRINT "K /"; 
540 INPUT T4 
550 GO TO 400 
560 PRINT "KI"; 
570 INPUT SZ 
580 PRINT "KI /"; 
590 INPUT T4 
GO TO 400 
PRINT II KII II; 
INPUT c·~ ._., 
PRINT "KII / II ; 
INPUT T4 
GO TO 400 
PAGE 












PRINT "BR-82 E. C. F. 
PRINT II I II ; 
PRINT USING 710: 
710 IMAGE32C"-") 
720 PRINT "SUBJECT:"; 
730 INPUT Z$ 
740 PRINT "J" 
544 
VOLUME DETERMINATION" 
750 PRINT "ENTER VOLUME OF PLASMA SAMPLE(ML):"; 
760 INPUT }< 
770 T(1)=X 
780 PRINT "J" 
790 PRINT "ENTER VOLUME OF RED CELL SAMPLE<ML):"; 
800 INPUT X 
810 TC2)=X 
820 PRINT "J" 
830 PRINT "ENTER VOLUME OF URINE SAMPLE(ML):"; 
840 INPUT }< 
850 T(3)=X 
860 PRINT "J" 
870 PRINT "ENTER TOTAL PLASMA VOLUME<ML):"; 
880 INPUT Vi 
890 PRINT "K +-"; 
900 INPUT V6 
910 PRINT "J" 
920 PRINT "ENTER TOTAL RED CELL VOLUME<ML):"; 
930 INPUT V2 
940 PRINT "K +-"; 
950 INPUT VS 
960 PRINT "J" 
970 PRINT "ENTER TOTAL URINE VOLUME(ML):"; 
980 INPUT V3 
990 PAGE 
1000 GOSUB 130 
1010 V4=<100-B<3>*V3-B(2)*V2)/B(1)*0.93*0.977 
1020 C8=0.93*0.977*(V3*C(3)*B(3)+V2*C(2)*B(2)+8(2)*V5)/8(1)+V4*C(1) 
1030 PRINT "JJJ" 
1040 0$="BR-82 EXTRACELLULAR VOLUME<ML>" 
1050 PRINT USING 1060:0$ 
1060 IMAGE20X,30A 
1070 PRINT USING 1080: 
1080 IMAGEZOX,30<"-"> 
1090 PRINT USING 1100:V4,C8 
545 
1100 IMAGE30X,5D.2D,"+-",2D.2D 
1110 PRINT "JJ"; 
1120 PRINT "%I.0./ML PLASMA" 
1130 PRINT "KI"; 
1140 PRINT "%I.0./ML RED CELLS" 
1150 PRINT "KII"; 
1160 PRINT "%I.D./ML URINE" 
1170 PRINT USING 1180:8(1) ,CClJ 
1180 IMAGE"J",3D.3D,"+-",3D.3D 
1190 PRINT USING 1200:8(2) ,C(2) 
1200 IMAGE"KI",30.30,"+-",30.30 





FACTOR TO TRANSFORM IN-113M PROFILE TO PB-203 BLOOD PROFILE 
100 REM CALCULATION OF FACTOR TO SUBTRACT BLOOD 
110 REM BACKGROUND FROM PROFILE SCANS 
120 PAGE 
130 PRINT ''CALCULATION OF FACTOR FOR PROFILE BLOOD BKGD. SUBTRACTION" 
140 PRINT USING 150: 
150 IMAGE57("-") 
160 INIT 
170 DIM A<30),e.(30),C(30),D(30) 
180 PRINT "J" 
190 PIUNT "ENTEF.: SUBJECT IDENTIFICATION:"; 
200 INPUT Z$ 
210 PF.:INT 11 J 11 
220 PRINT "ENTER PB-203/IN-113M RESPONSE FACTOR:
11
; 
230 INPUT C9 
240 PRINT 11 J 11 
250 PRINT "ENTER PB-203 ACTIVITY(MCI):"; 
260 INPUT R9 
270 PRINT 11 J 11 
280 PF.:INT "ENTER IN-113M ACTIVITY(MCI): "; 
290 INPUT R8 
300 PIUNT "J" 
310 Pf.:INT "ENTEF.: DECAY TIME OF IN-113M PF.:OFILE<FRACTIONAL Hf.:S): "; 
320 INPUT T8 
330 PIUNT "J" 
340 PRINT "ENTER i!l.D. WHOLE BODY AT T=6.0HRS:"; 
350 INPUT W9 
360 PRINT "J" 
370 PRINT "ENTER NO. OF DATA POINTS:"; 
380 INPUT Nl 
390 A$= 11 TIME 11 
400 B$="IN-113M BACKGROUND FACTOR=" 
410 C$="%A.D.BL00D" 
420 D$="STANDARD COUNTS" 
430 E$="IN-113M PROFILE* FACTOR" 
440 C8=R9*EXP<0.378*T8)/(C9*R8) 
450 PAGE 
460 PRINT USING 470:A$,C$,D$ 
470 IMAGE4A,14X,10A,14X,15A 
480 PRINT USING 490: 
490 IMAGE4("-"),14~{,10("-"),14X,15("- 11 ) 
500 FOR I=l TO Nl 
510 INPUT Tl 
520 A(I)=Tl 
530 PRINT "IK"; 
540 INPUT Bl 
550 B<I>=Bl 
560 PRINT "IIK 




600 NE)<T I 
610 PRINT @3,32: USING 620: 
620 IMAGE"L" 
547 
630 PRINT @3,32: USING 640:2$ 
640 IMAGE30X,40A 
650 PRINT @3,32: USING 660: 
660 IMAGE"J" 
670 PRINT @3,32: USING 680:B$,C8 
680 IMAGE18X,26A,3D.3D 
690 PRINT @3,32: USING 700: 
700 IMAGE"J" 
710 PRINT @3,32: USING 720:A$,E$ 
720 IMAGE18X,4A,10X,24A 
730 PRINT @3,32: USING 740: 
740 IMAGE18}{,4("-"),10X,24("-" ) 
750 FOR I=1 TO Nl 
760 PRINT @3,32: USING 770:A(I),O(I I 
770 IMAGE18X,3D.3D,22X,2D.4D 




FACTOR TO TRANSFORM BR-82 PROFILE TO PB-203 E.C.F PROFILE 
100 REM CALC. OF CORRECTION FACTORS FOR SUBTRACTION 
110 REM OF I SOFT TISSUE' E.C.F. BACKGROUND PROFILE SCANS 
120 PAGE 
130 PRINT "CALCULATION OF FACTOR FOR PROFILE E.C.F. BKGD. SUB." 
140 PRINT USING 150: 
150 IMAGE55("-") 
160 INIT 
170 DIM A(30) ,8(30) ,C:(30) ,0(30) 
180 PRINT ":::IJBJECT IDENTIFICATION:"; 
190 INPUT Z$ 
200 PfUNT "ENTER PLA:::MA VOLUME(Ml):"; 
210 INPUT Vl 
























BR-82 %.I.0,/ML IN PLASMA:"; 
PRINT "ENTER 300 BR-82 %I.0,/ML IN RED CELLS:"; 
310 INPUT R9 
PIUNT "ENTER 320 BR-82 %1.D./ML IN URINE:"; 
330 INPUT U9 
PfUNT II ENTEi<: 340 PB-203 ACTIVITY(MCI):"; 
350 INPUT A9 
PRINT "ENTER 360 BR-82 ACTIVITY(MCI):"; 
370 INPUT A8 
Pf.:INT II ENTEi<: 380 BLOOD BACKGROUND FACTOR FOR IN-113M:"; 
390 INPUT F9 
PRINT II ENTEi<: 400 PB-203/BR-82 RESPONSE FACTOR:"; 
410 INPUT F8 
PfUNT "ENTER 420 i:I. D. WHOLE BODY AT T=6. OOHR:3. : "; 
430 INPUT W9 












540 B$="%1.D. SOFT TISSUE E.C.F." 
550 C$= 11 STANDARD COUNTS" 
560 D$="BR-82 PROFILE*FACTOR" 
570 E$="FACTOR*IN-113M PROFILE FOR BR-82 SUBTR.=
11 
580 PRINT USING 590:A$,B$,C$ 
590 IMAGE4A,14X,24A,X,15A 
549 
600 PRINT USING 610: 
61 0 IM I~ GE 4 < 11 - 11 ) , 1 4 }< , 2 Lt < 11 - JI ) , 5 ){ , 15 ( 11 - JI l 
620 FOR I=l TO N9 
630 INPUT Tl 
640 A<Il=Tl 
650 PRINT II IK JI; 
660 INPUT Bl 
670 B(I)=Bl 
680 PRINT 11 IIt( 
690 INPUT S1 




720 NE}<T I 
730 PRINT @3,32: USING 740: 
740 IMAGEJIL 11 
750 PRINT @3,32: USING 760:ZS 
760 IMAGE30X,40A 
770 PRINT @3,32: USING 780: 
780 IMAGE 11 J" 
790 PRINT @3,32: USING 800:E$,C9 
800 IMAGE18X,40A,3D.3D 
810 PRINT @3,32: USING 820: 
820 IMAGE"J" 
830 PRINT @3,32: USING 840:A$,D$ 
840 IMAGE18X,4A,18~,24A 
850 PRINT @3,32: USING 860: 
860 IMAGE18)<,4("-") ,10}{,20( 11 - 11 ) 
870 FOR I=1 TO N9 
880 PRINT @3,32: USING 890:A(I) ,D<Il 
890 IMAGE17X,3D.2D,15X,2D.4D 




FACTOR TO TRANSFORM IN-113M IN VIVO DATA TO PB-203 BLOOD BKGa 
100 REM DETERMINATION OF PB-203 100% VALUES IN BLOOD 
110 INIT 
120 DIM GC4),HC4),TC4),S(4),Q(4),P(4) 
130 GO TO 900 






200 C6=C1 /C:2* ::;8 
210 RETURN 
220 P$= 11 ANKLE 11 
230 Q$= 11 CALF 11 
240 R$= 11 LIVEf.: 11 
250 S$= 11 SMALL BOWEL" 
260 F.:ETUf.:N 






























PRINT USING 300: 
IM AGE 5 ( " - 11 ) , 12 ){ , 4 < 11 - " ) , 14 X , 5 < " - " ) , 13 ){ , 11 < " - 11 > 
RETURN 
PRINT "%A.O. IN STANDARD:"; 
INPUT S8 
PRINT "J" 
PRINT II BACKGROUND: II ; 
INPUT Bl 















PRINT "l(I II; 
INPUT S2 
PRINT "KI /"; 
INPUT T4 
560 GOSUB 150 
570 G<Z>=C6 
580 H<2)=C5*C6 
590 PRINT "KII"; 
600 INPUT S2 
610 PRINT "KII /"; 
620 INPUT T4 
630 GOSUB 150 
640 GC3)=C6 
650 H(3)=C511-C6 
660 PRINT "KIII"; 
670 INPUT S2 
680 PRINT "KIII /"; 
690 INPUT T4 
700 GOSUB 150 
710 G(4)=C6 
H(4)=C5*C6 






















PRINT "ENTER CORRECTION FACTOR:"; 
INPUT F9 
PRINT "K +-"; 
INPUT F8 







PRINT @3,32: USING 280:P$,Q$,R$,S$ 
PRINT @3,32: USING JOO: 
PRINT @3,32: USING 88Q:G(1),H(1),GC2),HC2),G(3),HC3),G(4),H(4) 
IMAGE4( 10.30, "+-" ,1D.3D,5}{) 
f.:ETUf.:N 
PAGE 
PRINT II DETERMINATION OF IN-113M POINT COUNT ~A.O." 
920 PRINT USING 930: 
930 IMAGE11X,42C"-") 
940 PRINT "J" 
950 PRINT "ENTER SLOPE OF IN-113M CLEARANCE:"; 
960 INPUT S9 
970 PRINT "K +-"; 
980 INPUT S7 
990 Pf.:INT "J" 
1000 PRINT "ENTER IN-11JM INJECTION TIMECFRACTIONAL HRS.):"; 
1010 INPUT T9 
1020 Pf.:INT "J" 
1030 PIUNT 11 
1040 PRINT USING 1050: 
1050 IMAGEZOX,36("-") 
1060 PRINT "J" 
1070 PRINT "STANDARD:"; 
1080 INPUT TB 
1090 PRINT "J" 
TIME OF MEASUREMENTCFRACTIONAL HRS.)" 
1100 GOSIJB 220 
1110 GO~;UB 270 
1120 INPUT T7 
1130 PRINT "f<I"; 
11't0 INPUT T6 
1150 PRINT "KII"; 
1160 INPUT T5 
1170 PRINT "KIII"; 










1280 PRINT "I"; 
1290 PRINT "POINT COUNTS" 
1300 PRINT "J" 
1310 GO~;LJB 220 
1320 GOSUB 320 
552 
1330 L$="100;-: BLOOD VALUES<IN-113M)" 
1340 PRINT @3,32: USING 1350:L$ 
1350 IMAGE"L",40)<,45A 




FACTOR TO TRANSFORM BR-82 IN VIVO DATA TO PB-203 E.C.F. BKGO 
100 REM DETERMINATION OF PB-203 100% VALUES IN E.C.F. 
110 DIM EC4) ,FC4) ,GC4) ,HC4) ,BCJ) ,CCJ) ,A(4) ,KC4) ,0(4) ,LC4l 




160 S$="SMALL BOWEL" 
170 RETURN 
180 PRINT USING 190:P$,Q$,R$,S$ 
190 IMAGE5A,12X,4A,14X,5A,13X,11A 
200 PRINT USING 210: 
210 IMAGE5("-"l,12>(,4C"-"),14X,5("-"),13X,11("-") 
220 RETURN 
230 INPUT X 
24D G< U=>( 
250 PRINT "K +-"; 
260 INPUT Y 
270 HC1)=Y 
280 PRINT "KI"; 
290 INPUT X 
JOO GC2)=}< 
310 PRINT "KI +-"; 
320 INPUT Y 
330 HC2)=Y 
340 PRINT "KII"; 
350 INPUT X 
360 GC3)=}< 
370 PRINT "KII +-"; 
380 INPUT Y 
390 H(3)=Y 
400 PRINT "KIII"; 
410 INPUT X 
420 GC4l=}< 
430 PRINT "KIII +-"; 
440 INPUT Y 
450 HC4)=Y 
460 RETURN 
470 FOR I=1 TO 4 
480 E<I>=G<Il 
490 FCI)=HCI) 
500 NEXT I 
510 RETURN 
520 PAGE 
530 PRINT "I"; 
540 PRINT "PB-203 100~ BLOOD VALUES" 
550 PRINT USING 560: 
560 IMAGE18X,20C"-"l 
570 PRINT "J" 
580 GOSUB 130 
590 GOSUB 180 
600 GO :WB 230 
610 GOSUB 470 
620 PAGE 
630 PFUNT " I "; 
640 PRINT "BF.:-82 FACTOF.:::;" 
650 PRINT USING 660: 
660 IMAGE18X,13("-") 
670 PRINT 11 J 11 
554 
680 PF.:INT "ENTER Bt.:-82 COF.:RECTION FACT OF.: FOF.: ANKLE:"; 
690 INPUT F9 
700 0(1)=F9 
710 PRINT "K +-"; 
720 INPUT F5 
730 L(1)=F5 
740 PRINT "J" 
750 PRINT "ENTER 
760 INPUT F8 
770 0(2)=F8 
780 PRINT "K 
790 INPUT F4 
800 L<2)=F4 
810 PRINT "J" 
820 PRINT "ENTER 
830 INPUT F7 
840 D<3>=F7 
850 PRINT "K 
860 INPUT F3 
870 L(3)=F3 
880 PRINT "J" 
890 PRINT "ENTER 
900 INPUT F6 
910 D<4>=F6 
BR-82 CORRECTION FACTOR FOR CALF "II" . ' 
BR-82 CORRECTION FACTOR FOR LIVER:"; 
BR-82 CORRECTION FACTOR FORS.BOWEL:"; 
+-It; 
+-II; 
920 PRINT "K +-"; 
930 INPUT F2 
940 L<4>=F2 
950 PAGE 
960 PRINT "I"; 
970 PRINT "BLOOD VOLUMES" 
980 PRINT USING 990: 
990 IMAGE18}{,13( 11 - 11 ) 
1000 PIUNT "J" 
1010 PRINT "ENTER TOTAL PLASMA VOLUME<ML):"; 
1020 INPUT Vl 
1030 PRINT "K +-"; 
1040 INPUT V6 
1050 PIUNT "J" 
1060 PIUNT "ENTEF.: TOTAL RED CELL VOLUHE(ML): "; 
1070 INPUT V2 
1080 PRINT "K +-"; 
1090 INPUT V5 
555 
1100 PRINT "J" 
1110 PRINT "ENTEfs: TOTAL UIUNE VOLUME<ML):"; 
1120 INPUT V7 
100 PAGE 









200 G!$= "CALF" 
210 R$="LIVER" 
220 ::;$="::;MALL BOWEL" 
230 RETURN 
240 PRINT USING 250:P$,Q$,R$,S$ 
250 IMAGE5A,12X,4A,14X,5A,13X,11A 
260 PRINT USING 270: 
270 IMAGE5("-"),12X,4("-"),14X,5("-"),13>{,11("-") 
280 RETURN 
290 PRINT "%I.D. IN STANDARD:"; 
300 INPUTS 
310 PF.:INT "J" 
320 PRINT "BACKGROUND:"; 
330 INPUT B1 
340 PRINT "K /"; 
350 INPUT T2 
360 PRINT "J" 
370 PRINT "STANDARD:"; 
380 INPUT ::;1 
390 PRINT "K / 11 ; 
400 INPUT T3 










c-r, ._, a:.. 
"K 
T4 
460 GOSUB 120 
470 G(1)=C6 
480 H<l>=C6*C5 
490 PF.:INT "KI"; 
500 INPUT S2 
I"; 
510 PRINT "KI /"; 
520 INPUT T4 
530 GOSUB 120 
540 G(2)=C6 
550 H(2)=C6*C5 
560 PRINT "KII"; 
570 INPUT S2 
580 PRINT "KII / 11 ; 
590 INPUT T4 
600 GO::;UB 120 
610 G(3)=C6 
620 H(3)=C6-II-C5 
630 PRINT "KIII"; 
640 INPUT S2 
650 PRINT "KIII /"; 
660 INPUT T4 





710 PRINT @3,32: USING 250:P$,Q$,R$,S$ 
720 PRINT @3,32: USING 270: 
730 PRINT li!3,J2: U::;ING 740:G(1),H(1),G(2),H(2),G(3),H(3),G(4),H(4) 
740 IMAGE4(1D.3D,"+-",1D.J0,5;{) 
750 f.:ETUF.:N 
760 PRINT "I"; 
770 PRINT "BR-82 SURFACE RADIOACTIVITY" 
780 PRINT USING 790: 
790 IMAGE18>(, 18< "-") 
800 PRINT " J" 
810 Pf.:INT "ENTER BF.:-82 ;-:I.D,/ML PLA::;MA:"; 
820 INPUT ){ 1 
830 PF.:INT "K +-"; 
840 INPUT )-{2 
850 8(1)=),(1 
860 C:(1)=){2 
870 PRINT "J" 
880 PRINT "ENTER BR-82 %I.D./ML RED CELLS:"; 
890 INPUT Yl 
900 PRINT "K +-"; 
910 INPUT Y2 
920 8(2)=Y1 
930 C(2)=Y2 
940 PRINT "J" 
950 PRINT "ENTER BF.:-82 ;-:I.D./ML URINE:"; 
960 INPUT Zl 
970 PRINT "K +-"; 
980 INPUT Z2 
990 8(3)=Z1*V7 
1000 C<3)=Z2*V7 
1010 PIUNT "I"; 
1020 PRINT "J" 
1030 GO~;LJB 190 
1040 GOSUB 290 
1050 B1=B(1)*V1+B(2)*V2 
1060 B2=8(1)*V1*C(1)+B(2)*VZ*C(2)+8(1)*V6+B(2)*V5 














1200 NEXT I 
1210 M$="100% E.C.F. VALUES" 
1220 PRINT @3,32: USING 1230:MS 
1230 IMAGE18X,18A 
1240 PRINT "J" 
1250 GO!:;LJB 71 D 
1260 END 
558 
TABLE: E .1. 11 
CALCULATION OF %INGESTED DOSE IN RED CELLS 
100 REM CALCULATION OF %I.D. IN RED CELLS 
110 DIM A(15) ,8(15) ,C(15) ,0(15) ,E(11) ,F(11) ,G<4> ,H<4> 
120 PRINT "SUBJECT IDENTIFICATION NO. ? " 
130 INPUT Z$ 
140 GO TO 630 
150 PRINT "I"; 






220 PRINT USING 230:AS,B$,C$,D$ 
230 IMAGE4A,13X,10A,8X,8A,10X,6A 
240 PRINT USING 250: 
250 IMAGE4("-"),13X,10("-"),8X,8("-"),10X,6("-"> 
260 FOR I=1 TO N1 
270 INPUT Tl 
280 PRINT "KI"; 
290 INPUT B1 
300 PRINT" KI /"; 
310 INPUT T2 
320 PRINT "KII"; 
330 INPUT S1 
340 PRINT" KI! /"; 
350 INPUT T3 
360 PRINT "KIII"i 
370 INPUT S2 
380 PRINT" KIII /"; 
390 INPUT T4 















sso R$=" ;n . o. " 
560 SS="S.0. 11 
570 PRINT @3,32: USING 580:P$,Q$,R$,S$ 
580 IMAGE"J",11A,7X,4A,10X , 5A,10X,4A 
590 PRINT @3,32: USING 600: 
559 
600 IMAGE11 ( "-"), 7)<,4( "-"), 10){,5( "-"), 10X,4( "-") 
610 f.:ETURN 
620 NE)<T I 
630 PAGE 
640 PRINT "ENTER NO. OF DATA POINTS" 
650 INPUT Ni 
660 PRINT "ENTER RED CELL SAMPLE VOLUMECML)" 
670 INPUT V5 
680 PRINT "ENTER TOTAL f.:EO CELL VOLUME (ML):"; 
690 INPUT V6 
700 PRINT "K +-"; 
710 INPUT V7 
720 PAGE 
730 PRINT "I"; 
740 PRINT "RED CELL DATA" 
750 GOSUB 150 
760 FIND 15 
770 PRINT t~J,32:"L" 
780 PRINT @3,32: USING 790:Z$ 
790 IMAGE40X,30A 
800 M$="FILE:15" 
810 PRINT @3,32: USING 840:M$ 
820 J$="FINAL RED CELL READINGS" 
830 PRINT @3,32: USING 840:J$ 
840 It1AGE"J",40X,30A 
850 GOSUB 530 
860 N=13 
870 FOR I=1 TO Nl 
880 B<I>=B<I>*V6/V5 
890 C<I>=B<I>*<C<I>+2+<V7/V6)+2)+0.5 
900 PIUNT @33: USING 910:N,A(I),B(I),C(I) 
910 IMAGE3D,9X,6D.60,2(X,70.60) 
920 PRINT @3,32: USING 930:N,A<I>,B<I>,C(I) 
930 IMAGE"J" ,30,9)<,6D.6D,2CX,70.6D> 




CALCULATION OF %INGESTED DOSE IN PLASMA AND E.C.F. 
100 REM CALCULATION OF %I.D.IN PLASMA AND E.C.F. 
110 DIM AC 15) ,BC 15) ,CC 15) ,DC 15) ,EC 11> ,F( 11> ,G(4) ,H(4) 
120 PRINT "SUBJECT IDENTIFICATION NO. ?" 
130 INPUT Z$ 
140 GO TO 630 
150 PRINT "I"; 






220 PRINT USING 230:A$,B$,C$,D$ 
230 IMAGE4A,13X,10A,8X,8A,10X,6A 
240 PRINT USING 250: 
250 IMAGE4<"-"l,13X,10("-"),8X,8("-"),1DX,6<"-") 
260 FOR I=l TO Nl 
270 INPUT Tl 
280 PRINT "KI"; 
290 INPUT Bl 
300 PRINT" KI /"; 
310 INPUT T2 
320 PRINT "KII"; 
330 INPUT Si 
340 PRINT " KII /"; 
350 INPUT T3 
360 PRINT "KIII"; 
370 INPUT S2 
380 PRINT" KIII /"; 
390 INPUT T4 

















570 PRINT @3,32: USING 580:P$,Q$,R$,S$ 
580 IMAGE"J",11A,7X,4A,10X,5A,10X,4A 
590 PRINT @3,32: USING 600: 
561 
600 I MAGE 11 < 11 - 11 ) , 7}{, 4 ( 11 - 11 > , 1 ox, 5 < 11 - 11 ) , 10}{, 4 ( 11 - 11 > 
610 f.:ETURN 
620 NE}<T I 
630 PAGE 
640 PF~INT "ENTER NO. OF DATA POINTS" 
650 INPUT N1 
660 PRINT "ENTER PLASMA SAMPLE VOLUME<ML>" 
670 INPUT V3 
680 PRINT "ENTER TOTAL PLASMA VOLUME(ML):"; 
690 INPUT V1 
700 PRINT "K +-"; 
710 INPUT V5 
720 PAGE 
730 PRINT "I 11 ; 
740 PRINT "PLASMA DATA" 
750 GOSUB 150 
760 FIND 13 
770 PRINT 1~3,3z: 11 L" 
780 PRINT @3,32: USING 790:ZS 
790 IMAGE40X,30A 
800 GS="FINAL PLASMA READINGS" 
810 PRINT @3,32: USING 840:GS 
820 MS="FILE:13" 
830 PRINT @3,32: USING 840:M$ 
840 IMAGE"J",40X,30A 
850 GOSUB 530 
860 N=11 
870 FOR I=1 TO Nl 
880 B<I>=B<I>*V1/V3 
890 C<I>=B<I>*(C(I>•2+(V5/V1>•2>•0.5 
900 PRINT @33: USING 910:N,A(I),B(I),C(I) 
910 IMAGE3D,9X,60.6D,2CX,70.6D> 
920 PRINT @3,32: USING 930:N,A(I),B(I),C(I) 
930 IMAGE"J",30,9X,60.60,2(X,70.60) 
940 NEXT I 
950 PRINT "ENTER E.C.F. VOLUMECML):"; 
960 INPUT V2 
970 PRINT "K +-"; 
980 INPUT V4 
990 FIND 14 
1000 PRINT 113,32:"L" 
1010 PRINT @3,32: USING 1020:zs 
1020 IMAGE40X,30A 
1030 MS="FILE:14" 
1040 PRINT @3,32: USING 1070:M$ 
1050 HS="FINAL E.C.F. READINGS" 
1060 PRINT @3,32: USING 1070:H$ 
1070 IMAGE"J",40X,30A 










1170 PRINT @JJ: USING 910:N,A<I>,B<I>,C<I> 
1180 PRINT @3,32: USING 930:N,ACI),B(I),C(I) 




CALCULATION OF ACCUMULATIVE %INGESTED DOSE IN URINE 
100 REM CALCULATION OF %I.D. IN ACCUMULATIVE URINE 
110 DIM A<15) ,8(15) ,C(15) ,D<15) ,E(11) ,F(11) ,GC4) ,H<4> 
120 PRINT "SUBJECT IDENTIFICATION NO. ?" 
130 INPUT Z$ 
140 GO TO 630 
150 PRINT "I"; 
160 PRINT "%I.D. IN STANDARD="; 
170 INPUTS 
180 A$= 11 TIME 11 
190 B$= 11 BACKGROUND 11 
200 C$= 11 STANDARD 11 
210 D$= 11 SAMPLE" 
220 PRINT USING 2JO:A$,B$,C$,O$ 
230 IMAGE4A,13X,10A,8X,8A,10X,6A 
240 PRINT USING 250: 
250 IMAGE4< 11 - 11 ) ,1JX,10( 11 -
11
) ,8X,8( 11 -") ,lOX,6("- 11 ) 
260 FOR I=l TO N1 
270 INPUT Tl 
280 PRINT "KI"; 
290 INPUT e.1 
300 PRINT II KI /"; 
310 INPUT T2 
320 PRINT "KII"; 
330 INPUT S1 
340 PRINT II KII /"; 
350 INPUT T3 
360 PRINT 11 KIII"; 
370 INPUT S2 
380 PRINT II KIII /"; 
390 INPUT T4 













530 P$= 11 COMPARTMENT 11 
540 Q$= 11 TIME 11 
550 R$= ";! I . D, 11 
560 S$= 11 S.0. 11 
570 PRINT @3,32: USING 580:P$,Q$,R$,S$ 
580 IMAGE 11 J 11 ,11A,7X,4A,10X,5A,10X,4A 
590 PRINT @3,32: USING 600: 
564 
6 0 0 IM AGE 11 ( II - II ) , 7 ){ , 4 ( 11 - 11 ) , 10 }{ , 5 ( 11 - 11 ) , 1 0 ){ , 4 ( 11 - 11 ) 
610 f.:ETUF.:N 
620 NEXT I 
630 PAGE 
640 PRINT "ENTEi-: NO. OF DATA POINTS" 
650 INPUT Nl 
660 PRINT "ENTER 24HR. URINE VOLUMES" 
670 Ul=O 
680 FOR I=1 TO Nl 
690 UZ=24+U1 
700 PRINT USING 710:Ul,UZ; 
710 IMAGE3D, 11 - 11 ,3D,":" 
720 INPUT U3 
730 D(I)=UJ 
740 U1=U1+24 
750 NE}<T I 
760 PAGE 
770 PRINT 11 I"; 
780 PRINT "URINE DATA" 
790 GOSUB 150 
800 FIND 16 
810 PRINT @J,32:"L" 
820 PRINT @3,32: USING 8JO:Z$ 
830 IMAGE40X,30A 
840 M$="FILE:16" 
850 PRINT @3,32: USING 880:M$ 
860 K$= 11 FINAL URINE READINGS" 
870 PRINT @3,32: USING 880:K$ 
880 IMAGE"J",40X,30A 









980 PRINT @33: USING 990:N,ACI),E(I+U,F<I+l) 
990 IMAGE3D,9X,60.60,2(X,7D.60) 
1000 PRINT @3,32: USING 1010:N,A<I>,E<I+l),F(I+l) 
1010 IMAGE"J",30,9X,60.60,2(X,70.60) 




AREA UNDER MODIFIED GAUSSIAN FUNCTION 
100 REM CALCULATION OF AREA UNDER MOD. GAUSSIAN FUNCTION 
110 DIM A(100),P(10) 
120 PAGE 
130 PRINT ''CALCULATION OF AREA UNDER MOD. GAUSSIAN FUNCTION" 
140 PRINT USING 150: 
150 IMAGE6X,45("-") 
160 PRINT "J" 
170 PRINT "ENTER START CHANNEL:"; 
180 INPUT S9 
190 PfUNT "J" 
200 PRINT "ENTER FINISH CHANNEL:"; 
210 INPUT F9 
220 PIUNT "J" 
230 PRINT "ENTER NO. OF PARAMETERS:"; 
240 INPUT N9 
250 PRINT "J" 
260 FOR I=l TO N9 
270 PRINT" F'(";I;")="; 
280 INPUT }<9 
290 P<I>=X9 
300 NE}<T I -
310 I=1 
320 A(l>=O 
330 IF S9=F9 THEN 440 
340 X1=S9 
350 GOSUB 490 
360 Y2=Y1 
370 X1=S9+1 





430 GO TO 330 
440 PRINT "J" 
450 PRINT "AREA="; 
460 PRINT USING 470:A(I),A(I)+0.5 




510 Y1=P<1>*<1+Z2*<Z1+P(J>+Z1+P(4>>>*EXPC-(Z1+2)/(2*P(5)+2) I 
520 RETURN 
566 
E.2 List of FORTRAN V programs 
E.2.1 Conversion of profile scan data (ASCII) to binary data . 
E.2.2 Savitzky filter and Iinuma and Nagai image restoration 
(Binary data ) 
E.2.3 Subtraction of profile scans (Binary data) 
567 
TABLE:E.2.1 






















































31 FORMAT(/' LAST TAG CA6)-C"RETURN" IF NEW FILE> : '/) 
READCICR,9) TAGC1> 
9 FORMAT CA6) 
WRITECILP,32) 
32 FORMAT(//' INPUT TAG,NCHAN CA6,I4)-C"RETURN" TO END> 
, I > 
IF CTAG(l).EQ,NULL> GO TO 1 
10 CALL NTRAN CIDIS,2,12,REF,J> 
IF CJ.EQ.-1) CALL NTRAN CIDIS,22) 
IF CJ.LE.-ZJ GO TO 20 
CALL NTRAN CIDIS,2,4096,IDAT,K) 
IF CK.EQ,-1) CALL NTRAN CIDIS,22> 
IF (K.LE.-2) GO TO 20 
IFCTAG(1).NE.REFC1)) GO TO 10 
1 READ CICR,6) REFC1),NCHAN 
6 FORMATCA6,I4) 
IF CNCHAN.EQ.OJ GO TO 7 
IF (NCHAN.LT.0) CALL DIGIT CNCHAN) 
IF( NCHAN.GT.OJCALL INTAP CREFC1J,NCHANJ 
NCHAN=IABSCNCHAN) 
II=NCHAN+l 
DO 2 I=II,4096 
2 IDAT<IJ=O 
-CALL DISOUT (REF) 
WRITE <ILP,8) REF<l> 
8 FORMAT (15X,A6,' TRANSFERRED TO DISC') 
GO TO 1 
20 WRITE IILP,11> J,K 
11 FORMAT C///8X,'MAIN'/,8X,'J=',I6/8X,'K=',I6) 
7 CALL NTRAN <IDIS,10) 
WRITECILP,5> 






























IF(Ll.EQ.-1) CALL NTRAN<IDIS,22) 
IF<LL.LE.-2) GO TO 2 
CALL NTRAN<IDIS,1,4096,IDAT,MM> 
IF(MM.EQ.-1) CALL NTRAN<IDIS,22) 
IF<MM.LE.-2) GO TO 2 
"'.ET URN 
WRITE CILP,2001) Ll,MN 

















































DIMENSION TDATA(6) ,T~;HAF'E<6) ,TITLE(12) ,DIT(4096), A(20 
0),STD(200) 
DIMENSION JDAT(4096) 
COMMON /TAPIN/ IDAT(4096) 
COMMON ICJ.:, ILP 
INTEGER TIT,TSHAPE,TOATA,TAG 
DATA TIT,ICR,ILP/6H ,5,6/ 










IF CTSHAPE.EQ.TIT) GO TO 33 
NS=ISTOP-ISTART+l 
NINT=NS/2 
DO 13 I=l,200 
13 STDCI)=fJ.O 
IF (TAG.NE.TIT) CALL INTAP<TAG,12,2) 
CALL INTAPCTSHAPE(l),11,2) 
DO 813 I=l,4096 
IDAT(I)=IDAT(I)-IBGLSR 
813 IF(IDAT(Il.LT.0) IDATCI)=O 
IF(NSMOO.GT.0) CALL SMOOTH(NSPT,NSM00,4096,ISTART,ISTO 
P> 
TOT=O 





2 FORMATC1H1,':, ,3X,6A6,//,1X, ,·rAG= 1 ,A6,1X, 'IBGLSR=' ,I5 
1 3X, 'ISTART=' ,I4,3X, 'ISTOP=' ,I4, 
* 3X, 'NSPT=' ,I2,3X, 'NSMOO=' ,I2,//, 
2 6X,'TOTAL COUNTS IN STANDARD PEAK=',F11.1,///,6X,' 
CHAN 1 , 
3 6X,'IDAT', 9X,'X',10X,'STD',/) 
DO 32 I=ISTART,ISTOP 
J=I-ISTART+1 
STDCJ)= DITCI)/TOT 
32 WRITE(ILP,3) I,DITCI),J,STD(J) 
3 FORMAT(I10,F10.1,I10,F13.4) 

























































DO 814 I=l,III 
814 JDATCI+ISHIFT)=IDAT<I)-IBGDAT 
DO 815 I=l,4096 
IDAT(I)=JDAT(I) 
815 IFCIDAT<I>.LT.O> IDAT<I>=O 
WRITECILP,91)TDATA,IBGDAT,ISHIFT,ITR,NBLK,IBEG,IFIN, N 
DPT,NDSMO 




* 'ITR=' ,I3,3}<, 'NBLK=' ,I3,3}<, 
1 'IBEG=' ,I4,3X, 'IFIN=' ,I4,3X, 'NDPT=' ,I2,3}{, 'NDSMO=' ,I2
 
,3X) 
95 FORMAT(///,'-----------------' ,A6, ' -----------------
--
- ' , I > 
WRITE<ILP,92)(JK,JK=1,ITR> 
92 FORMAT(11}{, '0' ,15I7> 
WRITE < IL P , 2111 > 
2111 FORMAT( I) 




DO 717 I=IFINl,4096 
IDAT(I)=O 
717 DIT(I)=O.O 













DO 392 I=1,NCHAN 
392 DIT(I)=FLOATCIDATCI)l 














































DO 35 J=IBEG,IFIN 
0=0.0 
DO 37 K=l,NS 
L=J+NS1-K+<IT-1>*NCHAN 
IF<L.GT.LTOP) GO TO 37 














DO 67 I=IBEG,IFIN 
67 WRITE(ILP,18)I,<IDAT((J-1>*NCHAN+I),J=1,ITR1> 
18 FORMAT<1H ,I4,16I7) 
WRITE (ILP,171) 
171 FORMAT(1H1,':' ,1X, 'IT' ,5X, 'SSMOO' ,7}{, 'SRAW' ,3X, 'SSM
OO-
SRAW' ,3}<, 
1 'CHI SQ' , 7X, 'H' , 5X, 'H-S~;MOO' , / / > 
DO 17 !=1,ITR 
C=A(I)-SSMOO . 
17 WRITE(ILP,19)I,SSMOO,SRAW,DIFF,CHISQ,A(I),C 
19 FORMAT(1H ,I3,2E11.4,2E10.1,E10.4,E10.1) 
CALL INTAP(TITLE(i),12,1) 
WRITE (ILP,283)TITLE(1) 
283 FORMAT(////,5X,A6,' WRITTEN ON DISC',////) 
GO TO 111 
99 WRITE<ILP,284) 
284 FORMAT(//////SX,'END OF OPERATION'///) 
CALL DISLIS(12> 








































































DO 4 I=l,4096 
4 DATA<I>=FLOAT<IDAT<I>> 
ISMOV=O 















































































4 FORMAT ( I 1X,' REFOAT REFLST ' l 
READ <ICR,2) REFDAT,REFLST 
2 FORMAT C1X,2CA6,1Xl> 











IF (J.EQ.1) NCHAN=4096 
NSTART=CN-1>*NCHAN 
00 7 K=1,J 
KCH=CK-1>*NCHAN 














1 FORMAT(1X,A6,' TRANSFERRED TO DISC') 
IF(JJ.EQ.2) GO TO 9 
JJ=2 











































2 FORMATC1H1,/' SPECTRA FOUND'/) 
CALL NTRAN CIDIS,10,22) 
1 CALL NTRANCIDIS,2,12,NAME,M) 
IFCM.EQ.-1> CALL NTRANCIDIS,22) 
IFCM.LE.-2) GO TO 4 
N=N+l 
CALL NTRANCIDIS,2,4096,IDAT,L) 
IF CL.EQ.-1) CALL NTRAN CIDIS,22) 
IF CL.LE.-2) GO TO 4 
WRITE CILP,3> N,NAME(l) 
3 FORMATC1X,I3,4X,A6) 
IFCN.GT.1000) RETURN 
GO TO 1 
4 WRITE<ILP,5)M,L 
2·3 APR 19B1 
5 FORMATC//B}(, 'DISLIS' / ,BX, 'M=', I6, / ,BX, 'L=', I6!) 
RETURN 
END 
2 2 JA 1981 
" 
SUBJECT: D.W. EXPERIMENT KINETIC 1 
T=0,23hrs T=3,25hrs T = 5, 25 hrs 
T=10,25hrs T =15, 35 hrs T= 24 hrs 













SUBJECT KB EXPERIMENT KINETIC 2 
T=_O, 20 hrs T=3,12hrs T=S,12 hrs 
L· 
T=1 0,65hrs T= 16,00 hrs T=24 hrs 
T=4Bhrs 
LIVER --I--












SUBJECT: O.W. EXPE RIMENT: KINET IC 2 
T = 0,13 hrs T = 3,23 hrs 
&.'' • :I -~ . ' ·' .~: 
T=10,12 hrs T =16,15 hrs 
T=4E3 hrs 
LI VER --.&---
TRANSVERSE \ 'r. 
COLON 
DUODENUM 












SUBJECT JB. EXPERIMENT KINETIC 1 
T=0,20 hrs T = 3,00 hrs T = 5,50 hrs 
T = 10,17 hrs T = 2 4 hrs 
T= 4f3 hrs T=72hrs T= 96 hrs 
LIVER--~-
TRANSVERSE 1 'l~ 
COLON 
DUODENUM 








SUBJECT JB. EXPER IMENT KINETIC 2 
T=0.22hrs T=3,22hrs T = 5,25 hrs 
1= 10,15 hrs T=16,0U hrs T = 2 4 hrs 
T= 4t3 hrs T=72 hrs T= 96 hrs 
LI VER --I---
~JEJUNUM 
TRANSVERSE 1 '/A?'. 
COLON 
DUODENUM 







SUBJECT : G.E. EXPERIMENT • KINETIC 1 
T=0,30hrs T=2,5Bhrs T= 5,58 hrs 
T= 10, 22 hrs T=24hrs 
T=4E3hrs T= 72 hrs T=96hrs 
LIVER--+--











SUBJ ECTG.E. EXPER IMENT KINET IC 2 
T= 0,5 hrs T= 3, 12 hrs 
T= 10,1 7 hrs T= 16,50 hrs T= 24 hrs 
T= 4B hrs T= 72 hrs T=96hrs 
LI VER --t---











SUBJECT : B.C. EXPERIMENT : KINET IC 1 
T = 0,32 hrs T= 3,30 hrs T= 5,43 hrs 













SUBJECT: B.C. EXPERIMENT= KINETIC 2 
T=0,33hrs T= 3, 25 hrs T= 5,34 hrs 
T=10,32 hrs T=16,12 hrs T= 24 hrs 
T= 4B hrs 
LIVER----
TRANSVERSE \ 'J:it::< 
COLON 
DUODENUM 
ASCENDING--+-
COLON 
CAECUM--t--
~~JEJUNUM 
DESCENDING 
COLON 
-r--- RECTUM 
ILEUM 
